data_1m30_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1m30 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.547 0.213 . . . . 0.0 111.019 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.505 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 11.4 m -129.24 154.72 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 4.5 ptp180 -131.76 142.1 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.13 . . . . 0.0 110.24 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.979 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -94.36 129.72 40.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 109.295 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.498 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -116.51 25.63 10.46 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 0.0 109.319 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.6 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.6 -10.2 1.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.457 1.098 . . . . 0.0 111.032 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.521 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 55.03 159.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.3 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.673 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 24.4 t80 . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.494 1.121 . . . . 0.0 110.962 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.501 ' OD1' ' CZ3' ' A' ' 169' ' ' TRP . 19.1 m-20 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.563 ' O ' ' CG2' ' A' ' 182' ' ' ILE . 0.7 OUTLIER -69.4 115.77 35.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.469 1.106 . . . . 0.0 109.275 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.442 ' N ' HD11 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.98 121.21 6.44 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.455 1.766 . . . . 0.0 111.016 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.692 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 36.2 p90 -127.82 175.09 8.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.474 1.109 . . . . 0.0 110.994 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.464 ' CD ' ' HE2' ' A' ' 155' ' ' LYS . 5.7 mttt -115.49 -177.94 3.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 0.0 109.292 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.521 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -80.21 49.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.544 1.153 . . . . 0.0 109.28 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.979 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 147.43 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.132 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.602 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 14.1 t0 -89.7 155.07 19.46 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 0.773 . . . . 0.0 109.244 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.472 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 1.3 mp -105.42 141.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.508 1.13 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.52 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -149.3 -179.39 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.318 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.581 ' HG2' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -133.12 143.13 49.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.581 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 1.0 OUTLIER -87.2 117.34 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -107.89 -48.81 3.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 0.0 110.33 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.96 167.63 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 0.0 109.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -155.1 84.3 3.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.554 1.159 . . . . 0.0 109.305 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -45.76 0.26 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.509 1.794 . . . . 0.0 110.989 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -99.78 -173.26 2.41 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.496 1.123 . . . . 0.0 110.268 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.71 -32.21 8.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.471 1.107 . . . . 0.0 110.344 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.554 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 6.3 tt0 -89.46 -33.07 16.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.554 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.4 m95 -110.68 132.07 54.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 108.041 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.53 ' CD2' ' CG2' ' A' ' 184' ' ' VAL . 42.4 m0 -119.04 144.31 46.62 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 0.0 109.262 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -105.11 160.3 15.17 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 0.0 109.244 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.486 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 2.9 mt-10 -108.69 132.5 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.51 1.131 . . . . 0.0 110.271 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.412 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 7.5 t70 -74.15 163.53 27.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 0.0 109.318 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.5 m -53.92 -18.75 3.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.65 -22.35 37.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.501 1.125 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.85 31.03 6.83 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.508 1.13 . . . . 0.0 110.976 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 ptpp? -99.8 122.42 42.75 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 0.771 . . . . 0.0 109.315 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.486 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.0 mtm180 -85.98 112.92 21.66 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.533 1.146 . . . . 0.0 110.334 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.8 159.45 28.09 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.422 1.076 . . . . 0.0 110.991 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.6 mtm -87.55 141.16 28.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 0.775 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.563 ' CG2' ' O ' ' A' ' 151' ' ' LEU . 2.2 pp -142.91 163.17 39.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.473 1.108 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.587 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 136.57 20.55 Favored 'Trans proline' 0 C--N 1.361 1.184 0 O-C-N 124.484 1.781 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.846 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 36.7 t -80.54 -30.7 0.59 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.846 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.03 -21.19 16.05 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.488 1.783 . . . . 0.0 111.008 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -93.99 8.25 42.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 0.0 111.008 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.528 HG12 ' CB ' ' A' ' 139' ' ' ALA . 1.7 m -148.57 176.02 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.29 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -140.65 -169.17 2.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 110.287 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.401 ' O ' ' OE1' ' A' ' 188' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 0.0 109.276 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 42.0 m-85 . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.475 0.178 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.496 HG22 ' CD1' ' A' ' 161' ' ' ILE . 22.4 m -135.92 152.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 0.0 109.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -124.14 144.15 50.07 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 0.0 110.358 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 1.067 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.13 118.53 37.09 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 0.0 109.309 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.488 ' CD1' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -111.9 32.67 5.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.644 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -138.92 -13.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.519 1.137 . . . . 0.0 111.038 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 54.04 156.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.372 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.704 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.471 1.107 . . . . 0.0 111.047 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 43.2 m-20 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.541 HD11 ' CD2' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -56.68 106.96 0.75 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 109.294 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 150' ' ' ASP . 18.2 Cg_endo -74.94 121.68 6.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.53 1.805 . . . . 0.0 111.015 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.704 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 31.9 p90 -124.77 162.64 23.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.414 1.071 . . . . 0.0 110.98 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.419 ' C ' ' HA ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -108.31 -175.95 2.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 0.0 109.35 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.536 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -84.56 68.4 10.32 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 0.0 109.346 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 1.067 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.7 32.79 0.63 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.557 1.161 . . . . 0.0 111.005 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 9.0 t0 -83.3 161.8 21.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 0.779 . . . . 0.0 109.312 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.491 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 9.1 tp -121.01 129.24 75.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.401 1.063 . . . . 0.0 109.334 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.541 ' CD2' HD11 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -145.95 169.65 18.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.563 1.164 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 2.9 mtt85 -118.42 149.38 41.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.578 1.174 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' HG22 ' A' ' 137' ' ' VAL . 1.1 mp -91.95 119.52 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.421 ' NH1' ' CD ' ' A' ' 179' ' ' ARG . 39.2 ttt180 -101.6 -46.66 4.89 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 110.274 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -149.49 176.16 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.271 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.93 104.82 0.56 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.56 1.162 . . . . 0.0 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -46.09 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.522 1.801 . . . . 0.0 111.015 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -93.9 -175.07 3.61 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.539 1.149 . . . . 0.0 110.299 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.33 7.95 23.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 0.0 110.326 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -118.59 -45.13 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.521 ' CG ' ' HE3' ' A' ' 181' ' ' MET . 69.2 m95 -101.6 134.53 44.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 108.049 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.463 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 30.6 m0 -118.03 132.46 56.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 108.01 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 t-20 -83.73 95.2 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.307 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -109.59 162.93 13.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -109.39 137.9 46.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.481 1.113 . . . . 0.0 110.276 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.458 ' CG ' HD11 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -79.83 161.81 25.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.4 p -51.2 -20.88 1.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.115 . . . . 0.0 109.989 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -78.92 -28.15 43.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.12 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 103.99 31.23 4.83 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.48 1.112 . . . . 0.0 111.042 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -101.7 121.73 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.469 0.747 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.421 ' CD ' ' NH1' ' A' ' 162' ' ' ARG . 7.4 mtt85 -87.41 115.83 25.1 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.69 172.74 28.81 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.559 1.162 . . . . 0.0 111.024 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.521 ' HE3' ' CG ' ' A' ' 169' ' ' TRP . 3.6 ptm -87.55 127.5 35.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 0.743 . . . . 0.0 110.985 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.528 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 10.9 tt -124.53 142.31 40.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 0.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.571 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 135.24 18.78 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.452 1.764 . . . . 0.0 110.974 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.9 t -77.21 -31.46 0.87 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.05 -33.11 4.78 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.563 1.823 . . . . 0.0 110.961 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.644 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -89.99 18.42 5.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.967 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 13.1 m -149.36 177.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 140' ' ' LEU . 2.3 mt-10 -138.04 -161.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.548 1.155 . . . . 0.0 110.243 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.6 tptt . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.229 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 62.5 m-85 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.456 0.17 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.19 160.87 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.588 1.18 . . . . 0.0 109.231 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.599 ' O ' ' N ' ' A' ' 188' ' ' GLU . 8.5 tpp85 -126.64 128.27 46.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 0.0 110.316 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.947 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.3 119.64 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.428 1.08 . . . . 0.0 109.363 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.441 ' CD2' ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -125.3 26.87 6.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.31 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' ' CZ ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -134.15 -21.16 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.419 1.074 . . . . 0.0 111.049 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.432 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 1.6 t70 58.79 155.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 109.34 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.653 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 0.0 110.968 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.447 ' OD2' ' CE2' ' A' ' 143' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.512 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 1.7 tp -93.88 118.91 67.36 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.471 1.107 . . . . 0.0 109.279 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 126.15 9.75 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.478 1.778 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.653 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 38.8 p90 -127.55 169.96 13.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.451 1.094 . . . . 0.0 111.06 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.95 178.19 4.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 0.0 109.287 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.587 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -80.62 51.75 1.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.947 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 149.82 35.23 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.547 1.154 . . . . 0.0 110.965 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -94.89 162.07 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.5 0.765 . . . . 0.0 109.36 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.484 ' CD1' ' CZ ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -118.47 122.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 0.0 109.285 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -131.13 -179.63 5.45 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.519 1.137 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 2.5 ptp85 -133.02 155.22 49.58 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -93.84 116.72 35.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 0.0 109.296 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -100.64 -49.08 4.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.452 1.095 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.75 174.32 12.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.18 118.53 8.47 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.465 1.103 . . . . 0.0 109.269 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -52.37 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.469 1.773 . . . . 0.0 110.984 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -127.76 -98.8 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.597 1.186 . . . . 0.0 110.291 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.83 -44.52 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.31 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -57.43 -43.58 83.96 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -118.89 144.22 46.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 0.0 108.052 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.536 ' CE2' HG23 ' A' ' 184' ' ' VAL . 46.5 m0 -118.14 145.26 45.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 107.976 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -87.19 86.18 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.528 1.143 . . . . 0.0 109.357 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -98.83 168.02 10.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 0.0 109.264 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -115.35 140.34 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 0.0 110.319 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.502 ' OD2' ' CD1' ' A' ' 151' ' ' LEU . 2.1 t0 -78.08 159.96 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.265 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -21.29 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.503 1.127 . . . . 0.0 110.0 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.8 -28.51 33.14 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.387 1.054 . . . . 0.0 110.254 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.04 30.62 3.6 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 124.452 1.095 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 mmmt -95.01 117.31 29.94 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.406 0.71 . . . . 0.0 109.238 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.475 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -85.17 111.85 20.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 0.0 110.296 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.61 167.58 30.37 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.47 1.106 . . . . 0.0 110.977 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 ptp -88.52 138.62 31.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 0.778 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 6.8 pt -134.86 164.18 45.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.613 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.9 143.64 29.66 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.443 1.76 . . . . 0.0 111.044 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.765 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 55.1 t -79.54 -35.86 1.02 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.765 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -67.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.586 1.835 . . . . 0.0 111.021 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.75 ' CZ ' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -38.82 -26.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.451 1.094 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 2.9 m -117.33 169.65 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.541 1.151 . . . . 0.0 109.268 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.599 ' N ' ' O ' ' A' ' 138' ' ' ARG . 2.6 mt-10 -125.07 -161.25 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.448 1.092 . . . . 0.0 110.365 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.518 0 O-C-N 124.467 1.105 . . . . 0.0 109.282 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.474 0.178 . . . . 0.0 110.978 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 188' ' ' GLU . 2.0 m -128.91 169.62 19.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.8 ptp180 -132.07 174.63 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 153' ' ' PHE . . . -134.13 92.04 2.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 0.0 109.338 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.507 ' CD1' ' HG3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -92.41 16.82 10.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 1.105 . . . . 0.0 109.292 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.657 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -126.79 -13.98 5.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.448 1.093 . . . . 0.0 111.038 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.7 158.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 0.0 109.327 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.65 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 28.7 t80 . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.542 1.151 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 1.2 tp -63.69 116.8 29.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 0.0 109.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.423 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 132.39 15.27 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.5 1.789 . . . . 0.0 110.974 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.65 ' CE1' ' CB ' ' A' ' 143' ' ' PHE . 13.4 p90 -142.36 155.53 45.16 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -165.58 146.57 7.07 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.608 1.193 . . . . 0.0 109.3 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.449 ' HA ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 61.29 78.24 0.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 0.0 109.336 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 33.4 47.1 0.39 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.508 1.13 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.735 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 42.4 t0 -39.91 161.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.313 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.453 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 2.1 mm -126.56 116.52 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.533 ' CD2' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -138.03 -176.04 4.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 109.294 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.56 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 2.8 ptp180 -131.76 147.69 52.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -87.18 117.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.507 1.129 . . . . 0.0 109.306 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.511 ' NE ' ' CZ ' ' A' ' 179' ' ' ARG . 3.2 ttt180 -103.33 -48.13 4.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 0.0 110.354 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.78 165.27 30.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 109.34 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 103.28 3.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.482 1.114 . . . . 0.0 109.255 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.423 ' CD ' ' HE1' ' A' ' 181' ' ' MET . 18.2 Cg_endo -75.05 -57.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -107.39 -173.27 2.25 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.468 1.105 . . . . 0.0 110.307 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.39 18.16 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.441 1.088 . . . . 0.0 110.303 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -114.22 -48.8 2.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.532 1.145 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.422 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 52.7 m95 -119.29 137.95 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 108.03 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.556 ' CD2' ' CG2' ' A' ' 184' ' ' VAL . 43.7 m0 -114.81 144.95 42.68 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.521 1.138 . . . . 0.0 108.005 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -94.29 95.14 8.72 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 0.0 109.297 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -107.36 163.51 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 179' ' ' ARG . 2.2 mt-10 -108.44 141.07 40.84 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.539 1.149 . . . . 0.0 110.269 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.464 ' CB ' ' HE2' ' A' ' 178' ' ' LYS . 3.9 t70 -83.89 164.62 19.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 94.6 p -51.79 -21.04 2.5 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.153 . . . . 0.0 109.972 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.04 -28.12 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.485 1.115 . . . . 0.0 110.292 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 104.59 32.14 4.3 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.479 1.112 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.464 ' HE2' ' CB ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -103.1 118.97 37.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 0.745 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.511 ' CZ ' ' NE ' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -86.71 115.38 24.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.49 1.119 . . . . 0.0 110.32 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.52 164.74 27.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.513 1.133 . . . . 0.0 111.022 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.423 ' HE1' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -87.14 137.63 32.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.454 0.738 . . . . 0.0 110.998 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.546 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 28.1 pt -139.18 158.71 68.77 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 0.0 109.352 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.627 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.0 139.56 24.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.527 1.803 . . . . 0.0 111.068 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.5 t -78.5 -32.05 0.81 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.241 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -33.3 4.76 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.541 1.811 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.657 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -91.52 26.13 2.4 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.16 . . . . 0.0 111.01 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 22.9 m -151.69 168.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.157 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.512 ' HB2' ' CG ' ' A' ' 138' ' ' ARG . 3.2 mt-10 -139.91 -162.23 1.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.321 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.404 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.507 1.13 . . . . 0.0 109.3 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 1.9 m-85 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.452 0.168 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.47 ' CG1' HD13 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -127.43 157.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.154 . . . . 0.0 109.273 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.9 OUTLIER -116.56 147.28 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.309 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.9 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.88 93.74 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 0.0 109.268 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.509 ' CD1' ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -107.61 37.65 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.565 1.165 . . . . 0.0 109.368 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.77 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 1.5 m-85 -142.53 -17.73 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.44 1.088 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 55.13 160.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.555 1.159 . . . . 0.0 109.364 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.647 ' HB3' ' CE2' ' A' ' 153' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.525 0 O-C-N 124.511 1.132 . . . . 0.0 111.006 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.469 ' CD1' ' HD2' ' A' ' 152' ' ' PRO . 5.9 tp -73.52 114.08 28.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 0.0 109.307 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.469 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 120.87 6.22 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.477 1.777 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.647 ' CE2' ' HB3' ' A' ' 143' ' ' PHE . 48.4 p90 -130.32 167.89 17.78 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.516 1.135 . . . . 0.0 110.997 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -114.83 172.8 6.82 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 109.293 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.451 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -78.5 83.26 4.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 0.0 109.337 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.9 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.33 20.73 1.74 Allowed Glycine 0 CA--C 1.529 0.916 0 O-C-N 124.488 1.117 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 19.5 t0 -85.31 155.42 21.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.415 0.715 . . . . 0.0 109.353 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.463 HG13 ' NH2' ' A' ' 138' ' ' ARG . 1.8 mp -117.12 130.81 71.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 109.275 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -137.7 -178.87 5.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 0.0 109.263 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 1.7 mtm105 -131.24 145.86 52.08 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.508 1.13 . . . . 0.0 110.246 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.47 HD13 ' CG1' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -88.01 117.76 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.13 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.7 tpp85 -108.48 -48.04 3.4 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 0.0 110.317 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -145.94 -176.4 5.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 109.295 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -176.54 109.16 0.24 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -53.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.526 1.803 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -100.78 -169.85 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.489 1.118 . . . . 0.0 110.286 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.56 -34.0 9.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -73.07 -46.24 52.7 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 0.0 110.263 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.19 137.95 45.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.687 ' O ' ' HA ' ' A' ' 181' ' ' MET . 22.7 m0 -116.92 176.44 5.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 107.983 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -124.53 98.62 5.81 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -115.49 164.66 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 0.0 109.275 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -106.31 138.45 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.539 1.15 . . . . 0.0 110.263 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.496 ' O ' ' NH2' ' A' ' 160' ' ' ARG . 9.9 t0 -80.69 161.72 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 0.0 109.279 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.7 t -51.09 -21.36 1.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.559 1.162 . . . . 0.0 110.022 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -78.44 -23.63 46.49 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.574 1.171 . . . . 0.0 110.384 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 97.59 31.93 6.52 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.513 1.133 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -103.24 126.63 50.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 0.746 . . . . 0.0 109.317 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.441 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.8 mtp-105 -86.15 111.54 20.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 0.0 110.299 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -144.53 169.78 26.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.501 1.125 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.687 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 mtm -87.82 132.85 34.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.783 . . . . 0.0 111.015 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.546 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -128.22 151.09 75.7 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.46 1.1 . . . . 0.0 109.311 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.617 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.04 141.21 26.24 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.473 1.775 . . . . 0.0 110.964 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 65.0 t -80.78 -32.57 0.67 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.474 1.109 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -37.68 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.542 1.812 . . . . 0.0 111.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.77 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.2 m-85 -87.12 22.48 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.462 1.101 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.1 m -152.75 164.31 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.509 ' CG ' ' CD1' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -125.51 -161.82 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.459 1.099 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.451 1.095 . . . . 0.0 109.305 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.485 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 1.4 m-85 . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.519 0.199 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.503 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 17.2 m -145.33 147.17 18.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 109.289 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -127.17 136.44 52.07 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 0.0 110.285 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 1.001 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -91.17 138.17 31.8 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.481 1.113 . . . . 0.0 109.226 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.465 ' CD2' ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.98 19.6 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.539 1.149 . . . . 0.0 109.336 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.581 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -135.07 -4.7 2.41 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.4 OUTLIER 54.45 163.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 1.7 t80 . . . . . 0 C--N 1.324 -0.523 0 O-C-N 124.498 1.124 . . . . 0.0 111.043 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 143' ' ' PHE . 59.1 m-20 . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD13 ' N ' ' A' ' 152' ' ' PRO . 0.8 OUTLIER -77.35 119.6 78.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 0.0 109.319 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.442 ' N ' HD13 ' A' ' 151' ' ' LEU . 18.5 Cg_endo -74.92 121.58 6.7 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.463 1.77 . . . . 0.0 111.005 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.629 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 29.3 p90 -134.7 169.52 17.2 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.424 1.077 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.26 175.77 5.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.564 1.165 . . . . 0.0 109.263 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.593 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -78.48 83.4 4.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.573 1.171 . . . . 0.0 109.281 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 1.001 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.81 23.84 2.43 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.52 1.138 . . . . 0.0 111.013 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 27.8 t0 -84.82 158.15 20.75 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.508 0.769 . . . . 0.0 109.37 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.456 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 10.1 mm -111.12 140.54 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.453 1.095 . . . . 0.0 109.293 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.512 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -149.89 -172.8 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.488 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 4.2 mpp_? -137.53 156.88 47.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.255 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.486 ' CD1' ' HB3' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -98.93 115.14 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.12 . . . . 0.0 109.293 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.535 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 6.2 ptt85 -104.13 -43.85 5.14 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.555 1.16 . . . . 0.0 110.309 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.535 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -136.86 166.06 24.51 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.539 1.149 . . . . 0.0 109.267 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.27 88.13 2.61 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.371 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -43.86 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.481 1.78 . . . . 0.0 111.029 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.34 -170.59 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 0.0 110.358 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.81 -32.2 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.541 1.15 . . . . 0.0 110.28 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.98 -35.99 64.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.513 1.133 . . . . 0.0 110.277 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.495 ' CZ3' ' CG ' ' A' ' 150' ' ' ASP . 47.6 m95 -122.05 138.77 54.32 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.533 1.146 . . . . 0.0 107.962 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.653 ' CE3' ' CG2' ' A' ' 184' ' ' VAL . 29.5 m0 -120.35 143.8 48.2 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.515 1.134 . . . . 0.0 107.953 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 3.1 t-20 -88.63 92.99 9.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 109.26 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -106.0 166.19 10.67 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.535 1.147 . . . . 0.0 109.3 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.0 mt-10 -115.0 138.58 50.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 0.0 110.346 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 177' ' ' GLY . 3.1 t0 -77.18 160.63 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.519 1.137 . . . . 0.0 109.33 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.4 m -51.16 -21.25 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 0.0 110.038 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.85 -27.99 28.33 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.463 1.102 . . . . 0.0 110.298 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.68 29.64 3.8 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.443 1.089 . . . . 0.0 111.032 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -89.57 114.98 26.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.542 0.789 . . . . 0.0 109.334 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.523 ' CZ ' ' NH1' ' A' ' 162' ' ' ARG . 4.2 mtp180 -86.36 108.58 18.52 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 0.0 110.26 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.84 162.5 29.72 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.393 1.058 . . . . 0.0 110.986 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 5.9 mtm -88.67 147.28 24.6 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 0.75 . . . . 0.0 110.99 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.507 ' CD1' ' CD1' ' A' ' 159' ' ' LEU . 23.0 pt -148.8 163.36 26.14 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.0 138.42 23.01 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.439 1.757 . . . . 0.0 110.999 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.828 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 1.0 OUTLIER -79.81 -31.85 0.69 Allowed Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 0.0 109.365 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.828 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -10.79 21.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.518 1.799 . . . . 0.0 111.027 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.692 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -99.64 -4.52 30.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.501 HG13 ' CB ' ' A' ' 139' ' ' ALA . 0.9 OUTLIER -142.79 170.47 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 109.286 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -119.52 -171.6 2.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.601 ' NZ ' ' CZ3' ' A' ' 170' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 0.0 109.3 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.55 0.214 . . . . 0.0 110.989 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.487 ' CG2' HD13 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -127.73 159.43 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.416 1.073 . . . . 0.0 109.281 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.2 tpp85 -124.95 116.41 22.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.303 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.92 114.88 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 0.0 109.284 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.594 ' CD1' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.38 28.95 5.88 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.508 1.13 . . . . 0.0 109.296 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -139.72 -6.87 1.29 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 1.1 . . . . 0.0 111.023 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.578 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 50.42 165.35 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 0.0 109.309 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.61 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.459 ' CD2' HD22 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -106.83 116.26 59.01 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 0.0 109.31 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 143' ' ' PHE . 18.3 Cg_endo -75.04 121.32 6.49 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.469 1.773 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.618 ' CE1' ' HD2' ' A' ' 183' ' ' PRO . 18.1 p90 -119.42 -175.87 3.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 0.0 111.027 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.461 ' O ' ' HB1' ' A' ' 139' ' ' ALA . 8.3 tmtt? -140.52 164.04 31.23 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.115 . . . . 0.0 109.331 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -65.62 90.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.287 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 118.92 19.92 4.26 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.485 1.116 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.42 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 24.9 t0 -84.32 145.98 27.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 0.754 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.459 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 1.7 mp -111.85 124.67 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.436 1.085 . . . . 0.0 109.29 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.487 HD13 ' CG2' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -131.49 -174.95 3.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 0.0 109.309 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.602 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.1 147.67 46.21 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.525 1.14 . . . . 0.0 110.299 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.449 ' N ' ' HG3' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -86.35 118.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.237 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.6 ttt180 -103.52 -47.37 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 0.0 110.318 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 50.4 m-20 -148.75 158.46 44.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -127.69 85.4 60.87 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 0.0 109.33 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.427 ' CG ' ' HE2' ' A' ' 181' ' ' MET . 18.2 Cg_endo -75.02 -44.57 0.33 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.517 1.799 . . . . 0.0 110.983 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -109.21 -164.78 0.96 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 0.0 110.316 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -105.71 -55.42 2.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 110.283 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.413 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 15.3 pt20 -77.95 -26.26 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.542 1.151 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.564 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 72.5 m95 -106.98 133.19 52.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.483 1.115 . . . . 0.0 108.004 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.48 ' O ' ' CD1' ' A' ' 182' ' ' ILE . 7.9 m0 -125.76 141.86 51.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 0.0 108.027 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' A' ' 171' ' ' ASN . 9.6 t-20 -91.9 87.52 6.26 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.602 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -104.11 164.29 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.217 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.468 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 3.5 mt-10 -105.91 137.88 43.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.404 1.065 . . . . 0.0 110.323 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.37 167.93 20.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.584 1.178 . . . . 0.0 109.256 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.6 m -57.91 -15.93 10.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -84.67 -21.87 30.06 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 1.083 . . . . 0.0 110.316 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 99.23 28.41 7.67 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.495 1.122 . . . . 0.0 110.989 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -102.21 121.81 42.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.472 0.748 . . . . 0.0 109.283 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -85.21 114.42 22.31 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 110.259 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -145.64 174.52 25.59 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.533 1.146 . . . . 0.0 111.043 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.564 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -86.78 146.62 26.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 0.741 . . . . 0.0 110.972 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -148.79 145.43 19.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.423 1.077 . . . . 0.0 109.325 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.634 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.05 130.68 13.45 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.533 1.807 . . . . 0.0 111.015 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.835 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 16.9 m -74.47 -28.62 0.86 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.127 . . . . 0.0 109.255 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -13.93 21.35 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.434 1.755 . . . . 0.0 110.989 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.591 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.3 m-85 -96.52 -36.4 10.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 0.0 111.005 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 2.6 m -108.81 173.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.532 1.145 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.594 ' CG ' ' CD1' ' A' ' 140' ' ' LEU . 1.7 mt-10 -124.88 -159.69 0.9 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.447 1.092 . . . . 0.0 110.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 0.0 109.295 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 18.3 m-85 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.466 0.174 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.6 m -147.99 154.94 10.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.488 1.117 . . . . 0.0 109.257 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -133.6 144.68 49.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.542 1.152 . . . . 0.0 110.265 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.929 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.73 128.71 45.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.549 1.156 . . . . 0.0 109.303 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.563 ' CD2' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -120.0 22.03 11.63 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.43 1.082 . . . . 0.0 109.285 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -138.26 -10.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 110.976 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 55.45 154.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.551 1.157 . . . . 0.0 109.34 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.5 t80 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.962 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.502 ' CD2' HD23 ' A' ' 159' ' ' LEU . 1.4 tp -93.6 114.39 62.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.281 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.03 134.13 17.39 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.509 1.794 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.651 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 18.3 p90 -151.88 171.62 17.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 0.0 110.975 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -108.75 -171.03 1.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.339 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.536 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.79 34.25 0.6 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.459 1.099 . . . . 0.0 109.336 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.929 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.29 39.77 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.432 1.082 . . . . 0.0 111.091 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 3.8 m-20 -91.84 166.64 12.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 0.779 . . . . 0.0 109.332 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 138' ' ' ARG . 1.5 mp -128.09 134.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.586 1.179 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.502 HD23 ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -146.01 -178.16 5.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 0.0 109.291 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.578 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.47 146.5 52.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.102 . . . . 0.0 110.272 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.564 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 1.2 mp -83.94 124.32 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.526 1.141 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -100.22 -51.72 3.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 0.0 110.248 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -150.33 163.59 37.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.298 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.499 ' HE3' ' CG1' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -117.39 89.6 32.11 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.122 . . . . 0.0 109.294 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -35.6 3.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.469 1.773 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.15 -160.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.271 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.35 -49.46 2.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -82.39 -22.39 35.43 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.57 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 67.4 m95 -110.95 138.94 46.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 0.0 108.033 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -119.91 134.3 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 0.0 107.946 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.521 ' ND2' ' CE ' ' A' ' 181' ' ' MET . 27.9 t-20 -86.88 101.64 13.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.265 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -118.6 166.61 12.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 109.287 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.459 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 3.3 mt-10 -111.33 133.94 53.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.318 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -77.34 164.49 25.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 0.0 109.296 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 92.2 p -53.55 -18.98 3.25 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 0.0 109.992 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.03 -20.92 37.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.495 1.122 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.99 31.75 7.16 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.571 1.169 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -103.09 118.71 37.41 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 0.762 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.5 mtt85 -87.59 115.24 24.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.62 178.42 26.2 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.454 1.096 . . . . 0.0 111.065 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.57 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -85.96 136.39 33.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.524 0.779 . . . . 0.0 110.981 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.527 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 11.6 tt -131.67 142.38 45.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.576 1.172 . . . . 0.0 109.282 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.622 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 138.12 22.67 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.435 1.755 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.766 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.5 t -70.81 -36.07 4.96 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.128 . . . . 0.0 109.32 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.766 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.475 1.776 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.622 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -38.43 -27.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 0.0 110.981 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.573 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 1.3 m -118.84 177.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.423 1.077 . . . . 0.0 109.33 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.563 ' HG3' ' CD2' ' A' ' 140' ' ' LEU . 0.8 OUTLIER -135.5 -163.14 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 0.0 110.269 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.3 tptp . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.125 . . . . 0.0 109.24 -179.904 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.481 0.181 . . . . 0.0 110.981 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 31.6 m -124.39 141.06 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 0.0 109.308 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.551 ' O ' ' HB ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -97.53 -170.0 1.93 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -149.2 94.19 2.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.553 ' CD2' ' HG3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.75 33.53 1.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 109.311 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.7 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -136.74 -10.63 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 111.073 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.593 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 49.89 165.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.092 . . . . 0.0 109.365 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 111.075 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.513 ' HB3' ' CZ3' ' A' ' 169' ' ' TRP . 10.5 m-20 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.55 ' CD2' ' CD2' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -108.25 119.13 50.68 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.457 1.098 . . . . 0.0 109.309 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.412 ' N ' HD12 ' A' ' 151' ' ' LEU . 17.9 Cg_endo -75.07 121.32 6.48 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.527 1.804 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 143' ' ' PHE . 38.0 p90 -117.44 170.47 8.7 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.524 1.14 . . . . 0.0 111.032 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 139' ' ' ALA . 3.0 mptt -108.36 -179.96 4.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.449 1.093 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.497 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.99 85.62 7.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 109.272 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.33 23.21 2.68 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.445 1.091 . . . . 0.0 111.017 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.6 t70 -83.91 157.28 22.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.551 0.795 . . . . 0.0 109.338 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.4 mp -114.08 131.77 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.58 1.175 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.55 ' CD2' ' CD2' ' A' ' 151' ' ' LEU . 3.1 mp -144.48 133.92 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 0.0 109.271 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.576 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -91.58 143.36 26.65 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.423 ' CD1' ' HB3' ' A' ' 172' ' ' ALA . 1.1 mp -87.06 116.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.56 1.162 . . . . 0.0 109.295 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -109.28 -34.79 6.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.435 ' HB2' ' CD ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -138.64 155.72 48.06 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.554 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 6.5 ttpt -143.59 88.74 7.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 109.296 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.04 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.502 1.791 . . . . 0.0 110.978 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -101.18 -168.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 168' ' ' GLN . 21.4 pt-20 -105.44 -43.0 5.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.473 1.108 . . . . 0.0 110.344 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 167' ' ' GLU . 17.9 pt20 -62.86 -39.15 93.54 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.588 1.18 . . . . 0.0 110.326 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.513 ' CZ3' ' HB3' ' A' ' 150' ' ' ASP . 31.5 m95 -124.94 145.61 49.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.571 ' O ' ' HA ' ' A' ' 181' ' ' MET . 25.0 m0 -123.07 -179.61 4.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.68 104.23 7.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -123.92 167.55 13.97 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.4 1.062 . . . . 0.0 109.244 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.2 mt-10 -108.93 134.01 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.58 160.53 32.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.1 m -53.06 -19.83 3.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.122 . . . . 0.0 110.06 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.2 -26.81 35.66 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.565 1.165 . . . . 0.0 110.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.9 31.04 4.31 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.543 1.152 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.2 mmtp -99.56 121.07 40.66 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.547 0.793 . . . . 0.0 109.343 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.45 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 3.0 mtt85 -85.8 111.09 19.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 0.0 110.282 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.14 -175.52 20.86 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.559 1.162 . . . . 0.0 111.056 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -88.24 146.02 25.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.564 ' CG2' HG13 ' A' ' 187' ' ' VAL . 4.2 mp -139.62 145.14 42.14 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 182' ' ' ILE . 18.4 Cg_endo -75.05 152.49 40.59 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.477 1.777 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.4 t -87.05 -39.21 0.52 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.504 1.792 . . . . 0.0 110.963 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.7 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.4 m-85 -80.65 40.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.474 1.109 . . . . 0.0 111.019 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.564 HG13 ' CG2' ' A' ' 182' ' ' ILE . 18.2 m -155.63 164.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.579 1.174 . . . . 0.0 109.297 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.553 ' HG3' ' CD2' ' A' ' 140' ' ' LEU . 7.3 mm-40 -138.2 -168.45 2.37 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.55 1.156 . . . . 0.0 110.353 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.4 mptt . . . . . 0 C--N 1.324 -0.525 0 O-C-N 124.567 1.167 . . . . 0.0 109.273 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.591 ' CD1' ' HG3' ' A' ' 160' ' ' ARG . 5.7 m-85 . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.495 0.188 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.47 ' CG1' HD11 ' A' ' 161' ' ' ILE . 3.9 m -137.27 166.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.3 ptp180 -127.9 164.32 22.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 110.229 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.685 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.14 93.74 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.115 . . . . 0.0 109.344 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.464 ' H ' ' CD1' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -96.53 25.23 5.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.442 1.089 . . . . 0.0 109.312 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.729 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.79 -11.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 110.987 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.522 ' OD1' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.79 159.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 0.0 109.287 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.66 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 44.1 t80 . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.157 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.472 ' CD2' HD23 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -70.43 117.63 56.77 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.436 1.085 . . . . 0.0 109.355 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.465 ' N ' HD13 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -74.99 128.14 11.25 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.487 1.783 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.662 ' CD1' ' HB3' ' A' ' 139' ' ' ALA . 10.2 p90 -137.22 152.98 50.47 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.478 1.111 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.522 ' CG ' ' OD1' ' A' ' 142' ' ' ASP . 7.9 mtpt -155.82 149.47 25.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER 46.75 91.01 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 0.0 109.301 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 27.85 45.2 0.04 OUTLIER Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.508 1.13 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -43.78 168.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.536 0.786 . . . . 0.0 109.269 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.0 mm -118.08 127.63 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.512 1.132 . . . . 0.0 109.261 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.472 HD23 ' CD2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -143.23 177.75 8.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.494 1.121 . . . . 0.0 109.326 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.603 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 1.1 mpp_? -135.9 153.66 51.38 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.131 . . . . 0.0 110.255 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.537 HG13 ' CE ' ' A' ' 164' ' ' LYS . 1.2 mp -86.09 118.93 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.543 1.152 . . . . 0.0 109.308 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.83 -54.06 2.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.566 1.166 . . . . 0.0 110.301 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 171' ' ' ASN . 5.1 m-20 -149.75 123.9 9.48 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.583 ' CD ' ' CG ' ' A' ' 170' ' ' TRP . 8.5 mmtt -114.0 94.31 33.64 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 0.0 109.311 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.473 1.775 . . . . 0.0 111.008 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -115.54 -173.03 2.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.256 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.18 -29.91 10.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.426 1.079 . . . . 0.0 110.311 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.85 -50.48 70.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.582 1.176 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.496 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 17.3 m95 -122.08 151.15 41.19 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.583 1.177 . . . . 0.0 108.008 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.583 ' CG ' ' CD ' ' A' ' 164' ' ' LYS . 8.7 m0 -127.3 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 163' ' ' ASP . 6.1 t-20 -94.15 91.37 6.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.603 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -104.85 165.74 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 0.0 109.323 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.7 mt-10 -108.51 143.72 37.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 0.0 110.273 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.416 ' N ' HD22 ' A' ' 151' ' ' LEU . 29.8 t0 -78.3 165.75 23.5 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 109.345 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.1 t -56.88 -17.65 10.23 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 0.0 110.049 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.21 -27.22 26.25 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.468 1.105 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 107.78 29.92 4.2 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.433 1.083 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -97.79 122.8 41.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 0.797 . . . . 0.0 109.295 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.443 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.8 mtp180 -85.42 114.71 22.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.564 1.165 . . . . 0.0 110.261 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.32 167.75 29.04 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.455 1.097 . . . . 0.0 111.028 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 1.5 mtt -87.91 147.78 24.91 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 0.777 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.496 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 2.3 pp -148.72 160.71 35.17 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.451 1.094 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.567 ' HD2' ' CE2' ' A' ' 153' ' ' PHE . 18.4 Cg_endo -74.99 147.61 34.21 Favored 'Trans proline' 0 C--N 1.359 1.095 0 O-C-N 124.528 1.804 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.0 t -80.9 -37.17 0.94 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.04 -66.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.729 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.0 OUTLIER -42.53 -22.05 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.454 1.096 . . . . 0.0 110.994 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 138' ' ' ARG . 2.5 m -113.17 172.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.477 ' HB2' ' CG ' ' A' ' 138' ' ' ARG . 6.0 mm-40 -142.77 -166.91 2.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 110.247 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 C--N 1.326 -0.42 0 O-C-N 124.475 1.11 . . . . 0.0 109.352 179.931 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.51 0.195 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 188' ' ' GLU . 18.2 m -133.06 142.54 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 0.0 109.292 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.712 ' O ' ' HB ' ' A' ' 187' ' ' VAL . 2.6 ptp180 -115.84 170.62 8.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.833 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.78 137.5 54.67 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.477 1.111 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.588 ' CD2' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.55 22.57 4.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 0.0 109.296 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.665 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.6 OUTLIER -139.87 -3.26 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 0.0 110.963 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.528 ' CG ' ' HB3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 51.35 166.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 0.0 109.343 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.483 ' CD1' ' HD2' ' A' ' 152' ' ' PRO . 9.9 tp -95.73 115.92 65.87 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.111 . . . . 0.0 109.241 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 125.34 9.25 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.668 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 31.5 p90 -131.94 178.13 7.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.501 1.126 . . . . 0.0 111.012 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -124.81 -176.43 3.54 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.152 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.528 ' HB3' ' CG ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -83.08 42.82 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 0.0 109.238 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 161.69 39.26 0.02 OUTLIER Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.549 1.156 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 37.4 t70 -100.42 156.07 17.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.408 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.3 mp -118.24 129.31 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.149 . . . . 0.0 109.299 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.525 ' CD1' ' OD2' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -145.41 136.71 24.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.57 1.168 . . . . 0.0 109.28 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 12.2 ptm180 -90.12 147.76 23.41 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.484 1.115 . . . . 0.0 110.301 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.49 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -91.35 118.48 36.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 109.326 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.525 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 9.2 ptt85 -101.22 -44.22 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 1.092 . . . . 0.0 110.264 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 35.7 t0 -150.91 171.73 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 0.0 109.274 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.579 ' HG2' ' CD1' ' A' ' 170' ' ' TRP . 1.1 mptt -135.87 122.48 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.546 1.154 . . . . 0.0 109.275 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 181' ' ' MET . 18.3 Cg_endo -75.02 -47.63 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 O-C-N 124.434 1.755 . . . . 0.0 111.037 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -123.47 -100.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 110.391 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.74 -67.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 110.334 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.604 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 7.6 pt20 -53.87 -38.14 64.43 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.528 1.142 . . . . 0.0 110.283 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CD1' ' HG3' ' A' ' 168' ' ' GLN . 80.7 m95 -102.47 128.44 49.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 108.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.583 ' CE3' HG23 ' A' ' 184' ' ' VAL . 37.5 m0 -115.44 140.35 49.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.595 1.184 . . . . 0.0 108.006 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.85 98.4 11.46 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.596 1.185 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -114.62 165.62 12.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.47 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 4.0 mt-10 -108.23 133.41 52.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 110.269 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 177' ' ' GLY . 1.2 t0 -73.47 160.7 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 0.0 109.252 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.9 p -50.84 -21.24 1.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 109.977 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -83.24 -29.62 28.32 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 0.0 110.285 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.87 31.66 3.08 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.504 1.127 . . . . 0.0 111.036 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.0 OUTLIER -94.77 117.97 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.428 0.723 . . . . 0.0 109.236 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.4 mtp180 -86.09 108.43 18.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.396 1.06 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.26 174.04 30.55 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.529 1.143 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.437 ' CG ' ' HG3' ' A' ' 165' ' ' PRO . 24.2 mtp -87.84 146.27 25.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.589 0.817 . . . . 0.0 110.995 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.517 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -139.06 150.63 65.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.4 1.062 . . . . 0.0 109.285 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.646 ' O ' ' CG2' ' A' ' 187' ' ' VAL . 18.2 Cg_endo -74.96 136.32 20.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.49 1.784 . . . . 0.0 110.967 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.8 t -69.35 -36.87 7.71 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.141 . . . . 0.0 109.31 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -69.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.474 1.776 . . . . 0.0 110.961 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.665 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.9 OUTLIER -44.14 -18.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.712 ' HB ' ' O ' ' A' ' 138' ' ' ARG . 1.1 m -117.71 162.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 0.0 109.314 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.588 ' HG3' ' CD2' ' A' ' 140' ' ' LEU . 5.5 mm-40 -115.41 -170.89 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.558 1.162 . . . . 0.0 110.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.454 ' C ' ' NH2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 0.0 109.316 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 11.6 m-85 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.474 0.178 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.465 HG11 ' CD1' ' A' ' 161' ' ' ILE . 4.6 m -133.95 140.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.432 1.082 . . . . 0.0 109.318 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 188' ' ' GLU . 15.0 tpp85 -113.9 115.11 27.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.484 1.115 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 1.024 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.32 124.75 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.511 1.132 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -139.42 34.0 2.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.719 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.2 t80 -129.77 -15.97 3.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 111.037 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 53.59 159.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 0.0 109.295 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.649 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.998 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 181' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.556 ' O ' ' CG2' ' A' ' 182' ' ' ILE . 0.6 OUTLIER -98.2 117.03 65.43 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.255 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.442 ' N ' HD13 ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.04 120.66 6.15 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.454 1.765 . . . . 0.0 110.953 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.649 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.5 p90 -117.31 168.66 10.14 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -126.9 8.0 6.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 0.0 109.251 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 88.28 137.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.559 1.162 . . . . 0.0 109.28 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 1.024 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 81.19 20.11 65.48 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 124.504 1.127 . . . . 0.0 111.029 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.467 ' OD2' ' CB ' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -99.88 113.79 26.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.443 0.731 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.3 tp -88.57 126.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.432 1.083 . . . . 0.0 109.299 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.5 ' CD2' ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -130.99 -174.44 3.38 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.482 1.114 . . . . 0.0 109.266 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.596 ' HG3' ' N ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -127.23 144.7 50.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.531 1.144 . . . . 0.0 110.329 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.596 ' N ' ' HG3' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -84.5 116.1 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.52 1.137 . . . . 0.0 109.284 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 -49.05 2.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.4 161.96 28.24 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 109.328 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.554 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -154.66 85.71 3.65 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -38.81 1.42 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.468 1.772 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -118.34 -175.98 2.98 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.5 -30.84 9.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 0.0 110.316 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -76.87 -38.57 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.119 . . . . 0.0 110.316 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.475 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 60.9 m95 -117.24 139.09 51.23 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 108.015 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.554 ' CD1' ' HG3' ' A' ' 164' ' ' LYS . 34.1 m0 -120.86 144.33 48.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 0.0 108.016 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -91.36 95.76 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.57 1.169 . . . . 0.0 109.316 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.46 156.98 18.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.454 1.096 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.2 mt-10 -106.38 132.77 52.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.114 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.441 ' CG ' ' HG3' ' A' ' 178' ' ' LYS . 0.5 OUTLIER -75.57 162.69 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.58 1.175 . . . . 0.0 109.281 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.2 t -50.96 -20.95 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.52 1.137 . . . . 0.0 110.059 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.38 -27.91 41.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.463 1.102 . . . . 0.0 110.251 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 103.42 30.94 5.13 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.512 1.133 . . . . 0.0 111.032 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 11.1 ptmt -101.9 122.12 43.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 0.763 . . . . 0.0 109.254 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.454 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.73 116.08 24.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 0.0 110.29 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -146.34 152.55 24.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.485 1.115 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 10.4 mtp -87.19 131.21 34.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 0.802 . . . . 0.0 111.019 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.556 ' CG2' ' O ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -132.26 165.26 37.43 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 0.0 109.271 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.758 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.98 133.05 16.15 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 111.015 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.833 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.8 t -78.04 -31.5 0.8 Allowed Pre-proline 0 C--N 1.324 -0.539 0 O-C-N 124.523 1.139 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.833 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.99 -19.91 17.39 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.518 1.799 . . . . 0.0 110.97 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.758 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.54 -0.34 52.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.963 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 139' ' ' ALA . 7.1 m -135.04 169.77 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.433 1.083 . . . . 0.0 109.322 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 138' ' ' ARG . 1.2 mt-10 -125.26 -158.36 0.83 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.534 1.146 . . . . 0.0 110.223 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt . . . . . 0 C--N 1.326 -0.426 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 22.2 m-85 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.443 0.163 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.496 HG23 ' CD1' ' A' ' 161' ' ' ILE . 1.6 m -146.35 148.03 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.487 1.117 . . . . 0.0 109.325 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.758 HH21 ' N ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -113.75 112.86 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.367 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.95 121.41 30.32 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.531 1.144 . . . . 0.0 109.254 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.472 HD23 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.03 27.24 7.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.718 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -133.83 -17.16 2.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER 54.19 156.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.564 1.165 . . . . 0.0 109.239 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.511 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.501 ' CD1' ' OD1' ' A' ' 174' ' ' ASP . 0.5 OUTLIER -105.53 118.57 55.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 0.0 109.323 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.414 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -75.04 130.1 12.92 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.538 1.809 . . . . 0.0 110.984 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 42.2 p90 -134.35 175.9 9.1 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.518 1.136 . . . . 0.0 110.983 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.472 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -129.33 -176.83 4.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.294 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.498 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 1.4 tmpt? -82.32 82.9 7.63 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.413 1.07 . . . . 0.0 109.285 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 123.69 29.39 1.17 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.468 1.105 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.16 129.8 46.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.456 0.739 . . . . 0.0 109.294 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.758 ' N ' HH21 ' A' ' 138' ' ' ARG . 0.3 OUTLIER -99.26 120.8 49.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.487 1.117 . . . . 0.0 109.343 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -118.14 -173.32 2.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.445 1.091 . . . . 0.0 109.314 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.632 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 2.9 mpt_? -129.3 141.87 50.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.288 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' HG23 ' A' ' 137' ' ' VAL . 1.2 mp -87.88 116.03 29.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.451 1.094 . . . . 0.0 109.262 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.06 -48.91 4.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -148.96 165.37 31.81 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.464 1.103 . . . . 0.0 109.273 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.546 ' HE2' ' CD2' ' A' ' 170' ' ' TRP . 25.7 mttt -138.35 95.34 10.38 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.112 . . . . 0.0 109.256 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -29.13 8.48 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.497 1.788 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -128.27 -171.14 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.115 . . . . 0.0 110.376 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.77 -27.59 9.24 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 110.256 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -80.96 -36.22 31.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.451 1.094 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.506 ' CE3' ' C ' ' A' ' 182' ' ' ILE . 35.3 m95 -124.22 143.92 50.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 107.991 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.557 ' CZ2' HG11 ' A' ' 184' ' ' VAL . 54.5 m0 -119.88 146.53 45.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 0.0 108.064 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -87.55 92.83 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.583 1.177 . . . . 0.0 109.339 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -103.48 164.63 11.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.565 1.166 . . . . 0.0 109.304 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 1.9 mt-10 -112.5 135.01 53.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 0.0 110.277 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.501 ' OD1' ' CD1' ' A' ' 151' ' ' LEU . 1.1 t0 -73.15 158.17 35.8 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.518 1.136 . . . . 0.0 109.347 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.3 p -49.49 -22.06 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.529 1.143 . . . . 0.0 109.926 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -82.84 -29.79 29.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 112.06 30.99 2.78 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.496 1.123 . . . . 0.0 111.022 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -92.33 116.79 29.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.532 0.783 . . . . 0.0 109.278 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.484 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.4 mtp-105 -86.32 108.94 18.65 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.292 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.2 162.25 29.41 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.492 1.12 . . . . 0.0 111.002 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 1.7 mtp -87.62 137.36 32.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.504 0.767 . . . . 0.0 110.999 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.604 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 9.2 pt -133.33 168.98 15.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.421 1.075 . . . . 0.0 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 141.57 26.75 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 0.0 110.973 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.793 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 79.9 t -78.94 -34.16 0.94 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.521 1.138 . . . . 0.0 109.214 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.793 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.54 1.811 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.718 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.4 m-85 -31.55 -35.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.571 1.17 . . . . 0.0 110.979 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -115.88 172.35 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.475 1.11 . . . . 0.0 109.273 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.472 ' CD ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -123.62 -173.24 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 110.317 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 0.0 109.312 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.533 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.514 0.197 . . . . 0.0 110.949 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.481 ' O ' ' CD1' ' A' ' 158' ' ' ILE . 1.6 m -128.77 158.39 41.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 109.277 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 157' ' ' ASP . 2.9 tpp85 -129.36 121.46 27.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 110.324 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.846 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.24 126.48 34.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.452 1.095 . . . . 0.0 109.328 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.58 ' CD1' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.99 25.06 4.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.557 1.161 . . . . 0.0 109.308 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.602 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -143.03 0.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 111.026 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 141' ' ' PHE . 1.3 m-20 51.6 166.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.327 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 8.2 t80 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.495 1.122 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.604 ' OD2' ' CH2' ' A' ' 169' ' ' TRP . 89.1 m-20 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 152' ' ' PRO . 1.2 tp -79.31 121.56 83.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.561 1.163 . . . . 0.0 109.314 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.489 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.95 130.91 13.77 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.517 1.799 . . . . 0.0 110.981 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 143' ' ' PHE . 23.6 p90 -147.97 167.54 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.456 1.098 . . . . 0.0 111.025 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -125.66 173.34 9.07 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.479 1.112 . . . . 0.0 109.234 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.859 ' HG2' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -64.44 94.55 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.846 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.63 11.0 4.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.56 1.163 . . . . 0.0 110.994 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.544 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -75.51 153.44 37.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.591 0.818 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 137' ' ' VAL . 8.5 tp -134.68 129.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -138.08 177.75 7.64 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 109.269 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.56 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -123.68 140.19 53.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.402 1.064 . . . . 0.0 110.31 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.52 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 1.0 OUTLIER -84.12 118.65 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.52 1.138 . . . . 0.0 109.288 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.553 ' CZ ' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -103.18 -46.39 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 0.0 110.343 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -146.98 163.24 36.84 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 0.0 109.261 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 118.28 6.25 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.483 1.114 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.474 ' CD ' ' HE2' ' A' ' 181' ' ' MET . 18.2 Cg_endo -74.99 -65.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.451 1.764 . . . . 0.0 111.02 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -102.86 -105.76 0.27 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.551 1.157 . . . . 0.0 110.321 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.37 -46.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.519 1.137 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -54.99 -39.82 69.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 0.0 110.321 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CH2' ' OD2' ' A' ' 150' ' ' ASP . 24.1 m95 -118.66 144.77 45.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.546 ' CE2' HG23 ' A' ' 184' ' ' VAL . 41.3 m0 -124.78 148.5 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.455 ' CA ' ' HE1' ' A' ' 181' ' ' MET . 61.1 t-20 -99.5 101.76 13.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.475 1.109 . . . . 0.0 109.308 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -119.12 164.5 15.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 3.3 mt-10 -104.46 133.73 48.85 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 1.156 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.44 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 21.2 t0 -74.6 164.65 26.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.5 t -53.98 -18.86 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.028 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -81.97 -24.85 35.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 110.253 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.96 27.39 7.03 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.51 1.131 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.44 ' HG3' ' CB ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -99.43 121.15 40.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.474 0.749 . . . . 0.0 109.307 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.553 ' NH1' ' CZ ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -85.82 112.18 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 0.0 110.327 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.8 170.88 28.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.474 ' HE2' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -88.87 143.15 27.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 0.773 . . . . 0.0 110.971 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.504 ' CD1' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -139.64 160.28 61.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.467 1.105 . . . . 0.0 109.313 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.94 145.74 32.05 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.464 1.771 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.741 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.6 t -79.45 -37.74 1.21 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.498 1.124 . . . . 0.0 109.308 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.741 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.0 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.454 1.765 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.9 OUTLIER -32.3 -35.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.529 1.143 . . . . 0.0 110.971 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -112.09 169.18 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 0.0 109.316 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.58 ' CG ' ' CD1' ' A' ' 140' ' ' LEU . 1.5 mt-10 -126.61 -157.78 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.528 1.143 . . . . 0.0 110.307 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.582 1.176 . . . . 0.0 109.327 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 18.2 m-85 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.5 0.191 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.458 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 13.4 m -146.92 147.97 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 109.366 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 3.6 ptp180 -117.56 119.57 35.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.537 1.148 . . . . 0.0 110.308 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 1.043 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.24 100.04 12.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 0.0 109.251 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.485 ' CA ' ' HE3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -98.38 36.27 1.64 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.414 1.071 . . . . 0.0 109.318 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.645 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -140.2 -11.61 1.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.597 1.186 . . . . 0.0 111.036 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 52.38 158.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.188 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.477 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 2.0 t80 . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 0.0 110.975 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.505 ' CD2' HD22 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -108.22 118.29 52.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.431 ' N ' HD13 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.06 123.29 7.74 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.503 1.791 . . . . 0.0 110.984 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.628 ' CD1' ' HB3' ' A' ' 139' ' ' ALA . 21.8 p90 -125.02 -179.26 4.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.13 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -114.46 -176.53 2.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.499 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -81.44 66.07 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.336 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 1.043 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.04 35.56 0.62 Allowed Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.498 1.124 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 4.3 t70 -85.2 139.85 31.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 0.764 . . . . 0.0 109.274 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.405 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 8.9 mm -93.92 134.58 31.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.485 1.116 . . . . 0.0 109.315 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.518 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -143.77 172.37 12.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 0.0 109.312 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.612 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 9.6 ttt180 -113.34 139.65 48.69 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 0.0 110.334 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -90.55 111.36 23.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 0.0 109.23 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -53.66 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.337 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -150.31 -179.84 7.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.563 1.164 . . . . 0.0 109.303 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.597 ' CB ' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -162.62 111.97 1.09 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 0.0 109.252 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -57.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.484 1.781 . . . . 0.0 110.996 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.0 -121.85 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 0.0 110.342 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 -46.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.549 1.155 . . . . 0.0 110.3 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -66.19 -17.18 64.57 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.537 1.148 . . . . 0.0 110.284 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 79.1 m95 -133.17 132.77 41.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.494 1.122 . . . . 0.0 108.028 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.655 ' CE3' ' CG2' ' A' ' 184' ' ' VAL . 20.8 m0 -124.75 139.72 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.475 ' CB ' ' HE1' ' A' ' 181' ' ' MET . 36.9 t-20 -87.24 100.46 12.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.57 1.169 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -114.41 167.46 10.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 109.359 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.7 mt-10 -112.46 124.82 53.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.438 1.086 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.64 161.53 23.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 0.0 109.326 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.0 p -52.48 -20.57 2.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.118 . . . . 0.0 109.962 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -78.5 -25.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.125 . . . . 0.0 110.291 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.28 31.25 5.95 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.535 1.147 . . . . 0.0 110.991 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -104.2 124.74 49.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 0.773 . . . . 0.0 109.274 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 2.5 mtm180 -85.4 113.46 21.71 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.482 1.114 . . . . 0.0 110.319 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -145.22 176.7 24.1 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.544 1.153 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.495 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -88.39 144.61 26.28 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 0.746 . . . . 0.0 111.05 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.489 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 12.8 tt -144.53 140.74 16.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.265 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.595 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.89 139.3 24.43 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.421 1.748 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.809 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 3.0 t -81.9 -31.82 0.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 0.0 109.305 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.809 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -74.96 -26.76 10.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.415 1.745 . . . . 0.0 111.02 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 183' ' ' PRO . 1.5 m -146.86 -174.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 109.35 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 137' ' ' VAL . 3.2 mt-10 -134.13 -171.05 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 110.366 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.426 ' HA ' HG11 ' A' ' 137' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.422 1.076 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.598 0.237 . . . . 0.0 111.005 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 161' ' ' ILE . 6.1 m -148.13 142.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.386 1.054 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -106.49 146.33 30.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.46 1.1 . . . . 0.0 110.362 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.958 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -115.41 97.94 6.45 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.573 1.171 . . . . 0.0 109.269 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.89 30.62 6.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 0.0 109.348 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.753 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -133.77 -17.71 2.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 0.0 110.981 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER 54.31 159.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.457 1.098 . . . . 0.0 109.269 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.586 ' CE1' ' OD1' ' A' ' 150' ' ' ASP . 2.4 t80 . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 0.0 110.969 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 143' ' ' PHE . 2.8 p30 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.47 ' CD2' HD23 ' A' ' 159' ' ' LEU . 14.2 tp -74.01 117.28 60.06 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.03 117.5 4.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.541 1.811 . . . . 0.0 110.959 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.638 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 49.6 p90 -125.72 178.51 5.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 0.0 111.034 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 139' ' ' ALA . 12.5 mttm -125.77 179.69 5.06 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.53 1.144 . . . . 0.0 109.287 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.708 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.73 79.83 9.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 0.0 109.283 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.958 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 134.11 21.33 0.78 Allowed Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.509 1.131 . . . . 0.0 111.027 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -90.67 147.04 23.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.42 0.717 . . . . 0.0 109.313 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.452 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 7.6 tp -111.19 136.71 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.531 1.145 . . . . 0.0 109.294 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.47 HD23 ' CD2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -142.35 166.8 23.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.114 . . . . 0.0 109.299 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -115.61 146.82 41.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.483 1.114 . . . . 0.0 110.308 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.499 ' CD1' HG22 ' A' ' 137' ' ' VAL . 0.6 OUTLIER -88.04 121.74 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 0.0 109.304 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.438 ' CD ' ' HD3' ' A' ' 179' ' ' ARG . 11.6 ttm-85 -106.15 -45.76 4.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.45 1.094 . . . . 0.0 110.296 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -148.96 152.2 35.92 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.461 1.1 . . . . 0.0 109.334 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.566 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -141.1 90.09 9.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 0.0 109.341 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 -55.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.486 1.782 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.02 -177.08 5.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 110.353 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.84 5.91 20.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 0.0 110.331 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.36 -48.13 2.81 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.457 1.098 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.592 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 48.2 m95 -105.07 143.11 33.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.544 1.153 . . . . 0.0 108.038 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.566 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 15.5 m0 -127.11 136.15 51.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 108.027 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.3 m-80 -88.5 96.33 10.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.547 1.154 . . . . 0.0 109.29 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -109.99 160.79 16.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 0.0 109.255 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -103.03 129.36 49.78 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.47 1.106 . . . . 0.0 110.282 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.95 162.03 30.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 109.249 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.5 t -52.18 -20.3 2.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 0.0 109.951 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.97 -24.09 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.94 30.18 6.87 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.509 1.131 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.5 pttt -105.17 124.8 50.16 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.537 0.786 . . . . 0.0 109.256 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.438 ' HD3' ' CD ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -85.38 114.07 22.15 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.56 1.163 . . . . 0.0 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -146.22 176.9 24.91 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.39 1.056 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.592 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.7 OUTLIER -86.29 143.58 27.83 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.466 0.745 . . . . 0.0 111.031 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.42 HD13 ' CG ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -142.81 144.83 31.21 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 0.0 109.279 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.583 ' O ' ' CG2' ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.05 139.31 24.0 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.459 1.768 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 78.3 t -80.91 -32.3 0.65 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.343 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -35.65 3.02 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.52 1.8 . . . . 0.0 111.04 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.753 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 1.6 m-85 -88.13 15.05 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.583 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 2.4 m -152.86 164.06 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.122 . . . . 0.0 109.302 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -119.56 -162.83 0.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.239 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 O-C-N 124.507 1.129 . . . . 0.0 109.346 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 63.3 m-85 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.453 0.168 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.485 ' CG1' HD12 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -135.53 164.22 33.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.555 1.159 . . . . 0.0 109.33 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.726 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 18.2 tpp85 -119.94 156.18 31.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.432 1.082 . . . . 0.0 110.314 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.635 ' HB2' ' CE1' ' A' ' 153' ' ' PHE . . . -130.02 83.26 2.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.278 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.451 ' CD2' ' OE1' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -101.13 22.75 11.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 0.0 109.351 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.783 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -123.56 -18.93 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 111.016 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.88 152.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.52 1.138 . . . . 0.0 109.249 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.534 1.146 . . . . 0.0 110.996 -179.979 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.488 ' HB3' ' CZ3' ' A' ' 169' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 181' ' ' MET . 3.0 tp -99.9 120.73 56.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.42 ' O ' HD11 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.06 138.88 23.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.501 1.79 . . . . 0.0 111.04 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.635 ' CE1' ' HB2' ' A' ' 139' ' ' ALA . 8.3 p90 -160.78 -178.26 6.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER 170.73 146.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.305 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.23 68.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 37.97 50.15 2.07 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.485 1.115 . . . . 0.0 110.941 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.556 ' CB ' ' HB2' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -58.54 135.63 57.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 0.0 109.366 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.429 HD12 ' NH2' ' A' ' 138' ' ' ARG . 2.1 mm -99.35 122.65 51.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.503 1.127 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -128.46 -177.61 4.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 0.0 109.328 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -128.31 144.86 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 110.256 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.511 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 1.0 OUTLIER -86.45 116.03 28.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 0.0 109.299 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -105.56 -52.0 2.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.55 1.156 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.35 168.13 25.02 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.502 1.126 . . . . 0.0 109.199 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -140.48 114.39 7.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.443 1.089 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -73.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -98.76 -99.74 0.22 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.13 -50.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 0.0 110.339 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -52.81 -43.61 66.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.523 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 69.7 m95 -115.21 142.42 46.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 108.015 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.471 ' CD2' HG22 ' A' ' 184' ' ' VAL . 33.8 m0 -121.16 145.43 47.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.04 94.46 9.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 109.354 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -110.08 164.37 12.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.139 . . . . 0.0 109.273 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -110.37 134.19 52.54 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.33 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.45 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 6.2 t70 -74.56 165.4 25.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.3 t -56.04 -17.49 7.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.138 . . . . 0.0 109.953 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.53 -22.52 32.39 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.461 1.1 . . . . 0.0 110.246 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.72 32.11 6.08 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.546 1.154 . . . . 0.0 110.991 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -102.79 123.06 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 0.771 . . . . 0.0 109.356 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.449 ' NE ' ' OE2' ' A' ' 173' ' ' GLU . 5.3 mtt85 -86.28 115.22 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.11 167.37 28.94 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.541 1.151 . . . . 0.0 111.015 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 41.2 mmm -88.93 138.82 31.06 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.548 0.793 . . . . 0.0 111.005 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 2.3 pp -135.24 155.75 78.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.556 1.16 . . . . 0.0 109.294 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.624 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.95 138.52 23.27 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.462 1.769 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 51.3 t -78.67 -32.76 0.84 Allowed Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 109.305 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.01 2.81 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.405 1.739 . . . . 0.0 110.986 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.783 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 2.4 m-85 -90.01 23.43 2.8 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.726 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.3 m -152.55 157.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 0.0 109.317 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.451 ' OE1' ' CD2' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -113.77 -164.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 110.334 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 0.0 109.245 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 32.3 m-85 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.486 0.184 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -131.02 162.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.512 1.133 . . . . 0.0 109.232 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 10.4 tpp85 -129.98 112.64 13.7 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 110.348 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 1.083 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -84.13 117.1 23.25 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.481 ' CD1' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -127.32 25.44 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 0.0 109.263 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.23 -15.77 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 0.0 110.983 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.556 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 0.8 OUTLIER 53.91 161.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 0.0 109.324 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.5 1.125 . . . . 0.0 110.949 179.968 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.591 ' CG ' ' CH2' ' A' ' 169' ' ' TRP . 7.5 m-20 . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.53 ' CD1' ' HD2' ' A' ' 152' ' ' PRO . 5.4 tp -83.28 123.42 77.11 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 0.0 109.287 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.98 164.68 32.9 Favored 'Trans proline' 0 C--N 1.362 1.24 0 O-C-N 124.519 1.8 . . . . 0.0 111.043 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.574 ' CE2' HG21 ' A' ' 182' ' ' ILE . 28.5 p90 179.11 179.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 1.146 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -113.16 -177.51 3.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.257 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.503 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -94.07 77.91 4.07 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.531 1.145 . . . . 0.0 109.256 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 1.083 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 146.07 19.72 0.13 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.482 1.114 . . . . 0.0 110.994 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.82 163.77 13.93 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 0.0 109.344 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.5 HD11 ' CZ ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -118.42 128.22 75.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.244 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.449 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -132.89 -174.17 3.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.502 1.127 . . . . 0.0 109.281 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 1.3 ptp180 -133.34 150.1 51.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 110.265 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.44 HG13 ' NZ ' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -94.09 115.9 34.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.529 1.143 . . . . 0.0 109.29 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.403 ' HD2' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -96.29 -54.64 3.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 0.0 110.318 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.446 ' C ' ' HG2' ' A' ' 164' ' ' LYS . 0.4 OUTLIER -151.31 174.21 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.522 1.139 . . . . 0.0 109.322 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.446 ' HG2' ' C ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -127.86 100.46 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 109.337 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 -38.21 1.7 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.499 1.789 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -134.55 -165.77 1.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.522 1.139 . . . . 0.0 110.328 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -93.07 -71.48 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.511 1.132 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 169' ' ' TRP . 1.6 pt20 -61.74 -27.67 68.89 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.484 1.115 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.591 ' CH2' ' CG ' ' A' ' 150' ' ' ASP . 37.3 m95 -108.55 137.82 45.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.491 1.119 . . . . 0.0 108.043 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.612 ' O ' ' HA ' ' A' ' 181' ' ' MET . 9.1 m0 -123.72 175.06 7.08 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.458 1.099 . . . . 0.0 108.059 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -124.91 96.07 4.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 0.0 109.248 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -109.74 168.21 9.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 0.0 109.326 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.494 ' CD ' ' NH1' ' A' ' 179' ' ' ARG . 2.0 mt-10 -113.38 139.44 48.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 177' ' ' GLY . 4.9 t70 -78.0 161.73 27.28 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.57 -20.26 1.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.141 . . . . 0.0 110.027 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.46 -26.51 41.71 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 0.0 110.274 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 102.4 26.04 7.49 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.523 1.14 . . . . 0.0 110.991 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -94.36 128.57 40.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 0.754 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.494 ' NH1' ' CD ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -86.03 116.71 24.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 0.0 110.336 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.5 170.89 30.39 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.456 1.097 . . . . 0.0 111.005 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.7 mtt -86.35 144.65 27.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 0.0 110.951 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.574 HG21 ' CE2' ' A' ' 153' ' ' PHE . 97.1 mt -143.29 140.54 17.82 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.325 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.666 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.33 15.35 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.506 1.793 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.822 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.4 t -72.25 -31.2 1.6 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 0.0 109.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.822 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -7.67 19.34 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.478 1.778 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.666 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.6 m-85 -100.82 -30.25 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.529 ' O ' ' O ' ' A' ' 184' ' ' VAL . 1.0 OUTLIER -123.13 172.36 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 0.0 109.298 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.481 ' CG ' ' CD1' ' A' ' 140' ' ' LEU . 2.1 mt-10 -124.27 -158.6 0.82 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.487 1.117 . . . . 0.0 109.283 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 14.8 m-85 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.451 0.167 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.576 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 3.3 m -136.4 151.27 28.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.309 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.566 ' O ' ' HB ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -116.76 165.05 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 0.0 110.372 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -118.15 115.51 24.94 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.489 1.118 . . . . 0.0 109.299 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.567 ' CD2' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -112.6 28.73 8.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.422 1.076 . . . . 0.0 109.371 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.48 -13.18 2.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.963 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 53.83 155.98 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 0.0 109.33 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 143' ' ' PHE . 1.7 t80 . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 181' ' ' MET . 4.4 m-20 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.497 ' O ' ' CD1' ' A' ' 182' ' ' ILE . 0.4 OUTLIER -94.57 112.67 58.7 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 124.79 8.91 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.534 1.807 . . . . 0.0 110.997 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.594 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 1.2 p90 -141.83 176.26 9.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.469 1.106 . . . . 0.0 110.978 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.449 ' C ' ' HA ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -100.49 -172.12 2.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.533 1.146 . . . . 0.0 109.285 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.539 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.12 34.39 0.56 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 0.0 109.235 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.01 39.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.498 1.123 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -87.26 171.54 10.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.505 0.767 . . . . 0.0 109.317 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.3 mp -125.86 136.77 59.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 0.0 109.285 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -147.66 -172.05 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.516 1.135 . . . . 0.0 109.259 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 13.8 mtm180 -136.42 152.51 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.092 . . . . 0.0 110.251 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -89.61 119.69 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.246 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HD2' ' NE ' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -107.82 -48.72 3.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.548 1.155 . . . . 0.0 110.284 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.42 ' OD1' ' NE ' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -138.13 162.62 33.74 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.499 1.124 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 98.84 3.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.536 1.148 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -44.15 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.517 1.798 . . . . 0.0 110.979 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -174.96 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.08 -16.97 18.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.424 1.077 . . . . 0.0 110.318 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -89.79 -32.91 16.73 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.072 . . . . 0.0 110.3 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.588 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 44.3 m95 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.544 ' CD2' HG23 ' A' ' 184' ' ' VAL . 28.1 m0 -125.55 144.54 50.52 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 0.0 108.03 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -101.98 99.83 10.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 0.0 109.301 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -111.28 163.16 14.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.124 . . . . 0.0 109.309 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -106.28 134.56 49.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.325 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 177' ' ' GLY . 8.4 t0 -79.3 164.02 24.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.4 t -51.85 -20.0 2.02 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 110.002 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.91 -23.97 48.51 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.538 1.149 . . . . 0.0 110.263 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 95.93 30.42 7.95 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.403 1.065 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -107.3 132.55 52.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 0.751 . . . . 0.0 109.311 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.425 ' NE ' ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -87.01 122.39 30.8 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.24 150.98 22.86 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.486 1.116 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 150' ' ' ASP . 2.3 ptm -103.66 138.19 40.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.57 0.806 . . . . 0.0 111.014 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -149.55 172.2 5.49 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 0.0 109.323 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.822 ' HB2' ' HD2' ' A' ' 185' ' ' PRO . 18.3 Cg_endo -74.96 145.7 31.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 O-C-N 124.501 1.79 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 13.5 t -71.85 -30.28 1.48 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.448 1.093 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -3.73 14.35 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.456 1.766 . . . . 0.0 111.0 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.679 ' CG ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -102.56 -14.42 16.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 0.0 111.011 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 138' ' ' ARG . 32.4 m -132.19 169.34 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.576 ' O ' ' CB ' ' A' ' 137' ' ' VAL . 4.1 mm-40 -130.11 -168.75 2.01 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.486 1.117 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 57.6 m-85 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.513 0.196 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 27.3 m -133.78 145.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 109.287 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.807 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -123.44 152.72 41.35 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.453 1.096 . . . . 0.0 110.239 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.707 ' CB ' ' CD1' ' A' ' 153' ' ' PHE . . . -110.62 107.9 17.64 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.269 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -105.06 22.72 14.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 0.0 109.325 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.809 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.3 t80 -122.44 -14.37 7.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.604 1.19 . . . . 0.0 111.047 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 3.2 m-20 57.97 145.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.553 1.158 . . . . 0.0 109.294 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.616 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 181' ' ' MET . 16.6 m-20 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.476 HD11 ' N ' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -102.02 126.57 33.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.476 ' N ' HD11 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.99 140.49 25.53 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.56 1.821 . . . . 0.0 111.034 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.707 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 2.5 p90 -158.92 165.58 33.8 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.442 1.089 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 174.31 158.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 109.332 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.43 40.28 14.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 109.328 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 59.42 40.51 96.2 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.47 1.106 . . . . 0.0 111.049 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.807 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 5.5 t0 -46.87 141.23 4.13 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.774 . . . . 0.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.483 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -95.19 125.64 47.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 109.362 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.483 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -139.27 -178.57 5.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.502 1.126 . . . . 0.0 109.315 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -133.0 146.82 52.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 0.0 110.261 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.476 HD11 ' CG1' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -87.52 120.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.482 1.114 . . . . 0.0 109.249 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -103.12 -48.02 4.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.561 1.163 . . . . 0.0 110.251 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -148.78 166.87 27.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.477 1.11 . . . . 0.0 109.284 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.92 100.6 5.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.566 1.166 . . . . 0.0 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.452 ' CD ' ' HE3' ' A' ' 181' ' ' MET . 18.3 Cg_endo -74.98 -52.03 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.469 1.773 . . . . 0.0 111.028 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -104.15 -173.1 2.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.459 1.099 . . . . 0.0 110.287 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -109.7 13.5 23.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.562 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 10.4 tt0 -123.43 -42.13 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.0 m95 -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.565 1.166 . . . . 0.0 108.018 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.448 ' CE2' HG23 ' A' ' 184' ' ' VAL . 49.9 m0 -114.46 142.57 46.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 14.1 t30 -91.49 94.24 9.36 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.343 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -111.46 162.22 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 2.3 mt-10 -104.05 134.09 47.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 0.0 110.363 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.458 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 7.4 t0 -75.98 166.77 23.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 0.0 109.359 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.441 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 33.2 m -55.31 -18.51 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.482 1.114 . . . . 0.0 110.003 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.28 -20.2 34.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 0.0 110.276 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.81 26.18 10.82 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.538 1.149 . . . . 0.0 111.02 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.458 ' HG3' ' CB ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.3 119.95 35.7 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 0.774 . . . . 0.0 109.289 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.437 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.15 113.4 22.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 0.0 110.341 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.8 173.53 28.7 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.462 1.101 . . . . 0.0 110.966 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.452 ' HE3' ' CD ' ' A' ' 165' ' ' PRO . 37.6 mmm -87.47 144.76 26.57 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.458 0.74 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.451 ' CD1' HG21 ' A' ' 137' ' ' VAL . 7.9 pt -140.76 155.25 69.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.439 1.087 . . . . 0.0 109.367 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.08 143.98 29.44 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.547 1.814 . . . . 0.0 110.974 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 48.8 t -73.89 -39.45 4.4 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -75.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.415 1.745 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.809 ' CE2' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -32.57 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.525 1.141 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.644 ' HB ' ' O ' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -112.68 171.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.137 . . . . 0.0 109.247 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -137.4 -167.44 2.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 0.0 110.304 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.403 ' HA ' HG11 ' A' ' 137' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.282 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.48 ' CB ' HG23 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.568 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER 167.87 -37.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 110.312 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER -147.15 111.51 5.2 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 0.0 111.019 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.505 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 11.4 m -129.24 154.72 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.652 ' NH2' ' CD1' ' A' ' 190' ' ' TYR . 4.5 ptp180 -131.76 142.1 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.13 . . . . 0.0 110.24 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.979 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -94.36 129.72 40.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 109.295 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.498 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -116.51 25.63 10.46 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 0.0 109.319 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.6 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.6 -10.2 1.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.457 1.098 . . . . 0.0 111.032 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.521 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 55.03 159.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.3 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.673 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 24.4 t80 -165.31 -48.49 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.494 1.121 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.572 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 0.6 OUTLIER 50.13 93.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.526 1.141 . . . . 0.0 109.31 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -86.88 -68.8 1.33 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.541 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 1.7 m-20 158.51 -18.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.536 0.786 . . . . 0.0 109.332 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER 86.6 173.59 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.105 . . . . 0.0 109.29 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.546 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 69.77 9.0 7.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.46 1.1 . . . . 0.0 110.314 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 179.83 -26.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.5 1.125 . . . . 0.0 110.303 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.501 ' OD1' ' CZ3' ' A' ' 169' ' ' TRP . 19.1 m-20 -150.18 115.07 5.32 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.135 . . . . 0.0 109.314 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.563 ' O ' ' CG2' ' A' ' 182' ' ' ILE . 0.7 OUTLIER -69.4 115.77 35.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.469 1.106 . . . . 0.0 109.275 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.572 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.2 Cg_endo -74.98 121.21 6.44 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.455 1.766 . . . . 0.0 111.016 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.692 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 36.2 p90 -127.82 175.09 8.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.474 1.109 . . . . 0.0 110.994 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.464 ' CD ' ' HE2' ' A' ' 155' ' ' LYS . 5.7 mttt -115.49 -177.94 3.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 0.0 109.292 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.521 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -80.21 49.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.544 1.153 . . . . 0.0 109.28 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.979 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 147.43 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.132 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.602 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 14.1 t0 -89.7 155.07 19.46 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 0.773 . . . . 0.0 109.244 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.472 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 1.3 mp -105.42 141.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.508 1.13 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.52 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -149.3 -179.39 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.318 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.581 ' HG2' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -133.12 143.13 49.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.581 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 1.0 OUTLIER -87.2 117.34 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -107.89 -48.81 3.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 0.0 110.33 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.96 167.63 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 0.0 109.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -155.1 84.3 3.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.554 1.159 . . . . 0.0 109.305 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -45.76 0.26 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.509 1.794 . . . . 0.0 110.989 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -99.78 -173.26 2.41 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.496 1.123 . . . . 0.0 110.268 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.71 -32.21 8.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.471 1.107 . . . . 0.0 110.344 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.554 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 6.3 tt0 -89.46 -33.07 16.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.554 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.4 m95 -110.68 132.07 54.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 108.041 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.53 ' CD2' ' CG2' ' A' ' 184' ' ' VAL . 42.4 m0 -119.04 144.31 46.62 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 0.0 109.262 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -105.11 160.3 15.17 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 0.0 109.244 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.486 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 2.9 mt-10 -108.69 132.5 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.51 1.131 . . . . 0.0 110.271 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.412 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 7.5 t70 -74.15 163.53 27.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 0.0 109.318 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.5 m -53.92 -18.75 3.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.65 -22.35 37.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.501 1.125 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.85 31.03 6.83 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.508 1.13 . . . . 0.0 110.976 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 ptpp? -99.8 122.42 42.75 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 0.771 . . . . 0.0 109.315 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.486 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.0 mtm180 -85.98 112.92 21.66 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.533 1.146 . . . . 0.0 110.334 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.8 159.45 28.09 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.422 1.076 . . . . 0.0 110.991 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.6 mtm -87.55 141.16 28.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 0.775 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.563 ' CG2' ' O ' ' A' ' 151' ' ' LEU . 2.2 pp -142.91 163.17 39.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.473 1.108 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.587 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 136.57 20.55 Favored 'Trans proline' 0 C--N 1.361 1.184 0 O-C-N 124.484 1.781 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.846 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 36.7 t -80.54 -30.7 0.59 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.846 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.03 -21.19 16.05 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.488 1.783 . . . . 0.0 111.008 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -93.99 8.25 42.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 0.0 111.008 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.528 HG12 ' CB ' ' A' ' 139' ' ' ALA . 1.7 m -148.57 176.02 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.29 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -140.65 -169.17 2.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 110.287 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.401 ' O ' ' OE1' ' A' ' 188' ' ' GLU . 0.8 OUTLIER -109.32 160.78 15.87 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 0.0 109.276 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.652 ' CD1' ' NH2' ' A' ' 138' ' ' ARG . 30.8 t80 -124.6 163.93 20.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.142 . . . . 0.0 111.008 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.464 ' O ' ' CE2' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.001 0 O-C-N 124.54 1.15 . . . . 0.0 111.02 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.546 ' C ' ' CD1' ' A' ' 136' ' ' TYR . 1.1 mt-10 -143.26 -165.97 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.559 1.162 . . . . 0.0 110.274 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 135' ' ' GLU . 42.0 m-85 -149.1 121.51 8.47 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 111.014 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.496 HG22 ' CD1' ' A' ' 161' ' ' ILE . 22.4 m -135.92 152.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 0.0 109.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -124.14 144.15 50.07 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 0.0 110.358 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 1.067 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.13 118.53 37.09 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 0.0 109.309 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.488 ' CD1' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -111.9 32.67 5.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.644 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -138.92 -13.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.519 1.137 . . . . 0.0 111.038 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 54.04 156.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.372 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.704 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 -162.29 -53.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.471 1.107 . . . . 0.0 111.047 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.513 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER 54.78 81.97 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.51 1.132 . . . . 0.0 109.356 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.7 ' CA ' ' CZ ' ' A' ' 143' ' ' PHE . . . -76.6 -63.95 2.25 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.575 1.172 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 1.3 m-20 161.07 -22.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.428 0.722 . . . . 0.0 109.251 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER 84.37 174.58 0.06 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.541 1.15 . . . . 0.0 109.306 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 67.09 10.42 7.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 0.0 110.287 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 176.67 -31.05 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.564 1.165 . . . . 0.0 110.287 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 43.2 m-20 -135.55 100.52 4.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.467 1.104 . . . . 0.0 109.267 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.541 HD11 ' CD2' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -56.68 106.96 0.75 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 109.294 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.513 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.2 Cg_endo -74.94 121.68 6.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.53 1.805 . . . . 0.0 111.015 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.704 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 31.9 p90 -124.77 162.64 23.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.414 1.071 . . . . 0.0 110.98 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.419 ' C ' ' HA ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -108.31 -175.95 2.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 0.0 109.35 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.536 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -84.56 68.4 10.32 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 0.0 109.346 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 1.067 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.7 32.79 0.63 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.557 1.161 . . . . 0.0 111.005 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 9.0 t0 -83.3 161.8 21.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 0.779 . . . . 0.0 109.312 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.491 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 9.1 tp -121.01 129.24 75.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.401 1.063 . . . . 0.0 109.334 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.541 ' CD2' HD11 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -145.95 169.65 18.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.563 1.164 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 2.9 mtt85 -118.42 149.38 41.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.578 1.174 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' HG22 ' A' ' 137' ' ' VAL . 1.1 mp -91.95 119.52 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.421 ' NH1' ' CD ' ' A' ' 179' ' ' ARG . 39.2 ttt180 -101.6 -46.66 4.89 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 110.274 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -149.49 176.16 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.271 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.93 104.82 0.56 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.56 1.162 . . . . 0.0 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -46.09 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.522 1.801 . . . . 0.0 111.015 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -93.9 -175.07 3.61 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.539 1.149 . . . . 0.0 110.299 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.33 7.95 23.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 0.0 110.326 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -118.59 -45.13 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.521 ' CG ' ' HE3' ' A' ' 181' ' ' MET . 69.2 m95 -101.6 134.53 44.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 108.049 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.463 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 30.6 m0 -118.03 132.46 56.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 108.01 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 t-20 -83.73 95.2 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.307 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -109.59 162.93 13.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -109.39 137.9 46.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.481 1.113 . . . . 0.0 110.276 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.458 ' CG ' HD11 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -79.83 161.81 25.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.4 p -51.2 -20.88 1.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.115 . . . . 0.0 109.989 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -78.92 -28.15 43.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.12 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 103.99 31.23 4.83 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.48 1.112 . . . . 0.0 111.042 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -101.7 121.73 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.469 0.747 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.421 ' CD ' ' NH1' ' A' ' 162' ' ' ARG . 7.4 mtt85 -87.41 115.83 25.1 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.69 172.74 28.81 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.559 1.162 . . . . 0.0 111.024 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.521 ' HE3' ' CG ' ' A' ' 169' ' ' TRP . 3.6 ptm -87.55 127.5 35.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 0.743 . . . . 0.0 110.985 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.528 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 10.9 tt -124.53 142.31 40.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 0.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.571 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 135.24 18.78 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.452 1.764 . . . . 0.0 110.974 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.9 t -77.21 -31.46 0.87 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.05 -33.11 4.78 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.563 1.823 . . . . 0.0 110.961 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.644 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -89.99 18.42 5.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.967 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 13.1 m -149.36 177.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 140' ' ' LEU . 2.3 mt-10 -138.04 -161.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.548 1.155 . . . . 0.0 110.243 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 190' ' ' TYR . 7.6 tptt -107.82 145.91 32.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.229 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 191' ' ' GLY . 0.9 OUTLIER -76.26 -57.14 4.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.098 . . . . 0.0 111.064 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.569 ' N ' ' CD1' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.531 1.057 0 O-C-N 124.48 1.112 . . . . 0.0 110.953 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -105.24 -159.79 0.72 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.439 1.087 . . . . 0.0 110.316 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 62.5 m-85 -138.5 134.68 34.27 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.491 1.119 . . . . 0.0 111.028 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.19 160.87 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.588 1.18 . . . . 0.0 109.231 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.599 ' O ' ' N ' ' A' ' 188' ' ' GLU . 8.5 tpp85 -126.64 128.27 46.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 0.0 110.316 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.947 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.3 119.64 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.428 1.08 . . . . 0.0 109.363 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.441 ' CD2' ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -125.3 26.87 6.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.31 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' ' CZ ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -134.15 -21.16 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.419 1.074 . . . . 0.0 111.049 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.432 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 1.6 t70 58.79 155.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 109.34 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.706 ' O ' ' C ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER -159.96 -46.69 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 0.0 110.968 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.706 ' C ' ' O ' ' A' ' 143' ' ' PHE . 1.6 t30 -7.79 87.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.567 1.167 . . . . 0.0 109.305 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . -108.27 -38.82 1.9 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.547 1.155 . . . . 0.0 110.972 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.476 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 1.5 t-20 -163.34 -25.23 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.505 0.768 . . . . 0.0 109.276 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 3.3 p-10 47.47 46.32 17.38 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.517 1.136 . . . . 0.0 109.297 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.21 -7.68 55.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.44 1.087 . . . . 0.0 110.29 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -175.86 34.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.504 1.127 . . . . 0.0 110.285 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.447 ' OD2' ' CE2' ' A' ' 143' ' ' PHE . 0.0 OUTLIER -158.03 170.96 21.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.604 1.19 . . . . 0.0 109.269 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.512 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 1.7 tp -93.88 118.91 67.36 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.471 1.107 . . . . 0.0 109.279 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 144' ' ' ASN . 18.1 Cg_endo -75.05 126.15 9.75 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.478 1.778 . . . . 0.0 110.946 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.653 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 38.8 p90 -127.55 169.96 13.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.451 1.094 . . . . 0.0 111.06 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.95 178.19 4.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 0.0 109.287 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.587 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -80.62 51.75 1.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.947 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 149.82 35.23 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.547 1.154 . . . . 0.0 110.965 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -94.89 162.07 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.5 0.765 . . . . 0.0 109.36 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.484 ' CD1' ' CZ ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -118.47 122.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 0.0 109.285 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -131.13 -179.63 5.45 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.519 1.137 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.592 ' CB ' ' O ' ' A' ' 135' ' ' GLU . 2.5 ptp85 -133.02 155.22 49.58 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.471 ' HB ' ' CB ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -93.84 116.72 35.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 0.0 109.296 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -100.64 -49.08 4.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.452 1.095 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.75 174.32 12.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.18 118.53 8.47 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.465 1.103 . . . . 0.0 109.269 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -52.37 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.469 1.773 . . . . 0.0 110.984 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -127.76 -98.8 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.597 1.186 . . . . 0.0 110.291 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.83 -44.52 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.31 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -57.43 -43.58 83.96 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -118.89 144.22 46.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 0.0 108.052 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.536 ' CE2' HG23 ' A' ' 184' ' ' VAL . 46.5 m0 -118.14 145.26 45.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 107.976 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -87.19 86.18 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.528 1.143 . . . . 0.0 109.357 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -98.83 168.02 10.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 0.0 109.264 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -115.35 140.34 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 0.0 110.319 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.502 ' OD2' ' CD1' ' A' ' 151' ' ' LEU . 2.1 t0 -78.08 159.96 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.265 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -21.29 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.503 1.127 . . . . 0.0 110.0 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.8 -28.51 33.14 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.387 1.054 . . . . 0.0 110.254 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.04 30.62 3.6 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 124.452 1.095 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 mmmt -95.01 117.31 29.94 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.406 0.71 . . . . 0.0 109.238 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.475 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -85.17 111.85 20.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 0.0 110.296 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.61 167.58 30.37 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.47 1.106 . . . . 0.0 110.977 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 ptp -88.52 138.62 31.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 0.778 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 6.8 pt -134.86 164.18 45.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.613 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.9 143.64 29.66 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.443 1.76 . . . . 0.0 111.044 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.765 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 55.1 t -79.54 -35.86 1.02 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.765 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -67.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.586 1.835 . . . . 0.0 111.021 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.75 ' CZ ' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -38.82 -26.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.451 1.094 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 2.9 m -117.33 169.65 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.541 1.151 . . . . 0.0 109.268 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.599 ' N ' ' O ' ' A' ' 138' ' ' ARG . 2.6 mt-10 -125.07 -161.25 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.448 1.092 . . . . 0.0 110.365 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.09 130.26 51.9 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.467 1.105 . . . . 0.0 109.282 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.456 ' HB3' ' CB ' ' A' ' 136' ' ' TYR . 52.2 t80 -96.99 -44.0 7.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.464 1.102 . . . . 0.0 111.008 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 O-C-N 124.477 1.111 . . . . 0.0 111.063 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.476 ' CB ' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.508 ' O ' ' CB ' ' A' ' 160' ' ' ARG . 0.5 OUTLIER -179.8 -50.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.541 1.151 . . . . 0.0 110.286 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -143.58 122.38 12.66 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.462 1.101 . . . . 0.0 110.978 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 188' ' ' GLU . 2.0 m -128.91 169.62 19.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.8 ptp180 -132.07 174.63 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 153' ' ' PHE . . . -134.13 92.04 2.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 0.0 109.338 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.507 ' CD1' ' HG3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -92.41 16.82 10.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 1.105 . . . . 0.0 109.292 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.657 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -126.79 -13.98 5.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.448 1.093 . . . . 0.0 111.038 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.7 158.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 0.0 109.327 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.65 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 28.7 t80 -159.35 -56.28 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.542 1.151 . . . . 0.0 110.984 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.0 t30 70.92 53.15 0.27 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.547 1.155 . . . . 0.0 109.353 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.583 ' HA2' ' CE2' ' A' ' 143' ' ' PHE . . . -38.74 -75.54 0.09 OUTLIER Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.495 1.122 . . . . 0.0 111.011 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 0.8 OUTLIER 156.05 -18.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.488 0.758 . . . . 0.0 109.238 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 83.87 172.1 0.08 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.519 1.137 . . . . 0.0 109.333 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.486 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 1.2 tm-20 61.84 10.22 3.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 0.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 2.0 pt-20 179.64 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.427 1.08 . . . . 0.0 110.36 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.413 ' N ' ' HG2' ' A' ' 149' ' ' GLU . 79.9 m-20 -143.63 109.88 5.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.53 1.144 . . . . 0.0 109.336 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 1.2 tp -63.69 116.8 29.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 0.0 109.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.423 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 132.39 15.27 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.5 1.789 . . . . 0.0 110.974 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.65 ' CE1' ' CB ' ' A' ' 143' ' ' PHE . 13.4 p90 -142.36 155.53 45.16 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -165.58 146.57 7.07 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.608 1.193 . . . . 0.0 109.3 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.449 ' HA ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 61.29 78.24 0.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 0.0 109.336 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 33.4 47.1 0.39 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.508 1.13 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.735 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 42.4 t0 -39.91 161.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.313 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.453 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 2.1 mm -126.56 116.52 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.533 ' CD2' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -138.03 -176.04 4.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 109.294 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.56 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 2.8 ptp180 -131.76 147.69 52.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.476 HG21 ' CB ' ' A' ' 134' ' ' ALA . 0.7 OUTLIER -87.18 117.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.507 1.129 . . . . 0.0 109.306 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.511 ' NE ' ' CZ ' ' A' ' 179' ' ' ARG . 3.2 ttt180 -103.33 -48.13 4.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 0.0 110.354 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.78 165.27 30.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 109.34 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 103.28 3.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.482 1.114 . . . . 0.0 109.255 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.423 ' CD ' ' HE1' ' A' ' 181' ' ' MET . 18.2 Cg_endo -75.05 -57.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -107.39 -173.27 2.25 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.468 1.105 . . . . 0.0 110.307 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.39 18.16 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.441 1.088 . . . . 0.0 110.303 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -114.22 -48.8 2.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.532 1.145 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.422 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 52.7 m95 -119.29 137.95 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 108.03 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.556 ' CD2' ' CG2' ' A' ' 184' ' ' VAL . 43.7 m0 -114.81 144.95 42.68 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.521 1.138 . . . . 0.0 108.005 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -94.29 95.14 8.72 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 0.0 109.297 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -107.36 163.51 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 179' ' ' ARG . 2.2 mt-10 -108.44 141.07 40.84 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.539 1.149 . . . . 0.0 110.269 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.464 ' CB ' ' HE2' ' A' ' 178' ' ' LYS . 3.9 t70 -83.89 164.62 19.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 94.6 p -51.79 -21.04 2.5 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.153 . . . . 0.0 109.972 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.04 -28.12 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.485 1.115 . . . . 0.0 110.292 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 104.59 32.14 4.3 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.479 1.112 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.464 ' HE2' ' CB ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -103.1 118.97 37.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 0.745 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.511 ' CZ ' ' NE ' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -86.71 115.38 24.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.49 1.119 . . . . 0.0 110.32 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.52 164.74 27.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.513 1.133 . . . . 0.0 111.022 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.423 ' HE1' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -87.14 137.63 32.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.454 0.738 . . . . 0.0 110.998 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.546 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 28.1 pt -139.18 158.71 68.77 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 0.0 109.352 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.627 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.0 139.56 24.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.527 1.803 . . . . 0.0 111.068 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.5 t -78.5 -32.05 0.81 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.241 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -33.3 4.76 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.541 1.811 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.657 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -91.52 26.13 2.4 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.16 . . . . 0.0 111.01 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 22.9 m -151.69 168.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.157 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.512 ' HB2' ' CG ' ' A' ' 138' ' ' ARG . 3.2 mt-10 -139.91 -162.23 1.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.321 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.404 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 0.2 OUTLIER -119.32 141.92 48.58 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.507 1.13 . . . . 0.0 109.3 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 138' ' ' ARG . 1.6 t80 -67.01 -51.42 55.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 0.0 110.972 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.056 0 O-C-N 124.535 1.147 . . . . 0.0 110.988 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 135' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 160' ' ' ARG . 1.0 OUTLIER 172.6 -58.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 0.0 110.28 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 1.9 m-85 -133.04 133.42 43.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 0.0 111.039 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.47 ' CG1' HD13 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -127.43 157.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.154 . . . . 0.0 109.273 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.9 OUTLIER -116.56 147.28 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.309 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.9 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.88 93.74 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 0.0 109.268 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.509 ' CD1' ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -107.61 37.65 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.565 1.165 . . . . 0.0 109.368 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.77 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 1.5 m-85 -142.53 -17.73 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.44 1.088 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 55.13 160.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.555 1.159 . . . . 0.0 109.364 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.647 ' HB3' ' CE2' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -160.5 -43.75 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.511 1.132 . . . . 0.0 111.006 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.64 ' C ' ' O ' ' A' ' 143' ' ' PHE . 7.9 t30 18.07 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.577 1.173 . . . . 0.0 109.314 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . 67.31 -66.95 0.24 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.436 1.085 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 147' ' ' ASP . 18.7 p30 -168.02 -18.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.439 0.729 . . . . 0.0 109.262 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.527 ' CG ' ' O ' ' A' ' 146' ' ' ASN . 5.1 p-10 50.63 59.73 4.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 0.0 109.225 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.9 OUTLIER -73.6 -12.19 60.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.139 . . . . 0.0 110.261 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 16.5 tt0 -179.64 36.1 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.511 1.132 . . . . 0.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 73.9 m-20 -153.61 156.53 38.13 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 0.0 109.321 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.469 ' CD1' ' HD2' ' A' ' 152' ' ' PRO . 5.9 tp -73.52 114.08 28.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 0.0 109.307 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.469 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 120.87 6.22 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.477 1.777 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.647 ' CE2' ' HB3' ' A' ' 143' ' ' PHE . 48.4 p90 -130.32 167.89 17.78 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.516 1.135 . . . . 0.0 110.997 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -114.83 172.8 6.82 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 109.293 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.451 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -78.5 83.26 4.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 0.0 109.337 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.9 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.33 20.73 1.74 Allowed Glycine 0 CA--C 1.529 0.916 0 O-C-N 124.488 1.117 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 19.5 t0 -85.31 155.42 21.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.415 0.715 . . . . 0.0 109.353 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.463 HG13 ' NH2' ' A' ' 138' ' ' ARG . 1.8 mp -117.12 130.81 71.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 109.275 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -137.7 -178.87 5.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 0.0 109.263 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 1.7 mtm105 -131.24 145.86 52.08 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.508 1.13 . . . . 0.0 110.246 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.47 HD13 ' CG1' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -88.01 117.76 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.13 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.7 tpp85 -108.48 -48.04 3.4 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 0.0 110.317 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -145.94 -176.4 5.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 109.295 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -176.54 109.16 0.24 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -53.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.526 1.803 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -100.78 -169.85 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.489 1.118 . . . . 0.0 110.286 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.56 -34.0 9.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -73.07 -46.24 52.7 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 0.0 110.263 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.19 137.95 45.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.687 ' O ' ' HA ' ' A' ' 181' ' ' MET . 22.7 m0 -116.92 176.44 5.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 107.983 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -124.53 98.62 5.81 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -115.49 164.66 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 0.0 109.275 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -106.31 138.45 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.539 1.15 . . . . 0.0 110.263 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.496 ' O ' ' NH2' ' A' ' 160' ' ' ARG . 9.9 t0 -80.69 161.72 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 0.0 109.279 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.7 t -51.09 -21.36 1.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.559 1.162 . . . . 0.0 110.022 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -78.44 -23.63 46.49 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.574 1.171 . . . . 0.0 110.384 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 97.59 31.93 6.52 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.513 1.133 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -103.24 126.63 50.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 0.746 . . . . 0.0 109.317 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.441 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.8 mtp-105 -86.15 111.54 20.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 0.0 110.299 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -144.53 169.78 26.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.501 1.125 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.687 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 mtm -87.82 132.85 34.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.783 . . . . 0.0 111.015 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.546 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -128.22 151.09 75.7 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.46 1.1 . . . . 0.0 109.311 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.617 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.04 141.21 26.24 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.473 1.775 . . . . 0.0 110.964 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 65.0 t -80.78 -32.57 0.67 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.474 1.109 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -37.68 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.542 1.812 . . . . 0.0 111.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.77 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.2 m-85 -87.12 22.48 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.462 1.101 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.1 m -152.75 164.31 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.509 ' CG ' ' CD1' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -125.51 -161.82 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.459 1.099 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.0 137.02 53.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.451 1.095 . . . . 0.0 109.305 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.485 ' CB ' ' HB3' ' A' ' 136' ' ' TYR . 4.5 t80 -69.0 -52.04 32.96 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 0.0 111.023 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.021 0 O-C-N 124.467 1.104 . . . . 0.0 110.971 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.498 ' N ' ' HZ2' ' A' ' 189' ' ' LYS . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 160' ' ' ARG . 1.6 tt0 171.61 -36.61 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.54 1.15 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.485 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 1.4 m-85 -141.82 126.66 18.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.424 1.078 . . . . 0.0 111.013 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.503 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 17.2 m -145.33 147.17 18.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 109.289 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -127.17 136.44 52.07 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 0.0 110.285 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 1.001 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -91.17 138.17 31.8 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.481 1.113 . . . . 0.0 109.226 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.465 ' CD2' ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.98 19.6 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.539 1.149 . . . . 0.0 109.336 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.581 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -135.07 -4.7 2.41 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.4 OUTLIER 54.45 163.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.701 ' O ' ' N ' ' A' ' 145' ' ' GLY . 1.7 t80 -161.37 -36.94 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.498 1.124 . . . . 0.0 111.043 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 143' ' ' PHE . 21.7 t30 -35.67 85.84 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 0.0 109.236 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . -122.49 -29.63 1.28 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.485 1.116 . . . . 0.0 110.997 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 0.2 OUTLIER -151.27 -33.66 0.15 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.533 0.784 . . . . 0.0 109.287 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.494 ' CB ' ' HG3' ' A' ' 152' ' ' PRO . 4.5 p-10 45.66 53.17 8.86 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.454 1.096 . . . . 0.0 109.345 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.65 9.13 8.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 1.163 . . . . 0.0 110.28 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 170.7 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.54 1.15 . . . . 0.0 110.363 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 143' ' ' PHE . 59.1 m-20 -92.22 157.36 16.73 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.473 1.108 . . . . 0.0 109.294 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD13 ' N ' ' A' ' 152' ' ' PRO . 0.8 OUTLIER -77.35 119.6 78.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 0.0 109.319 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.494 ' HG3' ' CB ' ' A' ' 147' ' ' ASP . 18.5 Cg_endo -74.92 121.58 6.7 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.463 1.77 . . . . 0.0 111.005 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.629 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 29.3 p90 -134.7 169.52 17.2 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.424 1.077 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.26 175.77 5.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.564 1.165 . . . . 0.0 109.263 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.593 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -78.48 83.4 4.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.573 1.171 . . . . 0.0 109.281 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 1.001 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.81 23.84 2.43 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.52 1.138 . . . . 0.0 111.013 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 27.8 t0 -84.82 158.15 20.75 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.508 0.769 . . . . 0.0 109.37 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.456 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 10.1 mm -111.12 140.54 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.453 1.095 . . . . 0.0 109.293 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.512 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -149.89 -172.8 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.488 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 4.2 mpp_? -137.53 156.88 47.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.255 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.486 ' CD1' ' HB3' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -98.93 115.14 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.12 . . . . 0.0 109.293 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.535 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 6.2 ptt85 -104.13 -43.85 5.14 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.555 1.16 . . . . 0.0 110.309 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.535 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -136.86 166.06 24.51 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.539 1.149 . . . . 0.0 109.267 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.27 88.13 2.61 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.371 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -43.86 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.481 1.78 . . . . 0.0 111.029 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.34 -170.59 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 0.0 110.358 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.81 -32.2 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.541 1.15 . . . . 0.0 110.28 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.98 -35.99 64.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.513 1.133 . . . . 0.0 110.277 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.495 ' CZ3' ' CG ' ' A' ' 150' ' ' ASP . 47.6 m95 -122.05 138.77 54.32 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.533 1.146 . . . . 0.0 107.962 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.653 ' CE3' ' CG2' ' A' ' 184' ' ' VAL . 29.5 m0 -120.35 143.8 48.2 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.515 1.134 . . . . 0.0 107.953 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 3.1 t-20 -88.63 92.99 9.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 109.26 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -106.0 166.19 10.67 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.535 1.147 . . . . 0.0 109.3 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.0 mt-10 -115.0 138.58 50.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 0.0 110.346 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 177' ' ' GLY . 3.1 t0 -77.18 160.63 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.519 1.137 . . . . 0.0 109.33 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.4 m -51.16 -21.25 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 0.0 110.038 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.85 -27.99 28.33 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.463 1.102 . . . . 0.0 110.298 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.68 29.64 3.8 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.443 1.089 . . . . 0.0 111.032 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -89.57 114.98 26.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.542 0.789 . . . . 0.0 109.334 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.523 ' CZ ' ' NH1' ' A' ' 162' ' ' ARG . 4.2 mtp180 -86.36 108.58 18.52 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 0.0 110.26 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.84 162.5 29.72 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.393 1.058 . . . . 0.0 110.986 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 5.9 mtm -88.67 147.28 24.6 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 0.75 . . . . 0.0 110.99 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.507 ' CD1' ' CD1' ' A' ' 159' ' ' LEU . 23.0 pt -148.8 163.36 26.14 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.0 138.42 23.01 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.439 1.757 . . . . 0.0 110.999 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.828 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 1.0 OUTLIER -79.81 -31.85 0.69 Allowed Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 0.0 109.365 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.828 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -10.79 21.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.518 1.799 . . . . 0.0 111.027 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.692 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -99.64 -4.52 30.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.501 HG13 ' CB ' ' A' ' 139' ' ' ALA . 0.9 OUTLIER -142.79 170.47 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 109.286 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -119.52 -171.6 2.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.601 ' NZ ' ' CZ3' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -123.01 116.32 23.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 0.0 109.3 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -101.15 97.62 8.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 0.0 110.954 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 O-C-N 124.587 1.179 . . . . 0.0 111.022 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.557 ' O ' ' CB ' ' A' ' 135' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.557 ' CB ' ' O ' ' A' ' 134' ' ' ALA . 1.7 tt0 156.35 -36.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 0.0 110.288 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -137.27 134.93 36.69 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.533 1.146 . . . . 0.0 110.989 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.487 ' CG2' HD13 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -127.73 159.43 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.416 1.073 . . . . 0.0 109.281 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.2 tpp85 -124.95 116.41 22.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.303 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.92 114.88 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 0.0 109.284 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.594 ' CD1' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.38 28.95 5.88 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.508 1.13 . . . . 0.0 109.296 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -139.72 -6.87 1.29 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 1.1 . . . . 0.0 111.023 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.578 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 50.42 165.35 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 0.0 109.309 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.632 ' O ' ' C ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER -159.03 -44.33 0.06 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.632 ' C ' ' O ' ' A' ' 143' ' ' PHE . 17.9 t30 19.16 92.69 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.47 1.106 . . . . 0.0 109.302 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.586 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -108.85 -44.82 1.08 Allowed Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.534 1.146 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 145' ' ' GLY . 7.0 p30 149.62 6.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.496 0.762 . . . . 0.0 109.258 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.507 ' OD2' ' O ' ' A' ' 147' ' ' ASP . 0.8 OUTLIER 49.35 37.76 12.38 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.127 . . . . 0.0 109.326 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.9 OUTLIER -83.74 10.33 9.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.438 1.086 . . . . 0.0 110.304 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 3.2 tt0 169.54 -26.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.482 1.114 . . . . 0.0 110.333 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -114.33 -178.82 3.46 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.525 1.14 . . . . 0.0 109.387 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.459 ' CD2' HD22 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -106.83 116.26 59.01 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 0.0 109.31 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 143' ' ' PHE . 18.3 Cg_endo -75.04 121.32 6.49 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.469 1.773 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.618 ' CE1' ' HD2' ' A' ' 183' ' ' PRO . 18.1 p90 -119.42 -175.87 3.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 0.0 111.027 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.461 ' O ' ' HB1' ' A' ' 139' ' ' ALA . 8.3 tmtt? -140.52 164.04 31.23 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.115 . . . . 0.0 109.331 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -65.62 90.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.287 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 118.92 19.92 4.26 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.485 1.116 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.42 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 24.9 t0 -84.32 145.98 27.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 0.754 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.459 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 1.7 mp -111.85 124.67 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.436 1.085 . . . . 0.0 109.29 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.487 HD13 ' CG2' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -131.49 -174.95 3.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 0.0 109.309 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.602 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.1 147.67 46.21 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.525 1.14 . . . . 0.0 110.299 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 134' ' ' ALA . 0.6 OUTLIER -86.35 118.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.237 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.6 ttt180 -103.52 -47.37 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 0.0 110.318 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 50.4 m-20 -148.75 158.46 44.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -127.69 85.4 60.87 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 0.0 109.33 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.427 ' CG ' ' HE2' ' A' ' 181' ' ' MET . 18.2 Cg_endo -75.02 -44.57 0.33 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.517 1.799 . . . . 0.0 110.983 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -109.21 -164.78 0.96 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 0.0 110.316 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -105.71 -55.42 2.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 110.283 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.413 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 15.3 pt20 -77.95 -26.26 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.542 1.151 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.564 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 72.5 m95 -106.98 133.19 52.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.483 1.115 . . . . 0.0 108.004 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.48 ' O ' ' CD1' ' A' ' 182' ' ' ILE . 7.9 m0 -125.76 141.86 51.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 0.0 108.027 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' A' ' 171' ' ' ASN . 9.6 t-20 -91.9 87.52 6.26 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.602 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -104.11 164.29 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.217 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.468 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 3.5 mt-10 -105.91 137.88 43.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.404 1.065 . . . . 0.0 110.323 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.37 167.93 20.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.584 1.178 . . . . 0.0 109.256 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.6 m -57.91 -15.93 10.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -84.67 -21.87 30.06 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 1.083 . . . . 0.0 110.316 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 99.23 28.41 7.67 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.495 1.122 . . . . 0.0 110.989 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -102.21 121.81 42.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.472 0.748 . . . . 0.0 109.283 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -85.21 114.42 22.31 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 110.259 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -145.64 174.52 25.59 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.533 1.146 . . . . 0.0 111.043 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.564 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -86.78 146.62 26.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 0.741 . . . . 0.0 110.972 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -148.79 145.43 19.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.423 1.077 . . . . 0.0 109.325 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.634 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.05 130.68 13.45 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.533 1.807 . . . . 0.0 111.015 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.835 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 16.9 m -74.47 -28.62 0.86 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.127 . . . . 0.0 109.255 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -13.93 21.35 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.434 1.755 . . . . 0.0 110.989 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.591 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.3 m-85 -96.52 -36.4 10.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 0.0 111.005 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 2.6 m -108.81 173.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.532 1.145 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.594 ' CG ' ' CD1' ' A' ' 140' ' ' LEU . 1.7 mt-10 -124.88 -159.69 0.9 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.447 1.092 . . . . 0.0 110.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.417 ' HE3' ' CB ' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -122.28 125.39 45.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 0.0 109.295 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -114.47 155.75 25.82 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 0.0 110.993 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.026 0 O-C-N 124.474 1.109 . . . . 0.0 111.016 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.51 ' N ' ' NZ ' ' A' ' 189' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.573 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 5.2 pt-20 173.23 -42.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.13 . . . . 0.0 110.281 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 135' ' ' GLU . 18.3 m-85 -145.39 137.52 25.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.48 1.113 . . . . 0.0 111.006 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.6 m -147.99 154.94 10.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.488 1.117 . . . . 0.0 109.257 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -133.6 144.68 49.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.542 1.152 . . . . 0.0 110.265 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.929 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.73 128.71 45.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.549 1.156 . . . . 0.0 109.303 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.563 ' CD2' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -120.0 22.03 11.63 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.43 1.082 . . . . 0.0 109.285 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -138.26 -10.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 110.976 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 55.45 154.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.551 1.157 . . . . 0.0 109.34 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.644 ' CE1' ' OD1' ' A' ' 144' ' ' ASN . 1.5 t80 -144.18 -85.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.644 ' OD1' ' CE1' ' A' ' 143' ' ' PHE . 15.7 p30 149.33 -14.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.573 1.171 . . . . 0.0 109.308 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.43 -144.32 47.18 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.522 1.139 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.498 ' CB ' ' HB2' ' A' ' 150' ' ' ASP . 0.5 OUTLIER 171.17 -31.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.482 0.754 . . . . 0.0 109.343 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 81.22 161.65 0.15 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.509 1.131 . . . . 0.0 109.252 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 0.7 OUTLIER 70.43 -4.13 1.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.516 1.135 . . . . 0.0 110.275 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 3.4 mt-10 157.24 35.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 0.0 110.29 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.498 ' HB2' ' CB ' ' A' ' 146' ' ' ASN . 1.4 m-20 -161.46 117.11 2.1 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.507 1.13 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.502 ' CD2' HD23 ' A' ' 159' ' ' LEU . 1.4 tp -93.6 114.39 62.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.281 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HB3' ' O ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.03 134.13 17.39 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.509 1.794 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.651 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 18.3 p90 -151.88 171.62 17.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 0.0 110.975 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -108.75 -171.03 1.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.339 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.536 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.79 34.25 0.6 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.459 1.099 . . . . 0.0 109.336 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.929 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.29 39.77 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.432 1.082 . . . . 0.0 111.091 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 3.8 m-20 -91.84 166.64 12.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 0.779 . . . . 0.0 109.332 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.454 ' CG1' ' HA2' ' A' ' 191' ' ' GLY . 1.5 mp -128.09 134.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.586 1.179 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.502 HD23 ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -146.01 -178.16 5.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 0.0 109.291 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.578 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.47 146.5 52.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.102 . . . . 0.0 110.272 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.564 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 1.2 mp -83.94 124.32 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.526 1.141 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -100.22 -51.72 3.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 0.0 110.248 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -150.33 163.59 37.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.298 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.499 ' HE3' ' CG1' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -117.39 89.6 32.11 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.122 . . . . 0.0 109.294 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -35.6 3.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.469 1.773 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.15 -160.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.271 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.35 -49.46 2.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -82.39 -22.39 35.43 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.57 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 67.4 m95 -110.95 138.94 46.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 0.0 108.033 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -119.91 134.3 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 0.0 107.946 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.521 ' ND2' ' CE ' ' A' ' 181' ' ' MET . 27.9 t-20 -86.88 101.64 13.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.265 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -118.6 166.61 12.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 109.287 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.459 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 3.3 mt-10 -111.33 133.94 53.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.318 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -77.34 164.49 25.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 0.0 109.296 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 92.2 p -53.55 -18.98 3.25 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 0.0 109.992 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.03 -20.92 37.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.495 1.122 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.99 31.75 7.16 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.571 1.169 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -103.09 118.71 37.41 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 0.762 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.5 mtt85 -87.59 115.24 24.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.62 178.42 26.2 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.454 1.096 . . . . 0.0 111.065 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.57 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -85.96 136.39 33.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.524 0.779 . . . . 0.0 110.981 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.527 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 11.6 tt -131.67 142.38 45.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.576 1.172 . . . . 0.0 109.282 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.622 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 138.12 22.67 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.435 1.755 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.766 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.5 t -70.81 -36.07 4.96 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.128 . . . . 0.0 109.32 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.766 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.475 1.776 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.622 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -38.43 -27.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 0.0 110.981 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.573 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 1.3 m -118.84 177.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.423 1.077 . . . . 0.0 109.33 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.563 ' HG3' ' CD2' ' A' ' 140' ' ' LEU . 0.8 OUTLIER -135.5 -163.14 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 0.0 110.269 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 10.3 tptp -96.22 165.81 12.04 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.125 . . . . 0.0 109.24 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.556 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 0.8 OUTLIER 78.09 147.66 0.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.505 1.128 . . . . 0.0 111.0 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.454 ' HA2' ' CG1' ' A' ' 158' ' ' ILE . . . . . . . . 0 CA--C 1.529 0.948 0 O-C-N 124.497 1.123 . . . . 0.0 111.063 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 2.3 tt0 -118.67 -172.1 2.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.139 . . . . 0.0 110.333 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 0.3 OUTLIER -147.78 99.9 3.15 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.512 1.133 . . . . 0.0 110.981 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 31.6 m -124.39 141.06 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 0.0 109.308 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.551 ' O ' ' HB ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -97.53 -170.0 1.93 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -149.2 94.19 2.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.553 ' CD2' ' HG3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.75 33.53 1.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 109.311 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.7 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -136.74 -10.63 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 111.073 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.593 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 49.89 165.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.092 . . . . 0.0 109.365 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 -153.32 -50.77 0.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 111.075 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.544 ' C ' ' O ' ' A' ' 143' ' ' PHE . 12.3 t-20 29.27 90.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 0.0 109.304 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -105.04 -42.14 1.84 Allowed Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.497 1.123 . . . . 0.0 110.992 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.588 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 5.8 p30 150.35 -8.85 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.467 0.745 . . . . 0.0 109.288 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.681 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 61.96 36.55 15.6 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 1.156 . . . . 0.0 109.313 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -78.1 3.93 13.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.475 1.109 . . . . 0.0 110.316 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' HG2' ' N ' ' A' ' 150' ' ' ASP . 2.3 pt-20 179.85 -29.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.52 1.137 . . . . 0.0 110.328 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.513 ' HB3' ' CZ3' ' A' ' 169' ' ' TRP . 10.5 m-20 -113.23 -175.01 2.57 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.467 1.104 . . . . 0.0 109.297 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.55 ' CD2' ' CD2' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -108.25 119.13 50.68 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.457 1.098 . . . . 0.0 109.309 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.5 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 17.9 Cg_endo -75.07 121.32 6.48 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.527 1.804 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 143' ' ' PHE . 38.0 p90 -117.44 170.47 8.7 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.524 1.14 . . . . 0.0 111.032 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 139' ' ' ALA . 3.0 mptt -108.36 -179.96 4.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.449 1.093 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.497 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.99 85.62 7.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 109.272 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.33 23.21 2.68 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.445 1.091 . . . . 0.0 111.017 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.6 t70 -83.91 157.28 22.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.551 0.795 . . . . 0.0 109.338 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.4 mp -114.08 131.77 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.58 1.175 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.55 ' CD2' ' CD2' ' A' ' 151' ' ' LEU . 3.1 mp -144.48 133.92 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 0.0 109.271 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.576 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -91.58 143.36 26.65 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.519 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 1.1 mp -87.06 116.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.56 1.162 . . . . 0.0 109.295 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -109.28 -34.79 6.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.435 ' HB2' ' CD ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -138.64 155.72 48.06 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.554 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 6.5 ttpt -143.59 88.74 7.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 109.296 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.04 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.502 1.791 . . . . 0.0 110.978 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -101.18 -168.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 168' ' ' GLN . 21.4 pt-20 -105.44 -43.0 5.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.473 1.108 . . . . 0.0 110.344 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 167' ' ' GLU . 17.9 pt20 -62.86 -39.15 93.54 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.588 1.18 . . . . 0.0 110.326 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.513 ' CZ3' ' HB3' ' A' ' 150' ' ' ASP . 31.5 m95 -124.94 145.61 49.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.571 ' O ' ' HA ' ' A' ' 181' ' ' MET . 25.0 m0 -123.07 -179.61 4.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.68 104.23 7.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -123.92 167.55 13.97 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.4 1.062 . . . . 0.0 109.244 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.2 mt-10 -108.93 134.01 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.58 160.53 32.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.1 m -53.06 -19.83 3.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.122 . . . . 0.0 110.06 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.2 -26.81 35.66 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.565 1.165 . . . . 0.0 110.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.9 31.04 4.31 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.543 1.152 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.2 mmtp -99.56 121.07 40.66 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.547 0.793 . . . . 0.0 109.343 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.45 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 3.0 mtt85 -85.8 111.09 19.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 0.0 110.282 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.14 -175.52 20.86 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.559 1.162 . . . . 0.0 111.056 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -88.24 146.02 25.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.564 ' CG2' HG13 ' A' ' 187' ' ' VAL . 4.2 mp -139.62 145.14 42.14 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 182' ' ' ILE . 18.4 Cg_endo -75.05 152.49 40.59 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.477 1.777 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.4 t -87.05 -39.21 0.52 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.504 1.792 . . . . 0.0 110.963 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.7 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.4 m-85 -80.65 40.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.474 1.109 . . . . 0.0 111.019 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.564 HG13 ' CG2' ' A' ' 182' ' ' ILE . 18.2 m -155.63 164.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.579 1.174 . . . . 0.0 109.297 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.553 ' HG3' ' CD2' ' A' ' 140' ' ' LEU . 7.3 mm-40 -138.2 -168.45 2.37 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.55 1.156 . . . . 0.0 110.353 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -102.98 138.43 39.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.567 1.167 . . . . 0.0 109.273 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 138' ' ' ARG . 0.8 OUTLIER -75.13 132.0 40.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 0.0 110.934 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.969 0 O-C-N 124.572 1.17 . . . . 0.0 110.942 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 135' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' N ' ' HB ' ' A' ' 161' ' ' ILE . 15.7 tt0 171.89 -39.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.48 1.113 . . . . 0.0 110.283 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.591 ' CD1' ' HG3' ' A' ' 160' ' ' ARG . 5.7 m-85 -142.25 133.06 25.63 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.449 1.093 . . . . 0.0 111.016 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.47 ' CG1' HD11 ' A' ' 161' ' ' ILE . 3.9 m -137.27 166.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.3 ptp180 -127.9 164.32 22.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 110.229 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.685 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.14 93.74 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.115 . . . . 0.0 109.344 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.464 ' H ' ' CD1' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -96.53 25.23 5.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.442 1.089 . . . . 0.0 109.312 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.729 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.79 -11.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 110.987 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.522 ' OD1' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.79 159.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 0.0 109.287 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.66 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 44.1 t80 -164.05 -55.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.157 . . . . 0.0 110.989 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.494 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 20.7 t30 58.91 93.02 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.146 . . . . 0.0 109.315 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -86.75 -67.53 1.35 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.508 1.13 . . . . 0.0 111.003 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 2.5 t30 152.29 -17.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 0.745 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 87.27 171.99 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.095 . . . . 0.0 109.256 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.556 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 3.5 mt-10 68.08 10.76 8.02 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 0.0 110.287 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -178.05 -32.84 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.514 1.134 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -148.8 117.87 6.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.414 1.071 . . . . 0.0 109.298 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.472 ' CD2' HD23 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -70.43 117.63 56.77 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.436 1.085 . . . . 0.0 109.355 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.494 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.1 Cg_endo -74.99 128.14 11.25 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.487 1.783 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.662 ' CD1' ' HB3' ' A' ' 139' ' ' ALA . 10.2 p90 -137.22 152.98 50.47 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.478 1.111 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.522 ' CG ' ' OD1' ' A' ' 142' ' ' ASP . 7.9 mtpt -155.82 149.47 25.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER 46.75 91.01 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 0.0 109.301 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 27.85 45.2 0.04 OUTLIER Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.508 1.13 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -43.78 168.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.536 0.786 . . . . 0.0 109.269 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.0 mm -118.08 127.63 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.512 1.132 . . . . 0.0 109.261 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.472 HD23 ' CD2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -143.23 177.75 8.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.494 1.121 . . . . 0.0 109.326 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.603 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 1.1 mpp_? -135.9 153.66 51.38 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.131 . . . . 0.0 110.255 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.537 HG13 ' CE ' ' A' ' 164' ' ' LYS . 1.2 mp -86.09 118.93 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.543 1.152 . . . . 0.0 109.308 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.83 -54.06 2.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.566 1.166 . . . . 0.0 110.301 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 171' ' ' ASN . 5.1 m-20 -149.75 123.9 9.48 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.583 ' CD ' ' CG ' ' A' ' 170' ' ' TRP . 8.5 mmtt -114.0 94.31 33.64 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 0.0 109.311 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.473 1.775 . . . . 0.0 111.008 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -115.54 -173.03 2.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.256 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.18 -29.91 10.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.426 1.079 . . . . 0.0 110.311 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.85 -50.48 70.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.582 1.176 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.496 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 17.3 m95 -122.08 151.15 41.19 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.583 1.177 . . . . 0.0 108.008 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.583 ' CG ' ' CD ' ' A' ' 164' ' ' LYS . 8.7 m0 -127.3 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 163' ' ' ASP . 6.1 t-20 -94.15 91.37 6.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.603 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -104.85 165.74 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 0.0 109.323 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.7 mt-10 -108.51 143.72 37.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 0.0 110.273 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.416 ' N ' HD22 ' A' ' 151' ' ' LEU . 29.8 t0 -78.3 165.75 23.5 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 109.345 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.1 t -56.88 -17.65 10.23 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 0.0 110.049 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.21 -27.22 26.25 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.468 1.105 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 107.78 29.92 4.2 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.433 1.083 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -97.79 122.8 41.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 0.797 . . . . 0.0 109.295 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.443 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.8 mtp180 -85.42 114.71 22.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.564 1.165 . . . . 0.0 110.261 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.32 167.75 29.04 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.455 1.097 . . . . 0.0 111.028 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 1.5 mtt -87.91 147.78 24.91 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 0.777 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.496 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 2.3 pp -148.72 160.71 35.17 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.451 1.094 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.567 ' HD2' ' CE2' ' A' ' 153' ' ' PHE . 18.4 Cg_endo -74.99 147.61 34.21 Favored 'Trans proline' 0 C--N 1.359 1.095 0 O-C-N 124.528 1.804 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.0 t -80.9 -37.17 0.94 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.04 -66.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.729 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.0 OUTLIER -42.53 -22.05 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.454 1.096 . . . . 0.0 110.994 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 138' ' ' ARG . 2.5 m -113.17 172.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.477 ' HB2' ' CG ' ' A' ' 138' ' ' ARG . 6.0 mm-40 -142.77 -166.91 2.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 110.247 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -104.43 149.28 25.56 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.475 1.11 . . . . 0.0 109.352 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.524 ' CB ' ' HB3' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -90.71 85.85 6.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.53 1.144 . . . . 0.0 111.051 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 O-C-N 124.504 1.128 . . . . 0.0 110.964 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.432 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 160' ' ' ARG . 3.5 tt0 172.39 -40.01 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 0.0 110.273 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.78 112.71 6.04 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 0.0 110.982 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 188' ' ' GLU . 18.2 m -133.06 142.54 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 0.0 109.292 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.712 ' O ' ' HB ' ' A' ' 187' ' ' VAL . 2.6 ptp180 -115.84 170.62 8.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.833 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.78 137.5 54.67 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.477 1.111 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.588 ' CD2' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.55 22.57 4.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 0.0 109.296 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.665 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.6 OUTLIER -139.87 -3.26 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 0.0 110.963 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.528 ' CG ' ' HB3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 51.35 166.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 0.0 109.343 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -162.03 -53.64 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 111.05 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 48.48 -84.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.5 1.125 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . 72.13 -56.6 1.48 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.462 1.101 . . . . 0.0 111.031 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.508 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 3.1 m-20 156.08 -16.92 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.549 0.794 . . . . 0.0 109.299 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.755 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 70.24 37.11 1.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.507 1.13 . . . . 0.0 109.316 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 5.6 mt-10 -66.45 -13.75 61.23 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.487 1.117 . . . . 0.0 110.283 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.502 ' O ' ' CG ' ' A' ' 149' ' ' GLU . 7.5 tt0 176.44 32.31 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.555 1.159 . . . . 0.0 110.293 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.464 ' OD1' ' C ' ' A' ' 149' ' ' GLU . 0.8 OUTLIER -154.54 173.92 15.64 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.578 1.174 . . . . 0.0 109.3 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.483 ' CD1' ' HD2' ' A' ' 152' ' ' PRO . 9.9 tp -95.73 115.92 65.87 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.111 . . . . 0.0 109.241 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 125.34 9.25 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.668 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 31.5 p90 -131.94 178.13 7.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.501 1.126 . . . . 0.0 111.012 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -124.81 -176.43 3.54 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.152 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.528 ' HB3' ' CG ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -83.08 42.82 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 0.0 109.238 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 161.69 39.26 0.02 OUTLIER Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.549 1.156 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 37.4 t70 -100.42 156.07 17.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.408 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.3 mp -118.24 129.31 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.149 . . . . 0.0 109.299 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.525 ' CD1' ' OD2' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -145.41 136.71 24.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.57 1.168 . . . . 0.0 109.28 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 12.2 ptm180 -90.12 147.76 23.41 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.484 1.115 . . . . 0.0 110.301 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.49 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -91.35 118.48 36.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 109.326 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.525 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 9.2 ptt85 -101.22 -44.22 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 1.092 . . . . 0.0 110.264 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 35.7 t0 -150.91 171.73 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 0.0 109.274 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.579 ' HG2' ' CD1' ' A' ' 170' ' ' TRP . 1.1 mptt -135.87 122.48 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.546 1.154 . . . . 0.0 109.275 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 181' ' ' MET . 18.3 Cg_endo -75.02 -47.63 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 O-C-N 124.434 1.755 . . . . 0.0 111.037 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -123.47 -100.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 110.391 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.74 -67.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 110.334 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.604 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 7.6 pt20 -53.87 -38.14 64.43 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.528 1.142 . . . . 0.0 110.283 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CD1' ' HG3' ' A' ' 168' ' ' GLN . 80.7 m95 -102.47 128.44 49.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 108.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.583 ' CE3' HG23 ' A' ' 184' ' ' VAL . 37.5 m0 -115.44 140.35 49.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.595 1.184 . . . . 0.0 108.006 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.85 98.4 11.46 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.596 1.185 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -114.62 165.62 12.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.47 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 4.0 mt-10 -108.23 133.41 52.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 110.269 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 177' ' ' GLY . 1.2 t0 -73.47 160.7 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 0.0 109.252 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.9 p -50.84 -21.24 1.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 109.977 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -83.24 -29.62 28.32 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 0.0 110.285 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.87 31.66 3.08 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.504 1.127 . . . . 0.0 111.036 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.0 OUTLIER -94.77 117.97 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.428 0.723 . . . . 0.0 109.236 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.4 mtp180 -86.09 108.43 18.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.396 1.06 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.26 174.04 30.55 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.529 1.143 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.437 ' CG ' ' HG3' ' A' ' 165' ' ' PRO . 24.2 mtp -87.84 146.27 25.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.589 0.817 . . . . 0.0 110.995 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.517 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -139.06 150.63 65.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.4 1.062 . . . . 0.0 109.285 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.646 ' O ' ' CG2' ' A' ' 187' ' ' VAL . 18.2 Cg_endo -74.96 136.32 20.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.49 1.784 . . . . 0.0 110.967 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.8 t -69.35 -36.87 7.71 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.141 . . . . 0.0 109.31 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -69.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.474 1.776 . . . . 0.0 110.961 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.665 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.9 OUTLIER -44.14 -18.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.712 ' HB ' ' O ' ' A' ' 138' ' ' ARG . 1.1 m -117.71 162.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 0.0 109.314 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.588 ' HG3' ' CD2' ' A' ' 140' ' ' LEU . 5.5 mm-40 -115.41 -170.89 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.558 1.162 . . . . 0.0 110.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.454 ' C ' ' NH2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -138.65 154.64 48.65 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 0.0 109.316 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.518 ' HB2' ' NH2' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -120.28 112.05 18.56 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.502 1.126 . . . . 0.0 110.916 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 O-C-N 124.457 1.098 . . . . 0.0 111.024 179.927 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -116.61 -155.48 0.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 0.0 110.319 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 11.6 m-85 -144.86 136.34 25.34 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.502 1.127 . . . . 0.0 111.024 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.465 HG11 ' CD1' ' A' ' 161' ' ' ILE . 4.6 m -133.95 140.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.432 1.082 . . . . 0.0 109.318 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 188' ' ' GLU . 15.0 tpp85 -113.9 115.11 27.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.484 1.115 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 1.024 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.32 124.75 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.511 1.132 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -139.42 34.0 2.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.719 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.2 t80 -129.77 -15.97 3.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 111.037 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 53.59 159.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 0.0 109.295 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.649 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -165.52 -50.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.998 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 143' ' ' PHE . 3.4 p30 30.42 93.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 0.0 109.303 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -107.79 -40.92 1.65 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.533 1.146 . . . . 0.0 111.037 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.547 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 6.4 p30 154.79 -20.5 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.6 0.823 . . . . 0.0 109.338 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.783 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 77.88 43.02 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.331 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 3.8 mt-10 -77.87 8.25 4.86 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.579 1.174 . . . . 0.0 110.279 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 2.0 tt0 166.38 -23.91 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 0.0 110.315 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 181' ' ' MET . 0.3 OUTLIER -113.13 174.77 5.74 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.553 1.158 . . . . 0.0 109.33 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.556 ' O ' ' CG2' ' A' ' 182' ' ' ILE . 0.6 OUTLIER -98.2 117.03 65.43 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.255 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.521 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.0 Cg_endo -75.04 120.66 6.15 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.454 1.765 . . . . 0.0 110.953 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.649 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.5 p90 -117.31 168.66 10.14 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -126.9 8.0 6.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 0.0 109.251 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 88.28 137.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.559 1.162 . . . . 0.0 109.28 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 1.024 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 81.19 20.11 65.48 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 124.504 1.127 . . . . 0.0 111.029 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.467 ' OD2' ' CB ' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -99.88 113.79 26.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.443 0.731 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.3 tp -88.57 126.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.432 1.083 . . . . 0.0 109.299 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.5 ' CD2' ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -130.99 -174.44 3.38 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.482 1.114 . . . . 0.0 109.266 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.596 ' HG3' ' N ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -127.23 144.7 50.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.531 1.144 . . . . 0.0 110.329 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.596 ' N ' ' HG3' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -84.5 116.1 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.52 1.137 . . . . 0.0 109.284 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 -49.05 2.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.4 161.96 28.24 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 109.328 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.554 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -154.66 85.71 3.65 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -38.81 1.42 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.468 1.772 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -118.34 -175.98 2.98 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.5 -30.84 9.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 0.0 110.316 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -76.87 -38.57 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.119 . . . . 0.0 110.316 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.475 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 60.9 m95 -117.24 139.09 51.23 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 108.015 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.554 ' CD1' ' HG3' ' A' ' 164' ' ' LYS . 34.1 m0 -120.86 144.33 48.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 0.0 108.016 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -91.36 95.76 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.57 1.169 . . . . 0.0 109.316 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.46 156.98 18.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.454 1.096 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.2 mt-10 -106.38 132.77 52.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.114 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.441 ' CG ' ' HG3' ' A' ' 178' ' ' LYS . 0.5 OUTLIER -75.57 162.69 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.58 1.175 . . . . 0.0 109.281 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.2 t -50.96 -20.95 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.52 1.137 . . . . 0.0 110.059 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.38 -27.91 41.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.463 1.102 . . . . 0.0 110.251 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 103.42 30.94 5.13 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.512 1.133 . . . . 0.0 111.032 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 11.1 ptmt -101.9 122.12 43.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 0.763 . . . . 0.0 109.254 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.454 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.73 116.08 24.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 0.0 110.29 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -146.34 152.55 24.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.485 1.115 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 10.4 mtp -87.19 131.21 34.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 0.802 . . . . 0.0 111.019 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.556 ' CG2' ' O ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -132.26 165.26 37.43 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 0.0 109.271 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.758 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.98 133.05 16.15 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 111.015 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.833 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.8 t -78.04 -31.5 0.8 Allowed Pre-proline 0 C--N 1.324 -0.539 0 O-C-N 124.523 1.139 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.833 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.99 -19.91 17.39 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.518 1.799 . . . . 0.0 110.97 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.758 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.54 -0.34 52.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.963 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 139' ' ' ALA . 7.1 m -135.04 169.77 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.433 1.083 . . . . 0.0 109.322 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 138' ' ' ARG . 1.2 mt-10 -125.26 -158.36 0.83 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.534 1.146 . . . . 0.0 110.223 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 22.9 mmmt -107.02 108.1 19.43 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.467 ' O ' ' NH2' ' A' ' 138' ' ' ARG . 0.3 OUTLIER 69.06 -57.74 0.51 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 0.0 111.012 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.961 0 O-C-N 124.45 1.094 . . . . 0.0 111.031 -179.95 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -148.64 -159.04 0.98 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.571 1.169 . . . . 0.0 110.309 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 22.2 m-85 -141.34 162.25 35.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 0.0 111.02 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.496 HG23 ' CD1' ' A' ' 161' ' ' ILE . 1.6 m -146.35 148.03 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.487 1.117 . . . . 0.0 109.325 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.758 HH21 ' N ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -113.75 112.86 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.367 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.95 121.41 30.32 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.531 1.144 . . . . 0.0 109.254 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.472 HD23 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.03 27.24 7.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.718 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -133.83 -17.16 2.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER 54.19 156.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.564 1.165 . . . . 0.0 109.239 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.62 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 0.8 OUTLIER -163.83 -94.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.62 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 3.8 m-20 145.29 2.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 0.0 109.317 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.565 ' HA2' ' CE2' ' A' ' 143' ' ' PHE . . . 44.55 -101.87 0.03 OUTLIER Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.494 1.121 . . . . 0.0 110.984 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 20.8 t-20 170.42 -25.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.453 0.737 . . . . 0.0 109.288 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 82.23 167.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.105 . . . . 0.0 109.252 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER 61.06 13.36 4.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.557 1.161 . . . . 0.0 110.34 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 0.9 OUTLIER 164.31 -25.24 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.542 1.151 . . . . 0.0 110.296 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.512 ' HB3' ' CA ' ' A' ' 145' ' ' GLY . 1.1 m-20 -116.29 142.35 46.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.603 1.19 . . . . 0.0 109.315 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.501 ' CD1' ' OD1' ' A' ' 174' ' ' ASP . 0.5 OUTLIER -105.53 118.57 55.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 0.0 109.323 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 144' ' ' ASN . 18.4 Cg_endo -75.04 130.1 12.92 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.538 1.809 . . . . 0.0 110.984 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 42.2 p90 -134.35 175.9 9.1 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.518 1.136 . . . . 0.0 110.983 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.472 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -129.33 -176.83 4.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.294 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.498 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 1.4 tmpt? -82.32 82.9 7.63 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.413 1.07 . . . . 0.0 109.285 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 123.69 29.39 1.17 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.468 1.105 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.16 129.8 46.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.456 0.739 . . . . 0.0 109.294 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.758 ' N ' HH21 ' A' ' 138' ' ' ARG . 0.3 OUTLIER -99.26 120.8 49.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.487 1.117 . . . . 0.0 109.343 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -118.14 -173.32 2.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.445 1.091 . . . . 0.0 109.314 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.632 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 2.9 mpt_? -129.3 141.87 50.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.288 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.496 ' CD1' HG23 ' A' ' 137' ' ' VAL . 1.2 mp -87.88 116.03 29.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.451 1.094 . . . . 0.0 109.262 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.06 -48.91 4.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -148.96 165.37 31.81 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.464 1.103 . . . . 0.0 109.273 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.546 ' HE2' ' CD2' ' A' ' 170' ' ' TRP . 25.7 mttt -138.35 95.34 10.38 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.112 . . . . 0.0 109.256 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -29.13 8.48 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.497 1.788 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -128.27 -171.14 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.115 . . . . 0.0 110.376 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.77 -27.59 9.24 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 110.256 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -80.96 -36.22 31.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.451 1.094 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.506 ' CE3' ' C ' ' A' ' 182' ' ' ILE . 35.3 m95 -124.22 143.92 50.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 107.991 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.557 ' CZ2' HG11 ' A' ' 184' ' ' VAL . 54.5 m0 -119.88 146.53 45.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 0.0 108.064 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -87.55 92.83 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.583 1.177 . . . . 0.0 109.339 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -103.48 164.63 11.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.565 1.166 . . . . 0.0 109.304 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 1.9 mt-10 -112.5 135.01 53.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 0.0 110.277 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.501 ' OD1' ' CD1' ' A' ' 151' ' ' LEU . 1.1 t0 -73.15 158.17 35.8 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.518 1.136 . . . . 0.0 109.347 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.3 p -49.49 -22.06 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.529 1.143 . . . . 0.0 109.926 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -82.84 -29.79 29.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 112.06 30.99 2.78 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.496 1.123 . . . . 0.0 111.022 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -92.33 116.79 29.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.532 0.783 . . . . 0.0 109.278 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.484 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.4 mtp-105 -86.32 108.94 18.65 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.292 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.2 162.25 29.41 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.492 1.12 . . . . 0.0 111.002 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 1.7 mtp -87.62 137.36 32.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.504 0.767 . . . . 0.0 110.999 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.604 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 9.2 pt -133.33 168.98 15.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.421 1.075 . . . . 0.0 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 141.57 26.75 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 0.0 110.973 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.793 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 79.9 t -78.94 -34.16 0.94 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.521 1.138 . . . . 0.0 109.214 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.793 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.54 1.811 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.718 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.4 m-85 -31.55 -35.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.571 1.17 . . . . 0.0 110.979 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -115.88 172.35 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.475 1.11 . . . . 0.0 109.273 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.472 ' CD ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -123.62 -173.24 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 110.317 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -107.23 135.24 49.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 0.0 109.312 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -122.45 -36.54 2.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 0.0 110.956 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.44 ' N ' ' HB2' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.984 0 O-C-N 124.438 1.087 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.437 ' N ' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.594 ' HG2' ' CE2' ' A' ' 136' ' ' TYR . 3.6 tt0 177.12 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.441 1.088 . . . . 0.0 110.309 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.609 ' CD2' ' C ' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -149.23 131.24 15.29 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.503 1.127 . . . . 0.0 110.949 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.481 ' O ' ' CD1' ' A' ' 158' ' ' ILE . 1.6 m -128.77 158.39 41.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 109.277 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 157' ' ' ASP . 2.9 tpp85 -129.36 121.46 27.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 110.324 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.846 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.24 126.48 34.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.452 1.095 . . . . 0.0 109.328 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.58 ' CD1' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.99 25.06 4.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.557 1.161 . . . . 0.0 109.308 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.602 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -143.03 0.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 111.026 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 141' ' ' PHE . 1.3 m-20 51.6 166.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.327 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.709 ' O ' ' C ' ' A' ' 144' ' ' ASN . 8.2 t80 -167.93 -38.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.495 1.122 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.728 HD21 ' N ' ' A' ' 145' ' ' GLY . 1.2 t30 2.73 -80.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.54 1.15 . . . . 0.0 109.331 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.728 ' N ' HD21 ' A' ' 144' ' ' ASN . . . 60.74 -74.48 0.01 OUTLIER Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.578 1.174 . . . . 0.0 110.998 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 144' ' ' ASN . 29.9 p-10 -149.95 -24.47 0.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.541 0.789 . . . . 0.0 109.275 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 146' ' ' ASN . 5.1 p-10 49.17 59.26 4.59 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.489 1.118 . . . . 0.0 109.314 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.67 5.11 9.9 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.473 1.108 . . . . 0.0 110.332 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 179.79 -31.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.536 1.147 . . . . 0.0 110.351 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.604 ' OD2' ' CH2' ' A' ' 169' ' ' TRP . 89.1 m-20 -87.26 160.12 18.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 0.0 109.256 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 152' ' ' PRO . 1.2 tp -79.31 121.56 83.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.561 1.163 . . . . 0.0 109.314 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.489 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.95 130.91 13.77 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.517 1.799 . . . . 0.0 110.981 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 143' ' ' PHE . 23.6 p90 -147.97 167.54 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.456 1.098 . . . . 0.0 111.025 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -125.66 173.34 9.07 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.479 1.112 . . . . 0.0 109.234 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.859 ' HG2' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -64.44 94.55 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.846 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.63 11.0 4.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.56 1.163 . . . . 0.0 110.994 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.544 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -75.51 153.44 37.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.591 0.818 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.547 HD13 ' CD2' ' A' ' 190' ' ' TYR . 8.5 tp -134.68 129.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -138.08 177.75 7.64 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 109.269 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -123.68 140.19 53.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.402 1.064 . . . . 0.0 110.31 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.52 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 1.0 OUTLIER -84.12 118.65 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.52 1.138 . . . . 0.0 109.288 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.553 ' CZ ' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -103.18 -46.39 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 0.0 110.343 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -146.98 163.24 36.84 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 0.0 109.261 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 118.28 6.25 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.483 1.114 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.474 ' CD ' ' HE2' ' A' ' 181' ' ' MET . 18.2 Cg_endo -74.99 -65.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.451 1.764 . . . . 0.0 111.02 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -102.86 -105.76 0.27 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.551 1.157 . . . . 0.0 110.321 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.37 -46.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.519 1.137 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -54.99 -39.82 69.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 0.0 110.321 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CH2' ' OD2' ' A' ' 150' ' ' ASP . 24.1 m95 -118.66 144.77 45.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.546 ' CE2' HG23 ' A' ' 184' ' ' VAL . 41.3 m0 -124.78 148.5 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.455 ' CA ' ' HE1' ' A' ' 181' ' ' MET . 61.1 t-20 -99.5 101.76 13.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.475 1.109 . . . . 0.0 109.308 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -119.12 164.5 15.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 3.3 mt-10 -104.46 133.73 48.85 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 1.156 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.44 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 21.2 t0 -74.6 164.65 26.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.5 t -53.98 -18.86 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.028 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -81.97 -24.85 35.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 110.253 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.96 27.39 7.03 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.51 1.131 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.44 ' HG3' ' CB ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -99.43 121.15 40.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.474 0.749 . . . . 0.0 109.307 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.553 ' NH1' ' CZ ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -85.82 112.18 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 0.0 110.327 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.8 170.88 28.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.474 ' HE2' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -88.87 143.15 27.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 0.773 . . . . 0.0 110.971 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.504 ' CD1' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -139.64 160.28 61.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.467 1.105 . . . . 0.0 109.313 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.94 145.74 32.05 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.464 1.771 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.741 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.6 t -79.45 -37.74 1.21 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.498 1.124 . . . . 0.0 109.308 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.741 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.0 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.454 1.765 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.9 OUTLIER -32.3 -35.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.529 1.143 . . . . 0.0 110.971 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -112.09 169.18 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 0.0 109.316 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.58 ' CG ' ' CD1' ' A' ' 140' ' ' LEU . 1.5 mt-10 -126.61 -157.78 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.528 1.143 . . . . 0.0 110.307 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.33 130.96 54.67 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.582 1.176 . . . . 0.0 109.327 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.547 ' CD2' HD13 ' A' ' 158' ' ' ILE . 17.8 t80 -107.89 -99.39 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.478 1.111 . . . . 0.0 110.977 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.609 ' C ' ' CD2' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.993 0 O-C-N 124.489 1.118 . . . . 0.0 110.986 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -178.8 -137.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.12 . . . . 0.0 110.264 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 18.2 m-85 -145.64 164.74 30.8 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.484 1.115 . . . . 0.0 111.012 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.458 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 13.4 m -146.92 147.97 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 109.366 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 3.6 ptp180 -117.56 119.57 35.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.537 1.148 . . . . 0.0 110.308 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 1.043 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.24 100.04 12.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 0.0 109.251 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.485 ' CA ' ' HE3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -98.38 36.27 1.64 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.414 1.071 . . . . 0.0 109.318 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.645 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -140.2 -11.61 1.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.597 1.186 . . . . 0.0 111.036 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 52.38 158.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.188 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.599 ' O ' ' C ' ' A' ' 144' ' ' ASN . 2.0 t80 -157.88 -49.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 0.0 110.975 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 143' ' ' PHE . 37.7 m-80 23.83 90.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.438 1.086 . . . . 0.0 109.366 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -103.48 -46.0 1.48 Allowed Glycine 0 CA--C 1.529 0.94 0 O-C-N 124.483 1.114 . . . . 0.0 111.05 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.548 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 0.9 OUTLIER 160.2 -24.11 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.446 0.733 . . . . 0.0 109.277 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.717 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 79.7 34.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.538 1.149 . . . . 0.0 109.283 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 0.6 OUTLIER -80.82 14.09 2.33 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.504 1.128 . . . . 0.0 110.314 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 8.8 tt0 168.05 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.466 1.104 . . . . 0.0 110.273 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 0.5 OUTLIER -114.77 -176.99 3.02 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.519 1.137 . . . . 0.0 109.351 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.505 ' CD2' HD22 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -108.22 118.29 52.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.528 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.06 123.29 7.74 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.503 1.791 . . . . 0.0 110.984 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.628 ' CD1' ' HB3' ' A' ' 139' ' ' ALA . 21.8 p90 -125.02 -179.26 4.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.13 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -114.46 -176.53 2.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.499 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -81.44 66.07 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.336 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 1.043 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.04 35.56 0.62 Allowed Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.498 1.124 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 4.3 t70 -85.2 139.85 31.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 0.764 . . . . 0.0 109.274 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.456 ' CG2' ' C ' ' A' ' 191' ' ' GLY . 8.9 mm -93.92 134.58 31.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.485 1.116 . . . . 0.0 109.315 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.518 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -143.77 172.37 12.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 0.0 109.312 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.612 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 9.6 ttt180 -113.34 139.65 48.69 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 0.0 110.334 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -90.55 111.36 23.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 0.0 109.23 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -53.66 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.337 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -150.31 -179.84 7.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.563 1.164 . . . . 0.0 109.303 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.597 ' CB ' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -162.62 111.97 1.09 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 0.0 109.252 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -57.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.484 1.781 . . . . 0.0 110.996 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.0 -121.85 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 0.0 110.342 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 -46.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.549 1.155 . . . . 0.0 110.3 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -66.19 -17.18 64.57 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.537 1.148 . . . . 0.0 110.284 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 79.1 m95 -133.17 132.77 41.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.494 1.122 . . . . 0.0 108.028 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.655 ' CE3' ' CG2' ' A' ' 184' ' ' VAL . 20.8 m0 -124.75 139.72 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.475 ' CB ' ' HE1' ' A' ' 181' ' ' MET . 36.9 t-20 -87.24 100.46 12.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.57 1.169 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -114.41 167.46 10.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 109.359 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.7 mt-10 -112.46 124.82 53.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.438 1.086 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.64 161.53 23.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 0.0 109.326 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.0 p -52.48 -20.57 2.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.118 . . . . 0.0 109.962 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -78.5 -25.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.125 . . . . 0.0 110.291 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.28 31.25 5.95 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.535 1.147 . . . . 0.0 110.991 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -104.2 124.74 49.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 0.773 . . . . 0.0 109.274 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 2.5 mtm180 -85.4 113.46 21.71 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.482 1.114 . . . . 0.0 110.319 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -145.22 176.7 24.1 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.544 1.153 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.495 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -88.39 144.61 26.28 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 0.746 . . . . 0.0 111.05 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.489 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 12.8 tt -144.53 140.74 16.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.265 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.595 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.89 139.3 24.43 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.421 1.748 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.809 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 3.0 t -81.9 -31.82 0.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 0.0 109.305 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.809 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -74.96 -26.76 10.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.415 1.745 . . . . 0.0 111.02 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 183' ' ' PRO . 1.5 m -146.86 -174.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 109.35 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 137' ' ' VAL . 3.2 mt-10 -134.13 -171.05 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 110.366 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.9 OUTLIER -101.08 168.05 9.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.422 1.076 . . . . 0.0 109.317 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.618 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 1.6 t80 81.43 -37.77 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 0.0 111.009 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.456 ' C ' ' CG2' ' A' ' 158' ' ' ILE . . . . . . . . 0 CA--C 1.531 1.064 0 O-C-N 124.492 1.12 . . . . 0.0 111.001 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.636 ' OE2' ' CE1' ' A' ' 136' ' ' TYR . 4.7 mm-40 -115.7 -163.23 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 1.116 . . . . 0.0 110.242 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.636 ' CE1' ' OE2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -137.9 144.72 41.45 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.443 1.09 . . . . 0.0 111.005 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 161' ' ' ILE . 6.1 m -148.13 142.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.386 1.054 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -106.49 146.33 30.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.46 1.1 . . . . 0.0 110.362 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.958 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -115.41 97.94 6.45 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.573 1.171 . . . . 0.0 109.269 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.89 30.62 6.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 0.0 109.348 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.753 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -133.77 -17.71 2.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 0.0 110.981 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER 54.31 159.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.457 1.098 . . . . 0.0 109.269 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' A' ' 145' ' ' GLY . 2.4 t80 -164.82 -38.46 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 0.0 110.969 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.534 ' C ' ' O ' ' A' ' 143' ' ' PHE . 15.8 t30 -29.9 89.15 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.529 1.143 . . . . 0.0 109.256 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . -126.14 -30.34 0.87 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.477 1.111 . . . . 0.0 111.044 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 5.6 m-20 -153.73 -35.67 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.48 0.753 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 4.4 p-10 47.92 47.85 18.29 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.547 1.154 . . . . 0.0 109.329 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.11 -8.08 54.89 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.12 . . . . 0.0 110.304 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -178.96 34.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.47 1.106 . . . . 0.0 110.28 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 143' ' ' PHE . 2.8 p30 -158.43 154.69 27.3 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.45 1.094 . . . . 0.0 109.29 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.47 ' CD2' HD23 ' A' ' 159' ' ' LEU . 14.2 tp -74.01 117.28 60.06 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.03 117.5 4.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.541 1.811 . . . . 0.0 110.959 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.638 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 49.6 p90 -125.72 178.51 5.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 0.0 111.034 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 139' ' ' ALA . 12.5 mttm -125.77 179.69 5.06 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.53 1.144 . . . . 0.0 109.287 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.708 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.73 79.83 9.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 0.0 109.283 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.958 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 134.11 21.33 0.78 Allowed Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.509 1.131 . . . . 0.0 111.027 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -90.67 147.04 23.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.42 0.717 . . . . 0.0 109.313 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.452 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 7.6 tp -111.19 136.71 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.531 1.145 . . . . 0.0 109.294 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.47 HD23 ' CD2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -142.35 166.8 23.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.114 . . . . 0.0 109.299 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -115.61 146.82 41.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.483 1.114 . . . . 0.0 110.308 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.562 ' CG2' ' HB2' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -88.04 121.74 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 0.0 109.304 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.438 ' CD ' ' HD3' ' A' ' 179' ' ' ARG . 11.6 ttm-85 -106.15 -45.76 4.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.45 1.094 . . . . 0.0 110.296 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -148.96 152.2 35.92 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.461 1.1 . . . . 0.0 109.334 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.566 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -141.1 90.09 9.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 0.0 109.341 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 -55.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.486 1.782 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.02 -177.08 5.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 110.353 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.84 5.91 20.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 0.0 110.331 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.36 -48.13 2.81 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.457 1.098 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.592 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 48.2 m95 -105.07 143.11 33.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.544 1.153 . . . . 0.0 108.038 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.566 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 15.5 m0 -127.11 136.15 51.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 108.027 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.3 m-80 -88.5 96.33 10.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.547 1.154 . . . . 0.0 109.29 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -109.99 160.79 16.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 0.0 109.255 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -103.03 129.36 49.78 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.47 1.106 . . . . 0.0 110.282 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.95 162.03 30.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 109.249 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.5 t -52.18 -20.3 2.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 0.0 109.951 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.97 -24.09 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.94 30.18 6.87 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.509 1.131 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.5 pttt -105.17 124.8 50.16 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.537 0.786 . . . . 0.0 109.256 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.438 ' HD3' ' CD ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -85.38 114.07 22.15 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.56 1.163 . . . . 0.0 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -146.22 176.9 24.91 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.39 1.056 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.592 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.7 OUTLIER -86.29 143.58 27.83 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.466 0.745 . . . . 0.0 111.031 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.42 HD13 ' CG ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -142.81 144.83 31.21 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 0.0 109.279 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.583 ' O ' ' CG2' ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.05 139.31 24.0 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.459 1.768 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 78.3 t -80.91 -32.3 0.65 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.343 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -35.65 3.02 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.52 1.8 . . . . 0.0 111.04 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.753 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 1.6 m-85 -88.13 15.05 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.583 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 2.4 m -152.86 164.06 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.122 . . . . 0.0 109.302 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -119.56 -162.83 0.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.239 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.6 OUTLIER -116.85 150.41 38.45 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.507 1.129 . . . . 0.0 109.346 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.572 ' HA ' ' CD1' ' A' ' 136' ' ' TYR . 1.9 t80 77.67 -67.61 0.19 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.49 1.119 . . . . 0.0 111.023 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 138' ' ' ARG . . . . . . . . 0 CA--C 1.53 1.025 0 O-C-N 124.536 1.147 . . . . 0.0 111.015 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.562 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -136.69 -156.1 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.536 1.147 . . . . 0.0 110.408 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 63.3 m-85 -145.54 142.98 29.66 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.47 1.106 . . . . 0.0 110.994 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.485 ' CG1' HD12 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -135.53 164.22 33.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.555 1.159 . . . . 0.0 109.33 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.726 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 18.2 tpp85 -119.94 156.18 31.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.432 1.082 . . . . 0.0 110.314 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.635 ' HB2' ' CE1' ' A' ' 153' ' ' PHE . . . -130.02 83.26 2.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.278 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.451 ' CD2' ' OE1' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -101.13 22.75 11.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 0.0 109.351 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.783 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -123.56 -18.93 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 111.016 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.88 152.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.52 1.138 . . . . 0.0 109.249 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.599 ' O ' ' C ' ' A' ' 144' ' ' ASN . 2.6 t80 -153.0 -53.05 0.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.534 1.146 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 143' ' ' PHE . 6.3 t30 22.05 90.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 0.0 109.279 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -107.43 -45.6 1.13 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.477 1.11 . . . . 0.0 110.962 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.623 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 0.6 OUTLIER 169.25 -31.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.571 0.806 . . . . 0.0 109.282 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.679 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 87.48 38.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 0.0 109.335 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 6.3 tp10 -78.77 11.71 2.47 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.572 1.17 . . . . 0.0 110.302 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 7.3 tt0 166.3 -26.47 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.462 1.101 . . . . 0.0 110.286 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.488 ' HB3' ' CZ3' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -109.68 172.51 6.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.548 1.155 . . . . 0.0 109.255 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 181' ' ' MET . 3.0 tp -99.9 120.73 56.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.421 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.06 138.88 23.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.501 1.79 . . . . 0.0 111.04 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.635 ' CE1' ' HB2' ' A' ' 139' ' ' ALA . 8.3 p90 -160.78 -178.26 6.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER 170.73 146.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.305 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.23 68.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 37.97 50.15 2.07 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.485 1.115 . . . . 0.0 110.941 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.556 ' CB ' ' HB2' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -58.54 135.63 57.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 0.0 109.366 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.429 HD12 ' NH2' ' A' ' 138' ' ' ARG . 2.1 mm -99.35 122.65 51.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.503 1.127 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -128.46 -177.61 4.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 0.0 109.328 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.562 ' CG ' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -128.31 144.86 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 110.256 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.511 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 1.0 OUTLIER -86.45 116.03 28.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 0.0 109.299 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -105.56 -52.0 2.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.55 1.156 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.35 168.13 25.02 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.502 1.126 . . . . 0.0 109.199 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -140.48 114.39 7.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.443 1.089 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -73.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -98.76 -99.74 0.22 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.13 -50.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 0.0 110.339 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -52.81 -43.61 66.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.523 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 69.7 m95 -115.21 142.42 46.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 108.015 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.471 ' CD2' HG22 ' A' ' 184' ' ' VAL . 33.8 m0 -121.16 145.43 47.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.04 94.46 9.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 109.354 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -110.08 164.37 12.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.139 . . . . 0.0 109.273 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -110.37 134.19 52.54 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.33 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.45 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 6.2 t70 -74.56 165.4 25.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.3 t -56.04 -17.49 7.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.138 . . . . 0.0 109.953 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.53 -22.52 32.39 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.461 1.1 . . . . 0.0 110.246 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.72 32.11 6.08 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.546 1.154 . . . . 0.0 110.991 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -102.79 123.06 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 0.771 . . . . 0.0 109.356 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.449 ' NE ' ' OE2' ' A' ' 173' ' ' GLU . 5.3 mtt85 -86.28 115.22 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.11 167.37 28.94 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.541 1.151 . . . . 0.0 111.015 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 41.2 mmm -88.93 138.82 31.06 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.548 0.793 . . . . 0.0 111.005 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 2.3 pp -135.24 155.75 78.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.556 1.16 . . . . 0.0 109.294 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.624 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.95 138.52 23.27 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.462 1.769 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 51.3 t -78.67 -32.76 0.84 Allowed Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 109.305 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.01 2.81 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.405 1.739 . . . . 0.0 110.986 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.783 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 2.4 m-85 -90.01 23.43 2.8 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.726 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.3 m -152.55 157.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 0.0 109.317 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.451 ' OE1' ' CD2' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -113.77 -164.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 110.334 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 141.24 49.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 0.0 109.245 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -119.52 123.37 43.83 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.411 1.069 . . . . 0.0 111.013 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 O-C-N 124.495 1.122 . . . . 0.0 110.983 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.481 ' CB ' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 6.6 pt-20 169.62 -45.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.451 1.095 . . . . 0.0 110.305 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 32.3 m-85 -136.26 140.47 43.48 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 0.0 111.0 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -131.02 162.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.512 1.133 . . . . 0.0 109.232 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 10.4 tpp85 -129.98 112.64 13.7 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 110.348 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 1.083 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -84.13 117.1 23.25 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.481 ' CD1' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -127.32 25.44 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 0.0 109.263 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.23 -15.77 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 0.0 110.983 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.556 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 0.8 OUTLIER 53.91 161.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 0.0 109.324 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.627 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 9.7 t80 -136.12 -79.84 0.41 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.5 1.125 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.627 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 9.4 m-20 145.87 138.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 0.0 109.26 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.577 ' HA2' ' CB ' ' A' ' 152' ' ' PRO . . . -58.02 128.85 48.55 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.449 1.093 . . . . 0.0 110.978 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 147' ' ' ASP . 7.8 p-10 -161.57 -44.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 0.765 . . . . 0.0 109.275 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 146' ' ' ASN . 3.5 p30 44.46 -173.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 0.0 109.293 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 72.33 3.19 4.6 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.479 1.112 . . . . 0.0 110.266 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -160.99 -46.96 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.591 ' CG ' ' CH2' ' A' ' 169' ' ' TRP . 7.5 m-20 -144.06 153.66 42.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 109.252 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.53 ' CD1' ' HD2' ' A' ' 152' ' ' PRO . 5.4 tp -83.28 123.42 77.11 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 0.0 109.287 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.577 ' CB ' ' HA2' ' A' ' 145' ' ' GLY . 18.4 Cg_endo -74.98 164.68 32.9 Favored 'Trans proline' 0 C--N 1.362 1.24 0 O-C-N 124.519 1.8 . . . . 0.0 111.043 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.574 ' CE2' HG21 ' A' ' 182' ' ' ILE . 28.5 p90 179.11 179.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 1.146 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -113.16 -177.51 3.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.257 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.503 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -94.07 77.91 4.07 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.531 1.145 . . . . 0.0 109.256 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 1.083 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 146.07 19.72 0.13 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.482 1.114 . . . . 0.0 110.994 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.82 163.77 13.93 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 0.0 109.344 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.5 HD11 ' CZ ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -118.42 128.22 75.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.244 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.449 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -132.89 -174.17 3.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.502 1.127 . . . . 0.0 109.281 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 1.3 ptp180 -133.34 150.1 51.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 110.265 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.481 HG21 ' CB ' ' A' ' 134' ' ' ALA . 0.5 OUTLIER -94.09 115.9 34.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.529 1.143 . . . . 0.0 109.29 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.403 ' HD2' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -96.29 -54.64 3.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 0.0 110.318 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.446 ' C ' ' HG2' ' A' ' 164' ' ' LYS . 0.4 OUTLIER -151.31 174.21 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.522 1.139 . . . . 0.0 109.322 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.446 ' HG2' ' C ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -127.86 100.46 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 109.337 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 -38.21 1.7 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.499 1.789 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -134.55 -165.77 1.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.522 1.139 . . . . 0.0 110.328 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -93.07 -71.48 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.511 1.132 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 169' ' ' TRP . 1.6 pt20 -61.74 -27.67 68.89 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.484 1.115 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.591 ' CH2' ' CG ' ' A' ' 150' ' ' ASP . 37.3 m95 -108.55 137.82 45.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.491 1.119 . . . . 0.0 108.043 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.612 ' O ' ' HA ' ' A' ' 181' ' ' MET . 9.1 m0 -123.72 175.06 7.08 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.458 1.099 . . . . 0.0 108.059 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -124.91 96.07 4.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 0.0 109.248 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -109.74 168.21 9.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 0.0 109.326 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.494 ' CD ' ' NH1' ' A' ' 179' ' ' ARG . 2.0 mt-10 -113.38 139.44 48.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 177' ' ' GLY . 4.9 t70 -78.0 161.73 27.28 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.57 -20.26 1.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.141 . . . . 0.0 110.027 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.46 -26.51 41.71 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 0.0 110.274 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 102.4 26.04 7.49 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.523 1.14 . . . . 0.0 110.991 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -94.36 128.57 40.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 0.754 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.494 ' NH1' ' CD ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -86.03 116.71 24.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 0.0 110.336 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.5 170.89 30.39 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.456 1.097 . . . . 0.0 111.005 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.7 mtt -86.35 144.65 27.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 0.0 110.951 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.574 HG21 ' CE2' ' A' ' 153' ' ' PHE . 97.1 mt -143.29 140.54 17.82 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.325 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.666 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.33 15.35 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.506 1.793 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.822 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.4 t -72.25 -31.2 1.6 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 0.0 109.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.822 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -7.67 19.34 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.478 1.778 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.666 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.6 m-85 -100.82 -30.25 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.529 ' O ' ' O ' ' A' ' 184' ' ' VAL . 1.0 OUTLIER -123.13 172.36 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 0.0 109.298 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.481 ' CG ' ' CD1' ' A' ' 140' ' ' LEU . 2.1 mt-10 -124.27 -158.6 0.82 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.425 ' HE3' ' N ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -118.36 129.55 55.49 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.487 1.117 . . . . 0.0 109.283 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -113.47 118.84 35.61 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.452 1.095 . . . . 0.0 110.972 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 O-C-N 124.457 1.098 . . . . 0.0 111.075 179.933 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 160' ' ' ARG . 0.9 OUTLIER 171.86 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.457 1.098 . . . . 0.0 110.295 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.499 ' CD1' ' HA3' ' A' ' 191' ' ' GLY . 14.8 m-85 -141.25 119.95 12.54 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 0.0 111.038 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.576 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 3.3 m -136.4 151.27 28.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.309 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.566 ' O ' ' HB ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -116.76 165.05 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 0.0 110.372 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -118.15 115.51 24.94 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.489 1.118 . . . . 0.0 109.299 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.567 ' CD2' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -112.6 28.73 8.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.422 1.076 . . . . 0.0 109.371 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.48 -13.18 2.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.963 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 53.83 155.98 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 0.0 109.33 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.64 ' O ' ' C ' ' A' ' 144' ' ' ASN . 1.7 t80 -162.92 -47.57 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 0.0 111.093 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.64 ' C ' ' O ' ' A' ' 143' ' ' PHE . 12.7 t-20 19.08 90.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -107.36 -38.35 2.12 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 124.472 1.107 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' GLY . 1.8 m-20 153.03 -18.32 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 0.752 . . . . 0.0 109.237 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.772 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 76.59 38.49 0.28 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.082 . . . . 0.0 109.292 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 39.7 tt0 -74.2 -0.71 17.66 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.56 1.162 . . . . 0.0 110.338 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 2.8 pt-20 174.92 -23.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.464 1.103 . . . . 0.0 110.41 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 4.4 m-20 -111.73 171.21 7.63 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.528 1.143 . . . . 0.0 109.329 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.497 ' O ' ' CD1' ' A' ' 182' ' ' ILE . 0.4 OUTLIER -94.57 112.67 58.7 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.539 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.2 Cg_endo -74.96 124.79 8.91 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.534 1.807 . . . . 0.0 110.997 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.594 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 1.2 p90 -141.83 176.26 9.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.469 1.106 . . . . 0.0 110.978 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.449 ' C ' ' HA ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -100.49 -172.12 2.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.533 1.146 . . . . 0.0 109.285 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.539 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.12 34.39 0.56 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 0.0 109.235 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.01 39.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.498 1.123 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -87.26 171.54 10.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.505 0.767 . . . . 0.0 109.317 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.3 mp -125.86 136.77 59.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 0.0 109.285 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -147.66 -172.05 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.516 1.135 . . . . 0.0 109.259 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 13.8 mtm180 -136.42 152.51 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.092 . . . . 0.0 110.251 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -89.61 119.69 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.246 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HD2' ' NE ' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -107.82 -48.72 3.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.548 1.155 . . . . 0.0 110.284 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.42 ' OD1' ' NE ' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -138.13 162.62 33.74 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.499 1.124 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 98.84 3.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.536 1.148 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -44.15 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.517 1.798 . . . . 0.0 110.979 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -174.96 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.08 -16.97 18.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.424 1.077 . . . . 0.0 110.318 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -89.79 -32.91 16.73 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.072 . . . . 0.0 110.3 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.588 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 44.3 m95 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.544 ' CD2' HG23 ' A' ' 184' ' ' VAL . 28.1 m0 -125.55 144.54 50.52 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 0.0 108.03 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -101.98 99.83 10.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 0.0 109.301 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -111.28 163.16 14.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.124 . . . . 0.0 109.309 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -106.28 134.56 49.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.325 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 177' ' ' GLY . 8.4 t0 -79.3 164.02 24.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.4 t -51.85 -20.0 2.02 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 110.002 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.91 -23.97 48.51 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.538 1.149 . . . . 0.0 110.263 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 95.93 30.42 7.95 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.403 1.065 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -107.3 132.55 52.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 0.751 . . . . 0.0 109.311 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.425 ' NE ' ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -87.01 122.39 30.8 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.24 150.98 22.86 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.486 1.116 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 150' ' ' ASP . 2.3 ptm -103.66 138.19 40.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.57 0.806 . . . . 0.0 111.014 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -149.55 172.2 5.49 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 0.0 109.323 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.822 ' HB2' ' HD2' ' A' ' 185' ' ' PRO . 18.3 Cg_endo -74.96 145.7 31.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 O-C-N 124.501 1.79 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 13.5 t -71.85 -30.28 1.48 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.448 1.093 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -3.73 14.35 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.456 1.766 . . . . 0.0 111.0 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.679 ' CG ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -102.56 -14.42 16.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 0.0 111.011 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 138' ' ' ARG . 32.4 m -132.19 169.34 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.576 ' O ' ' CB ' ' A' ' 137' ' ' VAL . 4.1 mm-40 -130.11 -168.75 2.01 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.486 1.117 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.631 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.3 OUTLIER -95.36 172.45 8.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.631 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 1.6 t80 82.08 155.96 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.507 1.13 . . . . 0.0 110.986 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.499 ' HA3' ' CD1' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.936 0 O-C-N 124.551 1.157 . . . . 0.0 111.054 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.512 ' CB ' ' HD3' ' A' ' 160' ' ' ARG . . . . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -128.49 -164.38 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.454 1.096 . . . . 0.0 110.234 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.509 ' CG ' ' C ' ' A' ' 191' ' ' GLY . 57.6 m-85 -140.17 120.16 13.63 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.464 1.103 . . . . 0.0 111.026 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 27.3 m -133.78 145.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 109.287 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.807 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -123.44 152.72 41.35 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.453 1.096 . . . . 0.0 110.239 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.707 ' CB ' ' CD1' ' A' ' 153' ' ' PHE . . . -110.62 107.9 17.64 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.269 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -105.06 22.72 14.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 0.0 109.325 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.809 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.3 t80 -122.44 -14.37 7.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.604 1.19 . . . . 0.0 111.047 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 3.2 m-20 57.97 145.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.553 1.158 . . . . 0.0 109.294 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.616 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -156.87 -61.44 0.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 0.0 110.93 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 146' ' ' ASN . 45.5 m-20 69.04 -68.14 0.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.556 ' HA3' ' CE1' ' A' ' 143' ' ' PHE . . . 65.03 -64.17 0.08 OUTLIER Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.497 1.123 . . . . 0.0 110.961 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.616 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 5.1 p30 152.67 -6.32 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.474 0.75 . . . . 0.0 109.284 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.641 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 64.18 32.4 12.56 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 0.0 109.323 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 1.2 tt0 -75.87 3.45 10.03 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.472 1.108 . . . . 0.0 110.355 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 3.3 pt-20 177.69 -28.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.531 1.144 . . . . 0.0 110.284 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 16.6 m-20 -109.05 179.86 4.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.304 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.476 HD11 ' N ' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -102.02 126.57 33.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.476 ' N ' HD11 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.99 140.49 25.53 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.56 1.821 . . . . 0.0 111.034 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.707 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 2.5 p90 -158.92 165.58 33.8 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.442 1.089 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 174.31 158.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 109.332 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.43 40.28 14.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 109.328 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 59.42 40.51 96.2 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.47 1.106 . . . . 0.0 111.049 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.807 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 5.5 t0 -46.87 141.23 4.13 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.774 . . . . 0.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.483 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -95.19 125.64 47.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 109.362 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.483 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -139.27 -178.57 5.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.502 1.126 . . . . 0.0 109.315 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -133.0 146.82 52.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 0.0 110.261 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -87.52 120.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.482 1.114 . . . . 0.0 109.249 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -103.12 -48.02 4.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.561 1.163 . . . . 0.0 110.251 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -148.78 166.87 27.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.477 1.11 . . . . 0.0 109.284 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.92 100.6 5.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.566 1.166 . . . . 0.0 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.452 ' CD ' ' HE3' ' A' ' 181' ' ' MET . 18.3 Cg_endo -74.98 -52.03 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.469 1.773 . . . . 0.0 111.028 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -104.15 -173.1 2.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.459 1.099 . . . . 0.0 110.287 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -109.7 13.5 23.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.562 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 10.4 tt0 -123.43 -42.13 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.0 m95 -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.565 1.166 . . . . 0.0 108.018 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.448 ' CE2' HG23 ' A' ' 184' ' ' VAL . 49.9 m0 -114.46 142.57 46.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 14.1 t30 -91.49 94.24 9.36 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.343 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -111.46 162.22 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 2.3 mt-10 -104.05 134.09 47.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 0.0 110.363 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.458 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 7.4 t0 -75.98 166.77 23.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 0.0 109.359 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.441 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 33.2 m -55.31 -18.51 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.482 1.114 . . . . 0.0 110.003 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.28 -20.2 34.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 0.0 110.276 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.81 26.18 10.82 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.538 1.149 . . . . 0.0 111.02 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.458 ' HG3' ' CB ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.3 119.95 35.7 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 0.774 . . . . 0.0 109.289 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.437 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.15 113.4 22.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 0.0 110.341 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.8 173.53 28.7 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.462 1.101 . . . . 0.0 110.966 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.452 ' HE3' ' CD ' ' A' ' 165' ' ' PRO . 37.6 mmm -87.47 144.76 26.57 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.458 0.74 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.451 ' CD1' HG21 ' A' ' 137' ' ' VAL . 7.9 pt -140.76 155.25 69.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.439 1.087 . . . . 0.0 109.367 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.08 143.98 29.44 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.547 1.814 . . . . 0.0 110.974 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 48.8 t -73.89 -39.45 4.4 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -75.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.415 1.745 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.809 ' CE2' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -32.57 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.525 1.141 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.644 ' HB ' ' O ' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -112.68 171.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.137 . . . . 0.0 109.247 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -137.4 -167.44 2.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 0.0 110.304 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.635 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.3 OUTLIER -102.0 -174.46 2.59 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.282 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.635 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 1.9 t80 82.6 136.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.508 1.13 . . . . 0.0 111.013 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.509 ' C ' ' CG ' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.988 0 O-C-N 124.464 1.102 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.547 0.213 . . . . 0.0 111.019 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.4 m -129.24 154.72 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 4.5 ptp180 -131.76 142.1 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.13 . . . . 0.0 110.24 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.979 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -94.36 129.72 40.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 109.295 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -116.51 25.63 10.46 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 0.0 109.319 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.6 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.6 -10.2 1.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.457 1.098 . . . . 0.0 111.032 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.522 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 55.03 159.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.3 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.673 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 24.4 t80 . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.494 1.121 . . . . 0.0 110.962 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.501 ' OD1' ' CZ3' ' A' ' 169' ' ' TRP . 19.1 m-20 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.673 ' HB3' HG23 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -69.4 115.77 35.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.469 1.106 . . . . 0.0 109.275 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.656 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.98 121.21 6.44 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.455 1.766 . . . . 0.0 111.016 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.692 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 36.2 p90 -127.82 175.09 8.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.474 1.109 . . . . 0.0 110.994 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.464 ' CD ' ' HE2' ' A' ' 155' ' ' LYS . 5.7 mttt -115.49 -177.94 3.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 0.0 109.292 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.522 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -80.21 49.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.544 1.153 . . . . 0.0 109.28 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.979 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 147.43 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.132 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.654 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 14.1 t0 -89.7 155.07 19.46 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 0.773 . . . . 0.0 109.244 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.661 ' O ' HD23 ' A' ' 159' ' ' LEU . 1.3 mp -105.42 141.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.508 1.13 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -149.3 -179.39 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.318 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.581 ' HG2' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -133.12 143.13 49.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.581 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 1.0 OUTLIER -87.2 117.34 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -107.89 -48.81 3.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 0.0 110.33 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.96 167.63 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 0.0 109.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.517 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -155.1 84.3 3.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.554 1.159 . . . . 0.0 109.305 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -45.76 0.26 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.509 1.794 . . . . 0.0 110.989 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -99.78 -173.26 2.41 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.496 1.123 . . . . 0.0 110.268 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.71 -32.21 8.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.471 1.107 . . . . 0.0 110.344 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.555 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 6.3 tt0 -89.46 -33.07 16.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.555 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.4 m95 -110.68 132.07 54.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 108.041 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.56 ' CE2' HG21 ' A' ' 184' ' ' VAL . 42.4 m0 -119.04 144.31 46.62 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 0.0 109.262 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.516 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -105.11 160.3 15.17 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 0.0 109.244 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.9 mt-10 -108.69 132.5 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.51 1.131 . . . . 0.0 110.271 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.445 ' OD1' HD11 ' A' ' 151' ' ' LEU . 7.5 t70 -74.15 163.53 27.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 0.0 109.318 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.5 m -53.92 -18.75 3.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.65 -22.35 37.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.501 1.125 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.85 31.03 6.83 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.508 1.13 . . . . 0.0 110.976 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 ptpp? -99.8 122.42 42.75 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 0.771 . . . . 0.0 109.315 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.486 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.0 mtm180 -85.98 112.92 21.66 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.533 1.146 . . . . 0.0 110.334 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.8 159.45 28.09 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.422 1.076 . . . . 0.0 110.991 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.443 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.6 mtm -87.55 141.16 28.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 0.775 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 151' ' ' LEU . 2.2 pp -142.91 163.17 39.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.473 1.108 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.588 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 136.57 20.55 Favored 'Trans proline' 0 C--N 1.361 1.184 0 O-C-N 124.484 1.781 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.846 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 36.7 t -80.54 -30.7 0.59 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.846 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.03 -21.19 16.05 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.488 1.783 . . . . 0.0 111.008 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -93.99 8.25 42.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 0.0 111.008 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 139' ' ' ALA . 1.7 m -148.57 176.02 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.29 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.859 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -140.65 -169.17 2.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 110.287 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.419 ' HG3' HG12 ' A' ' 137' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 0.0 109.276 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 42.0 m-85 . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.475 0.178 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 22.4 m -135.92 152.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 0.0 109.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -124.14 144.15 50.07 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 0.0 110.358 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.067 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.13 118.53 37.09 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 0.0 109.309 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.764 HD11 ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -111.9 32.67 5.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.644 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -138.92 -13.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.519 1.137 . . . . 0.0 111.038 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 54.04 156.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.372 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.704 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.471 1.107 . . . . 0.0 111.047 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 43.2 m-20 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.926 HD21 HD22 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -56.68 106.96 0.75 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 109.294 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.653 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.94 121.68 6.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.53 1.805 . . . . 0.0 111.015 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.704 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 31.9 p90 -124.77 162.64 23.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.414 1.071 . . . . 0.0 110.98 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.31 -175.95 2.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 0.0 109.35 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.536 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -84.56 68.4 10.32 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 0.0 109.346 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 1.067 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.7 32.79 0.63 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.557 1.161 . . . . 0.0 111.005 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.737 ' OD2' HD11 ' A' ' 159' ' ' LEU . 9.0 t0 -83.3 161.8 21.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 0.779 . . . . 0.0 109.312 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.509 HD13 ' NH2' ' A' ' 138' ' ' ARG . 9.1 tp -121.01 129.24 75.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.401 1.063 . . . . 0.0 109.334 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.926 HD22 HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -145.95 169.65 18.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.563 1.164 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.681 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.9 mtt85 -118.42 149.38 41.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.578 1.174 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.1 mp -91.95 119.52 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.421 ' NH1' ' CD ' ' A' ' 179' ' ' ARG . 39.2 ttt180 -101.6 -46.66 4.89 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 110.274 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -149.49 176.16 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.271 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.462 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.93 104.82 0.56 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.56 1.162 . . . . 0.0 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -46.09 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.522 1.801 . . . . 0.0 111.015 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -93.9 -175.07 3.61 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.539 1.149 . . . . 0.0 110.299 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.33 7.95 23.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 0.0 110.326 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -118.59 -45.13 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.457 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 69.2 m95 -101.6 134.53 44.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 108.049 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.463 ' CD2' ' CG2' ' A' ' 184' ' ' VAL . 30.6 m0 -118.03 132.46 56.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 108.01 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 t-20 -83.73 95.2 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.307 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.793 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -109.59 162.93 13.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -109.39 137.9 46.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.481 1.113 . . . . 0.0 110.276 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.622 ' OD1' HD13 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -79.83 161.81 25.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.4 p -51.2 -20.88 1.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.115 . . . . 0.0 109.989 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -78.92 -28.15 43.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.12 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 103.99 31.23 4.83 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.48 1.112 . . . . 0.0 111.042 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -101.7 121.73 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.469 0.747 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.421 ' CD ' ' NH1' ' A' ' 162' ' ' ARG . 7.4 mtt85 -87.41 115.83 25.1 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.69 172.74 28.81 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.559 1.162 . . . . 0.0 111.024 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.405 ' HE2' ' CG ' ' A' ' 169' ' ' TRP . 3.6 ptm -87.55 127.5 35.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 0.743 . . . . 0.0 110.985 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.529 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 10.9 tt -124.53 142.31 40.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 0.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.772 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.02 135.24 18.78 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.452 1.764 . . . . 0.0 110.974 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.9 t -77.21 -31.46 0.87 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.05 -33.11 4.78 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.563 1.823 . . . . 0.0 110.961 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.644 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -89.99 18.42 5.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.967 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 183' ' ' PRO . 13.1 m -149.36 177.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.764 ' HG3' HD11 ' A' ' 140' ' ' LEU . 2.3 mt-10 -138.04 -161.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.548 1.155 . . . . 0.0 110.243 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.6 tptt . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.229 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 62.5 m-85 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.456 0.17 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -130.19 160.87 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.588 1.18 . . . . 0.0 109.231 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.744 ' NE ' HD13 ' A' ' 158' ' ' ILE . 8.5 tpp85 -126.64 128.27 46.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 0.0 110.316 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.947 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.3 119.64 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.428 1.08 . . . . 0.0 109.363 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.913 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -125.3 26.87 6.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.31 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' ' CZ ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -134.15 -21.16 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.419 1.074 . . . . 0.0 111.049 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.432 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 1.6 t70 58.79 155.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 109.34 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.653 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 0.0 110.968 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.447 ' OD2' ' CE2' ' A' ' 143' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.746 HD21 HD22 ' A' ' 159' ' ' LEU . 1.7 tp -93.88 118.91 67.36 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.471 1.107 . . . . 0.0 109.279 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.05 126.15 9.75 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.478 1.778 . . . . 0.0 110.946 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.653 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 38.8 p90 -127.55 169.96 13.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.451 1.094 . . . . 0.0 111.06 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -121.95 178.19 4.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 0.0 109.287 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.587 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -80.62 51.75 1.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.947 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 149.82 35.23 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.547 1.154 . . . . 0.0 110.965 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -94.89 162.07 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.5 0.765 . . . . 0.0 109.36 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.744 HD13 ' NE ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -118.47 122.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 0.0 109.285 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.746 HD22 HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -131.13 -179.63 5.45 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.519 1.137 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.655 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.5 ptp85 -133.02 155.22 49.58 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -93.84 116.72 35.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 0.0 109.296 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -100.64 -49.08 4.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.452 1.095 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.75 174.32 12.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.18 118.53 8.47 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.465 1.103 . . . . 0.0 109.269 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -52.37 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.469 1.773 . . . . 0.0 110.984 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -127.76 -98.8 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.597 1.186 . . . . 0.0 110.291 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.83 -44.52 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.31 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -57.43 -43.58 83.96 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.418 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 35.5 m95 -118.89 144.22 46.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 0.0 108.052 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.46 ' CD2' HG22 ' A' ' 184' ' ' VAL . 46.5 m0 -118.14 145.26 45.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 107.976 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -87.19 86.18 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.528 1.143 . . . . 0.0 109.357 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.739 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -98.83 168.02 10.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 0.0 109.264 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -115.35 140.34 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 0.0 110.319 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.659 ' HB2' HD13 ' A' ' 151' ' ' LEU . 2.1 t0 -78.08 159.96 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.265 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -21.29 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.503 1.127 . . . . 0.0 110.0 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.8 -28.51 33.14 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.387 1.054 . . . . 0.0 110.254 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.04 30.62 3.6 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 124.452 1.095 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 mmmt -95.01 117.31 29.94 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.406 0.71 . . . . 0.0 109.238 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.475 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -85.17 111.85 20.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 0.0 110.296 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.61 167.58 30.37 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.47 1.106 . . . . 0.0 110.977 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 ptp -88.52 138.62 31.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 0.778 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 6.8 pt -134.86 164.18 45.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.833 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.9 143.64 29.66 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.443 1.76 . . . . 0.0 111.044 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.765 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 55.1 t -79.54 -35.86 1.02 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.765 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -67.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.586 1.835 . . . . 0.0 111.021 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.75 ' CZ ' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -38.82 -26.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.451 1.094 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.9 m -117.33 169.65 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.541 1.151 . . . . 0.0 109.268 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.913 ' CD ' HD21 ' A' ' 140' ' ' LEU . 2.6 mt-10 -125.07 -161.25 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.448 1.092 . . . . 0.0 110.365 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.518 0 O-C-N 124.467 1.105 . . . . 0.0 109.282 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.474 0.178 . . . . 0.0 110.978 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 188' ' ' GLU . 2.0 m -128.91 169.62 19.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.778 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.8 ptp180 -132.07 174.63 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -134.13 92.04 2.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 0.0 109.338 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.855 HD21 ' OE1' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -92.41 16.82 10.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 1.105 . . . . 0.0 109.292 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.657 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -126.79 -13.98 5.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.448 1.093 . . . . 0.0 111.038 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.7 158.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 0.0 109.327 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.65 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 28.7 t80 . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.542 1.151 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.96 HD21 ' CD2' ' A' ' 159' ' ' LEU . 1.2 tp -63.69 116.8 29.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 0.0 109.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.551 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 132.39 15.27 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.5 1.789 . . . . 0.0 110.974 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.65 ' CE1' ' CB ' ' A' ' 143' ' ' PHE . 13.4 p90 -142.36 155.53 45.16 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -165.58 146.57 7.07 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.608 1.193 . . . . 0.0 109.3 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.474 ' HA ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 61.29 78.24 0.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 0.0 109.336 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 33.4 47.1 0.39 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.508 1.13 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.778 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 42.4 t0 -39.91 161.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.313 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.774 HD11 ' NH2' ' A' ' 138' ' ' ARG . 2.1 mm -126.56 116.52 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.96 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -138.03 -176.04 4.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 109.294 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.653 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.8 ptp180 -131.76 147.69 52.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.809 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -87.18 117.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.507 1.129 . . . . 0.0 109.306 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.511 ' NE ' ' CZ ' ' A' ' 179' ' ' ARG . 3.2 ttt180 -103.33 -48.13 4.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 0.0 110.354 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.78 165.27 30.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 109.34 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 103.28 3.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.482 1.114 . . . . 0.0 109.255 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.435 ' CD ' ' HE1' ' A' ' 181' ' ' MET . 18.2 Cg_endo -75.05 -57.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -107.39 -173.27 2.25 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.468 1.105 . . . . 0.0 110.307 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.39 18.16 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.441 1.088 . . . . 0.0 110.303 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -114.22 -48.8 2.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.532 1.145 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.423 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 52.7 m95 -119.29 137.95 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 108.03 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.618 ' CE2' HG21 ' A' ' 184' ' ' VAL . 43.7 m0 -114.81 144.95 42.68 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.521 1.138 . . . . 0.0 108.005 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 28.6 t-20 -94.29 95.14 8.72 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 0.0 109.297 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.809 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -107.36 163.51 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 179' ' ' ARG . 2.2 mt-10 -108.44 141.07 40.84 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.539 1.149 . . . . 0.0 110.269 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.557 ' HA ' HD23 ' A' ' 159' ' ' LEU . 3.9 t70 -83.89 164.62 19.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 94.6 p -51.79 -21.04 2.5 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.153 . . . . 0.0 109.972 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.04 -28.12 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.485 1.115 . . . . 0.0 110.292 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 104.59 32.14 4.3 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.479 1.112 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -103.1 118.97 37.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 0.745 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.511 ' CZ ' ' NE ' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -86.71 115.38 24.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.49 1.119 . . . . 0.0 110.32 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -143.52 164.74 27.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.513 1.133 . . . . 0.0 111.022 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.435 ' HE1' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -87.14 137.63 32.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.454 0.738 . . . . 0.0 110.998 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.547 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 28.1 pt -139.18 158.71 68.77 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 0.0 109.352 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.715 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.3 Cg_endo -75.0 139.56 24.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.527 1.803 . . . . 0.0 111.068 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.5 t -78.5 -32.05 0.81 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.241 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -33.3 4.76 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.541 1.811 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.657 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -91.52 26.13 2.4 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.16 . . . . 0.0 111.01 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 183' ' ' PRO . 22.9 m -151.69 168.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.157 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.855 ' OE1' HD21 ' A' ' 140' ' ' LEU . 3.2 mt-10 -139.91 -162.23 1.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.321 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.574 ' HD2' HG12 ' A' ' 137' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.507 1.13 . . . . 0.0 109.3 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 1.9 m-85 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.452 0.168 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.523 ' CG1' HD13 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -127.43 157.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.154 . . . . 0.0 109.273 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.9 OUTLIER -116.56 147.28 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.309 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.9 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.88 93.74 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 0.0 109.268 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.043 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -107.61 37.65 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.565 1.165 . . . . 0.0 109.368 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.77 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 1.5 m-85 -142.53 -17.73 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.44 1.088 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 55.13 160.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.555 1.159 . . . . 0.0 109.364 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.646 ' HB3' ' CE2' ' A' ' 153' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.525 0 O-C-N 124.511 1.132 . . . . 0.0 111.006 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.862 HD12 ' HD2' ' A' ' 152' ' ' PRO . 5.9 tp -73.52 114.08 28.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 0.0 109.307 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.862 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 120.87 6.22 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.477 1.777 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.695 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 48.4 p90 -130.32 167.89 17.78 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.516 1.135 . . . . 0.0 110.997 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -114.83 172.8 6.82 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 109.293 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.451 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -78.5 83.26 4.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 0.0 109.337 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.9 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.33 20.73 1.74 Allowed Glycine 0 CA--C 1.529 0.916 0 O-C-N 124.488 1.117 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.568 ' C ' HD12 ' A' ' 158' ' ' ILE . 19.5 t0 -85.31 155.42 21.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.415 0.715 . . . . 0.0 109.353 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.649 HD11 ' CZ ' ' A' ' 138' ' ' ARG . 1.8 mp -117.12 130.81 71.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 109.275 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.574 HD22 HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -137.7 -178.87 5.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 0.0 109.263 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.668 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.7 mtm105 -131.24 145.86 52.08 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.508 1.13 . . . . 0.0 110.246 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -88.01 117.76 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.13 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.7 tpp85 -108.48 -48.04 3.4 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 0.0 110.317 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -145.94 -176.4 5.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 109.295 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -176.54 109.16 0.24 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -53.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.526 1.803 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -100.78 -169.85 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.489 1.118 . . . . 0.0 110.286 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.56 -34.0 9.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -73.07 -46.24 52.7 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 0.0 110.263 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.19 137.95 45.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.729 ' O ' ' HA ' ' A' ' 181' ' ' MET . 22.7 m0 -116.92 176.44 5.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 107.983 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -124.53 98.62 5.81 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.846 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -115.49 164.66 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 0.0 109.275 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -106.31 138.45 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.539 1.15 . . . . 0.0 110.263 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.496 ' O ' ' NH2' ' A' ' 160' ' ' ARG . 9.9 t0 -80.69 161.72 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 0.0 109.279 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.7 t -51.09 -21.36 1.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.559 1.162 . . . . 0.0 110.022 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -78.44 -23.63 46.49 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.574 1.171 . . . . 0.0 110.384 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 97.59 31.93 6.52 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.513 1.133 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -103.24 126.63 50.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 0.746 . . . . 0.0 109.317 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.441 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.8 mtp-105 -86.15 111.54 20.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 0.0 110.299 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -144.53 169.78 26.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.501 1.125 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.729 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 mtm -87.82 132.85 34.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.783 . . . . 0.0 111.015 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.738 HD12 ' HG ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -128.22 151.09 75.7 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.46 1.1 . . . . 0.0 109.311 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.693 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.04 141.21 26.24 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.473 1.775 . . . . 0.0 110.964 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 65.0 t -80.78 -32.57 0.67 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.474 1.109 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -37.68 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.542 1.812 . . . . 0.0 111.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.77 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.2 m-85 -87.12 22.48 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.462 1.101 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.1 m -152.75 164.31 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 1.043 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.4 OUTLIER -125.51 -161.82 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.459 1.099 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.451 1.095 . . . . 0.0 109.305 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.486 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 1.4 m-85 . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.519 0.199 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 17.2 m -145.33 147.17 18.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 109.289 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.802 ' HB3' HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -127.17 136.44 52.07 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 0.0 110.285 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.001 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -91.17 138.17 31.8 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.481 1.113 . . . . 0.0 109.226 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.976 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.98 19.6 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.539 1.149 . . . . 0.0 109.336 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.581 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -135.07 -4.7 2.41 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.4 OUTLIER 54.45 163.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 1.7 t80 . . . . . 0 C--N 1.324 -0.523 0 O-C-N 124.498 1.124 . . . . 0.0 111.043 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 143' ' ' PHE . 59.1 m-20 . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.672 HD12 ' N ' ' A' ' 152' ' ' PRO . 0.8 OUTLIER -77.35 119.6 78.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 0.0 109.319 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.672 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.5 Cg_endo -74.92 121.58 6.7 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.463 1.77 . . . . 0.0 111.005 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.629 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 29.3 p90 -134.7 169.52 17.2 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.424 1.077 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.26 175.77 5.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.564 1.165 . . . . 0.0 109.263 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.593 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -78.48 83.4 4.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.573 1.171 . . . . 0.0 109.281 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 1.001 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.81 23.84 2.43 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.52 1.138 . . . . 0.0 111.013 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 27.8 t0 -84.82 158.15 20.75 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.508 0.769 . . . . 0.0 109.37 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 138' ' ' ARG . 10.1 mm -111.12 140.54 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.453 1.095 . . . . 0.0 109.293 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -149.89 -172.8 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.2 mpp_? -137.53 156.88 47.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.255 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -98.93 115.14 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.12 . . . . 0.0 109.293 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.535 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 6.2 ptt85 -104.13 -43.85 5.14 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.555 1.16 . . . . 0.0 110.309 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.535 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -136.86 166.06 24.51 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.539 1.149 . . . . 0.0 109.267 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.27 88.13 2.61 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.371 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -43.86 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.481 1.78 . . . . 0.0 111.029 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.34 -170.59 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 0.0 110.358 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.81 -32.2 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.541 1.15 . . . . 0.0 110.28 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.98 -35.99 64.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.513 1.133 . . . . 0.0 110.277 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.495 ' CZ3' ' CG ' ' A' ' 150' ' ' ASP . 47.6 m95 -122.05 138.77 54.32 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.533 1.146 . . . . 0.0 107.962 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.653 ' CE3' ' CG2' ' A' ' 184' ' ' VAL . 29.5 m0 -120.35 143.8 48.2 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.515 1.134 . . . . 0.0 107.953 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 3.1 t-20 -88.63 92.99 9.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 109.26 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -106.0 166.19 10.67 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.535 1.147 . . . . 0.0 109.3 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.0 mt-10 -115.0 138.58 50.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 0.0 110.346 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 177' ' ' GLY . 3.1 t0 -77.18 160.63 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.519 1.137 . . . . 0.0 109.33 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.4 m -51.16 -21.25 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 0.0 110.038 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.85 -27.99 28.33 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.463 1.102 . . . . 0.0 110.298 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.68 29.64 3.8 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.443 1.089 . . . . 0.0 111.032 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -89.57 114.98 26.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.542 0.789 . . . . 0.0 109.334 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.523 ' CZ ' ' NH1' ' A' ' 162' ' ' ARG . 4.2 mtp180 -86.36 108.58 18.52 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 0.0 110.26 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.84 162.5 29.72 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.393 1.058 . . . . 0.0 110.986 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 5.9 mtm -88.67 147.28 24.6 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 0.75 . . . . 0.0 110.99 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.507 ' CD1' ' CD1' ' A' ' 159' ' ' LEU . 23.0 pt -148.8 163.36 26.14 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.0 138.42 23.01 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.439 1.757 . . . . 0.0 110.999 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.828 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 1.0 OUTLIER -79.81 -31.85 0.69 Allowed Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 0.0 109.365 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.828 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -10.79 21.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.518 1.799 . . . . 0.0 111.027 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.692 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -99.64 -4.52 30.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.485 ' HB ' ' C ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -142.79 170.47 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 109.286 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.976 ' CD ' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -119.52 -171.6 2.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.586 ' NZ ' ' CZ3' ' A' ' 170' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 0.0 109.3 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.55 0.214 . . . . 0.0 110.989 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -127.73 159.43 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.416 1.073 . . . . 0.0 109.281 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.2 tpp85 -124.95 116.41 22.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.303 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.92 114.88 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 0.0 109.284 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.055 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.38 28.95 5.88 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.508 1.13 . . . . 0.0 109.296 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -139.72 -6.87 1.29 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 1.1 . . . . 0.0 111.023 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.578 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 50.42 165.35 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 0.0 109.309 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.659 ' CD2' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.72 HD21 ' CD2' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -106.83 116.26 59.01 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 0.0 109.31 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.659 ' HA ' ' CD2' ' A' ' 143' ' ' PHE . 18.3 Cg_endo -75.04 121.32 6.49 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.469 1.773 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.618 ' CE1' ' HD2' ' A' ' 183' ' ' PRO . 18.1 p90 -119.42 -175.87 3.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 0.0 111.027 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -140.52 164.04 31.23 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.115 . . . . 0.0 109.331 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -65.62 90.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.287 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 118.92 19.92 4.26 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.485 1.116 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 24.9 t0 -84.32 145.98 27.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 0.754 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.746 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.7 mp -111.85 124.67 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.436 1.085 . . . . 0.0 109.29 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.72 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -131.49 -174.95 3.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 0.0 109.309 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.716 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.1 147.67 46.21 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.525 1.14 . . . . 0.0 110.299 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.775 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -86.35 118.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.237 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.6 ttt180 -103.52 -47.37 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 0.0 110.318 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 50.4 m-20 -148.75 158.46 44.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -127.69 85.4 60.87 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 0.0 109.33 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -44.57 0.33 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.517 1.799 . . . . 0.0 110.983 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -109.21 -164.78 0.96 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 0.0 110.316 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -105.71 -55.42 2.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 110.283 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.413 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 15.3 pt20 -77.95 -26.26 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.542 1.151 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 72.5 m95 -106.98 133.19 52.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.483 1.115 . . . . 0.0 108.004 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.648 ' O ' HD13 ' A' ' 182' ' ' ILE . 7.9 m0 -125.76 141.86 51.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 0.0 108.027 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.432 ' HB2' ' HE2' ' A' ' 181' ' ' MET . 9.6 t-20 -91.9 87.52 6.26 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.775 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -104.11 164.29 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.217 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.5 mt-10 -105.91 137.88 43.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.404 1.065 . . . . 0.0 110.323 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.37 167.93 20.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.584 1.178 . . . . 0.0 109.256 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.6 m -57.91 -15.93 10.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -84.67 -21.87 30.06 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 1.083 . . . . 0.0 110.316 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 99.23 28.41 7.67 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.495 1.122 . . . . 0.0 110.989 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -102.21 121.81 42.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.472 0.748 . . . . 0.0 109.283 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -85.21 114.42 22.31 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 110.259 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -145.64 174.52 25.59 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.533 1.146 . . . . 0.0 111.043 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.563 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -86.78 146.62 26.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 0.741 . . . . 0.0 110.972 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -148.79 145.43 19.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.423 1.077 . . . . 0.0 109.325 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.634 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.05 130.68 13.45 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.533 1.807 . . . . 0.0 111.015 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.835 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 16.9 m -74.47 -28.62 0.86 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.127 . . . . 0.0 109.255 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -13.93 21.35 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.434 1.755 . . . . 0.0 110.989 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.712 ' O ' HD12 ' A' ' 140' ' ' LEU . 3.3 m-85 -96.52 -36.4 10.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 0.0 111.005 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' A' ' 139' ' ' ALA . 2.6 m -108.81 173.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.532 1.145 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 1.055 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.7 mt-10 -124.88 -159.69 0.9 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.447 1.092 . . . . 0.0 110.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 0.0 109.295 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 18.3 m-85 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.466 0.174 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 188' ' ' GLU . 10.6 m -147.99 154.94 10.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.488 1.117 . . . . 0.0 109.257 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -133.6 144.68 49.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.542 1.152 . . . . 0.0 110.265 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.929 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.73 128.71 45.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.549 1.156 . . . . 0.0 109.303 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.928 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -120.0 22.03 11.63 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.43 1.082 . . . . 0.0 109.285 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -138.26 -10.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 110.976 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 55.45 154.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.551 1.157 . . . . 0.0 109.34 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.5 t80 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.962 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 HD22 ' A' ' 159' ' ' LEU . 1.4 tp -93.6 114.39 62.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.281 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.03 134.13 17.39 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.509 1.794 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.651 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 18.3 p90 -151.88 171.62 17.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 0.0 110.975 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -108.75 -171.03 1.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.339 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.557 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.79 34.25 0.6 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.459 1.099 . . . . 0.0 109.336 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.929 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.29 39.77 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.432 1.082 . . . . 0.0 111.091 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.677 ' O ' HD12 ' A' ' 158' ' ' ILE . 3.8 m-20 -91.84 166.64 12.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 0.779 . . . . 0.0 109.332 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.677 HD12 ' O ' ' A' ' 157' ' ' ASP . 1.5 mp -128.09 134.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.586 1.179 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.885 HD22 HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -146.01 -178.16 5.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 0.0 109.291 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.729 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.47 146.5 52.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.102 . . . . 0.0 110.272 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.834 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.2 mp -83.94 124.32 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.526 1.141 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -100.22 -51.72 3.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 0.0 110.248 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -150.33 163.59 37.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.298 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HE2' HG23 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -117.39 89.6 32.11 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.122 . . . . 0.0 109.294 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -35.6 3.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.469 1.773 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.15 -160.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.271 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.35 -49.46 2.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -82.39 -22.39 35.43 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 67.4 m95 -110.95 138.94 46.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 0.0 108.033 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.502 ' O ' HG22 ' A' ' 182' ' ' ILE . 24.8 m0 -119.91 134.3 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 0.0 107.946 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.1 OUTLIER -86.88 101.64 13.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.265 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.834 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -118.6 166.61 12.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 109.287 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.459 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 3.3 mt-10 -111.33 133.94 53.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.318 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.466 ' HA ' HD23 ' A' ' 159' ' ' LEU . 4.5 t70 -77.34 164.49 25.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 0.0 109.296 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 92.2 p -53.55 -18.98 3.25 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 0.0 109.992 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.03 -20.92 37.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.495 1.122 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.99 31.75 7.16 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.571 1.169 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -103.09 118.71 37.41 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 0.762 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.5 mtt85 -87.59 115.24 24.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.62 178.42 26.2 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.454 1.096 . . . . 0.0 111.065 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.569 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -85.96 136.39 33.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.524 0.779 . . . . 0.0 110.981 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.723 HG12 HG11 ' A' ' 187' ' ' VAL . 11.6 tt -131.67 142.38 45.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.576 1.172 . . . . 0.0 109.282 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.966 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.97 138.12 22.67 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.435 1.755 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.766 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.5 t -70.81 -36.07 4.96 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.128 . . . . 0.0 109.32 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.766 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.475 1.776 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.623 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -38.43 -27.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 0.0 110.981 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.3 m -118.84 177.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.423 1.077 . . . . 0.0 109.33 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.928 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.8 OUTLIER -135.5 -163.14 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 0.0 110.269 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.3 tptp . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.125 . . . . 0.0 109.24 -179.904 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.481 0.181 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.516 HG22 HD13 ' A' ' 161' ' ' ILE . 31.6 m -124.39 141.06 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 0.0 109.308 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -97.53 -170.0 1.93 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -149.2 94.19 2.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.844 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.75 33.53 1.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 109.311 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.701 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -136.74 -10.63 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 111.073 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.593 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 49.89 165.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.092 . . . . 0.0 109.365 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 111.075 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 169' ' ' TRP . 10.5 m-20 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.929 HD23 HD11 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -108.25 119.13 50.68 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.457 1.098 . . . . 0.0 109.309 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.646 ' N ' HD12 ' A' ' 151' ' ' LEU . 17.9 Cg_endo -75.07 121.32 6.48 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.527 1.804 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.765 ' CD2' ' HB1' ' A' ' 139' ' ' ALA . 38.0 p90 -117.44 170.47 8.7 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.524 1.14 . . . . 0.0 111.032 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 139' ' ' ALA . 3.0 mptt -108.36 -179.96 4.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.449 1.093 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.497 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.99 85.62 7.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 109.272 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.33 23.21 2.68 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.445 1.091 . . . . 0.0 111.017 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.6 t70 -83.91 157.28 22.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.551 0.795 . . . . 0.0 109.338 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.4 mp -114.08 131.77 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.58 1.175 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD2' HD21 ' A' ' 151' ' ' LEU . 3.1 mp -144.48 133.92 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 0.0 109.271 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.713 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -91.58 143.36 26.65 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.1 mp -87.06 116.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.56 1.162 . . . . 0.0 109.295 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -109.28 -34.79 6.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.435 ' HB2' ' CD ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -138.64 155.72 48.06 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.553 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 6.5 ttpt -143.59 88.74 7.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 109.296 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.04 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.502 1.791 . . . . 0.0 110.978 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -101.18 -168.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 168' ' ' GLN . 21.4 pt-20 -105.44 -43.0 5.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.473 1.108 . . . . 0.0 110.344 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.424 ' N ' ' HG3' ' A' ' 167' ' ' GLU . 17.9 pt20 -62.86 -39.15 93.54 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.588 1.18 . . . . 0.0 110.326 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.512 ' CZ3' ' HB3' ' A' ' 150' ' ' ASP . 31.5 m95 -124.94 145.61 49.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 181' ' ' MET . 25.0 m0 -123.07 -179.61 4.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.68 104.23 7.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -123.92 167.55 13.97 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.4 1.062 . . . . 0.0 109.244 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.2 mt-10 -108.93 134.01 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.58 160.53 32.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.1 m -53.06 -19.83 3.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.122 . . . . 0.0 110.06 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.2 -26.81 35.66 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.565 1.165 . . . . 0.0 110.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.9 31.04 4.31 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.543 1.152 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.2 mmtp -99.56 121.07 40.66 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.547 0.793 . . . . 0.0 109.343 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.45 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 3.0 mtt85 -85.8 111.09 19.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 0.0 110.282 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.14 -175.52 20.86 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.559 1.162 . . . . 0.0 111.056 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.761 ' C ' HD12 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -88.24 146.02 25.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.929 HD11 HD23 ' A' ' 151' ' ' LEU . 4.2 mp -139.62 145.14 42.14 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.826 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -75.05 152.49 40.59 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.477 1.777 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.4 t -87.05 -39.21 0.52 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.504 1.792 . . . . 0.0 110.963 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.701 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.4 m-85 -80.65 40.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.474 1.109 . . . . 0.0 111.019 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 184' ' ' VAL . 18.2 m -155.63 164.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.579 1.174 . . . . 0.0 109.297 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.844 ' CG ' HD11 ' A' ' 140' ' ' LEU . 7.3 mm-40 -138.2 -168.45 2.37 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.55 1.156 . . . . 0.0 110.353 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.4 mptt . . . . . 0 C--N 1.324 -0.525 0 O-C-N 124.567 1.167 . . . . 0.0 109.273 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.591 ' CD1' ' HG3' ' A' ' 160' ' ' ARG . 5.7 m-85 . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.495 0.188 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.447 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 3.9 m -137.27 166.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.3 ptp180 -127.9 164.32 22.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 110.229 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.685 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.14 93.74 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.115 . . . . 0.0 109.344 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.891 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -96.53 25.23 5.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.442 1.089 . . . . 0.0 109.312 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.73 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.79 -11.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 110.987 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.522 ' OD1' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.79 159.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 0.0 109.287 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.66 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 44.1 t80 . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.157 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.849 ' CD2' HD23 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -70.43 117.63 56.77 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.436 1.085 . . . . 0.0 109.355 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.67 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -74.99 128.14 11.25 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.487 1.783 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.677 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 10.2 p90 -137.22 152.98 50.47 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.478 1.111 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.522 ' CG ' ' OD1' ' A' ' 142' ' ' ASP . 7.9 mtpt -155.82 149.47 25.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER 46.75 91.01 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 0.0 109.301 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 27.85 45.2 0.04 OUTLIER Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.508 1.13 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -43.78 168.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.536 0.786 . . . . 0.0 109.269 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 158' ' ' ILE . 21.0 mm -118.08 127.63 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.512 1.132 . . . . 0.0 109.261 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.849 HD23 ' CD2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -143.23 177.75 8.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.494 1.121 . . . . 0.0 109.326 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.723 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.1 mpp_? -135.9 153.66 51.38 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.131 . . . . 0.0 110.255 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.538 HG13 ' CE ' ' A' ' 164' ' ' LYS . 1.2 mp -86.09 118.93 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.543 1.152 . . . . 0.0 109.308 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.83 -54.06 2.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.566 1.166 . . . . 0.0 110.301 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 171' ' ' ASN . 5.1 m-20 -149.75 123.9 9.48 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.583 ' CD ' ' CG ' ' A' ' 170' ' ' TRP . 8.5 mmtt -114.0 94.31 33.64 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 0.0 109.311 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.473 1.775 . . . . 0.0 111.008 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -115.54 -173.03 2.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.256 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.18 -29.91 10.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.426 1.079 . . . . 0.0 110.311 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.85 -50.48 70.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.582 1.176 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.471 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 17.3 m95 -122.08 151.15 41.19 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.583 1.177 . . . . 0.0 108.008 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.583 ' CG ' ' CD ' ' A' ' 164' ' ' LYS . 8.7 m0 -127.3 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 163' ' ' ASP . 6.1 t-20 -94.15 91.37 6.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.723 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -104.85 165.74 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 0.0 109.323 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.7 mt-10 -108.51 143.72 37.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 0.0 110.273 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.444 ' HB2' HD13 ' A' ' 151' ' ' LEU . 29.8 t0 -78.3 165.75 23.5 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 109.345 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.1 t -56.88 -17.65 10.23 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 0.0 110.049 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.21 -27.22 26.25 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.468 1.105 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 107.78 29.92 4.2 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.433 1.083 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -97.79 122.8 41.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 0.797 . . . . 0.0 109.295 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.443 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.8 mtp180 -85.42 114.71 22.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.564 1.165 . . . . 0.0 110.261 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.32 167.75 29.04 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.455 1.097 . . . . 0.0 111.028 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 1.5 mtt -87.91 147.78 24.91 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 0.777 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.637 ' C ' HD12 ' A' ' 182' ' ' ILE . 2.3 pp -148.72 160.71 35.17 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.451 1.094 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.99 147.61 34.21 Favored 'Trans proline' 0 C--N 1.359 1.095 0 O-C-N 124.528 1.804 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.0 t -80.9 -37.17 0.94 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.04 -66.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.73 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.0 OUTLIER -42.53 -22.05 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.454 1.096 . . . . 0.0 110.994 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.5 m -113.17 172.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.891 ' CG ' HD11 ' A' ' 140' ' ' LEU . 6.0 mm-40 -142.77 -166.91 2.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 110.247 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 C--N 1.326 -0.42 0 O-C-N 124.475 1.11 . . . . 0.0 109.352 179.931 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.51 0.195 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.799 HG12 ' HG2' ' A' ' 189' ' ' LYS . 18.2 m -133.06 142.54 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 0.0 109.292 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.713 ' O ' ' HB ' ' A' ' 187' ' ' VAL . 2.6 ptp180 -115.84 170.62 8.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.833 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.78 137.5 54.67 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.477 1.111 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.014 HD21 ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.55 22.57 4.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 0.0 109.296 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.665 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.6 OUTLIER -139.87 -3.26 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 0.0 110.963 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 51.35 166.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 0.0 109.343 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.88 HD12 ' HD2' ' A' ' 152' ' ' PRO . 9.9 tp -95.73 115.92 65.87 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.111 . . . . 0.0 109.241 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.88 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 125.34 9.25 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.682 ' HB3' HD11 ' A' ' 182' ' ' ILE . 31.5 p90 -131.94 178.13 7.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.501 1.126 . . . . 0.0 111.012 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -124.81 -176.43 3.54 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.152 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.527 ' HB3' ' CG ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -83.08 42.82 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 0.0 109.238 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 161.69 39.26 0.02 OUTLIER Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.549 1.156 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.721 ' OD2' HD11 ' A' ' 159' ' ' LEU . 37.4 t70 -100.42 156.07 17.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.408 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.3 mp -118.24 129.31 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.149 . . . . 0.0 109.299 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.721 HD11 ' OD2' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -145.41 136.71 24.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.57 1.168 . . . . 0.0 109.28 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.677 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 12.2 ptm180 -90.12 147.76 23.41 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.484 1.115 . . . . 0.0 110.301 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -91.35 118.48 36.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 109.326 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.525 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 9.2 ptt85 -101.22 -44.22 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 1.092 . . . . 0.0 110.264 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 35.7 t0 -150.91 171.73 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 0.0 109.274 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.579 ' HG2' ' CD1' ' A' ' 170' ' ' TRP . 1.1 mptt -135.87 122.48 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.546 1.154 . . . . 0.0 109.275 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 181' ' ' MET . 18.3 Cg_endo -75.02 -47.63 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 O-C-N 124.434 1.755 . . . . 0.0 111.037 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -123.47 -100.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 110.391 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.74 -67.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 110.334 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.604 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 7.6 pt20 -53.87 -38.14 64.43 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.528 1.142 . . . . 0.0 110.283 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CD1' ' HG3' ' A' ' 168' ' ' GLN . 80.7 m95 -102.47 128.44 49.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 108.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.579 ' CD1' ' HG2' ' A' ' 164' ' ' LYS . 37.5 m0 -115.44 140.35 49.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.595 1.184 . . . . 0.0 108.006 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.85 98.4 11.46 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.596 1.185 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.9 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.62 165.62 12.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.0 mt-10 -108.23 133.41 52.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 110.269 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.526 ' HA ' HD23 ' A' ' 159' ' ' LEU . 1.2 t0 -73.47 160.7 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 0.0 109.252 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.9 p -50.84 -21.24 1.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 109.977 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -83.24 -29.62 28.32 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 0.0 110.285 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.87 31.66 3.08 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.504 1.127 . . . . 0.0 111.036 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.0 OUTLIER -94.77 117.97 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.428 0.723 . . . . 0.0 109.236 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.4 mtp180 -86.09 108.43 18.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.396 1.06 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.26 174.04 30.55 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.529 1.143 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.437 ' CG ' ' HG3' ' A' ' 165' ' ' PRO . 24.2 mtp -87.84 146.27 25.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.589 0.817 . . . . 0.0 110.995 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.705 HD12 ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -139.06 150.63 65.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.4 1.062 . . . . 0.0 109.285 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.829 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -74.96 136.32 20.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.49 1.784 . . . . 0.0 110.967 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.8 t -69.35 -36.87 7.71 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.141 . . . . 0.0 109.31 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -69.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.474 1.776 . . . . 0.0 110.961 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.665 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.9 OUTLIER -44.14 -18.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.1 m -117.71 162.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 0.0 109.314 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 1.014 ' HG3' HD21 ' A' ' 140' ' ' LEU . 5.5 mm-40 -115.41 -170.89 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.558 1.162 . . . . 0.0 110.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.799 ' HG2' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 0.0 109.316 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 11.6 m-85 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.474 0.178 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.523 ' O ' HD12 ' A' ' 158' ' ' ILE . 4.6 m -133.95 140.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.432 1.082 . . . . 0.0 109.318 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 15.0 tpp85 -113.9 115.11 27.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.484 1.115 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.024 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.32 124.75 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.511 1.132 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.954 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -139.42 34.0 2.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.719 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.2 t80 -129.77 -15.97 3.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 111.037 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 53.59 159.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 0.0 109.295 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.65 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.998 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 181' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.797 HD21 ' CD2' ' A' ' 159' ' ' LEU . 0.6 OUTLIER -98.2 117.03 65.43 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.255 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.676 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.04 120.66 6.15 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.454 1.765 . . . . 0.0 110.953 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.65 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.5 p90 -117.31 168.66 10.14 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -126.9 8.0 6.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 0.0 109.251 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 88.28 137.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.559 1.162 . . . . 0.0 109.28 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 1.024 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 81.19 20.11 65.48 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 124.504 1.127 . . . . 0.0 111.029 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.792 ' CG ' ' HB3' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -99.88 113.79 26.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.443 0.731 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 137' ' ' VAL . 5.3 tp -88.57 126.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.432 1.083 . . . . 0.0 109.299 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -130.99 -174.44 3.38 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.482 1.114 . . . . 0.0 109.266 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.597 ' HG3' ' N ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -127.23 144.7 50.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.531 1.144 . . . . 0.0 110.329 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -84.5 116.1 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.52 1.137 . . . . 0.0 109.284 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 -49.05 2.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.4 161.96 28.24 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 109.328 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.554 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -154.66 85.71 3.65 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -38.81 1.42 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.468 1.772 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -118.34 -175.98 2.98 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.5 -30.84 9.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 0.0 110.316 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -76.87 -38.57 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.119 . . . . 0.0 110.316 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.475 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 60.9 m95 -117.24 139.09 51.23 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 108.015 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.554 ' CD1' ' HG3' ' A' ' 164' ' ' LYS . 34.1 m0 -120.86 144.33 48.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 0.0 108.016 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -91.36 95.76 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.57 1.169 . . . . 0.0 109.316 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.602 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -107.46 156.98 18.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.454 1.096 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.2 mt-10 -106.38 132.77 52.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.114 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.747 ' OD1' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -75.57 162.69 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.58 1.175 . . . . 0.0 109.281 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.2 t -50.96 -20.95 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.52 1.137 . . . . 0.0 110.059 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.38 -27.91 41.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.463 1.102 . . . . 0.0 110.251 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 103.42 30.94 5.13 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.512 1.133 . . . . 0.0 111.032 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 11.1 ptmt -101.9 122.12 43.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 0.763 . . . . 0.0 109.254 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.457 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.73 116.08 24.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 0.0 110.29 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -146.34 152.55 24.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.485 1.115 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 10.4 mtp -87.19 131.21 34.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 0.802 . . . . 0.0 111.019 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.632 ' CD1' HD13 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -132.26 165.26 37.43 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 0.0 109.271 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.758 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.98 133.05 16.15 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 111.015 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.833 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.8 t -78.04 -31.5 0.8 Allowed Pre-proline 0 C--N 1.324 -0.539 0 O-C-N 124.523 1.139 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.833 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.99 -19.91 17.39 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.518 1.799 . . . . 0.0 110.97 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.758 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.54 -0.34 52.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.963 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 139' ' ' ALA . 7.1 m -135.04 169.77 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.433 1.083 . . . . 0.0 109.322 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.954 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.2 mt-10 -125.26 -158.36 0.83 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.534 1.146 . . . . 0.0 110.223 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt . . . . . 0 C--N 1.326 -0.426 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 22.2 m-85 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.443 0.163 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.908 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.6 m -146.35 148.03 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.487 1.117 . . . . 0.0 109.325 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.768 HH21 ' N ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -113.75 112.86 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.367 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.95 121.41 30.32 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.531 1.144 . . . . 0.0 109.254 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.923 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.03 27.24 7.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.719 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -133.83 -17.16 2.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER 54.19 156.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.564 1.165 . . . . 0.0 109.239 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.511 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.074 HD21 HD22 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -105.53 118.57 55.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 0.0 109.323 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.04 130.1 12.92 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.538 1.809 . . . . 0.0 110.984 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 42.2 p90 -134.35 175.9 9.1 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.518 1.136 . . . . 0.0 110.983 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -129.33 -176.83 4.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.294 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.503 ' HG2' ' HA ' ' A' ' 140' ' ' LEU . 1.4 tmpt? -82.32 82.9 7.63 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.413 1.07 . . . . 0.0 109.285 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 123.69 29.39 1.17 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.468 1.105 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.57 ' OD2' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -100.16 129.8 46.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.456 0.739 . . . . 0.0 109.294 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.908 HD13 ' O ' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -99.26 120.8 49.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.487 1.117 . . . . 0.0 109.343 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 1.074 HD22 HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -118.14 -173.32 2.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.445 1.091 . . . . 0.0 109.314 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 2.9 mpt_? -129.3 141.87 50.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.288 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.2 mp -87.88 116.03 29.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.451 1.094 . . . . 0.0 109.262 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.06 -48.91 4.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -148.96 165.37 31.81 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.464 1.103 . . . . 0.0 109.273 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.546 ' HE2' ' CD2' ' A' ' 170' ' ' TRP . 25.7 mttt -138.35 95.34 10.38 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.112 . . . . 0.0 109.256 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -29.13 8.48 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.497 1.788 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -128.27 -171.14 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.115 . . . . 0.0 110.376 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.77 -27.59 9.24 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 110.256 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -80.96 -36.22 31.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.451 1.094 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.506 ' CE3' ' C ' ' A' ' 182' ' ' ILE . 35.3 m95 -124.22 143.92 50.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 107.991 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.645 ' CD2' HG22 ' A' ' 184' ' ' VAL . 54.5 m0 -119.88 146.53 45.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 0.0 108.064 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -87.55 92.83 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.583 1.177 . . . . 0.0 109.339 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -103.48 164.63 11.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.565 1.166 . . . . 0.0 109.304 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 1.9 mt-10 -112.5 135.01 53.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 0.0 110.277 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.853 ' OD1' HD11 ' A' ' 151' ' ' LEU . 1.1 t0 -73.15 158.17 35.8 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.518 1.136 . . . . 0.0 109.347 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.3 p -49.49 -22.06 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.529 1.143 . . . . 0.0 109.926 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -82.84 -29.79 29.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 112.06 30.99 2.78 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.496 1.123 . . . . 0.0 111.022 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -92.33 116.79 29.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.532 0.783 . . . . 0.0 109.278 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.484 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.4 mtp-105 -86.32 108.94 18.65 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.292 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.2 162.25 29.41 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.492 1.12 . . . . 0.0 111.002 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.7 mtp -87.62 137.36 32.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.504 0.767 . . . . 0.0 110.999 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.762 HD13 HD13 ' A' ' 159' ' ' LEU . 9.2 pt -133.33 168.98 15.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.421 1.075 . . . . 0.0 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.643 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 141.57 26.75 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 0.0 110.973 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.793 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 79.9 t -78.94 -34.16 0.94 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.521 1.138 . . . . 0.0 109.214 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.793 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.54 1.811 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.719 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.4 m-85 -31.55 -35.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.571 1.17 . . . . 0.0 110.979 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -115.88 172.35 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.475 1.11 . . . . 0.0 109.273 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.923 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -123.62 -173.24 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 110.317 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 0.0 109.312 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.514 0.197 . . . . 0.0 110.949 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.02 ' O ' HD12 ' A' ' 158' ' ' ILE . 1.6 m -128.77 158.39 41.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 109.277 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.703 HH21 HD13 ' A' ' 158' ' ' ILE . 2.9 tpp85 -129.36 121.46 27.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 110.324 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.846 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.24 126.48 34.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.452 1.095 . . . . 0.0 109.328 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.043 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.99 25.06 4.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.557 1.161 . . . . 0.0 109.308 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -143.03 0.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 111.026 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 141' ' ' PHE . 1.3 m-20 51.6 166.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.327 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 8.2 t80 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.495 1.122 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.604 ' OD2' ' CH2' ' A' ' 169' ' ' TRP . 89.1 m-20 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.75 HD23 HD13 ' A' ' 159' ' ' LEU . 1.2 tp -79.31 121.56 83.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.561 1.163 . . . . 0.0 109.314 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.646 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.95 130.91 13.77 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.517 1.799 . . . . 0.0 110.981 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.656 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 23.6 p90 -147.97 167.54 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.456 1.098 . . . . 0.0 111.025 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -125.66 173.34 9.07 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.479 1.112 . . . . 0.0 109.234 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.86 ' O ' ' HG2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -64.44 94.55 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.846 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.63 11.0 4.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.56 1.163 . . . . 0.0 110.994 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.698 ' HB2' ' HB3' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -75.51 153.44 37.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.591 0.818 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.02 HD12 ' O ' ' A' ' 137' ' ' VAL . 8.5 tp -134.68 129.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.75 HD13 HD23 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -138.08 177.75 7.64 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 109.269 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.703 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -123.68 140.19 53.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.402 1.064 . . . . 0.0 110.31 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 1.029 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -84.12 118.65 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.52 1.138 . . . . 0.0 109.288 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.553 ' CZ ' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -103.18 -46.39 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 0.0 110.343 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -146.98 163.24 36.84 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 0.0 109.261 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 118.28 6.25 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.483 1.114 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.522 ' CD ' ' HE1' ' A' ' 181' ' ' MET . 18.2 Cg_endo -74.99 -65.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.451 1.764 . . . . 0.0 111.02 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -102.86 -105.76 0.27 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.551 1.157 . . . . 0.0 110.321 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.37 -46.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.519 1.137 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -54.99 -39.82 69.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 0.0 110.321 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CH2' ' OD2' ' A' ' 150' ' ' ASP . 24.1 m95 -118.66 144.77 45.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.615 ' CD2' HG22 ' A' ' 184' ' ' VAL . 41.3 m0 -124.78 148.5 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.424 ' CA ' ' HE3' ' A' ' 181' ' ' MET . 61.1 t-20 -99.5 101.76 13.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.475 1.109 . . . . 0.0 109.308 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 1.029 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -119.12 164.5 15.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 3.3 mt-10 -104.46 133.73 48.85 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 1.156 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.441 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 21.2 t0 -74.6 164.65 26.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.5 t -53.98 -18.86 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.028 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -81.97 -24.85 35.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 110.253 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.96 27.39 7.03 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.51 1.131 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.48 ' HD2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -99.43 121.15 40.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.474 0.749 . . . . 0.0 109.307 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.553 ' NH1' ' CZ ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -85.82 112.18 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 0.0 110.327 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.8 170.88 28.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.522 ' HE1' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -88.87 143.15 27.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 0.773 . . . . 0.0 110.971 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -139.64 160.28 61.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.467 1.105 . . . . 0.0 109.313 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.94 145.74 32.05 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.464 1.771 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.741 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.6 t -79.45 -37.74 1.21 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.498 1.124 . . . . 0.0 109.308 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.741 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.0 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.454 1.765 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.637 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.9 OUTLIER -32.3 -35.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.529 1.143 . . . . 0.0 110.971 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -112.09 169.18 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 0.0 109.316 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 1.043 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.5 mt-10 -126.61 -157.78 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.528 1.143 . . . . 0.0 110.307 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.582 1.176 . . . . 0.0 109.327 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 18.2 m-85 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.5 0.191 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 13.4 m -146.92 147.97 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 109.366 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 3.6 ptp180 -117.56 119.57 35.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.537 1.148 . . . . 0.0 110.308 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.043 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.24 100.04 12.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 0.0 109.251 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.904 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -98.38 36.27 1.64 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.414 1.071 . . . . 0.0 109.318 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.645 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -140.2 -11.61 1.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.597 1.186 . . . . 0.0 111.036 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 52.38 158.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.188 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.477 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 2.0 t80 . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 0.0 110.975 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 152' ' ' PRO . 0.9 OUTLIER -108.22 118.29 52.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.664 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.06 123.29 7.74 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.503 1.791 . . . . 0.0 110.984 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.688 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 21.8 p90 -125.02 -179.26 4.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.13 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -114.46 -176.53 2.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.498 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -81.44 66.07 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.336 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 1.043 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.04 35.56 0.62 Allowed Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.498 1.124 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.628 ' OD2' HD21 ' A' ' 159' ' ' LEU . 4.3 t70 -85.2 139.85 31.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 0.764 . . . . 0.0 109.274 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.404 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 8.9 mm -93.92 134.58 31.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.485 1.116 . . . . 0.0 109.315 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.628 HD21 ' OD2' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -143.77 172.37 12.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 0.0 109.312 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 9.6 ttt180 -113.34 139.65 48.69 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 0.0 110.334 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.935 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -90.55 111.36 23.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 0.0 109.23 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -53.66 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.337 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -150.31 -179.84 7.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.563 1.164 . . . . 0.0 109.303 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.597 ' CB ' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -162.62 111.97 1.09 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 0.0 109.252 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -57.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.484 1.781 . . . . 0.0 110.996 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.0 -121.85 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 0.0 110.342 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 -46.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.549 1.155 . . . . 0.0 110.3 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -66.19 -17.18 64.57 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.537 1.148 . . . . 0.0 110.284 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.507 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 79.1 m95 -133.17 132.77 41.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.494 1.122 . . . . 0.0 108.028 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 184' ' ' VAL . 20.8 m0 -124.75 139.72 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.49 ' CB ' ' HE3' ' A' ' 181' ' ' MET . 36.9 t-20 -87.24 100.46 12.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.57 1.169 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.935 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.41 167.46 10.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 109.359 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.7 mt-10 -112.46 124.82 53.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.438 1.086 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 159' ' ' LEU . 2.3 t70 -66.64 161.53 23.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 0.0 109.326 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.0 p -52.48 -20.57 2.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.118 . . . . 0.0 109.962 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -78.5 -25.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.125 . . . . 0.0 110.291 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.28 31.25 5.95 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.535 1.147 . . . . 0.0 110.991 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.647 ' HE2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -104.2 124.74 49.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 0.773 . . . . 0.0 109.274 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.44 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 2.5 mtm180 -85.4 113.46 21.71 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.482 1.114 . . . . 0.0 110.319 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -145.22 176.7 24.1 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.544 1.153 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.494 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -88.39 144.61 26.28 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 0.746 . . . . 0.0 111.05 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.489 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 12.8 tt -144.53 140.74 16.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.265 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.595 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.89 139.3 24.43 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.421 1.748 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.809 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 3.0 t -81.9 -31.82 0.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 0.0 109.305 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.809 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -74.96 -26.76 10.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.415 1.745 . . . . 0.0 111.02 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.691 HG12 ' CB ' ' A' ' 139' ' ' ALA . 1.5 m -146.86 -174.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 109.35 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.904 ' CD ' HD21 ' A' ' 140' ' ' LEU . 3.2 mt-10 -134.13 -171.05 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 110.366 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.422 1.076 . . . . 0.0 109.317 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.598 0.237 . . . . 0.0 111.005 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 158' ' ' ILE . 6.1 m -148.13 142.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.386 1.054 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.73 HH21 HD13 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -106.49 146.33 30.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.46 1.1 . . . . 0.0 110.362 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.958 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -115.41 97.94 6.45 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.573 1.171 . . . . 0.0 109.269 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.864 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -108.89 30.62 6.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 0.0 109.348 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.753 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -133.77 -17.71 2.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 0.0 110.981 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER 54.31 159.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.457 1.098 . . . . 0.0 109.269 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.586 ' CE1' ' OD1' ' A' ' 150' ' ' ASP . 2.4 t80 . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 0.0 110.969 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 143' ' ' PHE . 2.8 p30 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.9 HD12 ' HD2' ' A' ' 152' ' ' PRO . 14.2 tp -74.01 117.28 60.06 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.9 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.03 117.5 4.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.541 1.811 . . . . 0.0 110.959 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.67 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 49.6 p90 -125.72 178.51 5.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 0.0 111.034 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 139' ' ' ALA . 12.5 mttm -125.77 179.69 5.06 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.53 1.144 . . . . 0.0 109.287 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.708 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.73 79.83 9.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 0.0 109.283 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.958 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 134.11 21.33 0.78 Allowed Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.509 1.131 . . . . 0.0 111.027 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 17.6 t70 -90.67 147.04 23.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.42 0.717 . . . . 0.0 109.313 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.73 HD13 HH21 ' A' ' 138' ' ' ARG . 7.6 tp -111.19 136.71 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.531 1.145 . . . . 0.0 109.294 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.623 HD22 HD13 ' A' ' 182' ' ' ILE . 0.4 OUTLIER -142.35 166.8 23.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.114 . . . . 0.0 109.299 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.653 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -115.61 146.82 41.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.483 1.114 . . . . 0.0 110.308 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.851 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -88.04 121.74 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 0.0 109.304 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.439 ' CD ' ' HD3' ' A' ' 179' ' ' ARG . 11.6 ttm-85 -106.15 -45.76 4.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.45 1.094 . . . . 0.0 110.296 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -148.96 152.2 35.92 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.461 1.1 . . . . 0.0 109.334 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -141.1 90.09 9.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 0.0 109.341 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 -55.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.486 1.782 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.02 -177.08 5.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 110.353 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.84 5.91 20.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 0.0 110.331 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.36 -48.13 2.81 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.457 1.098 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.593 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 48.2 m95 -105.07 143.11 33.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.544 1.153 . . . . 0.0 108.038 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.565 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 15.5 m0 -127.11 136.15 51.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 108.027 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.3 m-80 -88.5 96.33 10.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.547 1.154 . . . . 0.0 109.29 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.851 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -109.99 160.79 16.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 0.0 109.255 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -103.03 129.36 49.78 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.47 1.106 . . . . 0.0 110.282 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.95 162.03 30.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 109.249 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.5 t -52.18 -20.3 2.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 0.0 109.951 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.97 -24.09 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.94 30.18 6.87 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.509 1.131 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.5 pttt -105.17 124.8 50.16 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.537 0.786 . . . . 0.0 109.256 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HD3' ' CD ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -85.38 114.07 22.15 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.56 1.163 . . . . 0.0 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -146.22 176.9 24.91 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.39 1.056 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.593 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.7 OUTLIER -86.29 143.58 27.83 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.466 0.745 . . . . 0.0 111.031 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.623 HD13 HD22 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -142.81 144.83 31.21 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 0.0 109.279 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.785 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.05 139.31 24.0 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.459 1.768 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 78.3 t -80.91 -32.3 0.65 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.343 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -35.65 3.02 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.52 1.8 . . . . 0.0 111.04 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.753 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 1.6 m-85 -88.13 15.05 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.4 m -152.86 164.06 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.122 . . . . 0.0 109.302 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.864 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.5 OUTLIER -119.56 -162.83 0.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.239 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 O-C-N 124.507 1.129 . . . . 0.0 109.346 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 63.3 m-85 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.453 0.168 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.552 HG13 HD13 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -135.53 164.22 33.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.555 1.159 . . . . 0.0 109.33 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 18.2 tpp85 -119.94 156.18 31.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.432 1.082 . . . . 0.0 110.314 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -130.02 83.26 2.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.278 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.916 HD21 ' OE1' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -101.13 22.75 11.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 0.0 109.351 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.783 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -123.56 -18.93 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 111.016 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.88 152.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.52 1.138 . . . . 0.0 109.249 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.534 1.146 . . . . 0.0 110.996 -179.979 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 169' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.895 HD21 HD22 ' A' ' 159' ' ' LEU . 3.0 tp -99.9 120.73 56.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.696 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.06 138.88 23.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.501 1.79 . . . . 0.0 111.04 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.867 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 8.3 p90 -160.78 -178.26 6.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER 170.73 146.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.305 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.23 68.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 37.97 50.15 2.07 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.485 1.115 . . . . 0.0 110.941 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.875 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -58.54 135.63 57.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 0.0 109.366 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.447 HD11 ' NH2' ' A' ' 138' ' ' ARG . 2.1 mm -99.35 122.65 51.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.503 1.127 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.895 HD22 HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -128.46 -177.61 4.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 0.0 109.328 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.611 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -128.31 144.86 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 110.256 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.552 HD13 HG13 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -86.45 116.03 28.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 0.0 109.299 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -105.56 -52.0 2.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.55 1.156 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.35 168.13 25.02 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.502 1.126 . . . . 0.0 109.199 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -140.48 114.39 7.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.443 1.089 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -73.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -98.76 -99.74 0.22 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.13 -50.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 0.0 110.339 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -52.81 -43.61 66.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.522 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 69.7 m95 -115.21 142.42 46.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 108.015 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.486 ' CD2' HG22 ' A' ' 184' ' ' VAL . 33.8 m0 -121.16 145.43 47.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.451 ' ND2' ' SD ' ' A' ' 181' ' ' MET . 3.8 t-20 -91.04 94.46 9.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 109.354 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -110.08 164.37 12.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.139 . . . . 0.0 109.273 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -110.37 134.19 52.54 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.33 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.451 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 6.2 t70 -74.56 165.4 25.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.3 t -56.04 -17.49 7.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.138 . . . . 0.0 109.953 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.53 -22.52 32.39 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.461 1.1 . . . . 0.0 110.246 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.72 32.11 6.08 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.546 1.154 . . . . 0.0 110.991 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.637 ' HD2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -102.79 123.06 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 0.771 . . . . 0.0 109.356 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.449 ' NE ' ' OE2' ' A' ' 173' ' ' GLU . 5.3 mtt85 -86.28 115.22 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.11 167.37 28.94 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.541 1.151 . . . . 0.0 111.015 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 41.2 mmm -88.93 138.82 31.06 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.548 0.793 . . . . 0.0 111.005 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.705 ' O ' HD12 ' A' ' 182' ' ' ILE . 2.3 pp -135.24 155.75 78.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.556 1.16 . . . . 0.0 109.294 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.711 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.3 Cg_endo -74.95 138.52 23.27 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.462 1.769 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 51.3 t -78.67 -32.76 0.84 Allowed Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 109.305 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.01 2.81 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.405 1.739 . . . . 0.0 110.986 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.783 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 2.4 m-85 -90.01 23.43 2.8 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.775 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.3 m -152.55 157.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 0.0 109.317 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.916 ' OE1' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -113.77 -164.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 110.334 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 0.0 109.245 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 32.3 m-85 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.486 0.184 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -131.02 162.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.512 1.133 . . . . 0.0 109.232 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 10.4 tpp85 -129.98 112.64 13.7 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 110.348 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.083 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -84.13 117.1 23.25 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.967 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -127.32 25.44 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 0.0 109.263 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.23 -15.77 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 0.0 110.983 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.556 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 0.8 OUTLIER 53.91 161.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 0.0 109.324 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.5 1.125 . . . . 0.0 110.949 179.968 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.591 ' CG ' ' CH2' ' A' ' 169' ' ' TRP . 7.5 m-20 . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.985 HD23 HD11 ' A' ' 182' ' ' ILE . 5.4 tp -83.28 123.42 77.11 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 0.0 109.287 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.894 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.98 164.68 32.9 Favored 'Trans proline' 0 C--N 1.362 1.24 0 O-C-N 124.519 1.8 . . . . 0.0 111.043 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.522 ' CE2' HG23 ' A' ' 182' ' ' ILE . 28.5 p90 179.11 179.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 1.146 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 9.7 mttt -113.16 -177.51 3.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.257 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -94.07 77.91 4.07 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.531 1.145 . . . . 0.0 109.256 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 1.083 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 146.07 19.72 0.13 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.482 1.114 . . . . 0.0 110.994 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.82 163.77 13.93 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 0.0 109.344 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.506 HG23 HH21 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -118.42 128.22 75.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.244 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.603 HD13 HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -132.89 -174.17 3.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.502 1.127 . . . . 0.0 109.281 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.663 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.3 ptp180 -133.34 150.1 51.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 110.265 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -94.09 115.9 34.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.529 1.143 . . . . 0.0 109.29 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HD2' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -96.29 -54.64 3.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 0.0 110.318 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.448 ' C ' ' HG2' ' A' ' 164' ' ' LYS . 0.4 OUTLIER -151.31 174.21 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.522 1.139 . . . . 0.0 109.322 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HZ1' HG13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -127.86 100.46 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 109.337 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 170' ' ' TRP . 18.2 Cg_endo -74.98 -38.21 1.7 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.499 1.789 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -134.55 -165.77 1.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.522 1.139 . . . . 0.0 110.328 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -93.07 -71.48 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.511 1.132 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 169' ' ' TRP . 1.6 pt20 -61.74 -27.67 68.89 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.484 1.115 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.591 ' CH2' ' CG ' ' A' ' 150' ' ' ASP . 37.3 m95 -108.55 137.82 45.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.491 1.119 . . . . 0.0 108.043 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.658 ' O ' ' HA ' ' A' ' 181' ' ' MET . 9.1 m0 -123.72 175.06 7.08 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.458 1.099 . . . . 0.0 108.059 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -124.91 96.07 4.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 0.0 109.248 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.918 ' HB3' HD12 ' A' ' 182' ' ' ILE . . . -109.74 168.21 9.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 0.0 109.326 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.494 ' CD ' ' NH1' ' A' ' 179' ' ' ARG . 2.0 mt-10 -113.38 139.44 48.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 151' ' ' LEU . 4.9 t70 -78.0 161.73 27.28 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.57 -20.26 1.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.141 . . . . 0.0 110.027 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.46 -26.51 41.71 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 0.0 110.274 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 102.4 26.04 7.49 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.523 1.14 . . . . 0.0 110.991 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.783 ' HD3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.36 128.57 40.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 0.754 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.494 ' NH1' ' CD ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -86.03 116.71 24.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 0.0 110.336 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.5 170.89 30.39 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.456 1.097 . . . . 0.0 111.005 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.658 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.7 mtt -86.35 144.65 27.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 0.0 110.951 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.985 HD11 HD23 ' A' ' 151' ' ' LEU . 97.1 mt -143.29 140.54 17.82 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.325 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.666 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.33 15.35 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.506 1.793 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.822 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.4 t -72.25 -31.2 1.6 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 0.0 109.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.822 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -7.67 19.34 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.478 1.778 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.666 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.6 m-85 -100.82 -30.25 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -123.13 172.36 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 0.0 109.298 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.967 ' CG ' HD11 ' A' ' 140' ' ' LEU . 2.1 mt-10 -124.27 -158.6 0.82 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.487 1.117 . . . . 0.0 109.283 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 14.8 m-85 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.451 0.167 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 188' ' ' GLU . 3.3 m -136.4 151.27 28.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.309 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -116.76 165.05 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 0.0 110.372 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -118.15 115.51 24.94 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.489 1.118 . . . . 0.0 109.299 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.95 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -112.6 28.73 8.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.422 1.076 . . . . 0.0 109.371 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.48 -13.18 2.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.963 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 53.83 155.98 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 0.0 109.33 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 143' ' ' PHE . 1.7 t80 . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.525 ' HB3' HD12 ' A' ' 182' ' ' ILE . 4.4 m-20 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -94.57 112.67 58.7 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.698 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.96 124.79 8.91 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.534 1.807 . . . . 0.0 110.997 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.685 ' HE2' HG21 ' A' ' 182' ' ' ILE . 1.2 p90 -141.83 176.26 9.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.469 1.106 . . . . 0.0 110.978 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.429 ' C ' ' HA ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -100.49 -172.12 2.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.533 1.146 . . . . 0.0 109.285 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.558 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.12 34.39 0.56 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 0.0 109.235 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.01 39.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.498 1.123 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.689 ' O ' HD12 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -87.26 171.54 10.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.505 0.767 . . . . 0.0 109.317 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 157' ' ' ASP . 1.3 mp -125.86 136.77 59.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 0.0 109.285 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.627 HD22 HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -147.66 -172.05 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.516 1.135 . . . . 0.0 109.259 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.65 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 13.8 mtm180 -136.42 152.51 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.092 . . . . 0.0 110.251 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -89.61 119.69 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.246 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HD2' ' NE ' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -107.82 -48.72 3.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.548 1.155 . . . . 0.0 110.284 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.42 ' OD1' ' NE ' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -138.13 162.62 33.74 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.499 1.124 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 98.84 3.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.536 1.148 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -44.15 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.517 1.798 . . . . 0.0 110.979 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -174.96 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.08 -16.97 18.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.424 1.077 . . . . 0.0 110.318 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -89.79 -32.91 16.73 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.072 . . . . 0.0 110.3 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.581 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 44.3 m95 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 184' ' ' VAL . 28.1 m0 -125.55 144.54 50.52 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 0.0 108.03 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -101.98 99.83 10.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 0.0 109.301 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.786 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -111.28 163.16 14.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.124 . . . . 0.0 109.309 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -106.28 134.56 49.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.325 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 177' ' ' GLY . 8.4 t0 -79.3 164.02 24.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.4 t -51.85 -20.0 2.02 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 110.002 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.91 -23.97 48.51 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.538 1.149 . . . . 0.0 110.263 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 95.93 30.42 7.95 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.403 1.065 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -107.3 132.55 52.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 0.751 . . . . 0.0 109.311 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.425 ' NE ' ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -87.01 122.39 30.8 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.24 150.98 22.86 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.486 1.116 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 150' ' ' ASP . 2.3 ptm -103.66 138.19 40.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.57 0.806 . . . . 0.0 111.014 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.685 HG21 ' HE2' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -149.55 172.2 5.49 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 0.0 109.323 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.821 ' HB2' ' HD2' ' A' ' 185' ' ' PRO . 18.3 Cg_endo -74.96 145.7 31.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 O-C-N 124.501 1.79 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 13.5 t -71.85 -30.28 1.48 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.448 1.093 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -3.73 14.35 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.456 1.766 . . . . 0.0 111.0 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.679 ' CG ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -102.56 -14.42 16.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 0.0 111.011 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 32.4 m -132.19 169.34 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.95 ' CG ' HD11 ' A' ' 140' ' ' LEU . 4.1 mm-40 -130.11 -168.75 2.01 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.486 1.117 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.408 ' HA ' HG12 ' A' ' 137' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 57.6 m-85 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.513 0.196 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 182' ' ' ILE . 27.3 m -133.78 145.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 109.287 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.845 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -123.44 152.72 41.35 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.453 1.096 . . . . 0.0 110.239 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.774 ' HB1' ' CD1' ' A' ' 153' ' ' PHE . . . -110.62 107.9 17.64 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.269 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.993 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -105.06 22.72 14.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 0.0 109.325 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.809 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.3 t80 -122.44 -14.37 7.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.604 1.19 . . . . 0.0 111.047 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 3.2 m-20 57.97 145.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.553 1.158 . . . . 0.0 109.294 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.617 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 181' ' ' MET . 16.6 m-20 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.02 HD21 HD22 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -102.02 126.57 33.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.99 140.49 25.53 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.56 1.821 . . . . 0.0 111.034 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.774 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 2.5 p90 -158.92 165.58 33.8 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.442 1.089 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 174.31 158.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 109.332 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.43 40.28 14.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 109.328 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 59.42 40.51 96.2 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.47 1.106 . . . . 0.0 111.049 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.845 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 5.5 t0 -46.87 141.23 4.13 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.774 . . . . 0.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.545 HD13 ' N ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -95.19 125.64 47.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 109.362 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 1.02 HD22 HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -139.27 -178.57 5.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.502 1.126 . . . . 0.0 109.315 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.713 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -133.0 146.82 52.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 0.0 110.261 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.989 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -87.52 120.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.482 1.114 . . . . 0.0 109.249 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -103.12 -48.02 4.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.561 1.163 . . . . 0.0 110.251 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -148.78 166.87 27.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.477 1.11 . . . . 0.0 109.284 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.92 100.6 5.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.566 1.166 . . . . 0.0 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -52.03 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.469 1.773 . . . . 0.0 111.028 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -104.15 -173.1 2.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.459 1.099 . . . . 0.0 110.287 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -109.7 13.5 23.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.561 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 10.4 tt0 -123.43 -42.13 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.561 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.0 m95 -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.565 1.166 . . . . 0.0 108.018 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -114.46 142.57 46.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 11.1 t-20 -91.49 94.24 9.36 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.343 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.989 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -111.46 162.22 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.482 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 2.3 mt-10 -104.05 134.09 47.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 0.0 110.363 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.736 ' HA ' HD23 ' A' ' 159' ' ' LEU . 7.4 t0 -75.98 166.77 23.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 0.0 109.359 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.441 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 33.2 m -55.31 -18.51 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.482 1.114 . . . . 0.0 110.003 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.28 -20.2 34.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 0.0 110.276 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.81 26.18 10.82 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.538 1.149 . . . . 0.0 111.02 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.458 ' HG3' ' CB ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.3 119.95 35.7 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 0.774 . . . . 0.0 109.289 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.15 113.4 22.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 0.0 110.341 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.8 173.53 28.7 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.462 1.101 . . . . 0.0 110.966 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.413 ' O ' ' HB3' ' A' ' 150' ' ' ASP . 37.6 mmm -87.47 144.76 26.57 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.458 0.74 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 137' ' ' VAL . 7.9 pt -140.76 155.25 69.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.439 1.087 . . . . 0.0 109.367 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.903 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.08 143.98 29.44 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.547 1.814 . . . . 0.0 110.974 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 48.8 t -73.89 -39.45 4.4 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -75.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.415 1.745 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.809 ' CE2' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -32.57 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.525 1.141 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.0 OUTLIER -112.68 171.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.137 . . . . 0.0 109.247 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.993 ' CD ' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -137.4 -167.44 2.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 0.0 110.304 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.282 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.916 ' HB1' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.568 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER 167.87 -37.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 110.312 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER -147.15 111.51 5.2 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 0.0 111.019 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.4 m -129.24 154.72 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 4.5 ptp180 -131.76 142.1 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.13 . . . . 0.0 110.24 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.979 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -94.36 129.72 40.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 109.295 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -116.51 25.63 10.46 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 0.0 109.319 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.6 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.6 -10.2 1.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.457 1.098 . . . . 0.0 111.032 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.522 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 55.03 159.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.3 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.673 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 24.4 t80 -165.31 -48.49 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.494 1.121 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.593 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 0.6 OUTLIER 50.13 93.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.526 1.141 . . . . 0.0 109.31 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -86.88 -68.8 1.33 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.541 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 1.7 m-20 158.51 -18.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.536 0.786 . . . . 0.0 109.332 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER 86.6 173.59 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.105 . . . . 0.0 109.29 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.546 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 69.77 9.0 7.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.46 1.1 . . . . 0.0 110.314 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 179.83 -26.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.5 1.125 . . . . 0.0 110.303 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.501 ' OD1' ' CZ3' ' A' ' 169' ' ' TRP . 19.1 m-20 -150.18 115.07 5.32 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.135 . . . . 0.0 109.314 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.673 ' HB3' HG23 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -69.4 115.77 35.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.469 1.106 . . . . 0.0 109.275 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.656 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.98 121.21 6.44 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.455 1.766 . . . . 0.0 111.016 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.692 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 36.2 p90 -127.82 175.09 8.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.474 1.109 . . . . 0.0 110.994 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.464 ' CD ' ' HE2' ' A' ' 155' ' ' LYS . 5.7 mttt -115.49 -177.94 3.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 0.0 109.292 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.522 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -80.21 49.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.544 1.153 . . . . 0.0 109.28 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.979 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 147.43 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.132 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.654 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 14.1 t0 -89.7 155.07 19.46 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 0.773 . . . . 0.0 109.244 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.661 ' O ' HD23 ' A' ' 159' ' ' LEU . 1.3 mp -105.42 141.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.508 1.13 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -149.3 -179.39 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.318 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.581 ' HG2' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -133.12 143.13 49.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.916 HG21 ' HB1' ' A' ' 134' ' ' ALA . 1.0 OUTLIER -87.2 117.34 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -107.89 -48.81 3.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 0.0 110.33 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.96 167.63 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 0.0 109.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.517 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -155.1 84.3 3.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.554 1.159 . . . . 0.0 109.305 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -45.76 0.26 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.509 1.794 . . . . 0.0 110.989 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -99.78 -173.26 2.41 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.496 1.123 . . . . 0.0 110.268 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.71 -32.21 8.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.471 1.107 . . . . 0.0 110.344 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.555 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 6.3 tt0 -89.46 -33.07 16.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.555 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.4 m95 -110.68 132.07 54.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 108.041 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.56 ' CE2' HG21 ' A' ' 184' ' ' VAL . 42.4 m0 -119.04 144.31 46.62 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 0.0 109.262 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.516 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -105.11 160.3 15.17 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 0.0 109.244 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.9 mt-10 -108.69 132.5 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.51 1.131 . . . . 0.0 110.271 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.445 ' OD1' HD11 ' A' ' 151' ' ' LEU . 7.5 t70 -74.15 163.53 27.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 0.0 109.318 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.5 m -53.92 -18.75 3.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.65 -22.35 37.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.501 1.125 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.85 31.03 6.83 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.508 1.13 . . . . 0.0 110.976 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 ptpp? -99.8 122.42 42.75 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 0.771 . . . . 0.0 109.315 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.486 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.0 mtm180 -85.98 112.92 21.66 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.533 1.146 . . . . 0.0 110.334 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.8 159.45 28.09 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.422 1.076 . . . . 0.0 110.991 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.443 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.6 mtm -87.55 141.16 28.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 0.775 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 151' ' ' LEU . 2.2 pp -142.91 163.17 39.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.473 1.108 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.588 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 136.57 20.55 Favored 'Trans proline' 0 C--N 1.361 1.184 0 O-C-N 124.484 1.781 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.846 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 36.7 t -80.54 -30.7 0.59 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.846 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.03 -21.19 16.05 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.488 1.783 . . . . 0.0 111.008 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -93.99 8.25 42.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 0.0 111.008 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 139' ' ' ALA . 1.7 m -148.57 176.02 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.29 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.859 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -140.65 -169.17 2.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 110.287 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.609 ' HZ3' ' N ' ' A' ' 134' ' ' ALA . 0.8 OUTLIER -109.32 160.78 15.87 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 0.0 109.276 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.652 ' CD1' ' NH2' ' A' ' 138' ' ' ARG . 30.8 t80 -124.6 163.93 20.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.142 . . . . 0.0 111.008 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.464 ' O ' ' CE2' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.001 0 O-C-N 124.54 1.15 . . . . 0.0 111.02 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.546 ' C ' ' CD1' ' A' ' 136' ' ' TYR . 1.1 mt-10 -143.26 -165.97 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.559 1.162 . . . . 0.0 110.274 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 135' ' ' GLU . 42.0 m-85 -149.1 121.51 8.47 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 111.014 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 22.4 m -135.92 152.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 0.0 109.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -124.14 144.15 50.07 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 0.0 110.358 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.067 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.13 118.53 37.09 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 0.0 109.309 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.764 HD11 ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -111.9 32.67 5.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.644 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -138.92 -13.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.519 1.137 . . . . 0.0 111.038 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 54.04 156.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.372 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.704 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 -162.29 -53.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.471 1.107 . . . . 0.0 111.047 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.531 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER 54.78 81.97 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.51 1.132 . . . . 0.0 109.356 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.7 ' CA ' ' CZ ' ' A' ' 143' ' ' PHE . . . -76.6 -63.95 2.25 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.575 1.172 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 1.3 m-20 161.07 -22.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.428 0.722 . . . . 0.0 109.251 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER 84.37 174.58 0.06 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.541 1.15 . . . . 0.0 109.306 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 67.09 10.42 7.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 0.0 110.287 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 176.67 -31.05 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.564 1.165 . . . . 0.0 110.287 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 43.2 m-20 -135.55 100.52 4.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.467 1.104 . . . . 0.0 109.267 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.926 HD21 HD22 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -56.68 106.96 0.75 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 109.294 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.653 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.94 121.68 6.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.53 1.805 . . . . 0.0 111.015 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.704 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 31.9 p90 -124.77 162.64 23.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.414 1.071 . . . . 0.0 110.98 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.31 -175.95 2.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 0.0 109.35 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.536 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -84.56 68.4 10.32 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 0.0 109.346 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 1.067 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.7 32.79 0.63 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.557 1.161 . . . . 0.0 111.005 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.737 ' OD2' HD11 ' A' ' 159' ' ' LEU . 9.0 t0 -83.3 161.8 21.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 0.779 . . . . 0.0 109.312 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.509 HD13 ' NH2' ' A' ' 138' ' ' ARG . 9.1 tp -121.01 129.24 75.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.401 1.063 . . . . 0.0 109.334 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.926 HD22 HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -145.95 169.65 18.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.563 1.164 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.681 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.9 mtt85 -118.42 149.38 41.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.578 1.174 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.1 mp -91.95 119.52 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.421 ' NH1' ' CD ' ' A' ' 179' ' ' ARG . 39.2 ttt180 -101.6 -46.66 4.89 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 110.274 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -149.49 176.16 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.271 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.462 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.93 104.82 0.56 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.56 1.162 . . . . 0.0 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -46.09 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.522 1.801 . . . . 0.0 111.015 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -93.9 -175.07 3.61 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.539 1.149 . . . . 0.0 110.299 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.33 7.95 23.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 0.0 110.326 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -118.59 -45.13 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.457 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 69.2 m95 -101.6 134.53 44.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 108.049 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.463 ' CD2' ' CG2' ' A' ' 184' ' ' VAL . 30.6 m0 -118.03 132.46 56.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 108.01 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 t-20 -83.73 95.2 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.307 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.793 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -109.59 162.93 13.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -109.39 137.9 46.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.481 1.113 . . . . 0.0 110.276 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.622 ' OD1' HD13 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -79.83 161.81 25.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.4 p -51.2 -20.88 1.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.115 . . . . 0.0 109.989 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -78.92 -28.15 43.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.12 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 103.99 31.23 4.83 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.48 1.112 . . . . 0.0 111.042 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -101.7 121.73 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.469 0.747 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.421 ' CD ' ' NH1' ' A' ' 162' ' ' ARG . 7.4 mtt85 -87.41 115.83 25.1 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.69 172.74 28.81 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.559 1.162 . . . . 0.0 111.024 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.405 ' HE2' ' CG ' ' A' ' 169' ' ' TRP . 3.6 ptm -87.55 127.5 35.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 0.743 . . . . 0.0 110.985 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.529 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 10.9 tt -124.53 142.31 40.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 0.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.772 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.02 135.24 18.78 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.452 1.764 . . . . 0.0 110.974 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.9 t -77.21 -31.46 0.87 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.05 -33.11 4.78 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.563 1.823 . . . . 0.0 110.961 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.644 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -89.99 18.42 5.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.967 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 183' ' ' PRO . 13.1 m -149.36 177.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.764 ' HG3' HD11 ' A' ' 140' ' ' LEU . 2.3 mt-10 -138.04 -161.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.548 1.155 . . . . 0.0 110.243 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 190' ' ' TYR . 7.6 tptt -107.82 145.91 32.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.229 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 191' ' ' GLY . 0.9 OUTLIER -76.26 -57.14 4.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.098 . . . . 0.0 111.064 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.569 ' N ' ' CD1' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.531 1.057 0 O-C-N 124.48 1.112 . . . . 0.0 110.953 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -105.24 -159.79 0.72 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.439 1.087 . . . . 0.0 110.316 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 62.5 m-85 -138.5 134.68 34.27 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.491 1.119 . . . . 0.0 111.028 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -130.19 160.87 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.588 1.18 . . . . 0.0 109.231 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.744 ' NE ' HD13 ' A' ' 158' ' ' ILE . 8.5 tpp85 -126.64 128.27 46.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 0.0 110.316 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.947 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.3 119.64 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.428 1.08 . . . . 0.0 109.363 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.913 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -125.3 26.87 6.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.31 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' ' CZ ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -134.15 -21.16 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.419 1.074 . . . . 0.0 111.049 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.432 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 1.6 t70 58.79 155.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 109.34 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.706 ' O ' ' C ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER -159.96 -46.69 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 0.0 110.968 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.706 ' C ' ' O ' ' A' ' 143' ' ' PHE . 1.6 t30 -7.79 87.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.567 1.167 . . . . 0.0 109.305 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . -108.27 -38.82 1.9 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.547 1.155 . . . . 0.0 110.972 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.476 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 1.5 t-20 -163.34 -25.23 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.505 0.768 . . . . 0.0 109.276 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 3.3 p-10 47.47 46.32 17.38 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.517 1.136 . . . . 0.0 109.297 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.21 -7.68 55.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.44 1.087 . . . . 0.0 110.29 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -175.86 34.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.504 1.127 . . . . 0.0 110.285 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.447 ' OD2' ' CE2' ' A' ' 143' ' ' PHE . 0.0 OUTLIER -158.03 170.96 21.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.604 1.19 . . . . 0.0 109.269 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.746 HD21 HD22 ' A' ' 159' ' ' LEU . 1.7 tp -93.88 118.91 67.36 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.471 1.107 . . . . 0.0 109.279 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.05 126.15 9.75 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.478 1.778 . . . . 0.0 110.946 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.653 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 38.8 p90 -127.55 169.96 13.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.451 1.094 . . . . 0.0 111.06 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -121.95 178.19 4.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 0.0 109.287 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.587 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -80.62 51.75 1.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.947 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 149.82 35.23 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.547 1.154 . . . . 0.0 110.965 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -94.89 162.07 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.5 0.765 . . . . 0.0 109.36 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.744 HD13 ' NE ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -118.47 122.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 0.0 109.285 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.746 HD22 HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -131.13 -179.63 5.45 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.519 1.137 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.655 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.5 ptp85 -133.02 155.22 49.58 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -93.84 116.72 35.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 0.0 109.296 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -100.64 -49.08 4.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.452 1.095 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.75 174.32 12.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.18 118.53 8.47 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.465 1.103 . . . . 0.0 109.269 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -52.37 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.469 1.773 . . . . 0.0 110.984 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -127.76 -98.8 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.597 1.186 . . . . 0.0 110.291 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.83 -44.52 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.31 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -57.43 -43.58 83.96 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.418 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 35.5 m95 -118.89 144.22 46.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 0.0 108.052 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.46 ' CD2' HG22 ' A' ' 184' ' ' VAL . 46.5 m0 -118.14 145.26 45.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 107.976 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -87.19 86.18 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.528 1.143 . . . . 0.0 109.357 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.739 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -98.83 168.02 10.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 0.0 109.264 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -115.35 140.34 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 0.0 110.319 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.659 ' HB2' HD13 ' A' ' 151' ' ' LEU . 2.1 t0 -78.08 159.96 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.265 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -21.29 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.503 1.127 . . . . 0.0 110.0 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.8 -28.51 33.14 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.387 1.054 . . . . 0.0 110.254 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.04 30.62 3.6 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 124.452 1.095 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 mmmt -95.01 117.31 29.94 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.406 0.71 . . . . 0.0 109.238 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.475 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -85.17 111.85 20.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 0.0 110.296 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.61 167.58 30.37 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.47 1.106 . . . . 0.0 110.977 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 ptp -88.52 138.62 31.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 0.778 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 6.8 pt -134.86 164.18 45.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.833 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.9 143.64 29.66 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.443 1.76 . . . . 0.0 111.044 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.765 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 55.1 t -79.54 -35.86 1.02 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.765 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -67.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.586 1.835 . . . . 0.0 111.021 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.75 ' CZ ' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -38.82 -26.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.451 1.094 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.9 m -117.33 169.65 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.541 1.151 . . . . 0.0 109.268 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.913 ' CD ' HD21 ' A' ' 140' ' ' LEU . 2.6 mt-10 -125.07 -161.25 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.448 1.092 . . . . 0.0 110.365 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.09 130.26 51.9 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.467 1.105 . . . . 0.0 109.282 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.457 ' HB3' ' CB ' ' A' ' 136' ' ' TYR . 52.2 t80 -96.99 -44.0 7.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.464 1.102 . . . . 0.0 111.008 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 O-C-N 124.477 1.111 . . . . 0.0 111.063 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.653 ' CB ' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.5 OUTLIER -179.8 -50.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.541 1.151 . . . . 0.0 110.286 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -143.58 122.38 12.66 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.462 1.101 . . . . 0.0 110.978 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 188' ' ' GLU . 2.0 m -128.91 169.62 19.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.778 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.8 ptp180 -132.07 174.63 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -134.13 92.04 2.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 0.0 109.338 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.855 HD21 ' OE1' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -92.41 16.82 10.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 1.105 . . . . 0.0 109.292 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.657 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -126.79 -13.98 5.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.448 1.093 . . . . 0.0 111.038 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.7 158.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 0.0 109.327 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.65 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 28.7 t80 -159.35 -56.28 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.542 1.151 . . . . 0.0 110.984 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.0 t30 70.92 53.15 0.27 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.547 1.155 . . . . 0.0 109.353 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.583 ' HA2' ' CE2' ' A' ' 143' ' ' PHE . . . -38.74 -75.54 0.09 OUTLIER Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.495 1.122 . . . . 0.0 111.011 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 145' ' ' GLY . 0.6 OUTLIER 156.05 -18.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.488 0.758 . . . . 0.0 109.238 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 83.87 172.1 0.08 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.519 1.137 . . . . 0.0 109.333 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.486 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 1.2 tm-20 61.84 10.22 3.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 0.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 2.0 pt-20 179.64 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.427 1.08 . . . . 0.0 110.36 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.413 ' N ' ' HG2' ' A' ' 149' ' ' GLU . 79.9 m-20 -143.63 109.88 5.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.53 1.144 . . . . 0.0 109.336 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.96 HD21 ' CD2' ' A' ' 159' ' ' LEU . 1.2 tp -63.69 116.8 29.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 0.0 109.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.551 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 132.39 15.27 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.5 1.789 . . . . 0.0 110.974 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.65 ' CE1' ' CB ' ' A' ' 143' ' ' PHE . 13.4 p90 -142.36 155.53 45.16 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -165.58 146.57 7.07 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.608 1.193 . . . . 0.0 109.3 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.474 ' HA ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 61.29 78.24 0.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 0.0 109.336 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 33.4 47.1 0.39 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.508 1.13 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.778 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 42.4 t0 -39.91 161.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.313 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.774 HD11 ' NH2' ' A' ' 138' ' ' ARG . 2.1 mm -126.56 116.52 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.96 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -138.03 -176.04 4.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 109.294 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.653 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.8 ptp180 -131.76 147.69 52.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.809 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -87.18 117.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.507 1.129 . . . . 0.0 109.306 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.511 ' NE ' ' CZ ' ' A' ' 179' ' ' ARG . 3.2 ttt180 -103.33 -48.13 4.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 0.0 110.354 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.78 165.27 30.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 109.34 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 103.28 3.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.482 1.114 . . . . 0.0 109.255 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.435 ' CD ' ' HE1' ' A' ' 181' ' ' MET . 18.2 Cg_endo -75.05 -57.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -107.39 -173.27 2.25 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.468 1.105 . . . . 0.0 110.307 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.39 18.16 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.441 1.088 . . . . 0.0 110.303 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -114.22 -48.8 2.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.532 1.145 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.423 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 52.7 m95 -119.29 137.95 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 108.03 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.618 ' CE2' HG21 ' A' ' 184' ' ' VAL . 43.7 m0 -114.81 144.95 42.68 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.521 1.138 . . . . 0.0 108.005 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 28.6 t-20 -94.29 95.14 8.72 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 0.0 109.297 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.809 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -107.36 163.51 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 179' ' ' ARG . 2.2 mt-10 -108.44 141.07 40.84 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.539 1.149 . . . . 0.0 110.269 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.557 ' HA ' HD23 ' A' ' 159' ' ' LEU . 3.9 t70 -83.89 164.62 19.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 94.6 p -51.79 -21.04 2.5 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.153 . . . . 0.0 109.972 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.04 -28.12 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.485 1.115 . . . . 0.0 110.292 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 104.59 32.14 4.3 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.479 1.112 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -103.1 118.97 37.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 0.745 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.511 ' CZ ' ' NE ' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -86.71 115.38 24.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.49 1.119 . . . . 0.0 110.32 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -143.52 164.74 27.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.513 1.133 . . . . 0.0 111.022 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.435 ' HE1' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -87.14 137.63 32.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.454 0.738 . . . . 0.0 110.998 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.547 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 28.1 pt -139.18 158.71 68.77 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 0.0 109.352 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.715 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.3 Cg_endo -75.0 139.56 24.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.527 1.803 . . . . 0.0 111.068 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.5 t -78.5 -32.05 0.81 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.241 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -33.3 4.76 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.541 1.811 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.657 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -91.52 26.13 2.4 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.16 . . . . 0.0 111.01 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 183' ' ' PRO . 22.9 m -151.69 168.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.157 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.855 ' OE1' HD21 ' A' ' 140' ' ' LEU . 3.2 mt-10 -139.91 -162.23 1.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.321 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.574 ' HD2' HG12 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -119.32 141.92 48.58 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.507 1.13 . . . . 0.0 109.3 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 138' ' ' ARG . 1.6 t80 -67.01 -51.42 55.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 0.0 110.972 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.056 0 O-C-N 124.535 1.147 . . . . 0.0 110.988 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 1.0 OUTLIER 172.6 -58.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 0.0 110.28 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.485 ' HB3' ' CB ' ' A' ' 190' ' ' TYR . 1.9 m-85 -133.04 133.42 43.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 0.0 111.039 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.523 ' CG1' HD13 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -127.43 157.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.154 . . . . 0.0 109.273 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.9 OUTLIER -116.56 147.28 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.309 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.9 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.88 93.74 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 0.0 109.268 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.043 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -107.61 37.65 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.565 1.165 . . . . 0.0 109.368 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.77 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 1.5 m-85 -142.53 -17.73 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.44 1.088 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 55.13 160.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.555 1.159 . . . . 0.0 109.364 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.646 ' HB3' ' CE2' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -160.5 -43.75 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.511 1.132 . . . . 0.0 111.006 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.64 ' C ' ' O ' ' A' ' 143' ' ' PHE . 7.9 t30 18.07 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.577 1.173 . . . . 0.0 109.314 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . 67.31 -66.95 0.24 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.436 1.085 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 147' ' ' ASP . 18.7 p30 -168.02 -18.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.439 0.729 . . . . 0.0 109.262 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.527 ' CG ' ' O ' ' A' ' 146' ' ' ASN . 5.1 p-10 50.63 59.73 4.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 0.0 109.225 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.9 OUTLIER -73.6 -12.19 60.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.139 . . . . 0.0 110.261 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 16.5 tt0 -179.64 36.1 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.511 1.132 . . . . 0.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 73.9 m-20 -153.61 156.53 38.13 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 0.0 109.321 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.862 HD12 ' HD2' ' A' ' 152' ' ' PRO . 5.9 tp -73.52 114.08 28.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 0.0 109.307 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.862 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 120.87 6.22 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.477 1.777 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.695 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 48.4 p90 -130.32 167.89 17.78 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.516 1.135 . . . . 0.0 110.997 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -114.83 172.8 6.82 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 109.293 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.451 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -78.5 83.26 4.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 0.0 109.337 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.9 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.33 20.73 1.74 Allowed Glycine 0 CA--C 1.529 0.916 0 O-C-N 124.488 1.117 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.568 ' C ' HD12 ' A' ' 158' ' ' ILE . 19.5 t0 -85.31 155.42 21.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.415 0.715 . . . . 0.0 109.353 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.649 HD11 ' CZ ' ' A' ' 138' ' ' ARG . 1.8 mp -117.12 130.81 71.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 109.275 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.574 HD22 HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -137.7 -178.87 5.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 0.0 109.263 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.668 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.7 mtm105 -131.24 145.86 52.08 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.508 1.13 . . . . 0.0 110.246 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -88.01 117.76 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.13 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.7 tpp85 -108.48 -48.04 3.4 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 0.0 110.317 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -145.94 -176.4 5.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 109.295 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -176.54 109.16 0.24 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -53.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.526 1.803 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -100.78 -169.85 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.489 1.118 . . . . 0.0 110.286 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.56 -34.0 9.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -73.07 -46.24 52.7 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 0.0 110.263 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.19 137.95 45.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.729 ' O ' ' HA ' ' A' ' 181' ' ' MET . 22.7 m0 -116.92 176.44 5.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 107.983 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -124.53 98.62 5.81 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.846 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -115.49 164.66 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 0.0 109.275 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -106.31 138.45 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.539 1.15 . . . . 0.0 110.263 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.496 ' O ' ' NH2' ' A' ' 160' ' ' ARG . 9.9 t0 -80.69 161.72 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 0.0 109.279 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.7 t -51.09 -21.36 1.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.559 1.162 . . . . 0.0 110.022 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -78.44 -23.63 46.49 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.574 1.171 . . . . 0.0 110.384 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 97.59 31.93 6.52 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.513 1.133 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -103.24 126.63 50.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 0.746 . . . . 0.0 109.317 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.441 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.8 mtp-105 -86.15 111.54 20.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 0.0 110.299 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -144.53 169.78 26.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.501 1.125 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.729 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 mtm -87.82 132.85 34.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.783 . . . . 0.0 111.015 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.738 HD12 ' HG ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -128.22 151.09 75.7 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.46 1.1 . . . . 0.0 109.311 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.693 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.04 141.21 26.24 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.473 1.775 . . . . 0.0 110.964 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 65.0 t -80.78 -32.57 0.67 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.474 1.109 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -37.68 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.542 1.812 . . . . 0.0 111.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.77 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.2 m-85 -87.12 22.48 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.462 1.101 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.1 m -152.75 164.31 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 1.043 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.4 OUTLIER -125.51 -161.82 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.459 1.099 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.0 137.02 53.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.451 1.095 . . . . 0.0 109.305 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.485 ' CB ' ' HB3' ' A' ' 136' ' ' TYR . 4.5 t80 -69.0 -52.04 32.96 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 0.0 111.023 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.021 0 O-C-N 124.467 1.104 . . . . 0.0 110.971 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.581 ' HB1' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 1.6 tt0 171.61 -36.61 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.54 1.15 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.486 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 1.4 m-85 -141.82 126.66 18.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.424 1.078 . . . . 0.0 111.013 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 17.2 m -145.33 147.17 18.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 109.289 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.802 ' HB3' HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -127.17 136.44 52.07 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 0.0 110.285 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.001 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -91.17 138.17 31.8 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.481 1.113 . . . . 0.0 109.226 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.976 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.98 19.6 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.539 1.149 . . . . 0.0 109.336 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.581 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -135.07 -4.7 2.41 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.4 OUTLIER 54.45 163.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.701 ' O ' ' N ' ' A' ' 145' ' ' GLY . 1.7 t80 -161.37 -36.94 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.498 1.124 . . . . 0.0 111.043 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 143' ' ' PHE . 21.7 t30 -35.67 85.84 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 0.0 109.236 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . -122.49 -29.63 1.28 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.485 1.116 . . . . 0.0 110.997 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 0.2 OUTLIER -151.27 -33.66 0.15 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.533 0.784 . . . . 0.0 109.287 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.493 ' CB ' ' HG3' ' A' ' 152' ' ' PRO . 4.5 p-10 45.66 53.17 8.86 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.454 1.096 . . . . 0.0 109.345 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.65 9.13 8.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 1.163 . . . . 0.0 110.28 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 170.7 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.54 1.15 . . . . 0.0 110.363 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 143' ' ' PHE . 59.1 m-20 -92.22 157.36 16.73 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.473 1.108 . . . . 0.0 109.294 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.672 HD12 ' N ' ' A' ' 152' ' ' PRO . 0.8 OUTLIER -77.35 119.6 78.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 0.0 109.319 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.672 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.5 Cg_endo -74.92 121.58 6.7 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.463 1.77 . . . . 0.0 111.005 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.629 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 29.3 p90 -134.7 169.52 17.2 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.424 1.077 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.26 175.77 5.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.564 1.165 . . . . 0.0 109.263 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.593 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -78.48 83.4 4.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.573 1.171 . . . . 0.0 109.281 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 1.001 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.81 23.84 2.43 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.52 1.138 . . . . 0.0 111.013 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 27.8 t0 -84.82 158.15 20.75 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.508 0.769 . . . . 0.0 109.37 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 138' ' ' ARG . 10.1 mm -111.12 140.54 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.453 1.095 . . . . 0.0 109.293 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -149.89 -172.8 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.2 mpp_? -137.53 156.88 47.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.255 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -98.93 115.14 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.12 . . . . 0.0 109.293 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.535 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 6.2 ptt85 -104.13 -43.85 5.14 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.555 1.16 . . . . 0.0 110.309 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.535 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -136.86 166.06 24.51 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.539 1.149 . . . . 0.0 109.267 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.27 88.13 2.61 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.371 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -43.86 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.481 1.78 . . . . 0.0 111.029 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.34 -170.59 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 0.0 110.358 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.81 -32.2 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.541 1.15 . . . . 0.0 110.28 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.98 -35.99 64.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.513 1.133 . . . . 0.0 110.277 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.495 ' CZ3' ' CG ' ' A' ' 150' ' ' ASP . 47.6 m95 -122.05 138.77 54.32 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.533 1.146 . . . . 0.0 107.962 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.653 ' CE3' ' CG2' ' A' ' 184' ' ' VAL . 29.5 m0 -120.35 143.8 48.2 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.515 1.134 . . . . 0.0 107.953 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 3.1 t-20 -88.63 92.99 9.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 109.26 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -106.0 166.19 10.67 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.535 1.147 . . . . 0.0 109.3 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.0 mt-10 -115.0 138.58 50.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 0.0 110.346 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 177' ' ' GLY . 3.1 t0 -77.18 160.63 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.519 1.137 . . . . 0.0 109.33 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.4 m -51.16 -21.25 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 0.0 110.038 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.85 -27.99 28.33 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.463 1.102 . . . . 0.0 110.298 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.68 29.64 3.8 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.443 1.089 . . . . 0.0 111.032 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -89.57 114.98 26.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.542 0.789 . . . . 0.0 109.334 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.523 ' CZ ' ' NH1' ' A' ' 162' ' ' ARG . 4.2 mtp180 -86.36 108.58 18.52 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 0.0 110.26 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.84 162.5 29.72 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.393 1.058 . . . . 0.0 110.986 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 5.9 mtm -88.67 147.28 24.6 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 0.75 . . . . 0.0 110.99 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.507 ' CD1' ' CD1' ' A' ' 159' ' ' LEU . 23.0 pt -148.8 163.36 26.14 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.0 138.42 23.01 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.439 1.757 . . . . 0.0 110.999 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.828 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 1.0 OUTLIER -79.81 -31.85 0.69 Allowed Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 0.0 109.365 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.828 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -10.79 21.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.518 1.799 . . . . 0.0 111.027 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.692 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -99.64 -4.52 30.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.485 ' HB ' ' C ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -142.79 170.47 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 109.286 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.976 ' CD ' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -119.52 -171.6 2.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.59 ' NZ ' ' CZ3' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -123.01 116.32 23.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 0.0 109.3 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -101.15 97.62 8.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 0.0 110.954 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 O-C-N 124.587 1.179 . . . . 0.0 111.022 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.894 ' HB2' ' HE3' ' A' ' 189' ' ' LYS . . . . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 1.7 tt0 156.35 -36.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 0.0 110.288 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.6 OUTLIER -137.27 134.93 36.69 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.533 1.146 . . . . 0.0 110.989 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -127.73 159.43 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.416 1.073 . . . . 0.0 109.281 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.2 tpp85 -124.95 116.41 22.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.303 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.92 114.88 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 0.0 109.284 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.055 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.38 28.95 5.88 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.508 1.13 . . . . 0.0 109.296 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -139.72 -6.87 1.29 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 1.1 . . . . 0.0 111.023 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.578 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 50.42 165.35 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 0.0 109.309 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.659 ' CD2' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -159.03 -44.33 0.06 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.632 ' C ' ' O ' ' A' ' 143' ' ' PHE . 17.9 t30 19.16 92.69 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.47 1.106 . . . . 0.0 109.302 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.586 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -108.85 -44.82 1.08 Allowed Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.534 1.146 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 145' ' ' GLY . 7.0 p30 149.62 6.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.496 0.762 . . . . 0.0 109.258 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.507 ' O ' ' OD2' ' A' ' 147' ' ' ASP . 0.8 OUTLIER 49.35 37.76 12.38 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.127 . . . . 0.0 109.326 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.9 OUTLIER -83.74 10.33 9.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.438 1.086 . . . . 0.0 110.304 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 3.2 tt0 169.54 -26.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.482 1.114 . . . . 0.0 110.333 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -114.33 -178.82 3.46 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.525 1.14 . . . . 0.0 109.387 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.72 HD21 ' CD2' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -106.83 116.26 59.01 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 0.0 109.31 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.659 ' HA ' ' CD2' ' A' ' 143' ' ' PHE . 18.3 Cg_endo -75.04 121.32 6.49 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.469 1.773 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.618 ' CE1' ' HD2' ' A' ' 183' ' ' PRO . 18.1 p90 -119.42 -175.87 3.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 0.0 111.027 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -140.52 164.04 31.23 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.115 . . . . 0.0 109.331 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -65.62 90.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.287 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 118.92 19.92 4.26 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.485 1.116 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 24.9 t0 -84.32 145.98 27.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 0.754 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.746 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.7 mp -111.85 124.67 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.436 1.085 . . . . 0.0 109.29 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.72 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -131.49 -174.95 3.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 0.0 109.309 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.716 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.1 147.67 46.21 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.525 1.14 . . . . 0.0 110.299 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.775 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -86.35 118.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.237 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.6 ttt180 -103.52 -47.37 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 0.0 110.318 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 50.4 m-20 -148.75 158.46 44.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -127.69 85.4 60.87 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 0.0 109.33 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -44.57 0.33 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.517 1.799 . . . . 0.0 110.983 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -109.21 -164.78 0.96 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 0.0 110.316 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -105.71 -55.42 2.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 110.283 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.413 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 15.3 pt20 -77.95 -26.26 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.542 1.151 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 72.5 m95 -106.98 133.19 52.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.483 1.115 . . . . 0.0 108.004 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.648 ' O ' HD13 ' A' ' 182' ' ' ILE . 7.9 m0 -125.76 141.86 51.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 0.0 108.027 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.432 ' HB2' ' HE2' ' A' ' 181' ' ' MET . 9.6 t-20 -91.9 87.52 6.26 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.775 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -104.11 164.29 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.217 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.5 mt-10 -105.91 137.88 43.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.404 1.065 . . . . 0.0 110.323 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.37 167.93 20.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.584 1.178 . . . . 0.0 109.256 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.6 m -57.91 -15.93 10.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -84.67 -21.87 30.06 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 1.083 . . . . 0.0 110.316 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 99.23 28.41 7.67 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.495 1.122 . . . . 0.0 110.989 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -102.21 121.81 42.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.472 0.748 . . . . 0.0 109.283 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -85.21 114.42 22.31 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 110.259 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -145.64 174.52 25.59 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.533 1.146 . . . . 0.0 111.043 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.563 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -86.78 146.62 26.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 0.741 . . . . 0.0 110.972 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -148.79 145.43 19.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.423 1.077 . . . . 0.0 109.325 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.634 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.05 130.68 13.45 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.533 1.807 . . . . 0.0 111.015 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.835 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 16.9 m -74.47 -28.62 0.86 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.127 . . . . 0.0 109.255 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -13.93 21.35 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.434 1.755 . . . . 0.0 110.989 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.712 ' O ' HD12 ' A' ' 140' ' ' LEU . 3.3 m-85 -96.52 -36.4 10.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 0.0 111.005 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' A' ' 139' ' ' ALA . 2.6 m -108.81 173.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.532 1.145 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 1.055 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.7 mt-10 -124.88 -159.69 0.9 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.447 1.092 . . . . 0.0 110.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.894 ' HE3' ' HB2' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -122.28 125.39 45.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 0.0 109.295 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -114.47 155.75 25.82 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 0.0 110.993 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.026 0 O-C-N 124.474 1.109 . . . . 0.0 111.016 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.899 ' HB1' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.573 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 5.2 pt-20 173.23 -42.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.13 . . . . 0.0 110.281 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 135' ' ' GLU . 18.3 m-85 -145.39 137.52 25.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.48 1.113 . . . . 0.0 111.006 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 188' ' ' GLU . 10.6 m -147.99 154.94 10.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.488 1.117 . . . . 0.0 109.257 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -133.6 144.68 49.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.542 1.152 . . . . 0.0 110.265 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.929 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.73 128.71 45.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.549 1.156 . . . . 0.0 109.303 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.928 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -120.0 22.03 11.63 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.43 1.082 . . . . 0.0 109.285 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -138.26 -10.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 110.976 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 55.45 154.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.551 1.157 . . . . 0.0 109.34 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.644 ' CE1' ' OD1' ' A' ' 144' ' ' ASN . 1.5 t80 -144.18 -85.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.644 ' OD1' ' CE1' ' A' ' 143' ' ' PHE . 15.7 p30 149.33 -14.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.573 1.171 . . . . 0.0 109.308 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.43 -144.32 47.18 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.522 1.139 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.499 ' CB ' ' HB2' ' A' ' 150' ' ' ASP . 0.5 OUTLIER 171.17 -31.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.482 0.754 . . . . 0.0 109.343 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 81.22 161.65 0.15 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.509 1.131 . . . . 0.0 109.252 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 0.7 OUTLIER 70.43 -4.13 1.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.516 1.135 . . . . 0.0 110.275 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 3.4 mt-10 157.24 35.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 0.0 110.29 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.499 ' HB2' ' CB ' ' A' ' 146' ' ' ASN . 1.4 m-20 -161.46 117.11 2.1 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.507 1.13 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 HD22 ' A' ' 159' ' ' LEU . 1.4 tp -93.6 114.39 62.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.281 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.03 134.13 17.39 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.509 1.794 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.651 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 18.3 p90 -151.88 171.62 17.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 0.0 110.975 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -108.75 -171.03 1.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.339 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.557 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.79 34.25 0.6 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.459 1.099 . . . . 0.0 109.336 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.929 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.29 39.77 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.432 1.082 . . . . 0.0 111.091 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.677 ' O ' HD12 ' A' ' 158' ' ' ILE . 3.8 m-20 -91.84 166.64 12.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 0.779 . . . . 0.0 109.332 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.677 HD12 ' O ' ' A' ' 157' ' ' ASP . 1.5 mp -128.09 134.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.586 1.179 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.885 HD22 HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -146.01 -178.16 5.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 0.0 109.291 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.729 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.47 146.5 52.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.102 . . . . 0.0 110.272 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.899 HG21 ' HB1' ' A' ' 134' ' ' ALA . 1.2 mp -83.94 124.32 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.526 1.141 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -100.22 -51.72 3.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 0.0 110.248 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -150.33 163.59 37.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.298 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HE2' HG23 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -117.39 89.6 32.11 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.122 . . . . 0.0 109.294 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -35.6 3.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.469 1.773 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.15 -160.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.271 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.35 -49.46 2.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -82.39 -22.39 35.43 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 67.4 m95 -110.95 138.94 46.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 0.0 108.033 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.502 ' O ' HG22 ' A' ' 182' ' ' ILE . 24.8 m0 -119.91 134.3 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 0.0 107.946 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.1 OUTLIER -86.88 101.64 13.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.265 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.834 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -118.6 166.61 12.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 109.287 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.459 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 3.3 mt-10 -111.33 133.94 53.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.318 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.466 ' HA ' HD23 ' A' ' 159' ' ' LEU . 4.5 t70 -77.34 164.49 25.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 0.0 109.296 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 92.2 p -53.55 -18.98 3.25 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 0.0 109.992 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.03 -20.92 37.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.495 1.122 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.99 31.75 7.16 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.571 1.169 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -103.09 118.71 37.41 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 0.762 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.5 mtt85 -87.59 115.24 24.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.62 178.42 26.2 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.454 1.096 . . . . 0.0 111.065 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.569 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -85.96 136.39 33.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.524 0.779 . . . . 0.0 110.981 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.723 HG12 HG11 ' A' ' 187' ' ' VAL . 11.6 tt -131.67 142.38 45.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.576 1.172 . . . . 0.0 109.282 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.966 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.97 138.12 22.67 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.435 1.755 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.766 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.5 t -70.81 -36.07 4.96 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.128 . . . . 0.0 109.32 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.766 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.475 1.776 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.623 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -38.43 -27.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 0.0 110.981 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.3 m -118.84 177.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.423 1.077 . . . . 0.0 109.33 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.928 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.8 OUTLIER -135.5 -163.14 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 0.0 110.269 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.7 ' HZ1' ' N ' ' A' ' 134' ' ' ALA . 10.3 tptp -96.22 165.81 12.04 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.125 . . . . 0.0 109.24 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.556 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 0.8 OUTLIER 78.09 147.66 0.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.505 1.128 . . . . 0.0 111.0 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.502 ' C ' HG23 ' A' ' 158' ' ' ILE . . . . . . . . 0 CA--C 1.529 0.948 0 O-C-N 124.497 1.123 . . . . 0.0 111.063 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.631 ' HB1' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 2.3 tt0 -118.67 -172.1 2.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.139 . . . . 0.0 110.333 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.78 99.9 3.15 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.512 1.133 . . . . 0.0 110.981 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.516 HG22 HD13 ' A' ' 161' ' ' ILE . 31.6 m -124.39 141.06 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 0.0 109.308 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -97.53 -170.0 1.93 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -149.2 94.19 2.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.844 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.75 33.53 1.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 109.311 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.701 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -136.74 -10.63 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 111.073 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.593 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 49.89 165.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.092 . . . . 0.0 109.365 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 -153.32 -50.77 0.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 111.075 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.544 ' C ' ' O ' ' A' ' 143' ' ' PHE . 12.3 t-20 29.27 90.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 0.0 109.304 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -105.04 -42.14 1.84 Allowed Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.497 1.123 . . . . 0.0 110.992 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.588 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 5.8 p30 150.35 -8.85 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.467 0.745 . . . . 0.0 109.288 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.681 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 61.96 36.55 15.6 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 1.156 . . . . 0.0 109.313 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -78.1 3.93 13.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.475 1.109 . . . . 0.0 110.316 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' HG2' ' N ' ' A' ' 150' ' ' ASP . 2.3 pt-20 179.85 -29.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.52 1.137 . . . . 0.0 110.328 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 10.5 m-20 -113.23 -175.01 2.57 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.467 1.104 . . . . 0.0 109.297 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.929 HD23 HD11 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -108.25 119.13 50.68 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.457 1.098 . . . . 0.0 109.309 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.646 ' N ' HD12 ' A' ' 151' ' ' LEU . 17.9 Cg_endo -75.07 121.32 6.48 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.527 1.804 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.765 ' CD2' ' HB1' ' A' ' 139' ' ' ALA . 38.0 p90 -117.44 170.47 8.7 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.524 1.14 . . . . 0.0 111.032 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 139' ' ' ALA . 3.0 mptt -108.36 -179.96 4.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.449 1.093 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.497 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.99 85.62 7.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 109.272 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.33 23.21 2.68 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.445 1.091 . . . . 0.0 111.017 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.6 t70 -83.91 157.28 22.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.551 0.795 . . . . 0.0 109.338 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.4 mp -114.08 131.77 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.58 1.175 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD2' HD21 ' A' ' 151' ' ' LEU . 3.1 mp -144.48 133.92 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 0.0 109.271 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.713 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -91.58 143.36 26.65 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.1 mp -87.06 116.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.56 1.162 . . . . 0.0 109.295 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -109.28 -34.79 6.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.435 ' HB2' ' CD ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -138.64 155.72 48.06 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.553 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 6.5 ttpt -143.59 88.74 7.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 109.296 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.04 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.502 1.791 . . . . 0.0 110.978 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -101.18 -168.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 168' ' ' GLN . 21.4 pt-20 -105.44 -43.0 5.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.473 1.108 . . . . 0.0 110.344 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.424 ' N ' ' HG3' ' A' ' 167' ' ' GLU . 17.9 pt20 -62.86 -39.15 93.54 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.588 1.18 . . . . 0.0 110.326 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.512 ' CZ3' ' HB3' ' A' ' 150' ' ' ASP . 31.5 m95 -124.94 145.61 49.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 181' ' ' MET . 25.0 m0 -123.07 -179.61 4.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.68 104.23 7.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -123.92 167.55 13.97 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.4 1.062 . . . . 0.0 109.244 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.2 mt-10 -108.93 134.01 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.58 160.53 32.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.1 m -53.06 -19.83 3.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.122 . . . . 0.0 110.06 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.2 -26.81 35.66 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.565 1.165 . . . . 0.0 110.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.9 31.04 4.31 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.543 1.152 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.2 mmtp -99.56 121.07 40.66 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.547 0.793 . . . . 0.0 109.343 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.45 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 3.0 mtt85 -85.8 111.09 19.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 0.0 110.282 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.14 -175.52 20.86 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.559 1.162 . . . . 0.0 111.056 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.761 ' C ' HD12 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -88.24 146.02 25.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.929 HD11 HD23 ' A' ' 151' ' ' LEU . 4.2 mp -139.62 145.14 42.14 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.826 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -75.05 152.49 40.59 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.477 1.777 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.4 t -87.05 -39.21 0.52 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.504 1.792 . . . . 0.0 110.963 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.701 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.4 m-85 -80.65 40.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.474 1.109 . . . . 0.0 111.019 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 184' ' ' VAL . 18.2 m -155.63 164.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.579 1.174 . . . . 0.0 109.297 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.844 ' CG ' HD11 ' A' ' 140' ' ' LEU . 7.3 mm-40 -138.2 -168.45 2.37 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.55 1.156 . . . . 0.0 110.353 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -102.98 138.43 39.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.567 1.167 . . . . 0.0 109.273 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 138' ' ' ARG . 0.8 OUTLIER -75.13 132.0 40.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 0.0 110.934 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.969 0 O-C-N 124.572 1.17 . . . . 0.0 110.942 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.725 ' HB1' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.514 ' N ' ' HB ' ' A' ' 161' ' ' ILE . 15.7 tt0 171.89 -39.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.48 1.113 . . . . 0.0 110.283 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.591 ' CD1' ' HG3' ' A' ' 160' ' ' ARG . 5.7 m-85 -142.25 133.06 25.63 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.449 1.093 . . . . 0.0 111.016 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.447 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 3.9 m -137.27 166.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.3 ptp180 -127.9 164.32 22.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 110.229 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.685 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.14 93.74 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.115 . . . . 0.0 109.344 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.891 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -96.53 25.23 5.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.442 1.089 . . . . 0.0 109.312 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.73 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.79 -11.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 110.987 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.522 ' OD1' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.79 159.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 0.0 109.287 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.66 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 44.1 t80 -164.05 -55.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.157 . . . . 0.0 110.989 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.517 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 20.7 t30 58.91 93.02 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.146 . . . . 0.0 109.315 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -86.75 -67.53 1.35 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.508 1.13 . . . . 0.0 111.003 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 2.5 t30 152.29 -17.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 0.745 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 87.27 171.99 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.095 . . . . 0.0 109.256 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.556 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 3.5 mt-10 68.08 10.76 8.02 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 0.0 110.287 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -178.05 -32.84 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.514 1.134 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -148.8 117.87 6.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.414 1.071 . . . . 0.0 109.298 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.849 ' CD2' HD23 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -70.43 117.63 56.77 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.436 1.085 . . . . 0.0 109.355 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.67 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -74.99 128.14 11.25 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.487 1.783 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.677 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 10.2 p90 -137.22 152.98 50.47 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.478 1.111 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.522 ' CG ' ' OD1' ' A' ' 142' ' ' ASP . 7.9 mtpt -155.82 149.47 25.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER 46.75 91.01 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 0.0 109.301 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 27.85 45.2 0.04 OUTLIER Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.508 1.13 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -43.78 168.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.536 0.786 . . . . 0.0 109.269 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 158' ' ' ILE . 21.0 mm -118.08 127.63 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.512 1.132 . . . . 0.0 109.261 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.849 HD23 ' CD2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -143.23 177.75 8.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.494 1.121 . . . . 0.0 109.326 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.723 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.1 mpp_? -135.9 153.66 51.38 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.131 . . . . 0.0 110.255 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.725 HG21 ' HB1' ' A' ' 134' ' ' ALA . 1.2 mp -86.09 118.93 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.543 1.152 . . . . 0.0 109.308 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.83 -54.06 2.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.566 1.166 . . . . 0.0 110.301 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 171' ' ' ASN . 5.1 m-20 -149.75 123.9 9.48 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.583 ' CD ' ' CG ' ' A' ' 170' ' ' TRP . 8.5 mmtt -114.0 94.31 33.64 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 0.0 109.311 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.473 1.775 . . . . 0.0 111.008 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -115.54 -173.03 2.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.256 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.18 -29.91 10.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.426 1.079 . . . . 0.0 110.311 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.85 -50.48 70.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.582 1.176 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.471 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 17.3 m95 -122.08 151.15 41.19 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.583 1.177 . . . . 0.0 108.008 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.583 ' CG ' ' CD ' ' A' ' 164' ' ' LYS . 8.7 m0 -127.3 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 163' ' ' ASP . 6.1 t-20 -94.15 91.37 6.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.723 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -104.85 165.74 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 0.0 109.323 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.7 mt-10 -108.51 143.72 37.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 0.0 110.273 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.444 ' HB2' HD13 ' A' ' 151' ' ' LEU . 29.8 t0 -78.3 165.75 23.5 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 109.345 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.1 t -56.88 -17.65 10.23 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 0.0 110.049 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.21 -27.22 26.25 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.468 1.105 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 107.78 29.92 4.2 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.433 1.083 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -97.79 122.8 41.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 0.797 . . . . 0.0 109.295 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.443 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.8 mtp180 -85.42 114.71 22.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.564 1.165 . . . . 0.0 110.261 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.32 167.75 29.04 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.455 1.097 . . . . 0.0 111.028 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 1.5 mtt -87.91 147.78 24.91 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 0.777 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.637 ' C ' HD12 ' A' ' 182' ' ' ILE . 2.3 pp -148.72 160.71 35.17 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.451 1.094 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.99 147.61 34.21 Favored 'Trans proline' 0 C--N 1.359 1.095 0 O-C-N 124.528 1.804 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.0 t -80.9 -37.17 0.94 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.04 -66.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.73 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.0 OUTLIER -42.53 -22.05 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.454 1.096 . . . . 0.0 110.994 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.5 m -113.17 172.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.891 ' CG ' HD11 ' A' ' 140' ' ' LEU . 6.0 mm-40 -142.77 -166.91 2.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 110.247 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -104.43 149.28 25.56 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.475 1.11 . . . . 0.0 109.352 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.525 ' CB ' ' HB3' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -90.71 85.85 6.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.53 1.144 . . . . 0.0 111.051 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 O-C-N 124.504 1.128 . . . . 0.0 110.964 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.556 ' CA ' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.5 tt0 172.39 -40.01 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 0.0 110.273 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.78 112.71 6.04 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 0.0 110.982 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.799 HG12 ' HG2' ' A' ' 189' ' ' LYS . 18.2 m -133.06 142.54 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 0.0 109.292 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.713 ' O ' ' HB ' ' A' ' 187' ' ' VAL . 2.6 ptp180 -115.84 170.62 8.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.833 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.78 137.5 54.67 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.477 1.111 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.014 HD21 ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.55 22.57 4.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 0.0 109.296 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.665 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.6 OUTLIER -139.87 -3.26 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 0.0 110.963 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 51.35 166.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 0.0 109.343 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -162.03 -53.64 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 111.05 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 48.48 -84.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.5 1.125 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . 72.13 -56.6 1.48 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.462 1.101 . . . . 0.0 111.031 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.508 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 3.1 m-20 156.08 -16.92 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.549 0.794 . . . . 0.0 109.299 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.755 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 70.24 37.11 1.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.507 1.13 . . . . 0.0 109.316 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 5.6 mt-10 -66.45 -13.75 61.23 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.487 1.117 . . . . 0.0 110.283 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.502 ' CG ' ' O ' ' A' ' 149' ' ' GLU . 7.5 tt0 176.44 32.31 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.555 1.159 . . . . 0.0 110.293 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.464 ' OD1' ' C ' ' A' ' 149' ' ' GLU . 0.8 OUTLIER -154.54 173.92 15.64 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.578 1.174 . . . . 0.0 109.3 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.88 HD12 ' HD2' ' A' ' 152' ' ' PRO . 9.9 tp -95.73 115.92 65.87 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.111 . . . . 0.0 109.241 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.88 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 125.34 9.25 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.682 ' HB3' HD11 ' A' ' 182' ' ' ILE . 31.5 p90 -131.94 178.13 7.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.501 1.126 . . . . 0.0 111.012 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -124.81 -176.43 3.54 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.152 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.527 ' HB3' ' CG ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -83.08 42.82 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 0.0 109.238 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 161.69 39.26 0.02 OUTLIER Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.549 1.156 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.721 ' OD2' HD11 ' A' ' 159' ' ' LEU . 37.4 t70 -100.42 156.07 17.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.408 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.3 mp -118.24 129.31 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.149 . . . . 0.0 109.299 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.721 HD11 ' OD2' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -145.41 136.71 24.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.57 1.168 . . . . 0.0 109.28 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.677 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 12.2 ptm180 -90.12 147.76 23.41 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.484 1.115 . . . . 0.0 110.301 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -91.35 118.48 36.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 109.326 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.525 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 9.2 ptt85 -101.22 -44.22 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 1.092 . . . . 0.0 110.264 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 35.7 t0 -150.91 171.73 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 0.0 109.274 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.579 ' HG2' ' CD1' ' A' ' 170' ' ' TRP . 1.1 mptt -135.87 122.48 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.546 1.154 . . . . 0.0 109.275 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 181' ' ' MET . 18.3 Cg_endo -75.02 -47.63 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 O-C-N 124.434 1.755 . . . . 0.0 111.037 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -123.47 -100.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 110.391 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.74 -67.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 110.334 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.604 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 7.6 pt20 -53.87 -38.14 64.43 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.528 1.142 . . . . 0.0 110.283 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CD1' ' HG3' ' A' ' 168' ' ' GLN . 80.7 m95 -102.47 128.44 49.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 108.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.579 ' CD1' ' HG2' ' A' ' 164' ' ' LYS . 37.5 m0 -115.44 140.35 49.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.595 1.184 . . . . 0.0 108.006 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.85 98.4 11.46 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.596 1.185 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.9 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.62 165.62 12.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.0 mt-10 -108.23 133.41 52.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 110.269 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.526 ' HA ' HD23 ' A' ' 159' ' ' LEU . 1.2 t0 -73.47 160.7 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 0.0 109.252 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.9 p -50.84 -21.24 1.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 109.977 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -83.24 -29.62 28.32 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 0.0 110.285 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.87 31.66 3.08 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.504 1.127 . . . . 0.0 111.036 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.0 OUTLIER -94.77 117.97 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.428 0.723 . . . . 0.0 109.236 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.4 mtp180 -86.09 108.43 18.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.396 1.06 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.26 174.04 30.55 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.529 1.143 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.437 ' CG ' ' HG3' ' A' ' 165' ' ' PRO . 24.2 mtp -87.84 146.27 25.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.589 0.817 . . . . 0.0 110.995 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.705 HD12 ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -139.06 150.63 65.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.4 1.062 . . . . 0.0 109.285 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.829 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -74.96 136.32 20.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.49 1.784 . . . . 0.0 110.967 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.8 t -69.35 -36.87 7.71 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.141 . . . . 0.0 109.31 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -69.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.474 1.776 . . . . 0.0 110.961 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.665 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.9 OUTLIER -44.14 -18.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.1 m -117.71 162.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 0.0 109.314 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 1.014 ' HG3' HD21 ' A' ' 140' ' ' LEU . 5.5 mm-40 -115.41 -170.89 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.558 1.162 . . . . 0.0 110.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.799 ' HG2' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -138.65 154.64 48.65 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 0.0 109.316 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.518 ' HB2' ' NH2' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -120.28 112.05 18.56 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.502 1.126 . . . . 0.0 110.916 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 O-C-N 124.457 1.098 . . . . 0.0 111.024 179.927 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.473 ' HB1' ' CZ ' ' A' ' 160' ' ' ARG . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -116.61 -155.48 0.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 0.0 110.319 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 11.6 m-85 -144.86 136.34 25.34 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.502 1.127 . . . . 0.0 111.024 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.523 ' O ' HD12 ' A' ' 158' ' ' ILE . 4.6 m -133.95 140.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.432 1.082 . . . . 0.0 109.318 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 15.0 tpp85 -113.9 115.11 27.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.484 1.115 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.024 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.32 124.75 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.511 1.132 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.954 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -139.42 34.0 2.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.719 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.2 t80 -129.77 -15.97 3.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 111.037 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 53.59 159.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 0.0 109.295 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.65 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -165.52 -50.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.998 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 143' ' ' PHE . 7.5 p-10 30.42 93.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 0.0 109.303 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -107.79 -40.92 1.65 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.533 1.146 . . . . 0.0 111.037 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.547 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 6.4 p30 154.79 -20.5 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.6 0.823 . . . . 0.0 109.338 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.783 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 77.88 43.02 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.331 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 3.8 mt-10 -77.87 8.25 4.86 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.579 1.174 . . . . 0.0 110.279 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 2.0 tt0 166.38 -23.91 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 0.0 110.315 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 181' ' ' MET . 0.3 OUTLIER -113.13 174.77 5.74 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.553 1.158 . . . . 0.0 109.33 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.797 HD21 ' CD2' ' A' ' 159' ' ' LEU . 0.6 OUTLIER -98.2 117.03 65.43 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.255 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.676 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.04 120.66 6.15 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.454 1.765 . . . . 0.0 110.953 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.65 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.5 p90 -117.31 168.66 10.14 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -126.9 8.0 6.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 0.0 109.251 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 88.28 137.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.559 1.162 . . . . 0.0 109.28 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 1.024 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 81.19 20.11 65.48 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 124.504 1.127 . . . . 0.0 111.029 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.792 ' CG ' ' HB3' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -99.88 113.79 26.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.443 0.731 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.63 HD13 ' O ' ' A' ' 190' ' ' TYR . 5.3 tp -88.57 126.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.432 1.083 . . . . 0.0 109.299 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -130.99 -174.44 3.38 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.482 1.114 . . . . 0.0 109.266 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.597 ' HG3' ' N ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -127.23 144.7 50.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.531 1.144 . . . . 0.0 110.329 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -84.5 116.1 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.52 1.137 . . . . 0.0 109.284 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 -49.05 2.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.4 161.96 28.24 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 109.328 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.554 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -154.66 85.71 3.65 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -38.81 1.42 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.468 1.772 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -118.34 -175.98 2.98 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.5 -30.84 9.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 0.0 110.316 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -76.87 -38.57 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.119 . . . . 0.0 110.316 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.475 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 60.9 m95 -117.24 139.09 51.23 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 108.015 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.554 ' CD1' ' HG3' ' A' ' 164' ' ' LYS . 34.1 m0 -120.86 144.33 48.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 0.0 108.016 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -91.36 95.76 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.57 1.169 . . . . 0.0 109.316 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.602 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -107.46 156.98 18.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.454 1.096 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.2 mt-10 -106.38 132.77 52.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.114 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.747 ' OD1' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -75.57 162.69 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.58 1.175 . . . . 0.0 109.281 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.2 t -50.96 -20.95 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.52 1.137 . . . . 0.0 110.059 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.38 -27.91 41.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.463 1.102 . . . . 0.0 110.251 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 103.42 30.94 5.13 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.512 1.133 . . . . 0.0 111.032 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 11.1 ptmt -101.9 122.12 43.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 0.763 . . . . 0.0 109.254 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.457 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.73 116.08 24.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 0.0 110.29 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -146.34 152.55 24.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.485 1.115 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 10.4 mtp -87.19 131.21 34.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 0.802 . . . . 0.0 111.019 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.632 ' CD1' HD13 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -132.26 165.26 37.43 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 0.0 109.271 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.758 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.98 133.05 16.15 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 111.015 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.833 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.8 t -78.04 -31.5 0.8 Allowed Pre-proline 0 C--N 1.324 -0.539 0 O-C-N 124.523 1.139 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.833 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.99 -19.91 17.39 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.518 1.799 . . . . 0.0 110.97 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.758 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.54 -0.34 52.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.963 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 139' ' ' ALA . 7.1 m -135.04 169.77 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.433 1.083 . . . . 0.0 109.322 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.954 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.2 mt-10 -125.26 -158.36 0.83 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.534 1.146 . . . . 0.0 110.223 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 22.9 mmmt -107.02 108.1 19.43 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.63 ' O ' HD13 ' A' ' 158' ' ' ILE . 0.3 OUTLIER 69.06 -57.74 0.51 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 0.0 111.012 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.961 0 O-C-N 124.45 1.094 . . . . 0.0 111.031 -179.95 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -148.64 -159.04 0.98 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.571 1.169 . . . . 0.0 110.309 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 22.2 m-85 -141.34 162.25 35.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 0.0 111.02 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.908 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.6 m -146.35 148.03 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.487 1.117 . . . . 0.0 109.325 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.768 HH21 ' N ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -113.75 112.86 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.367 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.95 121.41 30.32 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.531 1.144 . . . . 0.0 109.254 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.923 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.03 27.24 7.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.719 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -133.83 -17.16 2.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER 54.19 156.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.564 1.165 . . . . 0.0 109.239 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.62 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 0.8 OUTLIER -163.83 -94.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.62 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 3.8 m-20 145.29 2.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 0.0 109.317 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 143' ' ' PHE . . . 44.55 -101.87 0.03 OUTLIER Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.494 1.121 . . . . 0.0 110.984 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 20.8 t-20 170.42 -25.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.453 0.737 . . . . 0.0 109.288 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 82.23 167.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.105 . . . . 0.0 109.252 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER 61.06 13.36 4.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.557 1.161 . . . . 0.0 110.34 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 0.9 OUTLIER 164.31 -25.24 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.542 1.151 . . . . 0.0 110.296 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.511 ' HB3' ' CA ' ' A' ' 145' ' ' GLY . 1.1 m-20 -116.29 142.35 46.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.603 1.19 . . . . 0.0 109.315 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.074 HD21 HD22 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -105.53 118.57 55.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 0.0 109.323 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 144' ' ' ASN . 18.4 Cg_endo -75.04 130.1 12.92 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.538 1.809 . . . . 0.0 110.984 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 42.2 p90 -134.35 175.9 9.1 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.518 1.136 . . . . 0.0 110.983 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -129.33 -176.83 4.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.294 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.503 ' HG2' ' HA ' ' A' ' 140' ' ' LEU . 1.4 tmpt? -82.32 82.9 7.63 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.413 1.07 . . . . 0.0 109.285 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 123.69 29.39 1.17 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.468 1.105 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.57 ' OD2' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -100.16 129.8 46.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.456 0.739 . . . . 0.0 109.294 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.908 HD13 ' O ' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -99.26 120.8 49.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.487 1.117 . . . . 0.0 109.343 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 1.074 HD22 HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -118.14 -173.32 2.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.445 1.091 . . . . 0.0 109.314 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 2.9 mpt_? -129.3 141.87 50.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.288 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.429 ' HB ' ' CG ' ' A' ' 135' ' ' GLU . 1.2 mp -87.88 116.03 29.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.451 1.094 . . . . 0.0 109.262 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.06 -48.91 4.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -148.96 165.37 31.81 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.464 1.103 . . . . 0.0 109.273 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.546 ' HE2' ' CD2' ' A' ' 170' ' ' TRP . 25.7 mttt -138.35 95.34 10.38 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.112 . . . . 0.0 109.256 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -29.13 8.48 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.497 1.788 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -128.27 -171.14 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.115 . . . . 0.0 110.376 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.77 -27.59 9.24 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 110.256 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -80.96 -36.22 31.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.451 1.094 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.506 ' CE3' ' C ' ' A' ' 182' ' ' ILE . 35.3 m95 -124.22 143.92 50.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 107.991 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.645 ' CD2' HG22 ' A' ' 184' ' ' VAL . 54.5 m0 -119.88 146.53 45.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 0.0 108.064 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -87.55 92.83 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.583 1.177 . . . . 0.0 109.339 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -103.48 164.63 11.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.565 1.166 . . . . 0.0 109.304 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 1.9 mt-10 -112.5 135.01 53.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 0.0 110.277 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.853 ' OD1' HD11 ' A' ' 151' ' ' LEU . 1.1 t0 -73.15 158.17 35.8 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.518 1.136 . . . . 0.0 109.347 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.3 p -49.49 -22.06 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.529 1.143 . . . . 0.0 109.926 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -82.84 -29.79 29.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 112.06 30.99 2.78 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.496 1.123 . . . . 0.0 111.022 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -92.33 116.79 29.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.532 0.783 . . . . 0.0 109.278 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.484 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.4 mtp-105 -86.32 108.94 18.65 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.292 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.2 162.25 29.41 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.492 1.12 . . . . 0.0 111.002 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.7 mtp -87.62 137.36 32.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.504 0.767 . . . . 0.0 110.999 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.762 HD13 HD13 ' A' ' 159' ' ' LEU . 9.2 pt -133.33 168.98 15.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.421 1.075 . . . . 0.0 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.643 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 141.57 26.75 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 0.0 110.973 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.793 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 79.9 t -78.94 -34.16 0.94 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.521 1.138 . . . . 0.0 109.214 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.793 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.54 1.811 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.719 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.4 m-85 -31.55 -35.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.571 1.17 . . . . 0.0 110.979 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -115.88 172.35 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.475 1.11 . . . . 0.0 109.273 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.923 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -123.62 -173.24 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 110.317 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -107.23 135.24 49.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 0.0 109.312 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -122.45 -36.54 2.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 0.0 110.956 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.441 ' N ' ' HB2' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.984 0 O-C-N 124.438 1.087 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.561 ' CA ' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.6 tt0 177.12 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.441 1.088 . . . . 0.0 110.309 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.609 ' CD2' ' C ' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -149.23 131.24 15.29 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.503 1.127 . . . . 0.0 110.949 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.02 ' O ' HD12 ' A' ' 158' ' ' ILE . 1.6 m -128.77 158.39 41.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 109.277 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.703 HH21 HD13 ' A' ' 158' ' ' ILE . 2.9 tpp85 -129.36 121.46 27.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 110.324 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.846 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.24 126.48 34.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.452 1.095 . . . . 0.0 109.328 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.043 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.99 25.06 4.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.557 1.161 . . . . 0.0 109.308 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -143.03 0.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 111.026 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 141' ' ' PHE . 1.3 m-20 51.6 166.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.327 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.709 ' O ' ' C ' ' A' ' 144' ' ' ASN . 8.2 t80 -167.93 -38.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.495 1.122 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.709 ' C ' ' O ' ' A' ' 143' ' ' PHE . 20.4 t-20 2.73 -80.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.54 1.15 . . . . 0.0 109.331 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . 60.74 -74.48 0.01 OUTLIER Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.578 1.174 . . . . 0.0 110.998 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 144' ' ' ASN . 29.9 p-10 -149.95 -24.47 0.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.541 0.789 . . . . 0.0 109.275 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 146' ' ' ASN . 5.1 p-10 49.17 59.26 4.59 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.489 1.118 . . . . 0.0 109.314 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.67 5.11 9.9 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.473 1.108 . . . . 0.0 110.332 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 179.79 -31.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.536 1.147 . . . . 0.0 110.351 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.604 ' OD2' ' CH2' ' A' ' 169' ' ' TRP . 89.1 m-20 -87.26 160.12 18.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 0.0 109.256 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.75 HD23 HD13 ' A' ' 159' ' ' LEU . 1.2 tp -79.31 121.56 83.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.561 1.163 . . . . 0.0 109.314 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.646 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.95 130.91 13.77 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.517 1.799 . . . . 0.0 110.981 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.656 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 23.6 p90 -147.97 167.54 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.456 1.098 . . . . 0.0 111.025 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -125.66 173.34 9.07 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.479 1.112 . . . . 0.0 109.234 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.86 ' O ' ' HG2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -64.44 94.55 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.846 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.63 11.0 4.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.56 1.163 . . . . 0.0 110.994 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.698 ' HB2' ' HB3' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -75.51 153.44 37.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.591 0.818 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.02 HD12 ' O ' ' A' ' 137' ' ' VAL . 8.5 tp -134.68 129.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.75 HD13 HD23 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -138.08 177.75 7.64 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 109.269 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.703 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -123.68 140.19 53.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.402 1.064 . . . . 0.0 110.31 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 1.029 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -84.12 118.65 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.52 1.138 . . . . 0.0 109.288 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.553 ' CZ ' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -103.18 -46.39 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 0.0 110.343 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -146.98 163.24 36.84 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 0.0 109.261 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 118.28 6.25 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.483 1.114 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.522 ' CD ' ' HE1' ' A' ' 181' ' ' MET . 18.2 Cg_endo -74.99 -65.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.451 1.764 . . . . 0.0 111.02 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -102.86 -105.76 0.27 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.551 1.157 . . . . 0.0 110.321 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.37 -46.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.519 1.137 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -54.99 -39.82 69.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 0.0 110.321 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CH2' ' OD2' ' A' ' 150' ' ' ASP . 24.1 m95 -118.66 144.77 45.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.615 ' CD2' HG22 ' A' ' 184' ' ' VAL . 41.3 m0 -124.78 148.5 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.424 ' CA ' ' HE3' ' A' ' 181' ' ' MET . 61.1 t-20 -99.5 101.76 13.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.475 1.109 . . . . 0.0 109.308 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 1.029 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -119.12 164.5 15.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 3.3 mt-10 -104.46 133.73 48.85 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 1.156 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.441 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 21.2 t0 -74.6 164.65 26.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.5 t -53.98 -18.86 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.028 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -81.97 -24.85 35.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 110.253 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.96 27.39 7.03 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.51 1.131 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.48 ' HD2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -99.43 121.15 40.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.474 0.749 . . . . 0.0 109.307 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.553 ' NH1' ' CZ ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -85.82 112.18 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 0.0 110.327 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.8 170.88 28.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.522 ' HE1' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -88.87 143.15 27.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 0.773 . . . . 0.0 110.971 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -139.64 160.28 61.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.467 1.105 . . . . 0.0 109.313 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.94 145.74 32.05 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.464 1.771 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.741 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.6 t -79.45 -37.74 1.21 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.498 1.124 . . . . 0.0 109.308 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.741 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.0 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.454 1.765 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.637 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.9 OUTLIER -32.3 -35.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.529 1.143 . . . . 0.0 110.971 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -112.09 169.18 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 0.0 109.316 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 1.043 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.5 mt-10 -126.61 -157.78 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.528 1.143 . . . . 0.0 110.307 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.33 130.96 54.67 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.582 1.176 . . . . 0.0 109.327 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.53 ' CG ' ' N ' ' A' ' 191' ' ' GLY . 17.8 t80 -107.89 -99.39 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.478 1.111 . . . . 0.0 110.977 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.609 ' C ' ' CD2' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.993 0 O-C-N 124.489 1.118 . . . . 0.0 110.986 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -178.8 -137.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.12 . . . . 0.0 110.264 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 18.2 m-85 -145.64 164.74 30.8 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.484 1.115 . . . . 0.0 111.012 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 13.4 m -146.92 147.97 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 109.366 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 3.6 ptp180 -117.56 119.57 35.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.537 1.148 . . . . 0.0 110.308 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.043 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.24 100.04 12.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 0.0 109.251 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.904 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -98.38 36.27 1.64 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.414 1.071 . . . . 0.0 109.318 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.645 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -140.2 -11.61 1.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.597 1.186 . . . . 0.0 111.036 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 52.38 158.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.188 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.599 ' O ' ' C ' ' A' ' 144' ' ' ASN . 2.0 t80 -157.88 -49.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 0.0 110.975 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 143' ' ' PHE . 37.7 m-80 23.83 90.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.438 1.086 . . . . 0.0 109.366 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -103.48 -46.0 1.48 Allowed Glycine 0 CA--C 1.529 0.94 0 O-C-N 124.483 1.114 . . . . 0.0 111.05 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.548 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 0.9 OUTLIER 160.2 -24.11 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.446 0.733 . . . . 0.0 109.277 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.717 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 79.7 34.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.538 1.149 . . . . 0.0 109.283 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 0.6 OUTLIER -80.82 14.09 2.33 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.504 1.128 . . . . 0.0 110.314 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 8.8 tt0 168.05 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.466 1.104 . . . . 0.0 110.273 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 0.5 OUTLIER -114.77 -176.99 3.02 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.519 1.137 . . . . 0.0 109.351 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 152' ' ' PRO . 0.9 OUTLIER -108.22 118.29 52.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.664 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.06 123.29 7.74 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.503 1.791 . . . . 0.0 110.984 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.688 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 21.8 p90 -125.02 -179.26 4.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.13 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -114.46 -176.53 2.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.498 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -81.44 66.07 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.336 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 1.043 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.04 35.56 0.62 Allowed Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.498 1.124 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.628 ' OD2' HD21 ' A' ' 159' ' ' LEU . 4.3 t70 -85.2 139.85 31.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 0.764 . . . . 0.0 109.274 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.903 HG23 ' C ' ' A' ' 191' ' ' GLY . 8.9 mm -93.92 134.58 31.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.485 1.116 . . . . 0.0 109.315 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.628 HD21 ' OD2' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -143.77 172.37 12.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 0.0 109.312 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 9.6 ttt180 -113.34 139.65 48.69 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 0.0 110.334 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.935 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -90.55 111.36 23.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 0.0 109.23 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -53.66 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.337 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -150.31 -179.84 7.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.563 1.164 . . . . 0.0 109.303 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.597 ' CB ' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -162.62 111.97 1.09 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 0.0 109.252 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -57.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.484 1.781 . . . . 0.0 110.996 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.0 -121.85 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 0.0 110.342 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 -46.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.549 1.155 . . . . 0.0 110.3 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -66.19 -17.18 64.57 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.537 1.148 . . . . 0.0 110.284 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.507 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 79.1 m95 -133.17 132.77 41.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.494 1.122 . . . . 0.0 108.028 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 184' ' ' VAL . 20.8 m0 -124.75 139.72 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.49 ' CB ' ' HE3' ' A' ' 181' ' ' MET . 36.9 t-20 -87.24 100.46 12.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.57 1.169 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.935 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.41 167.46 10.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 109.359 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.7 mt-10 -112.46 124.82 53.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.438 1.086 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 159' ' ' LEU . 2.3 t70 -66.64 161.53 23.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 0.0 109.326 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.0 p -52.48 -20.57 2.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.118 . . . . 0.0 109.962 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -78.5 -25.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.125 . . . . 0.0 110.291 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.28 31.25 5.95 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.535 1.147 . . . . 0.0 110.991 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.647 ' HE2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -104.2 124.74 49.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 0.773 . . . . 0.0 109.274 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.44 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 2.5 mtm180 -85.4 113.46 21.71 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.482 1.114 . . . . 0.0 110.319 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -145.22 176.7 24.1 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.544 1.153 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.494 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -88.39 144.61 26.28 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 0.746 . . . . 0.0 111.05 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.489 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 12.8 tt -144.53 140.74 16.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.265 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.595 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.89 139.3 24.43 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.421 1.748 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.809 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 3.0 t -81.9 -31.82 0.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 0.0 109.305 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.809 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -74.96 -26.76 10.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.415 1.745 . . . . 0.0 111.02 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.691 HG12 ' CB ' ' A' ' 139' ' ' ALA . 1.5 m -146.86 -174.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 109.35 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.904 ' CD ' HD21 ' A' ' 140' ' ' LEU . 3.2 mt-10 -134.13 -171.05 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 110.366 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.9 OUTLIER -101.08 168.05 9.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.422 1.076 . . . . 0.0 109.317 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.618 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 1.6 t80 81.43 -37.77 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 0.0 111.009 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.903 ' C ' HG23 ' A' ' 158' ' ' ILE . . . . . . . . 0 CA--C 1.531 1.064 0 O-C-N 124.492 1.12 . . . . 0.0 111.001 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.636 ' OE2' ' CE1' ' A' ' 136' ' ' TYR . 4.7 mm-40 -115.7 -163.23 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 1.116 . . . . 0.0 110.242 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.636 ' CE1' ' OE2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -137.9 144.72 41.45 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.443 1.09 . . . . 0.0 111.005 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 158' ' ' ILE . 6.1 m -148.13 142.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.386 1.054 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.73 HH21 HD13 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -106.49 146.33 30.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.46 1.1 . . . . 0.0 110.362 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.958 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -115.41 97.94 6.45 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.573 1.171 . . . . 0.0 109.269 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.864 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -108.89 30.62 6.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 0.0 109.348 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.753 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -133.77 -17.71 2.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 0.0 110.981 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER 54.31 159.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.457 1.098 . . . . 0.0 109.269 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' A' ' 145' ' ' GLY . 2.4 t80 -164.82 -38.46 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 0.0 110.969 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.534 ' C ' ' O ' ' A' ' 143' ' ' PHE . 15.8 t30 -29.9 89.15 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.529 1.143 . . . . 0.0 109.256 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . -126.14 -30.34 0.87 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.477 1.111 . . . . 0.0 111.044 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 5.6 m-20 -153.73 -35.67 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.48 0.753 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 4.4 p-10 47.92 47.85 18.29 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.547 1.154 . . . . 0.0 109.329 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.11 -8.08 54.89 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.12 . . . . 0.0 110.304 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -178.96 34.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.47 1.106 . . . . 0.0 110.28 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 143' ' ' PHE . 2.8 p30 -158.43 154.69 27.3 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.45 1.094 . . . . 0.0 109.29 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.9 HD12 ' HD2' ' A' ' 152' ' ' PRO . 14.2 tp -74.01 117.28 60.06 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.9 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.03 117.5 4.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.541 1.811 . . . . 0.0 110.959 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.67 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 49.6 p90 -125.72 178.51 5.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 0.0 111.034 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 139' ' ' ALA . 12.5 mttm -125.77 179.69 5.06 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.53 1.144 . . . . 0.0 109.287 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.708 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.73 79.83 9.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 0.0 109.283 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.958 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 134.11 21.33 0.78 Allowed Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.509 1.131 . . . . 0.0 111.027 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 17.6 t70 -90.67 147.04 23.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.42 0.717 . . . . 0.0 109.313 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.73 HD13 HH21 ' A' ' 138' ' ' ARG . 7.6 tp -111.19 136.71 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.531 1.145 . . . . 0.0 109.294 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.623 HD22 HD13 ' A' ' 182' ' ' ILE . 0.4 OUTLIER -142.35 166.8 23.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.114 . . . . 0.0 109.299 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.653 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -115.61 146.82 41.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.483 1.114 . . . . 0.0 110.308 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.851 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -88.04 121.74 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 0.0 109.304 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.439 ' CD ' ' HD3' ' A' ' 179' ' ' ARG . 11.6 ttm-85 -106.15 -45.76 4.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.45 1.094 . . . . 0.0 110.296 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -148.96 152.2 35.92 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.461 1.1 . . . . 0.0 109.334 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -141.1 90.09 9.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 0.0 109.341 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 -55.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.486 1.782 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.02 -177.08 5.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 110.353 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.84 5.91 20.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 0.0 110.331 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.36 -48.13 2.81 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.457 1.098 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.593 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 48.2 m95 -105.07 143.11 33.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.544 1.153 . . . . 0.0 108.038 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.565 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 15.5 m0 -127.11 136.15 51.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 108.027 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.3 m-80 -88.5 96.33 10.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.547 1.154 . . . . 0.0 109.29 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.851 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -109.99 160.79 16.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 0.0 109.255 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -103.03 129.36 49.78 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.47 1.106 . . . . 0.0 110.282 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.95 162.03 30.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 109.249 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.5 t -52.18 -20.3 2.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 0.0 109.951 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.97 -24.09 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.94 30.18 6.87 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.509 1.131 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.5 pttt -105.17 124.8 50.16 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.537 0.786 . . . . 0.0 109.256 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HD3' ' CD ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -85.38 114.07 22.15 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.56 1.163 . . . . 0.0 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -146.22 176.9 24.91 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.39 1.056 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.593 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.7 OUTLIER -86.29 143.58 27.83 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.466 0.745 . . . . 0.0 111.031 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.623 HD13 HD22 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -142.81 144.83 31.21 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 0.0 109.279 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.785 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.05 139.31 24.0 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.459 1.768 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 78.3 t -80.91 -32.3 0.65 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.343 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -35.65 3.02 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.52 1.8 . . . . 0.0 111.04 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.753 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 1.6 m-85 -88.13 15.05 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.4 m -152.86 164.06 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.122 . . . . 0.0 109.302 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.864 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.5 OUTLIER -119.56 -162.83 0.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.239 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.6 OUTLIER -116.85 150.41 38.45 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.507 1.129 . . . . 0.0 109.346 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.55 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 1.9 t80 77.67 -67.61 0.19 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.49 1.119 . . . . 0.0 111.023 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.65 ' HA3' HD13 ' A' ' 158' ' ' ILE . . . . . . . . 0 CA--C 1.53 1.025 0 O-C-N 124.536 1.147 . . . . 0.0 111.015 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.562 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -136.69 -156.1 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.536 1.147 . . . . 0.0 110.408 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 63.3 m-85 -145.54 142.98 29.66 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.47 1.106 . . . . 0.0 110.994 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.552 HG13 HD13 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -135.53 164.22 33.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.555 1.159 . . . . 0.0 109.33 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 18.2 tpp85 -119.94 156.18 31.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.432 1.082 . . . . 0.0 110.314 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -130.02 83.26 2.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.278 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.916 HD21 ' OE1' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -101.13 22.75 11.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 0.0 109.351 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.783 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -123.56 -18.93 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 111.016 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.88 152.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.52 1.138 . . . . 0.0 109.249 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.599 ' O ' ' C ' ' A' ' 144' ' ' ASN . 2.6 t80 -153.0 -53.05 0.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.534 1.146 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 143' ' ' PHE . 17.7 t-20 22.05 90.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 0.0 109.279 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -107.43 -45.6 1.13 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.477 1.11 . . . . 0.0 110.962 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.623 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 0.6 OUTLIER 169.25 -31.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.571 0.806 . . . . 0.0 109.282 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.679 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 87.48 38.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 0.0 109.335 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 6.3 tp10 -78.77 11.71 2.47 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.572 1.17 . . . . 0.0 110.302 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 7.3 tt0 166.3 -26.47 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.462 1.101 . . . . 0.0 110.286 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 0.2 OUTLIER -109.68 172.51 6.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.548 1.155 . . . . 0.0 109.255 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.895 HD21 HD22 ' A' ' 159' ' ' LEU . 3.0 tp -99.9 120.73 56.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.696 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.06 138.88 23.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.501 1.79 . . . . 0.0 111.04 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.867 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 8.3 p90 -160.78 -178.26 6.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER 170.73 146.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.305 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.23 68.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 37.97 50.15 2.07 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.485 1.115 . . . . 0.0 110.941 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.875 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -58.54 135.63 57.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 0.0 109.366 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.447 HD11 ' NH2' ' A' ' 138' ' ' ARG . 2.1 mm -99.35 122.65 51.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.503 1.127 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.895 HD22 HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -128.46 -177.61 4.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 0.0 109.328 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.611 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -128.31 144.86 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 110.256 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.552 HD13 HG13 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -86.45 116.03 28.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 0.0 109.299 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -105.56 -52.0 2.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.55 1.156 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.35 168.13 25.02 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.502 1.126 . . . . 0.0 109.199 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -140.48 114.39 7.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.443 1.089 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -73.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -98.76 -99.74 0.22 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.13 -50.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 0.0 110.339 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -52.81 -43.61 66.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.522 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 69.7 m95 -115.21 142.42 46.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 108.015 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.486 ' CD2' HG22 ' A' ' 184' ' ' VAL . 33.8 m0 -121.16 145.43 47.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.451 ' ND2' ' SD ' ' A' ' 181' ' ' MET . 3.8 t-20 -91.04 94.46 9.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 109.354 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -110.08 164.37 12.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.139 . . . . 0.0 109.273 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -110.37 134.19 52.54 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.33 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.451 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 6.2 t70 -74.56 165.4 25.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.3 t -56.04 -17.49 7.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.138 . . . . 0.0 109.953 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.53 -22.52 32.39 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.461 1.1 . . . . 0.0 110.246 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.72 32.11 6.08 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.546 1.154 . . . . 0.0 110.991 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.637 ' HD2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -102.79 123.06 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 0.771 . . . . 0.0 109.356 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.449 ' NE ' ' OE2' ' A' ' 173' ' ' GLU . 5.3 mtt85 -86.28 115.22 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.11 167.37 28.94 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.541 1.151 . . . . 0.0 111.015 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 41.2 mmm -88.93 138.82 31.06 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.548 0.793 . . . . 0.0 111.005 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.705 ' O ' HD12 ' A' ' 182' ' ' ILE . 2.3 pp -135.24 155.75 78.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.556 1.16 . . . . 0.0 109.294 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.711 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.3 Cg_endo -74.95 138.52 23.27 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.462 1.769 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 51.3 t -78.67 -32.76 0.84 Allowed Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 109.305 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.01 2.81 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.405 1.739 . . . . 0.0 110.986 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.783 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 2.4 m-85 -90.01 23.43 2.8 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.775 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.3 m -152.55 157.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 0.0 109.317 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.916 ' OE1' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -113.77 -164.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 110.334 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 141.24 49.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 0.0 109.245 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -119.52 123.37 43.83 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.411 1.069 . . . . 0.0 111.013 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 O-C-N 124.495 1.122 . . . . 0.0 110.983 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 6.6 pt-20 169.62 -45.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.451 1.095 . . . . 0.0 110.305 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 32.3 m-85 -136.26 140.47 43.48 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 0.0 111.0 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -131.02 162.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.512 1.133 . . . . 0.0 109.232 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 10.4 tpp85 -129.98 112.64 13.7 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 110.348 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.083 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -84.13 117.1 23.25 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.967 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -127.32 25.44 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 0.0 109.263 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.23 -15.77 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 0.0 110.983 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.556 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 0.8 OUTLIER 53.91 161.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 0.0 109.324 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.627 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 9.7 t80 -136.12 -79.84 0.41 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.5 1.125 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.627 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 9.4 m-20 145.87 138.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 0.0 109.26 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 152' ' ' PRO . . . -58.02 128.85 48.55 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.449 1.093 . . . . 0.0 110.978 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 147' ' ' ASP . 7.8 p-10 -161.57 -44.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 0.765 . . . . 0.0 109.275 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 146' ' ' ASN . 3.5 p30 44.46 -173.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 0.0 109.293 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 72.33 3.19 4.6 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.479 1.112 . . . . 0.0 110.266 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -160.99 -46.96 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.591 ' CG ' ' CH2' ' A' ' 169' ' ' TRP . 7.5 m-20 -144.06 153.66 42.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 109.252 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.985 HD23 HD11 ' A' ' 182' ' ' ILE . 5.4 tp -83.28 123.42 77.11 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 0.0 109.287 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.894 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.98 164.68 32.9 Favored 'Trans proline' 0 C--N 1.362 1.24 0 O-C-N 124.519 1.8 . . . . 0.0 111.043 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.522 ' CE2' HG23 ' A' ' 182' ' ' ILE . 28.5 p90 179.11 179.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 1.146 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 9.7 mttt -113.16 -177.51 3.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.257 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -94.07 77.91 4.07 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.531 1.145 . . . . 0.0 109.256 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 1.083 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 146.07 19.72 0.13 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.482 1.114 . . . . 0.0 110.994 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.82 163.77 13.93 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 0.0 109.344 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.506 HG23 HH21 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -118.42 128.22 75.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.244 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.603 HD13 HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -132.89 -174.17 3.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.502 1.127 . . . . 0.0 109.281 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.663 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.3 ptp180 -133.34 150.1 51.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 110.265 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -94.09 115.9 34.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.529 1.143 . . . . 0.0 109.29 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HD2' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -96.29 -54.64 3.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 0.0 110.318 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.448 ' C ' ' HG2' ' A' ' 164' ' ' LYS . 0.4 OUTLIER -151.31 174.21 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.522 1.139 . . . . 0.0 109.322 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HZ1' HG13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -127.86 100.46 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 109.337 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 170' ' ' TRP . 18.2 Cg_endo -74.98 -38.21 1.7 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.499 1.789 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -134.55 -165.77 1.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.522 1.139 . . . . 0.0 110.328 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -93.07 -71.48 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.511 1.132 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 169' ' ' TRP . 1.6 pt20 -61.74 -27.67 68.89 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.484 1.115 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.591 ' CH2' ' CG ' ' A' ' 150' ' ' ASP . 37.3 m95 -108.55 137.82 45.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.491 1.119 . . . . 0.0 108.043 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.658 ' O ' ' HA ' ' A' ' 181' ' ' MET . 9.1 m0 -123.72 175.06 7.08 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.458 1.099 . . . . 0.0 108.059 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -124.91 96.07 4.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 0.0 109.248 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.918 ' HB3' HD12 ' A' ' 182' ' ' ILE . . . -109.74 168.21 9.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 0.0 109.326 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.494 ' CD ' ' NH1' ' A' ' 179' ' ' ARG . 2.0 mt-10 -113.38 139.44 48.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 151' ' ' LEU . 4.9 t70 -78.0 161.73 27.28 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.57 -20.26 1.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.141 . . . . 0.0 110.027 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.46 -26.51 41.71 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 0.0 110.274 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 102.4 26.04 7.49 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.523 1.14 . . . . 0.0 110.991 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.783 ' HD3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.36 128.57 40.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 0.754 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.494 ' NH1' ' CD ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -86.03 116.71 24.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 0.0 110.336 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.5 170.89 30.39 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.456 1.097 . . . . 0.0 111.005 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.658 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.7 mtt -86.35 144.65 27.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 0.0 110.951 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.985 HD11 HD23 ' A' ' 151' ' ' LEU . 97.1 mt -143.29 140.54 17.82 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.325 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.666 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.33 15.35 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.506 1.793 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.822 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.4 t -72.25 -31.2 1.6 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 0.0 109.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.822 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -7.67 19.34 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.478 1.778 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.666 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.6 m-85 -100.82 -30.25 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -123.13 172.36 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 0.0 109.298 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.967 ' CG ' HD11 ' A' ' 140' ' ' LEU . 2.1 mt-10 -124.27 -158.6 0.82 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.425 ' HE3' ' N ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -118.36 129.55 55.49 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.487 1.117 . . . . 0.0 109.283 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -113.47 118.84 35.61 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.452 1.095 . . . . 0.0 110.972 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 O-C-N 124.457 1.098 . . . . 0.0 111.075 179.933 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.9 OUTLIER 171.86 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.457 1.098 . . . . 0.0 110.295 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CD1' ' HA3' ' A' ' 191' ' ' GLY . 14.8 m-85 -141.25 119.95 12.54 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 0.0 111.038 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 188' ' ' GLU . 3.3 m -136.4 151.27 28.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.309 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -116.76 165.05 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 0.0 110.372 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -118.15 115.51 24.94 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.489 1.118 . . . . 0.0 109.299 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.95 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -112.6 28.73 8.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.422 1.076 . . . . 0.0 109.371 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.48 -13.18 2.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.963 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 53.83 155.98 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 0.0 109.33 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.64 ' O ' ' C ' ' A' ' 144' ' ' ASN . 1.7 t80 -162.92 -47.57 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 0.0 111.093 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.64 ' C ' ' O ' ' A' ' 143' ' ' PHE . 12.7 t-20 19.08 90.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -107.36 -38.35 2.12 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 124.472 1.107 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' GLY . 1.8 m-20 153.03 -18.32 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 0.752 . . . . 0.0 109.237 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.772 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 76.59 38.49 0.28 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.082 . . . . 0.0 109.292 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 39.7 tt0 -74.2 -0.71 17.66 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.56 1.162 . . . . 0.0 110.338 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 2.8 pt-20 174.92 -23.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.464 1.103 . . . . 0.0 110.41 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 4.4 m-20 -111.73 171.21 7.63 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.528 1.143 . . . . 0.0 109.329 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -94.57 112.67 58.7 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.698 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.96 124.79 8.91 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.534 1.807 . . . . 0.0 110.997 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.685 ' HE2' HG21 ' A' ' 182' ' ' ILE . 1.2 p90 -141.83 176.26 9.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.469 1.106 . . . . 0.0 110.978 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.429 ' C ' ' HA ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -100.49 -172.12 2.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.533 1.146 . . . . 0.0 109.285 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.558 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.12 34.39 0.56 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 0.0 109.235 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.01 39.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.498 1.123 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.689 ' O ' HD12 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -87.26 171.54 10.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.505 0.767 . . . . 0.0 109.317 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 157' ' ' ASP . 1.3 mp -125.86 136.77 59.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 0.0 109.285 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.627 HD22 HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -147.66 -172.05 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.516 1.135 . . . . 0.0 109.259 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.65 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 13.8 mtm180 -136.42 152.51 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.092 . . . . 0.0 110.251 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -89.61 119.69 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.246 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HD2' ' NE ' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -107.82 -48.72 3.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.548 1.155 . . . . 0.0 110.284 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.42 ' OD1' ' NE ' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -138.13 162.62 33.74 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.499 1.124 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 98.84 3.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.536 1.148 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -44.15 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.517 1.798 . . . . 0.0 110.979 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -174.96 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.08 -16.97 18.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.424 1.077 . . . . 0.0 110.318 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -89.79 -32.91 16.73 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.072 . . . . 0.0 110.3 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.581 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 44.3 m95 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 184' ' ' VAL . 28.1 m0 -125.55 144.54 50.52 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 0.0 108.03 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -101.98 99.83 10.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 0.0 109.301 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.786 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -111.28 163.16 14.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.124 . . . . 0.0 109.309 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -106.28 134.56 49.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.325 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 177' ' ' GLY . 8.4 t0 -79.3 164.02 24.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.4 t -51.85 -20.0 2.02 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 110.002 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.91 -23.97 48.51 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.538 1.149 . . . . 0.0 110.263 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 95.93 30.42 7.95 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.403 1.065 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -107.3 132.55 52.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 0.751 . . . . 0.0 109.311 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.425 ' NE ' ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -87.01 122.39 30.8 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.24 150.98 22.86 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.486 1.116 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 150' ' ' ASP . 2.3 ptm -103.66 138.19 40.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.57 0.806 . . . . 0.0 111.014 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.685 HG21 ' HE2' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -149.55 172.2 5.49 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 0.0 109.323 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.821 ' HB2' ' HD2' ' A' ' 185' ' ' PRO . 18.3 Cg_endo -74.96 145.7 31.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 O-C-N 124.501 1.79 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 13.5 t -71.85 -30.28 1.48 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.448 1.093 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -3.73 14.35 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.456 1.766 . . . . 0.0 111.0 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.679 ' CG ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -102.56 -14.42 16.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 0.0 111.011 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 32.4 m -132.19 169.34 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.95 ' CG ' HD11 ' A' ' 140' ' ' LEU . 4.1 mm-40 -130.11 -168.75 2.01 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.486 1.117 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.631 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.3 OUTLIER -95.36 172.45 8.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.631 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 1.6 t80 82.08 155.96 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.507 1.13 . . . . 0.0 110.986 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.5 ' HA3' ' CD1' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.936 0 O-C-N 124.551 1.157 . . . . 0.0 111.054 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.511 ' CB ' ' HD3' ' A' ' 160' ' ' ARG . . . . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -128.49 -164.38 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.454 1.096 . . . . 0.0 110.234 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.509 ' CG ' ' C ' ' A' ' 191' ' ' GLY . 57.6 m-85 -140.17 120.16 13.63 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.464 1.103 . . . . 0.0 111.026 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 182' ' ' ILE . 27.3 m -133.78 145.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 109.287 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.845 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -123.44 152.72 41.35 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.453 1.096 . . . . 0.0 110.239 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.774 ' HB1' ' CD1' ' A' ' 153' ' ' PHE . . . -110.62 107.9 17.64 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.269 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.993 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -105.06 22.72 14.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 0.0 109.325 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.809 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.3 t80 -122.44 -14.37 7.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.604 1.19 . . . . 0.0 111.047 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 3.2 m-20 57.97 145.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.553 1.158 . . . . 0.0 109.294 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.617 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -156.87 -61.44 0.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 0.0 110.93 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 146' ' ' ASN . 45.5 m-20 69.04 -68.14 0.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.556 ' HA3' ' CE1' ' A' ' 143' ' ' PHE . . . 65.03 -64.17 0.08 OUTLIER Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.497 1.123 . . . . 0.0 110.961 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.616 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 5.1 p30 152.67 -6.32 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.474 0.75 . . . . 0.0 109.284 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.641 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 64.18 32.4 12.56 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 0.0 109.323 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 1.2 tt0 -75.87 3.45 10.03 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.472 1.108 . . . . 0.0 110.355 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 3.3 pt-20 177.69 -28.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.531 1.144 . . . . 0.0 110.284 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 16.6 m-20 -109.05 179.86 4.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.304 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.02 HD21 HD22 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -102.02 126.57 33.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.99 140.49 25.53 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.56 1.821 . . . . 0.0 111.034 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.774 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 2.5 p90 -158.92 165.58 33.8 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.442 1.089 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 174.31 158.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 109.332 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.43 40.28 14.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 109.328 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 59.42 40.51 96.2 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.47 1.106 . . . . 0.0 111.049 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.845 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 5.5 t0 -46.87 141.23 4.13 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.774 . . . . 0.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.809 HD11 ' HA3' ' A' ' 191' ' ' GLY . 0.4 OUTLIER -95.19 125.64 47.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 109.362 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 1.02 HD22 HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -139.27 -178.57 5.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.502 1.126 . . . . 0.0 109.315 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.713 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -133.0 146.82 52.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 0.0 110.261 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.989 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -87.52 120.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.482 1.114 . . . . 0.0 109.249 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -103.12 -48.02 4.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.561 1.163 . . . . 0.0 110.251 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -148.78 166.87 27.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.477 1.11 . . . . 0.0 109.284 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.92 100.6 5.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.566 1.166 . . . . 0.0 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -52.03 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.469 1.773 . . . . 0.0 111.028 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -104.15 -173.1 2.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.459 1.099 . . . . 0.0 110.287 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -109.7 13.5 23.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.561 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 10.4 tt0 -123.43 -42.13 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.561 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.0 m95 -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.565 1.166 . . . . 0.0 108.018 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -114.46 142.57 46.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 11.1 t-20 -91.49 94.24 9.36 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.343 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.989 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -111.46 162.22 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.482 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 2.3 mt-10 -104.05 134.09 47.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 0.0 110.363 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.736 ' HA ' HD23 ' A' ' 159' ' ' LEU . 7.4 t0 -75.98 166.77 23.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 0.0 109.359 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.441 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 33.2 m -55.31 -18.51 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.482 1.114 . . . . 0.0 110.003 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.28 -20.2 34.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 0.0 110.276 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.81 26.18 10.82 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.538 1.149 . . . . 0.0 111.02 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.458 ' HG3' ' CB ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.3 119.95 35.7 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 0.774 . . . . 0.0 109.289 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.15 113.4 22.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 0.0 110.341 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.8 173.53 28.7 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.462 1.101 . . . . 0.0 110.966 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.413 ' O ' ' HB3' ' A' ' 150' ' ' ASP . 37.6 mmm -87.47 144.76 26.57 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.458 0.74 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 137' ' ' VAL . 7.9 pt -140.76 155.25 69.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.439 1.087 . . . . 0.0 109.367 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.903 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.08 143.98 29.44 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.547 1.814 . . . . 0.0 110.974 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 48.8 t -73.89 -39.45 4.4 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -75.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.415 1.745 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.809 ' CE2' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -32.57 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.525 1.141 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.0 OUTLIER -112.68 171.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.137 . . . . 0.0 109.247 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.993 ' CD ' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -137.4 -167.44 2.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 0.0 110.304 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.635 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.3 OUTLIER -102.0 -174.46 2.59 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.282 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.635 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 1.9 t80 82.6 136.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.508 1.13 . . . . 0.0 111.013 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.809 ' HA3' HD11 ' A' ' 158' ' ' ILE . . . . . . . . 0 CA--C 1.53 0.988 0 O-C-N 124.464 1.102 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.547 0.213 . . . . 0.0 111.019 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.4 m -129.24 154.72 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 4.5 ptp180 -131.76 142.1 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.13 . . . . 0.0 110.24 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.979 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -94.36 129.72 40.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 109.295 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -116.51 25.63 10.46 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 0.0 109.319 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.6 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.6 -10.2 1.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.457 1.098 . . . . 0.0 111.032 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.522 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 55.03 159.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.3 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.673 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 24.4 t80 . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.494 1.121 . . . . 0.0 110.962 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.501 ' OD1' ' CZ3' ' A' ' 169' ' ' TRP . 19.1 m-20 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.673 ' HB3' HG23 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -69.4 115.77 35.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.469 1.106 . . . . 0.0 109.275 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.656 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.98 121.21 6.44 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.455 1.766 . . . . 0.0 111.016 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.692 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 36.2 p90 -127.82 175.09 8.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.474 1.109 . . . . 0.0 110.994 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.464 ' CD ' ' HE2' ' A' ' 155' ' ' LYS . 5.7 mttt -115.49 -177.94 3.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 0.0 109.292 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.522 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -80.21 49.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.544 1.153 . . . . 0.0 109.28 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.979 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 147.43 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.132 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.654 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 14.1 t0 -89.7 155.07 19.46 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 0.773 . . . . 0.0 109.244 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.661 ' O ' HD23 ' A' ' 159' ' ' LEU . 1.3 mp -105.42 141.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.508 1.13 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -149.3 -179.39 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.318 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.581 ' HG2' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -133.12 143.13 49.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.581 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 1.0 OUTLIER -87.2 117.34 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -107.89 -48.81 3.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 0.0 110.33 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.96 167.63 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 0.0 109.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.517 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -155.1 84.3 3.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.554 1.159 . . . . 0.0 109.305 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -45.76 0.26 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.509 1.794 . . . . 0.0 110.989 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -99.78 -173.26 2.41 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.496 1.123 . . . . 0.0 110.268 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.71 -32.21 8.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.471 1.107 . . . . 0.0 110.344 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.555 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 6.3 tt0 -89.46 -33.07 16.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.555 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.4 m95 -110.68 132.07 54.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 108.041 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.56 ' CE2' HG21 ' A' ' 184' ' ' VAL . 42.4 m0 -119.04 144.31 46.62 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 0.0 109.262 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.516 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -105.11 160.3 15.17 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 0.0 109.244 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.9 mt-10 -108.69 132.5 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.51 1.131 . . . . 0.0 110.271 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.445 ' OD1' HD11 ' A' ' 151' ' ' LEU . 7.5 t70 -74.15 163.53 27.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 0.0 109.318 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.5 m -53.92 -18.75 3.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.65 -22.35 37.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.501 1.125 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.85 31.03 6.83 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.508 1.13 . . . . 0.0 110.976 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 ptpp? -99.8 122.42 42.75 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 0.771 . . . . 0.0 109.315 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.486 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.0 mtm180 -85.98 112.92 21.66 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.533 1.146 . . . . 0.0 110.334 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.8 159.45 28.09 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.422 1.076 . . . . 0.0 110.991 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.443 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.6 mtm -87.55 141.16 28.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 0.775 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 151' ' ' LEU . 2.2 pp -142.91 163.17 39.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.473 1.108 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.588 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 136.57 20.55 Favored 'Trans proline' 0 C--N 1.361 1.184 0 O-C-N 124.484 1.781 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.846 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 36.7 t -80.54 -30.7 0.59 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.846 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.03 -21.19 16.05 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.488 1.783 . . . . 0.0 111.008 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -93.99 8.25 42.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 0.0 111.008 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 139' ' ' ALA . 1.7 m -148.57 176.02 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.29 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.859 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -140.65 -169.17 2.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 110.287 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.419 ' HG3' HG12 ' A' ' 137' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 0.0 109.276 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 42.0 m-85 . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.475 0.178 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 22.4 m -135.92 152.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 0.0 109.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -124.14 144.15 50.07 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 0.0 110.358 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.067 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.13 118.53 37.09 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 0.0 109.309 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.764 HD11 ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -111.9 32.67 5.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.644 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -138.92 -13.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.519 1.137 . . . . 0.0 111.038 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 54.04 156.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.372 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.704 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.471 1.107 . . . . 0.0 111.047 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 43.2 m-20 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.926 HD21 HD22 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -56.68 106.96 0.75 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 109.294 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.653 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.94 121.68 6.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.53 1.805 . . . . 0.0 111.015 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.704 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 31.9 p90 -124.77 162.64 23.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.414 1.071 . . . . 0.0 110.98 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.31 -175.95 2.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 0.0 109.35 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.536 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -84.56 68.4 10.32 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 0.0 109.346 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 1.067 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.7 32.79 0.63 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.557 1.161 . . . . 0.0 111.005 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.737 ' OD2' HD11 ' A' ' 159' ' ' LEU . 9.0 t0 -83.3 161.8 21.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 0.779 . . . . 0.0 109.312 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.509 HD13 ' NH2' ' A' ' 138' ' ' ARG . 9.1 tp -121.01 129.24 75.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.401 1.063 . . . . 0.0 109.334 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.926 HD22 HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -145.95 169.65 18.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.563 1.164 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.681 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.9 mtt85 -118.42 149.38 41.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.578 1.174 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.1 mp -91.95 119.52 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.421 ' NH1' ' CD ' ' A' ' 179' ' ' ARG . 39.2 ttt180 -101.6 -46.66 4.89 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 110.274 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -149.49 176.16 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.271 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.462 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.93 104.82 0.56 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.56 1.162 . . . . 0.0 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -46.09 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.522 1.801 . . . . 0.0 111.015 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -93.9 -175.07 3.61 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.539 1.149 . . . . 0.0 110.299 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.33 7.95 23.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 0.0 110.326 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -118.59 -45.13 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.457 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 69.2 m95 -101.6 134.53 44.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 108.049 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.463 ' CD2' ' CG2' ' A' ' 184' ' ' VAL . 30.6 m0 -118.03 132.46 56.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 108.01 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 t-20 -83.73 95.2 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.307 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.793 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -109.59 162.93 13.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -109.39 137.9 46.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.481 1.113 . . . . 0.0 110.276 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.622 ' OD1' HD13 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -79.83 161.81 25.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.4 p -51.2 -20.88 1.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.115 . . . . 0.0 109.989 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -78.92 -28.15 43.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.12 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 103.99 31.23 4.83 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.48 1.112 . . . . 0.0 111.042 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -101.7 121.73 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.469 0.747 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.421 ' CD ' ' NH1' ' A' ' 162' ' ' ARG . 7.4 mtt85 -87.41 115.83 25.1 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.69 172.74 28.81 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.559 1.162 . . . . 0.0 111.024 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.405 ' HE2' ' CG ' ' A' ' 169' ' ' TRP . 3.6 ptm -87.55 127.5 35.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 0.743 . . . . 0.0 110.985 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.529 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 10.9 tt -124.53 142.31 40.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 0.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.772 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.02 135.24 18.78 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.452 1.764 . . . . 0.0 110.974 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.9 t -77.21 -31.46 0.87 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.05 -33.11 4.78 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.563 1.823 . . . . 0.0 110.961 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.644 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -89.99 18.42 5.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.967 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 183' ' ' PRO . 13.1 m -149.36 177.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.764 ' HG3' HD11 ' A' ' 140' ' ' LEU . 2.3 mt-10 -138.04 -161.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.548 1.155 . . . . 0.0 110.243 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.6 tptt . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.229 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 62.5 m-85 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.456 0.17 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -130.19 160.87 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.588 1.18 . . . . 0.0 109.231 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.744 ' NE ' HD13 ' A' ' 158' ' ' ILE . 8.5 tpp85 -126.64 128.27 46.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 0.0 110.316 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.947 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.3 119.64 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.428 1.08 . . . . 0.0 109.363 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.913 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -125.3 26.87 6.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.31 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' ' CZ ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -134.15 -21.16 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.419 1.074 . . . . 0.0 111.049 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.432 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 1.6 t70 58.79 155.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 109.34 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.653 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 0.0 110.968 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.447 ' OD2' ' CE2' ' A' ' 143' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.746 HD21 HD22 ' A' ' 159' ' ' LEU . 1.7 tp -93.88 118.91 67.36 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.471 1.107 . . . . 0.0 109.279 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.05 126.15 9.75 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.478 1.778 . . . . 0.0 110.946 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.653 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 38.8 p90 -127.55 169.96 13.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.451 1.094 . . . . 0.0 111.06 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -121.95 178.19 4.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 0.0 109.287 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.587 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -80.62 51.75 1.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.947 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 149.82 35.23 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.547 1.154 . . . . 0.0 110.965 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -94.89 162.07 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.5 0.765 . . . . 0.0 109.36 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.744 HD13 ' NE ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -118.47 122.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 0.0 109.285 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.746 HD22 HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -131.13 -179.63 5.45 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.519 1.137 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.655 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.5 ptp85 -133.02 155.22 49.58 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -93.84 116.72 35.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 0.0 109.296 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -100.64 -49.08 4.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.452 1.095 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.75 174.32 12.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.18 118.53 8.47 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.465 1.103 . . . . 0.0 109.269 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -52.37 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.469 1.773 . . . . 0.0 110.984 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -127.76 -98.8 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.597 1.186 . . . . 0.0 110.291 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.83 -44.52 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.31 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -57.43 -43.58 83.96 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.418 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 35.5 m95 -118.89 144.22 46.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 0.0 108.052 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.46 ' CD2' HG22 ' A' ' 184' ' ' VAL . 46.5 m0 -118.14 145.26 45.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 107.976 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -87.19 86.18 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.528 1.143 . . . . 0.0 109.357 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.739 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -98.83 168.02 10.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 0.0 109.264 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -115.35 140.34 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 0.0 110.319 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.659 ' HB2' HD13 ' A' ' 151' ' ' LEU . 2.1 t0 -78.08 159.96 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.265 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -21.29 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.503 1.127 . . . . 0.0 110.0 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.8 -28.51 33.14 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.387 1.054 . . . . 0.0 110.254 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.04 30.62 3.6 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 124.452 1.095 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 mmmt -95.01 117.31 29.94 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.406 0.71 . . . . 0.0 109.238 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.475 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -85.17 111.85 20.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 0.0 110.296 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.61 167.58 30.37 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.47 1.106 . . . . 0.0 110.977 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 ptp -88.52 138.62 31.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 0.778 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 6.8 pt -134.86 164.18 45.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.833 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.9 143.64 29.66 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.443 1.76 . . . . 0.0 111.044 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.765 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 55.1 t -79.54 -35.86 1.02 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.765 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -67.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.586 1.835 . . . . 0.0 111.021 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.75 ' CZ ' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -38.82 -26.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.451 1.094 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.9 m -117.33 169.65 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.541 1.151 . . . . 0.0 109.268 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.913 ' CD ' HD21 ' A' ' 140' ' ' LEU . 2.6 mt-10 -125.07 -161.25 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.448 1.092 . . . . 0.0 110.365 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.518 0 O-C-N 124.467 1.105 . . . . 0.0 109.282 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.474 0.178 . . . . 0.0 110.978 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 188' ' ' GLU . 2.0 m -128.91 169.62 19.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.778 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.8 ptp180 -132.07 174.63 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -134.13 92.04 2.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 0.0 109.338 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.855 HD21 ' OE1' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -92.41 16.82 10.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 1.105 . . . . 0.0 109.292 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.657 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -126.79 -13.98 5.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.448 1.093 . . . . 0.0 111.038 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.7 158.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 0.0 109.327 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.65 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 28.7 t80 . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.542 1.151 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.96 HD21 ' CD2' ' A' ' 159' ' ' LEU . 1.2 tp -63.69 116.8 29.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 0.0 109.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.551 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 132.39 15.27 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.5 1.789 . . . . 0.0 110.974 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.65 ' CE1' ' CB ' ' A' ' 143' ' ' PHE . 13.4 p90 -142.36 155.53 45.16 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -165.58 146.57 7.07 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.608 1.193 . . . . 0.0 109.3 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.474 ' HA ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 61.29 78.24 0.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 0.0 109.336 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 33.4 47.1 0.39 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.508 1.13 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.778 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 42.4 t0 -39.91 161.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.313 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.774 HD11 ' NH2' ' A' ' 138' ' ' ARG . 2.1 mm -126.56 116.52 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.96 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -138.03 -176.04 4.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 109.294 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.653 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.8 ptp180 -131.76 147.69 52.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.809 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -87.18 117.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.507 1.129 . . . . 0.0 109.306 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.511 ' NE ' ' CZ ' ' A' ' 179' ' ' ARG . 3.2 ttt180 -103.33 -48.13 4.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 0.0 110.354 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.78 165.27 30.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 109.34 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 103.28 3.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.482 1.114 . . . . 0.0 109.255 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.435 ' CD ' ' HE1' ' A' ' 181' ' ' MET . 18.2 Cg_endo -75.05 -57.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -107.39 -173.27 2.25 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.468 1.105 . . . . 0.0 110.307 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.39 18.16 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.441 1.088 . . . . 0.0 110.303 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -114.22 -48.8 2.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.532 1.145 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.423 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 52.7 m95 -119.29 137.95 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 108.03 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.618 ' CE2' HG21 ' A' ' 184' ' ' VAL . 43.7 m0 -114.81 144.95 42.68 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.521 1.138 . . . . 0.0 108.005 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 28.6 t-20 -94.29 95.14 8.72 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 0.0 109.297 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.809 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -107.36 163.51 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 179' ' ' ARG . 2.2 mt-10 -108.44 141.07 40.84 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.539 1.149 . . . . 0.0 110.269 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.557 ' HA ' HD23 ' A' ' 159' ' ' LEU . 3.9 t70 -83.89 164.62 19.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 94.6 p -51.79 -21.04 2.5 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.153 . . . . 0.0 109.972 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.04 -28.12 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.485 1.115 . . . . 0.0 110.292 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 104.59 32.14 4.3 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.479 1.112 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -103.1 118.97 37.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 0.745 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.511 ' CZ ' ' NE ' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -86.71 115.38 24.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.49 1.119 . . . . 0.0 110.32 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -143.52 164.74 27.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.513 1.133 . . . . 0.0 111.022 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.435 ' HE1' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -87.14 137.63 32.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.454 0.738 . . . . 0.0 110.998 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.547 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 28.1 pt -139.18 158.71 68.77 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 0.0 109.352 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.715 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.3 Cg_endo -75.0 139.56 24.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.527 1.803 . . . . 0.0 111.068 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.5 t -78.5 -32.05 0.81 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.241 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -33.3 4.76 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.541 1.811 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.657 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -91.52 26.13 2.4 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.16 . . . . 0.0 111.01 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 183' ' ' PRO . 22.9 m -151.69 168.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.157 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.855 ' OE1' HD21 ' A' ' 140' ' ' LEU . 3.2 mt-10 -139.91 -162.23 1.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.321 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.574 ' HD2' HG12 ' A' ' 137' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.507 1.13 . . . . 0.0 109.3 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 1.9 m-85 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.452 0.168 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.523 ' CG1' HD13 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -127.43 157.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.154 . . . . 0.0 109.273 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.9 OUTLIER -116.56 147.28 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.309 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.9 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.88 93.74 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 0.0 109.268 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.043 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -107.61 37.65 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.565 1.165 . . . . 0.0 109.368 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.77 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 1.5 m-85 -142.53 -17.73 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.44 1.088 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 55.13 160.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.555 1.159 . . . . 0.0 109.364 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.646 ' HB3' ' CE2' ' A' ' 153' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.525 0 O-C-N 124.511 1.132 . . . . 0.0 111.006 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.862 HD12 ' HD2' ' A' ' 152' ' ' PRO . 5.9 tp -73.52 114.08 28.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 0.0 109.307 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.862 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 120.87 6.22 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.477 1.777 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.695 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 48.4 p90 -130.32 167.89 17.78 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.516 1.135 . . . . 0.0 110.997 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -114.83 172.8 6.82 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 109.293 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.451 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -78.5 83.26 4.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 0.0 109.337 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.9 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.33 20.73 1.74 Allowed Glycine 0 CA--C 1.529 0.916 0 O-C-N 124.488 1.117 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.568 ' C ' HD12 ' A' ' 158' ' ' ILE . 19.5 t0 -85.31 155.42 21.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.415 0.715 . . . . 0.0 109.353 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.649 HD11 ' CZ ' ' A' ' 138' ' ' ARG . 1.8 mp -117.12 130.81 71.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 109.275 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.574 HD22 HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -137.7 -178.87 5.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 0.0 109.263 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.668 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.7 mtm105 -131.24 145.86 52.08 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.508 1.13 . . . . 0.0 110.246 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -88.01 117.76 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.13 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.7 tpp85 -108.48 -48.04 3.4 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 0.0 110.317 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -145.94 -176.4 5.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 109.295 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -176.54 109.16 0.24 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -53.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.526 1.803 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -100.78 -169.85 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.489 1.118 . . . . 0.0 110.286 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.56 -34.0 9.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -73.07 -46.24 52.7 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 0.0 110.263 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.19 137.95 45.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.729 ' O ' ' HA ' ' A' ' 181' ' ' MET . 22.7 m0 -116.92 176.44 5.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 107.983 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -124.53 98.62 5.81 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.846 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -115.49 164.66 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 0.0 109.275 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -106.31 138.45 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.539 1.15 . . . . 0.0 110.263 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.496 ' O ' ' NH2' ' A' ' 160' ' ' ARG . 9.9 t0 -80.69 161.72 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 0.0 109.279 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.7 t -51.09 -21.36 1.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.559 1.162 . . . . 0.0 110.022 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -78.44 -23.63 46.49 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.574 1.171 . . . . 0.0 110.384 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 97.59 31.93 6.52 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.513 1.133 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -103.24 126.63 50.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 0.746 . . . . 0.0 109.317 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.441 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.8 mtp-105 -86.15 111.54 20.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 0.0 110.299 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -144.53 169.78 26.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.501 1.125 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.729 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 mtm -87.82 132.85 34.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.783 . . . . 0.0 111.015 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.738 HD12 ' HG ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -128.22 151.09 75.7 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.46 1.1 . . . . 0.0 109.311 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.693 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.04 141.21 26.24 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.473 1.775 . . . . 0.0 110.964 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 65.0 t -80.78 -32.57 0.67 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.474 1.109 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -37.68 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.542 1.812 . . . . 0.0 111.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.77 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.2 m-85 -87.12 22.48 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.462 1.101 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.1 m -152.75 164.31 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 1.043 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.4 OUTLIER -125.51 -161.82 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.459 1.099 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.451 1.095 . . . . 0.0 109.305 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.486 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 1.4 m-85 . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.519 0.199 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 17.2 m -145.33 147.17 18.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 109.289 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.802 ' HB3' HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -127.17 136.44 52.07 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 0.0 110.285 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.001 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -91.17 138.17 31.8 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.481 1.113 . . . . 0.0 109.226 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.976 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.98 19.6 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.539 1.149 . . . . 0.0 109.336 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.581 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -135.07 -4.7 2.41 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.4 OUTLIER 54.45 163.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 1.7 t80 . . . . . 0 C--N 1.324 -0.523 0 O-C-N 124.498 1.124 . . . . 0.0 111.043 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 143' ' ' PHE . 59.1 m-20 . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.672 HD12 ' N ' ' A' ' 152' ' ' PRO . 0.8 OUTLIER -77.35 119.6 78.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 0.0 109.319 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.672 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.5 Cg_endo -74.92 121.58 6.7 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.463 1.77 . . . . 0.0 111.005 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.629 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 29.3 p90 -134.7 169.52 17.2 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.424 1.077 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.26 175.77 5.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.564 1.165 . . . . 0.0 109.263 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.593 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -78.48 83.4 4.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.573 1.171 . . . . 0.0 109.281 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 1.001 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.81 23.84 2.43 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.52 1.138 . . . . 0.0 111.013 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 27.8 t0 -84.82 158.15 20.75 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.508 0.769 . . . . 0.0 109.37 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 138' ' ' ARG . 10.1 mm -111.12 140.54 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.453 1.095 . . . . 0.0 109.293 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -149.89 -172.8 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.2 mpp_? -137.53 156.88 47.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.255 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -98.93 115.14 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.12 . . . . 0.0 109.293 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.535 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 6.2 ptt85 -104.13 -43.85 5.14 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.555 1.16 . . . . 0.0 110.309 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.535 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -136.86 166.06 24.51 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.539 1.149 . . . . 0.0 109.267 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.27 88.13 2.61 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.371 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -43.86 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.481 1.78 . . . . 0.0 111.029 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.34 -170.59 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 0.0 110.358 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.81 -32.2 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.541 1.15 . . . . 0.0 110.28 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.98 -35.99 64.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.513 1.133 . . . . 0.0 110.277 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.495 ' CZ3' ' CG ' ' A' ' 150' ' ' ASP . 47.6 m95 -122.05 138.77 54.32 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.533 1.146 . . . . 0.0 107.962 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.653 ' CE3' ' CG2' ' A' ' 184' ' ' VAL . 29.5 m0 -120.35 143.8 48.2 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.515 1.134 . . . . 0.0 107.953 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 3.1 t-20 -88.63 92.99 9.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 109.26 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -106.0 166.19 10.67 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.535 1.147 . . . . 0.0 109.3 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.0 mt-10 -115.0 138.58 50.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 0.0 110.346 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 177' ' ' GLY . 3.1 t0 -77.18 160.63 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.519 1.137 . . . . 0.0 109.33 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.4 m -51.16 -21.25 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 0.0 110.038 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.85 -27.99 28.33 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.463 1.102 . . . . 0.0 110.298 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.68 29.64 3.8 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.443 1.089 . . . . 0.0 111.032 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -89.57 114.98 26.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.542 0.789 . . . . 0.0 109.334 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.523 ' CZ ' ' NH1' ' A' ' 162' ' ' ARG . 4.2 mtp180 -86.36 108.58 18.52 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 0.0 110.26 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.84 162.5 29.72 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.393 1.058 . . . . 0.0 110.986 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 5.9 mtm -88.67 147.28 24.6 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 0.75 . . . . 0.0 110.99 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.507 ' CD1' ' CD1' ' A' ' 159' ' ' LEU . 23.0 pt -148.8 163.36 26.14 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.0 138.42 23.01 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.439 1.757 . . . . 0.0 110.999 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.828 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 1.0 OUTLIER -79.81 -31.85 0.69 Allowed Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 0.0 109.365 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.828 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -10.79 21.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.518 1.799 . . . . 0.0 111.027 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.692 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -99.64 -4.52 30.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.485 ' HB ' ' C ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -142.79 170.47 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 109.286 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.976 ' CD ' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -119.52 -171.6 2.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.586 ' NZ ' ' CZ3' ' A' ' 170' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 0.0 109.3 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.55 0.214 . . . . 0.0 110.989 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -127.73 159.43 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.416 1.073 . . . . 0.0 109.281 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.2 tpp85 -124.95 116.41 22.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.303 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.92 114.88 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 0.0 109.284 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.055 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.38 28.95 5.88 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.508 1.13 . . . . 0.0 109.296 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -139.72 -6.87 1.29 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 1.1 . . . . 0.0 111.023 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.578 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 50.42 165.35 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 0.0 109.309 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.659 ' CD2' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.72 HD21 ' CD2' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -106.83 116.26 59.01 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 0.0 109.31 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.659 ' HA ' ' CD2' ' A' ' 143' ' ' PHE . 18.3 Cg_endo -75.04 121.32 6.49 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.469 1.773 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.618 ' CE1' ' HD2' ' A' ' 183' ' ' PRO . 18.1 p90 -119.42 -175.87 3.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 0.0 111.027 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -140.52 164.04 31.23 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.115 . . . . 0.0 109.331 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -65.62 90.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.287 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 118.92 19.92 4.26 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.485 1.116 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 24.9 t0 -84.32 145.98 27.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 0.754 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.746 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.7 mp -111.85 124.67 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.436 1.085 . . . . 0.0 109.29 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.72 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -131.49 -174.95 3.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 0.0 109.309 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.716 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.1 147.67 46.21 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.525 1.14 . . . . 0.0 110.299 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.775 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -86.35 118.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.237 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.6 ttt180 -103.52 -47.37 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 0.0 110.318 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 50.4 m-20 -148.75 158.46 44.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -127.69 85.4 60.87 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 0.0 109.33 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -44.57 0.33 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.517 1.799 . . . . 0.0 110.983 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -109.21 -164.78 0.96 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 0.0 110.316 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -105.71 -55.42 2.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 110.283 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.413 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 15.3 pt20 -77.95 -26.26 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.542 1.151 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 72.5 m95 -106.98 133.19 52.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.483 1.115 . . . . 0.0 108.004 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.648 ' O ' HD13 ' A' ' 182' ' ' ILE . 7.9 m0 -125.76 141.86 51.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 0.0 108.027 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.432 ' HB2' ' HE2' ' A' ' 181' ' ' MET . 9.6 t-20 -91.9 87.52 6.26 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.775 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -104.11 164.29 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.217 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.5 mt-10 -105.91 137.88 43.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.404 1.065 . . . . 0.0 110.323 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.37 167.93 20.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.584 1.178 . . . . 0.0 109.256 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.6 m -57.91 -15.93 10.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -84.67 -21.87 30.06 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 1.083 . . . . 0.0 110.316 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 99.23 28.41 7.67 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.495 1.122 . . . . 0.0 110.989 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -102.21 121.81 42.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.472 0.748 . . . . 0.0 109.283 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -85.21 114.42 22.31 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 110.259 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -145.64 174.52 25.59 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.533 1.146 . . . . 0.0 111.043 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.563 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -86.78 146.62 26.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 0.741 . . . . 0.0 110.972 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -148.79 145.43 19.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.423 1.077 . . . . 0.0 109.325 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.634 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.05 130.68 13.45 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.533 1.807 . . . . 0.0 111.015 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.835 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 16.9 m -74.47 -28.62 0.86 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.127 . . . . 0.0 109.255 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -13.93 21.35 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.434 1.755 . . . . 0.0 110.989 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.712 ' O ' HD12 ' A' ' 140' ' ' LEU . 3.3 m-85 -96.52 -36.4 10.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 0.0 111.005 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' A' ' 139' ' ' ALA . 2.6 m -108.81 173.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.532 1.145 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 1.055 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.7 mt-10 -124.88 -159.69 0.9 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.447 1.092 . . . . 0.0 110.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 0.0 109.295 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 18.3 m-85 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.466 0.174 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 188' ' ' GLU . 10.6 m -147.99 154.94 10.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.488 1.117 . . . . 0.0 109.257 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -133.6 144.68 49.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.542 1.152 . . . . 0.0 110.265 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.929 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.73 128.71 45.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.549 1.156 . . . . 0.0 109.303 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.928 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -120.0 22.03 11.63 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.43 1.082 . . . . 0.0 109.285 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -138.26 -10.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 110.976 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 55.45 154.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.551 1.157 . . . . 0.0 109.34 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.5 t80 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.962 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 HD22 ' A' ' 159' ' ' LEU . 1.4 tp -93.6 114.39 62.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.281 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.03 134.13 17.39 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.509 1.794 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.651 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 18.3 p90 -151.88 171.62 17.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 0.0 110.975 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -108.75 -171.03 1.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.339 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.557 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.79 34.25 0.6 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.459 1.099 . . . . 0.0 109.336 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.929 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.29 39.77 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.432 1.082 . . . . 0.0 111.091 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.677 ' O ' HD12 ' A' ' 158' ' ' ILE . 3.8 m-20 -91.84 166.64 12.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 0.779 . . . . 0.0 109.332 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.677 HD12 ' O ' ' A' ' 157' ' ' ASP . 1.5 mp -128.09 134.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.586 1.179 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.885 HD22 HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -146.01 -178.16 5.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 0.0 109.291 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.729 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.47 146.5 52.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.102 . . . . 0.0 110.272 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.834 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.2 mp -83.94 124.32 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.526 1.141 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -100.22 -51.72 3.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 0.0 110.248 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -150.33 163.59 37.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.298 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HE2' HG23 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -117.39 89.6 32.11 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.122 . . . . 0.0 109.294 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -35.6 3.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.469 1.773 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.15 -160.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.271 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.35 -49.46 2.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -82.39 -22.39 35.43 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 67.4 m95 -110.95 138.94 46.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 0.0 108.033 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.502 ' O ' HG22 ' A' ' 182' ' ' ILE . 24.8 m0 -119.91 134.3 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 0.0 107.946 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.521 ' ND2' ' CE ' ' A' ' 181' ' ' MET . 27.9 t-20 -86.88 101.64 13.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.265 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.834 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -118.6 166.61 12.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 109.287 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.459 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 3.3 mt-10 -111.33 133.94 53.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.318 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.466 ' HA ' HD23 ' A' ' 159' ' ' LEU . 4.5 t70 -77.34 164.49 25.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 0.0 109.296 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 92.2 p -53.55 -18.98 3.25 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 0.0 109.992 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.03 -20.92 37.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.495 1.122 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.99 31.75 7.16 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.571 1.169 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -103.09 118.71 37.41 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 0.762 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.5 mtt85 -87.59 115.24 24.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.62 178.42 26.2 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.454 1.096 . . . . 0.0 111.065 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.569 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -85.96 136.39 33.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.524 0.779 . . . . 0.0 110.981 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.723 HG12 HG11 ' A' ' 187' ' ' VAL . 11.6 tt -131.67 142.38 45.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.576 1.172 . . . . 0.0 109.282 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.966 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.97 138.12 22.67 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.435 1.755 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.766 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.5 t -70.81 -36.07 4.96 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.128 . . . . 0.0 109.32 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.766 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.475 1.776 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.623 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -38.43 -27.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 0.0 110.981 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.3 m -118.84 177.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.423 1.077 . . . . 0.0 109.33 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.928 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.8 OUTLIER -135.5 -163.14 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 0.0 110.269 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.3 tptp . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.125 . . . . 0.0 109.24 -179.904 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.481 0.181 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.516 HG22 HD13 ' A' ' 161' ' ' ILE . 31.6 m -124.39 141.06 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 0.0 109.308 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -97.53 -170.0 1.93 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -149.2 94.19 2.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.844 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.75 33.53 1.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 109.311 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.701 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -136.74 -10.63 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 111.073 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.593 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 49.89 165.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.092 . . . . 0.0 109.365 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 111.075 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 169' ' ' TRP . 10.5 m-20 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.929 HD23 HD11 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -108.25 119.13 50.68 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.457 1.098 . . . . 0.0 109.309 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.646 ' N ' HD12 ' A' ' 151' ' ' LEU . 17.9 Cg_endo -75.07 121.32 6.48 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.527 1.804 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.765 ' CD2' ' HB1' ' A' ' 139' ' ' ALA . 38.0 p90 -117.44 170.47 8.7 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.524 1.14 . . . . 0.0 111.032 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 139' ' ' ALA . 3.0 mptt -108.36 -179.96 4.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.449 1.093 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.497 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.99 85.62 7.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 109.272 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.33 23.21 2.68 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.445 1.091 . . . . 0.0 111.017 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.6 t70 -83.91 157.28 22.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.551 0.795 . . . . 0.0 109.338 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.4 mp -114.08 131.77 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.58 1.175 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD2' HD21 ' A' ' 151' ' ' LEU . 3.1 mp -144.48 133.92 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 0.0 109.271 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.713 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -91.58 143.36 26.65 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.1 mp -87.06 116.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.56 1.162 . . . . 0.0 109.295 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -109.28 -34.79 6.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.435 ' HB2' ' CD ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -138.64 155.72 48.06 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.553 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 6.5 ttpt -143.59 88.74 7.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 109.296 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.04 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.502 1.791 . . . . 0.0 110.978 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -101.18 -168.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 168' ' ' GLN . 21.4 pt-20 -105.44 -43.0 5.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.473 1.108 . . . . 0.0 110.344 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.424 ' N ' ' HG3' ' A' ' 167' ' ' GLU . 17.9 pt20 -62.86 -39.15 93.54 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.588 1.18 . . . . 0.0 110.326 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.512 ' CZ3' ' HB3' ' A' ' 150' ' ' ASP . 31.5 m95 -124.94 145.61 49.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 181' ' ' MET . 25.0 m0 -123.07 -179.61 4.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.68 104.23 7.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -123.92 167.55 13.97 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.4 1.062 . . . . 0.0 109.244 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.2 mt-10 -108.93 134.01 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.58 160.53 32.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.1 m -53.06 -19.83 3.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.122 . . . . 0.0 110.06 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.2 -26.81 35.66 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.565 1.165 . . . . 0.0 110.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.9 31.04 4.31 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.543 1.152 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.2 mmtp -99.56 121.07 40.66 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.547 0.793 . . . . 0.0 109.343 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.45 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 3.0 mtt85 -85.8 111.09 19.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 0.0 110.282 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.14 -175.52 20.86 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.559 1.162 . . . . 0.0 111.056 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.761 ' C ' HD12 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -88.24 146.02 25.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.929 HD11 HD23 ' A' ' 151' ' ' LEU . 4.2 mp -139.62 145.14 42.14 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.826 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -75.05 152.49 40.59 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.477 1.777 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.4 t -87.05 -39.21 0.52 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.504 1.792 . . . . 0.0 110.963 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.701 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.4 m-85 -80.65 40.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.474 1.109 . . . . 0.0 111.019 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 184' ' ' VAL . 18.2 m -155.63 164.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.579 1.174 . . . . 0.0 109.297 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.844 ' CG ' HD11 ' A' ' 140' ' ' LEU . 7.3 mm-40 -138.2 -168.45 2.37 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.55 1.156 . . . . 0.0 110.353 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.4 mptt . . . . . 0 C--N 1.324 -0.525 0 O-C-N 124.567 1.167 . . . . 0.0 109.273 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.591 ' CD1' ' HG3' ' A' ' 160' ' ' ARG . 5.7 m-85 . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.495 0.188 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.447 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 3.9 m -137.27 166.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.3 ptp180 -127.9 164.32 22.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 110.229 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.685 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.14 93.74 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.115 . . . . 0.0 109.344 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.891 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -96.53 25.23 5.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.442 1.089 . . . . 0.0 109.312 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.73 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.79 -11.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 110.987 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.522 ' OD1' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.79 159.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 0.0 109.287 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.66 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 44.1 t80 . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.157 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.849 ' CD2' HD23 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -70.43 117.63 56.77 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.436 1.085 . . . . 0.0 109.355 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.67 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -74.99 128.14 11.25 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.487 1.783 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.677 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 10.2 p90 -137.22 152.98 50.47 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.478 1.111 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.522 ' CG ' ' OD1' ' A' ' 142' ' ' ASP . 7.9 mtpt -155.82 149.47 25.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER 46.75 91.01 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 0.0 109.301 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 27.85 45.2 0.04 OUTLIER Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.508 1.13 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -43.78 168.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.536 0.786 . . . . 0.0 109.269 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 158' ' ' ILE . 21.0 mm -118.08 127.63 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.512 1.132 . . . . 0.0 109.261 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.849 HD23 ' CD2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -143.23 177.75 8.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.494 1.121 . . . . 0.0 109.326 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.723 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.1 mpp_? -135.9 153.66 51.38 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.131 . . . . 0.0 110.255 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.538 HG13 ' CE ' ' A' ' 164' ' ' LYS . 1.2 mp -86.09 118.93 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.543 1.152 . . . . 0.0 109.308 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.83 -54.06 2.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.566 1.166 . . . . 0.0 110.301 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 171' ' ' ASN . 5.1 m-20 -149.75 123.9 9.48 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.583 ' CD ' ' CG ' ' A' ' 170' ' ' TRP . 8.5 mmtt -114.0 94.31 33.64 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 0.0 109.311 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.473 1.775 . . . . 0.0 111.008 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -115.54 -173.03 2.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.256 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.18 -29.91 10.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.426 1.079 . . . . 0.0 110.311 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.85 -50.48 70.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.582 1.176 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.471 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 17.3 m95 -122.08 151.15 41.19 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.583 1.177 . . . . 0.0 108.008 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.583 ' CG ' ' CD ' ' A' ' 164' ' ' LYS . 8.7 m0 -127.3 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 163' ' ' ASP . 6.1 t-20 -94.15 91.37 6.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.723 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -104.85 165.74 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 0.0 109.323 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.7 mt-10 -108.51 143.72 37.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 0.0 110.273 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.444 ' HB2' HD13 ' A' ' 151' ' ' LEU . 29.8 t0 -78.3 165.75 23.5 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 109.345 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.1 t -56.88 -17.65 10.23 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 0.0 110.049 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.21 -27.22 26.25 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.468 1.105 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 107.78 29.92 4.2 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.433 1.083 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -97.79 122.8 41.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 0.797 . . . . 0.0 109.295 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.443 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.8 mtp180 -85.42 114.71 22.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.564 1.165 . . . . 0.0 110.261 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.32 167.75 29.04 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.455 1.097 . . . . 0.0 111.028 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 1.5 mtt -87.91 147.78 24.91 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 0.777 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.637 ' C ' HD12 ' A' ' 182' ' ' ILE . 2.3 pp -148.72 160.71 35.17 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.451 1.094 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.99 147.61 34.21 Favored 'Trans proline' 0 C--N 1.359 1.095 0 O-C-N 124.528 1.804 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.0 t -80.9 -37.17 0.94 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.04 -66.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.73 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.0 OUTLIER -42.53 -22.05 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.454 1.096 . . . . 0.0 110.994 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.5 m -113.17 172.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.891 ' CG ' HD11 ' A' ' 140' ' ' LEU . 6.0 mm-40 -142.77 -166.91 2.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 110.247 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 C--N 1.326 -0.42 0 O-C-N 124.475 1.11 . . . . 0.0 109.352 179.931 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.51 0.195 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.799 HG12 ' HG2' ' A' ' 189' ' ' LYS . 18.2 m -133.06 142.54 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 0.0 109.292 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.713 ' O ' ' HB ' ' A' ' 187' ' ' VAL . 2.6 ptp180 -115.84 170.62 8.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.833 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.78 137.5 54.67 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.477 1.111 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.014 HD21 ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.55 22.57 4.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 0.0 109.296 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.665 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.6 OUTLIER -139.87 -3.26 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 0.0 110.963 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 51.35 166.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 0.0 109.343 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.88 HD12 ' HD2' ' A' ' 152' ' ' PRO . 9.9 tp -95.73 115.92 65.87 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.111 . . . . 0.0 109.241 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.88 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 125.34 9.25 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.682 ' HB3' HD11 ' A' ' 182' ' ' ILE . 31.5 p90 -131.94 178.13 7.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.501 1.126 . . . . 0.0 111.012 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -124.81 -176.43 3.54 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.152 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.527 ' HB3' ' CG ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -83.08 42.82 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 0.0 109.238 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 161.69 39.26 0.02 OUTLIER Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.549 1.156 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.721 ' OD2' HD11 ' A' ' 159' ' ' LEU . 37.4 t70 -100.42 156.07 17.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.408 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.3 mp -118.24 129.31 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.149 . . . . 0.0 109.299 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.721 HD11 ' OD2' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -145.41 136.71 24.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.57 1.168 . . . . 0.0 109.28 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.677 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 12.2 ptm180 -90.12 147.76 23.41 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.484 1.115 . . . . 0.0 110.301 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -91.35 118.48 36.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 109.326 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.525 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 9.2 ptt85 -101.22 -44.22 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 1.092 . . . . 0.0 110.264 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 35.7 t0 -150.91 171.73 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 0.0 109.274 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.579 ' HG2' ' CD1' ' A' ' 170' ' ' TRP . 1.1 mptt -135.87 122.48 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.546 1.154 . . . . 0.0 109.275 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 181' ' ' MET . 18.3 Cg_endo -75.02 -47.63 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 O-C-N 124.434 1.755 . . . . 0.0 111.037 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -123.47 -100.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 110.391 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.74 -67.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 110.334 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.604 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 7.6 pt20 -53.87 -38.14 64.43 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.528 1.142 . . . . 0.0 110.283 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CD1' ' HG3' ' A' ' 168' ' ' GLN . 80.7 m95 -102.47 128.44 49.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 108.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.579 ' CD1' ' HG2' ' A' ' 164' ' ' LYS . 37.5 m0 -115.44 140.35 49.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.595 1.184 . . . . 0.0 108.006 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.85 98.4 11.46 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.596 1.185 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.9 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.62 165.62 12.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.0 mt-10 -108.23 133.41 52.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 110.269 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.526 ' HA ' HD23 ' A' ' 159' ' ' LEU . 1.2 t0 -73.47 160.7 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 0.0 109.252 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.9 p -50.84 -21.24 1.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 109.977 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -83.24 -29.62 28.32 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 0.0 110.285 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.87 31.66 3.08 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.504 1.127 . . . . 0.0 111.036 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.0 OUTLIER -94.77 117.97 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.428 0.723 . . . . 0.0 109.236 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.4 mtp180 -86.09 108.43 18.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.396 1.06 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.26 174.04 30.55 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.529 1.143 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.437 ' CG ' ' HG3' ' A' ' 165' ' ' PRO . 24.2 mtp -87.84 146.27 25.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.589 0.817 . . . . 0.0 110.995 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.705 HD12 ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -139.06 150.63 65.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.4 1.062 . . . . 0.0 109.285 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.829 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -74.96 136.32 20.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.49 1.784 . . . . 0.0 110.967 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.8 t -69.35 -36.87 7.71 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.141 . . . . 0.0 109.31 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -69.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.474 1.776 . . . . 0.0 110.961 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.665 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.9 OUTLIER -44.14 -18.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.1 m -117.71 162.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 0.0 109.314 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 1.014 ' HG3' HD21 ' A' ' 140' ' ' LEU . 5.5 mm-40 -115.41 -170.89 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.558 1.162 . . . . 0.0 110.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.799 ' HG2' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 0.0 109.316 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 11.6 m-85 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.474 0.178 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.523 ' O ' HD12 ' A' ' 158' ' ' ILE . 4.6 m -133.95 140.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.432 1.082 . . . . 0.0 109.318 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 15.0 tpp85 -113.9 115.11 27.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.484 1.115 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.024 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.32 124.75 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.511 1.132 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.954 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -139.42 34.0 2.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.719 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.2 t80 -129.77 -15.97 3.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 111.037 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 53.59 159.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 0.0 109.295 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.65 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.998 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 181' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.797 HD21 ' CD2' ' A' ' 159' ' ' LEU . 0.6 OUTLIER -98.2 117.03 65.43 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.255 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.676 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.04 120.66 6.15 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.454 1.765 . . . . 0.0 110.953 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.65 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.5 p90 -117.31 168.66 10.14 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -126.9 8.0 6.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 0.0 109.251 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 88.28 137.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.559 1.162 . . . . 0.0 109.28 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 1.024 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 81.19 20.11 65.48 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 124.504 1.127 . . . . 0.0 111.029 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.792 ' CG ' ' HB3' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -99.88 113.79 26.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.443 0.731 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 137' ' ' VAL . 5.3 tp -88.57 126.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.432 1.083 . . . . 0.0 109.299 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -130.99 -174.44 3.38 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.482 1.114 . . . . 0.0 109.266 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.597 ' HG3' ' N ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -127.23 144.7 50.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.531 1.144 . . . . 0.0 110.329 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -84.5 116.1 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.52 1.137 . . . . 0.0 109.284 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 -49.05 2.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.4 161.96 28.24 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 109.328 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.554 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -154.66 85.71 3.65 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -38.81 1.42 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.468 1.772 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -118.34 -175.98 2.98 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.5 -30.84 9.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 0.0 110.316 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -76.87 -38.57 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.119 . . . . 0.0 110.316 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.475 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 60.9 m95 -117.24 139.09 51.23 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 108.015 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.554 ' CD1' ' HG3' ' A' ' 164' ' ' LYS . 34.1 m0 -120.86 144.33 48.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 0.0 108.016 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -91.36 95.76 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.57 1.169 . . . . 0.0 109.316 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.602 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -107.46 156.98 18.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.454 1.096 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.2 mt-10 -106.38 132.77 52.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.114 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.747 ' OD1' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -75.57 162.69 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.58 1.175 . . . . 0.0 109.281 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.2 t -50.96 -20.95 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.52 1.137 . . . . 0.0 110.059 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.38 -27.91 41.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.463 1.102 . . . . 0.0 110.251 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 103.42 30.94 5.13 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.512 1.133 . . . . 0.0 111.032 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 11.1 ptmt -101.9 122.12 43.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 0.763 . . . . 0.0 109.254 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.457 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.73 116.08 24.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 0.0 110.29 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -146.34 152.55 24.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.485 1.115 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 10.4 mtp -87.19 131.21 34.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 0.802 . . . . 0.0 111.019 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.632 ' CD1' HD13 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -132.26 165.26 37.43 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 0.0 109.271 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.758 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.98 133.05 16.15 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 111.015 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.833 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.8 t -78.04 -31.5 0.8 Allowed Pre-proline 0 C--N 1.324 -0.539 0 O-C-N 124.523 1.139 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.833 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.99 -19.91 17.39 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.518 1.799 . . . . 0.0 110.97 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.758 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.54 -0.34 52.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.963 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 139' ' ' ALA . 7.1 m -135.04 169.77 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.433 1.083 . . . . 0.0 109.322 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.954 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.2 mt-10 -125.26 -158.36 0.83 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.534 1.146 . . . . 0.0 110.223 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt . . . . . 0 C--N 1.326 -0.426 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 22.2 m-85 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.443 0.163 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.908 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.6 m -146.35 148.03 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.487 1.117 . . . . 0.0 109.325 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.768 HH21 ' N ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -113.75 112.86 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.367 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.95 121.41 30.32 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.531 1.144 . . . . 0.0 109.254 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.923 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.03 27.24 7.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.719 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -133.83 -17.16 2.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER 54.19 156.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.564 1.165 . . . . 0.0 109.239 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.511 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.074 HD21 HD22 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -105.53 118.57 55.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 0.0 109.323 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.04 130.1 12.92 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.538 1.809 . . . . 0.0 110.984 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 42.2 p90 -134.35 175.9 9.1 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.518 1.136 . . . . 0.0 110.983 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -129.33 -176.83 4.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.294 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.503 ' HG2' ' HA ' ' A' ' 140' ' ' LEU . 1.4 tmpt? -82.32 82.9 7.63 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.413 1.07 . . . . 0.0 109.285 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 123.69 29.39 1.17 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.468 1.105 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.57 ' OD2' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -100.16 129.8 46.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.456 0.739 . . . . 0.0 109.294 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.908 HD13 ' O ' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -99.26 120.8 49.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.487 1.117 . . . . 0.0 109.343 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 1.074 HD22 HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -118.14 -173.32 2.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.445 1.091 . . . . 0.0 109.314 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 2.9 mpt_? -129.3 141.87 50.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.288 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.2 mp -87.88 116.03 29.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.451 1.094 . . . . 0.0 109.262 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.06 -48.91 4.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -148.96 165.37 31.81 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.464 1.103 . . . . 0.0 109.273 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.546 ' HE2' ' CD2' ' A' ' 170' ' ' TRP . 25.7 mttt -138.35 95.34 10.38 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.112 . . . . 0.0 109.256 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -29.13 8.48 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.497 1.788 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -128.27 -171.14 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.115 . . . . 0.0 110.376 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.77 -27.59 9.24 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 110.256 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -80.96 -36.22 31.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.451 1.094 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.506 ' CE3' ' C ' ' A' ' 182' ' ' ILE . 35.3 m95 -124.22 143.92 50.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 107.991 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.645 ' CD2' HG22 ' A' ' 184' ' ' VAL . 54.5 m0 -119.88 146.53 45.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 0.0 108.064 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -87.55 92.83 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.583 1.177 . . . . 0.0 109.339 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -103.48 164.63 11.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.565 1.166 . . . . 0.0 109.304 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 1.9 mt-10 -112.5 135.01 53.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 0.0 110.277 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.853 ' OD1' HD11 ' A' ' 151' ' ' LEU . 1.1 t0 -73.15 158.17 35.8 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.518 1.136 . . . . 0.0 109.347 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.3 p -49.49 -22.06 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.529 1.143 . . . . 0.0 109.926 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -82.84 -29.79 29.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 112.06 30.99 2.78 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.496 1.123 . . . . 0.0 111.022 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -92.33 116.79 29.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.532 0.783 . . . . 0.0 109.278 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.484 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.4 mtp-105 -86.32 108.94 18.65 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.292 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.2 162.25 29.41 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.492 1.12 . . . . 0.0 111.002 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.7 mtp -87.62 137.36 32.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.504 0.767 . . . . 0.0 110.999 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.762 HD13 HD13 ' A' ' 159' ' ' LEU . 9.2 pt -133.33 168.98 15.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.421 1.075 . . . . 0.0 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.643 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 141.57 26.75 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 0.0 110.973 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.793 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 79.9 t -78.94 -34.16 0.94 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.521 1.138 . . . . 0.0 109.214 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.793 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.54 1.811 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.719 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.4 m-85 -31.55 -35.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.571 1.17 . . . . 0.0 110.979 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -115.88 172.35 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.475 1.11 . . . . 0.0 109.273 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.923 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -123.62 -173.24 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 110.317 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 0.0 109.312 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.514 0.197 . . . . 0.0 110.949 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.02 ' O ' HD12 ' A' ' 158' ' ' ILE . 1.6 m -128.77 158.39 41.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 109.277 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.703 HH21 HD13 ' A' ' 158' ' ' ILE . 2.9 tpp85 -129.36 121.46 27.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 110.324 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.846 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.24 126.48 34.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.452 1.095 . . . . 0.0 109.328 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.043 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.99 25.06 4.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.557 1.161 . . . . 0.0 109.308 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -143.03 0.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 111.026 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 141' ' ' PHE . 1.3 m-20 51.6 166.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.327 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 8.2 t80 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.495 1.122 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.604 ' OD2' ' CH2' ' A' ' 169' ' ' TRP . 89.1 m-20 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.75 HD23 HD13 ' A' ' 159' ' ' LEU . 1.2 tp -79.31 121.56 83.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.561 1.163 . . . . 0.0 109.314 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.646 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.95 130.91 13.77 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.517 1.799 . . . . 0.0 110.981 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.656 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 23.6 p90 -147.97 167.54 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.456 1.098 . . . . 0.0 111.025 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -125.66 173.34 9.07 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.479 1.112 . . . . 0.0 109.234 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.86 ' HG2' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -64.44 94.55 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.846 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.63 11.0 4.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.56 1.163 . . . . 0.0 110.994 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.698 ' HB2' ' HB3' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -75.51 153.44 37.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.591 0.818 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.02 HD12 ' O ' ' A' ' 137' ' ' VAL . 8.5 tp -134.68 129.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.75 HD13 HD23 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -138.08 177.75 7.64 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 109.269 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.703 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -123.68 140.19 53.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.402 1.064 . . . . 0.0 110.31 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 1.029 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -84.12 118.65 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.52 1.138 . . . . 0.0 109.288 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.553 ' CZ ' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -103.18 -46.39 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 0.0 110.343 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -146.98 163.24 36.84 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 0.0 109.261 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 118.28 6.25 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.483 1.114 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.522 ' CD ' ' HE1' ' A' ' 181' ' ' MET . 18.2 Cg_endo -74.99 -65.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.451 1.764 . . . . 0.0 111.02 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -102.86 -105.76 0.27 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.551 1.157 . . . . 0.0 110.321 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.37 -46.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.519 1.137 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -54.99 -39.82 69.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 0.0 110.321 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CH2' ' OD2' ' A' ' 150' ' ' ASP . 24.1 m95 -118.66 144.77 45.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.615 ' CD2' HG22 ' A' ' 184' ' ' VAL . 41.3 m0 -124.78 148.5 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.424 ' CA ' ' HE3' ' A' ' 181' ' ' MET . 61.1 t-20 -99.5 101.76 13.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.475 1.109 . . . . 0.0 109.308 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 1.029 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -119.12 164.5 15.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 3.3 mt-10 -104.46 133.73 48.85 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 1.156 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.441 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 21.2 t0 -74.6 164.65 26.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.5 t -53.98 -18.86 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.028 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -81.97 -24.85 35.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 110.253 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.96 27.39 7.03 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.51 1.131 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.48 ' HD2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -99.43 121.15 40.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.474 0.749 . . . . 0.0 109.307 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.553 ' NH1' ' CZ ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -85.82 112.18 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 0.0 110.327 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.8 170.88 28.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.522 ' HE1' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -88.87 143.15 27.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 0.773 . . . . 0.0 110.971 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -139.64 160.28 61.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.467 1.105 . . . . 0.0 109.313 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.94 145.74 32.05 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.464 1.771 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.741 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.6 t -79.45 -37.74 1.21 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.498 1.124 . . . . 0.0 109.308 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.741 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.0 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.454 1.765 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.637 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.9 OUTLIER -32.3 -35.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.529 1.143 . . . . 0.0 110.971 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -112.09 169.18 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 0.0 109.316 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 1.043 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.5 mt-10 -126.61 -157.78 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.528 1.143 . . . . 0.0 110.307 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.582 1.176 . . . . 0.0 109.327 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 18.2 m-85 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.5 0.191 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 13.4 m -146.92 147.97 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 109.366 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 3.6 ptp180 -117.56 119.57 35.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.537 1.148 . . . . 0.0 110.308 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.043 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.24 100.04 12.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 0.0 109.251 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.904 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -98.38 36.27 1.64 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.414 1.071 . . . . 0.0 109.318 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.645 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -140.2 -11.61 1.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.597 1.186 . . . . 0.0 111.036 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 52.38 158.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.188 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.477 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 2.0 t80 . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 0.0 110.975 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 152' ' ' PRO . 0.9 OUTLIER -108.22 118.29 52.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.664 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.06 123.29 7.74 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.503 1.791 . . . . 0.0 110.984 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.688 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 21.8 p90 -125.02 -179.26 4.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.13 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -114.46 -176.53 2.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.498 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -81.44 66.07 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.336 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 1.043 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.04 35.56 0.62 Allowed Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.498 1.124 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.628 ' OD2' HD21 ' A' ' 159' ' ' LEU . 4.3 t70 -85.2 139.85 31.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 0.764 . . . . 0.0 109.274 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.404 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 8.9 mm -93.92 134.58 31.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.485 1.116 . . . . 0.0 109.315 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.628 HD21 ' OD2' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -143.77 172.37 12.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 0.0 109.312 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 9.6 ttt180 -113.34 139.65 48.69 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 0.0 110.334 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.935 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -90.55 111.36 23.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 0.0 109.23 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -53.66 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.337 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -150.31 -179.84 7.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.563 1.164 . . . . 0.0 109.303 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.597 ' CB ' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -162.62 111.97 1.09 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 0.0 109.252 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -57.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.484 1.781 . . . . 0.0 110.996 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.0 -121.85 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 0.0 110.342 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 -46.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.549 1.155 . . . . 0.0 110.3 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -66.19 -17.18 64.57 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.537 1.148 . . . . 0.0 110.284 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.507 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 79.1 m95 -133.17 132.77 41.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.494 1.122 . . . . 0.0 108.028 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 184' ' ' VAL . 20.8 m0 -124.75 139.72 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.49 ' CB ' ' HE3' ' A' ' 181' ' ' MET . 36.9 t-20 -87.24 100.46 12.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.57 1.169 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.935 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.41 167.46 10.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 109.359 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.7 mt-10 -112.46 124.82 53.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.438 1.086 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 159' ' ' LEU . 2.3 t70 -66.64 161.53 23.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 0.0 109.326 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.0 p -52.48 -20.57 2.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.118 . . . . 0.0 109.962 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -78.5 -25.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.125 . . . . 0.0 110.291 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.28 31.25 5.95 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.535 1.147 . . . . 0.0 110.991 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.647 ' HE2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -104.2 124.74 49.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 0.773 . . . . 0.0 109.274 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.44 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 2.5 mtm180 -85.4 113.46 21.71 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.482 1.114 . . . . 0.0 110.319 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -145.22 176.7 24.1 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.544 1.153 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.494 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -88.39 144.61 26.28 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 0.746 . . . . 0.0 111.05 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.489 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 12.8 tt -144.53 140.74 16.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.265 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.595 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.89 139.3 24.43 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.421 1.748 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.809 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 3.0 t -81.9 -31.82 0.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 0.0 109.305 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.809 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -74.96 -26.76 10.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.415 1.745 . . . . 0.0 111.02 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.691 HG12 ' CB ' ' A' ' 139' ' ' ALA . 1.5 m -146.86 -174.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 109.35 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.904 ' CD ' HD21 ' A' ' 140' ' ' LEU . 3.2 mt-10 -134.13 -171.05 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 110.366 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.422 1.076 . . . . 0.0 109.317 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.598 0.237 . . . . 0.0 111.005 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 158' ' ' ILE . 6.1 m -148.13 142.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.386 1.054 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.73 HH21 HD13 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -106.49 146.33 30.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.46 1.1 . . . . 0.0 110.362 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.958 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -115.41 97.94 6.45 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.573 1.171 . . . . 0.0 109.269 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.864 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -108.89 30.62 6.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 0.0 109.348 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.753 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -133.77 -17.71 2.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 0.0 110.981 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER 54.31 159.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.457 1.098 . . . . 0.0 109.269 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.586 ' CE1' ' OD1' ' A' ' 150' ' ' ASP . 2.4 t80 . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 0.0 110.969 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 143' ' ' PHE . 2.8 p30 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.9 HD12 ' HD2' ' A' ' 152' ' ' PRO . 14.2 tp -74.01 117.28 60.06 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.9 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.03 117.5 4.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.541 1.811 . . . . 0.0 110.959 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.67 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 49.6 p90 -125.72 178.51 5.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 0.0 111.034 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 139' ' ' ALA . 12.5 mttm -125.77 179.69 5.06 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.53 1.144 . . . . 0.0 109.287 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.708 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.73 79.83 9.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 0.0 109.283 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.958 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 134.11 21.33 0.78 Allowed Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.509 1.131 . . . . 0.0 111.027 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 17.6 t70 -90.67 147.04 23.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.42 0.717 . . . . 0.0 109.313 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.73 HD13 HH21 ' A' ' 138' ' ' ARG . 7.6 tp -111.19 136.71 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.531 1.145 . . . . 0.0 109.294 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.623 HD22 HD13 ' A' ' 182' ' ' ILE . 0.4 OUTLIER -142.35 166.8 23.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.114 . . . . 0.0 109.299 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.653 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -115.61 146.82 41.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.483 1.114 . . . . 0.0 110.308 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.851 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -88.04 121.74 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 0.0 109.304 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.439 ' CD ' ' HD3' ' A' ' 179' ' ' ARG . 11.6 ttm-85 -106.15 -45.76 4.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.45 1.094 . . . . 0.0 110.296 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -148.96 152.2 35.92 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.461 1.1 . . . . 0.0 109.334 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -141.1 90.09 9.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 0.0 109.341 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 -55.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.486 1.782 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.02 -177.08 5.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 110.353 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.84 5.91 20.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 0.0 110.331 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.36 -48.13 2.81 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.457 1.098 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.593 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 48.2 m95 -105.07 143.11 33.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.544 1.153 . . . . 0.0 108.038 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.565 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 15.5 m0 -127.11 136.15 51.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 108.027 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.3 m-80 -88.5 96.33 10.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.547 1.154 . . . . 0.0 109.29 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.851 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -109.99 160.79 16.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 0.0 109.255 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -103.03 129.36 49.78 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.47 1.106 . . . . 0.0 110.282 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.95 162.03 30.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 109.249 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.5 t -52.18 -20.3 2.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 0.0 109.951 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.97 -24.09 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.94 30.18 6.87 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.509 1.131 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.5 pttt -105.17 124.8 50.16 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.537 0.786 . . . . 0.0 109.256 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HD3' ' CD ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -85.38 114.07 22.15 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.56 1.163 . . . . 0.0 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -146.22 176.9 24.91 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.39 1.056 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.593 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.7 OUTLIER -86.29 143.58 27.83 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.466 0.745 . . . . 0.0 111.031 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.623 HD13 HD22 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -142.81 144.83 31.21 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 0.0 109.279 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.785 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.05 139.31 24.0 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.459 1.768 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 78.3 t -80.91 -32.3 0.65 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.343 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -35.65 3.02 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.52 1.8 . . . . 0.0 111.04 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.753 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 1.6 m-85 -88.13 15.05 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.4 m -152.86 164.06 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.122 . . . . 0.0 109.302 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.864 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.5 OUTLIER -119.56 -162.83 0.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.239 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 O-C-N 124.507 1.129 . . . . 0.0 109.346 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 63.3 m-85 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.453 0.168 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.552 HG13 HD13 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -135.53 164.22 33.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.555 1.159 . . . . 0.0 109.33 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 18.2 tpp85 -119.94 156.18 31.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.432 1.082 . . . . 0.0 110.314 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -130.02 83.26 2.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.278 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.916 HD21 ' OE1' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -101.13 22.75 11.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 0.0 109.351 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.783 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -123.56 -18.93 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 111.016 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.88 152.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.52 1.138 . . . . 0.0 109.249 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.534 1.146 . . . . 0.0 110.996 -179.979 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 169' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.895 HD21 HD22 ' A' ' 159' ' ' LEU . 3.0 tp -99.9 120.73 56.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.696 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.06 138.88 23.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.501 1.79 . . . . 0.0 111.04 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.867 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 8.3 p90 -160.78 -178.26 6.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER 170.73 146.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.305 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.23 68.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 37.97 50.15 2.07 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.485 1.115 . . . . 0.0 110.941 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.875 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -58.54 135.63 57.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 0.0 109.366 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.447 HD11 ' NH2' ' A' ' 138' ' ' ARG . 2.1 mm -99.35 122.65 51.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.503 1.127 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.895 HD22 HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -128.46 -177.61 4.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 0.0 109.328 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.611 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -128.31 144.86 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 110.256 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.552 HD13 HG13 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -86.45 116.03 28.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 0.0 109.299 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -105.56 -52.0 2.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.55 1.156 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.35 168.13 25.02 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.502 1.126 . . . . 0.0 109.199 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -140.48 114.39 7.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.443 1.089 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -73.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -98.76 -99.74 0.22 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.13 -50.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 0.0 110.339 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -52.81 -43.61 66.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.522 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 69.7 m95 -115.21 142.42 46.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 108.015 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.486 ' CD2' HG22 ' A' ' 184' ' ' VAL . 33.8 m0 -121.16 145.43 47.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.04 94.46 9.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 109.354 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -110.08 164.37 12.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.139 . . . . 0.0 109.273 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -110.37 134.19 52.54 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.33 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.451 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 6.2 t70 -74.56 165.4 25.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.3 t -56.04 -17.49 7.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.138 . . . . 0.0 109.953 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.53 -22.52 32.39 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.461 1.1 . . . . 0.0 110.246 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.72 32.11 6.08 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.546 1.154 . . . . 0.0 110.991 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.637 ' HD2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -102.79 123.06 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 0.771 . . . . 0.0 109.356 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.449 ' NE ' ' OE2' ' A' ' 173' ' ' GLU . 5.3 mtt85 -86.28 115.22 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.11 167.37 28.94 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.541 1.151 . . . . 0.0 111.015 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 41.2 mmm -88.93 138.82 31.06 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.548 0.793 . . . . 0.0 111.005 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.705 HD12 ' O ' ' A' ' 182' ' ' ILE . 2.3 pp -135.24 155.75 78.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.556 1.16 . . . . 0.0 109.294 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.711 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.3 Cg_endo -74.95 138.52 23.27 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.462 1.769 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 51.3 t -78.67 -32.76 0.84 Allowed Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 109.305 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.01 2.81 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.405 1.739 . . . . 0.0 110.986 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.783 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 2.4 m-85 -90.01 23.43 2.8 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.775 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.3 m -152.55 157.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 0.0 109.317 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.916 ' OE1' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -113.77 -164.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 110.334 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 0.0 109.245 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 32.3 m-85 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.486 0.184 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -131.02 162.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.512 1.133 . . . . 0.0 109.232 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 10.4 tpp85 -129.98 112.64 13.7 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 110.348 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.083 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -84.13 117.1 23.25 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.967 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -127.32 25.44 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 0.0 109.263 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.23 -15.77 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 0.0 110.983 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.556 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 0.8 OUTLIER 53.91 161.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 0.0 109.324 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.5 1.125 . . . . 0.0 110.949 179.968 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.591 ' CG ' ' CH2' ' A' ' 169' ' ' TRP . 7.5 m-20 . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.985 HD23 HD11 ' A' ' 182' ' ' ILE . 5.4 tp -83.28 123.42 77.11 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 0.0 109.287 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.894 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.98 164.68 32.9 Favored 'Trans proline' 0 C--N 1.362 1.24 0 O-C-N 124.519 1.8 . . . . 0.0 111.043 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.522 ' CE2' HG23 ' A' ' 182' ' ' ILE . 28.5 p90 179.11 179.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 1.146 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 9.7 mttt -113.16 -177.51 3.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.257 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -94.07 77.91 4.07 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.531 1.145 . . . . 0.0 109.256 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 1.083 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 146.07 19.72 0.13 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.482 1.114 . . . . 0.0 110.994 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.82 163.77 13.93 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 0.0 109.344 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.506 HG23 HH21 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -118.42 128.22 75.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.244 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.603 HD13 HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -132.89 -174.17 3.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.502 1.127 . . . . 0.0 109.281 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.663 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.3 ptp180 -133.34 150.1 51.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 110.265 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -94.09 115.9 34.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.529 1.143 . . . . 0.0 109.29 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HD2' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -96.29 -54.64 3.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 0.0 110.318 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.448 ' C ' ' HG2' ' A' ' 164' ' ' LYS . 0.4 OUTLIER -151.31 174.21 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.522 1.139 . . . . 0.0 109.322 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HZ1' HG13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -127.86 100.46 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 109.337 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 170' ' ' TRP . 18.2 Cg_endo -74.98 -38.21 1.7 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.499 1.789 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -134.55 -165.77 1.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.522 1.139 . . . . 0.0 110.328 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -93.07 -71.48 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.511 1.132 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 169' ' ' TRP . 1.6 pt20 -61.74 -27.67 68.89 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.484 1.115 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.591 ' CH2' ' CG ' ' A' ' 150' ' ' ASP . 37.3 m95 -108.55 137.82 45.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.491 1.119 . . . . 0.0 108.043 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.658 ' O ' ' HA ' ' A' ' 181' ' ' MET . 9.1 m0 -123.72 175.06 7.08 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.458 1.099 . . . . 0.0 108.059 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -124.91 96.07 4.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 0.0 109.248 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.918 ' HB3' HD12 ' A' ' 182' ' ' ILE . . . -109.74 168.21 9.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 0.0 109.326 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.494 ' CD ' ' NH1' ' A' ' 179' ' ' ARG . 2.0 mt-10 -113.38 139.44 48.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 151' ' ' LEU . 4.9 t70 -78.0 161.73 27.28 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.57 -20.26 1.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.141 . . . . 0.0 110.027 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.46 -26.51 41.71 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 0.0 110.274 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 102.4 26.04 7.49 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.523 1.14 . . . . 0.0 110.991 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.783 ' HD3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.36 128.57 40.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 0.754 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.494 ' NH1' ' CD ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -86.03 116.71 24.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 0.0 110.336 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.5 170.89 30.39 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.456 1.097 . . . . 0.0 111.005 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.658 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.7 mtt -86.35 144.65 27.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 0.0 110.951 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.985 HD11 HD23 ' A' ' 151' ' ' LEU . 97.1 mt -143.29 140.54 17.82 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.325 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.666 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.33 15.35 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.506 1.793 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.822 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.4 t -72.25 -31.2 1.6 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 0.0 109.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.822 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -7.67 19.34 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.478 1.778 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.666 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.6 m-85 -100.82 -30.25 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -123.13 172.36 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 0.0 109.298 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.967 ' CG ' HD11 ' A' ' 140' ' ' LEU . 2.1 mt-10 -124.27 -158.6 0.82 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.487 1.117 . . . . 0.0 109.283 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 14.8 m-85 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.451 0.167 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 188' ' ' GLU . 3.3 m -136.4 151.27 28.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.309 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -116.76 165.05 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 0.0 110.372 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -118.15 115.51 24.94 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.489 1.118 . . . . 0.0 109.299 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.95 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -112.6 28.73 8.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.422 1.076 . . . . 0.0 109.371 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.48 -13.18 2.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.963 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 53.83 155.98 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 0.0 109.33 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 143' ' ' PHE . 1.7 t80 . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.525 ' HB3' HD12 ' A' ' 182' ' ' ILE . 4.4 m-20 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.716 ' C ' HD12 ' A' ' 151' ' ' LEU . 0.4 OUTLIER -94.57 112.67 58.7 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.698 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.96 124.79 8.91 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.534 1.807 . . . . 0.0 110.997 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.685 ' HE2' HG21 ' A' ' 182' ' ' ILE . 1.2 p90 -141.83 176.26 9.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.469 1.106 . . . . 0.0 110.978 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.429 ' C ' ' HA ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -100.49 -172.12 2.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.533 1.146 . . . . 0.0 109.285 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.558 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.12 34.39 0.56 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 0.0 109.235 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.01 39.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.498 1.123 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.689 ' O ' HD12 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -87.26 171.54 10.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.505 0.767 . . . . 0.0 109.317 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 157' ' ' ASP . 1.3 mp -125.86 136.77 59.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 0.0 109.285 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.627 HD22 HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -147.66 -172.05 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.516 1.135 . . . . 0.0 109.259 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.65 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 13.8 mtm180 -136.42 152.51 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.092 . . . . 0.0 110.251 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -89.61 119.69 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.246 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HD2' ' NE ' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -107.82 -48.72 3.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.548 1.155 . . . . 0.0 110.284 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.42 ' OD1' ' NE ' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -138.13 162.62 33.74 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.499 1.124 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 98.84 3.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.536 1.148 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -44.15 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.517 1.798 . . . . 0.0 110.979 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -174.96 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.08 -16.97 18.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.424 1.077 . . . . 0.0 110.318 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -89.79 -32.91 16.73 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.072 . . . . 0.0 110.3 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.581 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 44.3 m95 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 184' ' ' VAL . 28.1 m0 -125.55 144.54 50.52 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 0.0 108.03 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -101.98 99.83 10.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 0.0 109.301 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.786 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -111.28 163.16 14.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.124 . . . . 0.0 109.309 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -106.28 134.56 49.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.325 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 177' ' ' GLY . 8.4 t0 -79.3 164.02 24.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.4 t -51.85 -20.0 2.02 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 110.002 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.91 -23.97 48.51 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.538 1.149 . . . . 0.0 110.263 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 95.93 30.42 7.95 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.403 1.065 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -107.3 132.55 52.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 0.751 . . . . 0.0 109.311 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.425 ' NE ' ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -87.01 122.39 30.8 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.24 150.98 22.86 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.486 1.116 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 150' ' ' ASP . 2.3 ptm -103.66 138.19 40.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.57 0.806 . . . . 0.0 111.014 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.685 HG21 ' HE2' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -149.55 172.2 5.49 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 0.0 109.323 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.821 ' HB2' ' HD2' ' A' ' 185' ' ' PRO . 18.3 Cg_endo -74.96 145.7 31.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 O-C-N 124.501 1.79 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 13.5 t -71.85 -30.28 1.48 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.448 1.093 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -3.73 14.35 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.456 1.766 . . . . 0.0 111.0 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.679 ' CG ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -102.56 -14.42 16.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 0.0 111.011 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 32.4 m -132.19 169.34 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.95 ' CG ' HD11 ' A' ' 140' ' ' LEU . 4.1 mm-40 -130.11 -168.75 2.01 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.486 1.117 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.408 ' HA ' HG12 ' A' ' 137' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 57.6 m-85 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.513 0.196 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 182' ' ' ILE . 27.3 m -133.78 145.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 109.287 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.845 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -123.44 152.72 41.35 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.453 1.096 . . . . 0.0 110.239 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.774 ' HB1' ' CD1' ' A' ' 153' ' ' PHE . . . -110.62 107.9 17.64 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.269 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.993 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -105.06 22.72 14.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 0.0 109.325 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.809 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.3 t80 -122.44 -14.37 7.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.604 1.19 . . . . 0.0 111.047 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 3.2 m-20 57.97 145.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.553 1.158 . . . . 0.0 109.294 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.617 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 181' ' ' MET . 16.6 m-20 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.02 HD21 HD22 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -102.02 126.57 33.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.99 140.49 25.53 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.56 1.821 . . . . 0.0 111.034 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.774 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 2.5 p90 -158.92 165.58 33.8 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.442 1.089 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 174.31 158.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 109.332 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.43 40.28 14.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 109.328 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 59.42 40.51 96.2 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.47 1.106 . . . . 0.0 111.049 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.845 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 5.5 t0 -46.87 141.23 4.13 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.774 . . . . 0.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.545 HD13 ' N ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -95.19 125.64 47.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 109.362 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 1.02 HD22 HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -139.27 -178.57 5.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.502 1.126 . . . . 0.0 109.315 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.713 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -133.0 146.82 52.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 0.0 110.261 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.989 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -87.52 120.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.482 1.114 . . . . 0.0 109.249 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -103.12 -48.02 4.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.561 1.163 . . . . 0.0 110.251 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -148.78 166.87 27.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.477 1.11 . . . . 0.0 109.284 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.92 100.6 5.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.566 1.166 . . . . 0.0 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -52.03 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.469 1.773 . . . . 0.0 111.028 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -104.15 -173.1 2.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.459 1.099 . . . . 0.0 110.287 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -109.7 13.5 23.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.561 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 10.4 tt0 -123.43 -42.13 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.561 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.0 m95 -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.565 1.166 . . . . 0.0 108.018 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -114.46 142.57 46.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 14.1 t30 -91.49 94.24 9.36 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.343 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.989 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -111.46 162.22 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.482 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 2.3 mt-10 -104.05 134.09 47.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 0.0 110.363 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.736 ' HA ' HD23 ' A' ' 159' ' ' LEU . 7.4 t0 -75.98 166.77 23.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 0.0 109.359 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.441 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 33.2 m -55.31 -18.51 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.482 1.114 . . . . 0.0 110.003 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.28 -20.2 34.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 0.0 110.276 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.81 26.18 10.82 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.538 1.149 . . . . 0.0 111.02 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.458 ' HG3' ' CB ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.3 119.95 35.7 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 0.774 . . . . 0.0 109.289 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.15 113.4 22.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 0.0 110.341 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.8 173.53 28.7 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.462 1.101 . . . . 0.0 110.966 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.413 ' O ' ' HB3' ' A' ' 150' ' ' ASP . 37.6 mmm -87.47 144.76 26.57 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.458 0.74 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 137' ' ' VAL . 7.9 pt -140.76 155.25 69.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.439 1.087 . . . . 0.0 109.367 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.903 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.08 143.98 29.44 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.547 1.814 . . . . 0.0 110.974 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 48.8 t -73.89 -39.45 4.4 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -75.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.415 1.745 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.809 ' CE2' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -32.57 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.525 1.141 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.0 OUTLIER -112.68 171.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.137 . . . . 0.0 109.247 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.993 ' CD ' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -137.4 -167.44 2.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 0.0 110.304 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.282 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.916 ' HB1' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.568 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER 167.87 -37.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 110.312 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER -147.15 111.51 5.2 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 0.0 111.019 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.4 m -129.24 154.72 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 4.5 ptp180 -131.76 142.1 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.13 . . . . 0.0 110.24 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.979 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -94.36 129.72 40.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 109.295 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -116.51 25.63 10.46 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 0.0 109.319 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.6 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.6 -10.2 1.63 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.457 1.098 . . . . 0.0 111.032 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.522 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 55.03 159.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.3 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.673 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 24.4 t80 -165.31 -48.49 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.494 1.121 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.593 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 0.6 OUTLIER 50.13 93.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.526 1.141 . . . . 0.0 109.31 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -86.88 -68.8 1.33 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.541 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 1.7 m-20 158.51 -18.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.536 0.786 . . . . 0.0 109.332 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER 86.6 173.59 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.105 . . . . 0.0 109.29 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.546 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 69.77 9.0 7.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.46 1.1 . . . . 0.0 110.314 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 179.83 -26.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.5 1.125 . . . . 0.0 110.303 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.501 ' OD1' ' CZ3' ' A' ' 169' ' ' TRP . 19.1 m-20 -150.18 115.07 5.32 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.135 . . . . 0.0 109.314 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.673 ' HB3' HG23 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -69.4 115.77 35.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.469 1.106 . . . . 0.0 109.275 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.656 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.98 121.21 6.44 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.455 1.766 . . . . 0.0 111.016 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.692 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 36.2 p90 -127.82 175.09 8.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.474 1.109 . . . . 0.0 110.994 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.464 ' CD ' ' HE2' ' A' ' 155' ' ' LYS . 5.7 mttt -115.49 -177.94 3.26 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 0.0 109.292 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.522 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -80.21 49.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.544 1.153 . . . . 0.0 109.28 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.979 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 147.43 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.132 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.654 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 14.1 t0 -89.7 155.07 19.46 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 0.773 . . . . 0.0 109.244 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.661 ' O ' HD23 ' A' ' 159' ' ' LEU . 1.3 mp -105.42 141.82 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.508 1.13 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -149.3 -179.39 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.318 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.581 ' HG2' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -133.12 143.13 49.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.916 HG21 ' HB1' ' A' ' 134' ' ' ALA . 1.0 OUTLIER -87.2 117.34 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -107.89 -48.81 3.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 0.0 110.33 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.96 167.63 19.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 0.0 109.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.517 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -155.1 84.3 3.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.554 1.159 . . . . 0.0 109.305 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -45.76 0.26 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.509 1.794 . . . . 0.0 110.989 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -99.78 -173.26 2.41 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.496 1.123 . . . . 0.0 110.268 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.71 -32.21 8.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.471 1.107 . . . . 0.0 110.344 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.555 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 6.3 tt0 -89.46 -33.07 16.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.555 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.4 m95 -110.68 132.07 54.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 108.041 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.56 ' CE2' HG21 ' A' ' 184' ' ' VAL . 42.4 m0 -119.04 144.31 46.62 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.51 91.73 8.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 0.0 109.262 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.516 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -105.11 160.3 15.17 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 0.0 109.244 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.9 mt-10 -108.69 132.5 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.51 1.131 . . . . 0.0 110.271 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.445 ' OD1' HD11 ' A' ' 151' ' ' LEU . 7.5 t70 -74.15 163.53 27.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 0.0 109.318 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.5 m -53.92 -18.75 3.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.65 -22.35 37.61 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.501 1.125 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.85 31.03 6.83 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.508 1.13 . . . . 0.0 110.976 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 ptpp? -99.8 122.42 42.75 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 0.771 . . . . 0.0 109.315 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.486 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.0 mtm180 -85.98 112.92 21.66 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.533 1.146 . . . . 0.0 110.334 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.8 159.45 28.09 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.422 1.076 . . . . 0.0 110.991 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.443 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.6 mtm -87.55 141.16 28.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.517 0.775 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 151' ' ' LEU . 2.2 pp -142.91 163.17 39.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.473 1.108 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.588 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 136.57 20.55 Favored 'Trans proline' 0 C--N 1.361 1.184 0 O-C-N 124.484 1.781 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.846 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 36.7 t -80.54 -30.7 0.59 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.301 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.846 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.03 -21.19 16.05 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.488 1.783 . . . . 0.0 111.008 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -93.99 8.25 42.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 0.0 111.008 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 139' ' ' ALA . 1.7 m -148.57 176.02 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.29 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.859 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -140.65 -169.17 2.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 110.287 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.609 ' HZ3' ' N ' ' A' ' 134' ' ' ALA . 0.8 OUTLIER -109.32 160.78 15.87 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 0.0 109.276 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.652 ' CD1' ' NH2' ' A' ' 138' ' ' ARG . 30.8 t80 -124.6 163.93 20.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.142 . . . . 0.0 111.008 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.464 ' O ' ' CE2' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.001 0 O-C-N 124.54 1.15 . . . . 0.0 111.02 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.546 ' C ' ' CD1' ' A' ' 136' ' ' TYR . 1.1 mt-10 -143.26 -165.97 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.559 1.162 . . . . 0.0 110.274 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 135' ' ' GLU . 42.0 m-85 -149.1 121.51 8.47 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 111.014 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 22.4 m -135.92 152.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 0.0 109.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -124.14 144.15 50.07 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 0.0 110.358 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.067 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.13 118.53 37.09 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 0.0 109.309 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.764 HD11 ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -111.9 32.67 5.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.644 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -138.92 -13.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.519 1.137 . . . . 0.0 111.038 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 54.04 156.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.372 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.704 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 -162.29 -53.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.471 1.107 . . . . 0.0 111.047 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.531 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER 54.78 81.97 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.51 1.132 . . . . 0.0 109.356 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.7 ' CA ' ' CZ ' ' A' ' 143' ' ' PHE . . . -76.6 -63.95 2.25 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.575 1.172 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 1.3 m-20 161.07 -22.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.428 0.722 . . . . 0.0 109.251 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER 84.37 174.58 0.06 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.541 1.15 . . . . 0.0 109.306 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 67.09 10.42 7.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 0.0 110.287 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 176.67 -31.05 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.564 1.165 . . . . 0.0 110.287 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 43.2 m-20 -135.55 100.52 4.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.467 1.104 . . . . 0.0 109.267 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.926 HD21 HD22 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -56.68 106.96 0.75 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 109.294 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.653 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.94 121.68 6.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.53 1.805 . . . . 0.0 111.015 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.704 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 31.9 p90 -124.77 162.64 23.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.414 1.071 . . . . 0.0 110.98 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.31 -175.95 2.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 0.0 109.35 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.536 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -84.56 68.4 10.32 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 0.0 109.346 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 1.067 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.7 32.79 0.63 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.557 1.161 . . . . 0.0 111.005 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.737 ' OD2' HD11 ' A' ' 159' ' ' LEU . 9.0 t0 -83.3 161.8 21.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 0.779 . . . . 0.0 109.312 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.509 HD13 ' NH2' ' A' ' 138' ' ' ARG . 9.1 tp -121.01 129.24 75.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.401 1.063 . . . . 0.0 109.334 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.926 HD22 HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -145.95 169.65 18.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.563 1.164 . . . . 0.0 109.246 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.681 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.9 mtt85 -118.42 149.38 41.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.578 1.174 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.1 mp -91.95 119.52 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.421 ' NH1' ' CD ' ' A' ' 179' ' ' ARG . 39.2 ttt180 -101.6 -46.66 4.89 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 110.274 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.5 OUTLIER -149.49 176.16 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.271 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.462 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.93 104.82 0.56 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.56 1.162 . . . . 0.0 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -46.09 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.522 1.801 . . . . 0.0 111.015 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -93.9 -175.07 3.61 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.539 1.149 . . . . 0.0 110.299 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.33 7.95 23.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 0.0 110.326 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -118.59 -45.13 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.457 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 69.2 m95 -101.6 134.53 44.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 108.049 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.463 ' CD2' ' CG2' ' A' ' 184' ' ' VAL . 30.6 m0 -118.03 132.46 56.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 108.01 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 t-20 -83.73 95.2 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.307 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.793 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -109.59 162.93 13.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -109.39 137.9 46.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.481 1.113 . . . . 0.0 110.276 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.622 ' OD1' HD13 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -79.83 161.81 25.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.296 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.4 p -51.2 -20.88 1.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.115 . . . . 0.0 109.989 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -78.92 -28.15 43.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.12 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 103.99 31.23 4.83 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.48 1.112 . . . . 0.0 111.042 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -101.7 121.73 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.469 0.747 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.421 ' CD ' ' NH1' ' A' ' 162' ' ' ARG . 7.4 mtt85 -87.41 115.83 25.1 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.69 172.74 28.81 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.559 1.162 . . . . 0.0 111.024 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.405 ' HE2' ' CG ' ' A' ' 169' ' ' TRP . 3.6 ptm -87.55 127.5 35.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 0.743 . . . . 0.0 110.985 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.529 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 10.9 tt -124.53 142.31 40.12 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 0.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.772 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.02 135.24 18.78 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.452 1.764 . . . . 0.0 110.974 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.9 t -77.21 -31.46 0.87 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.05 -33.11 4.78 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.563 1.823 . . . . 0.0 110.961 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.644 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -89.99 18.42 5.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.967 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 183' ' ' PRO . 13.1 m -149.36 177.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.764 ' HG3' HD11 ' A' ' 140' ' ' LEU . 2.3 mt-10 -138.04 -161.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.548 1.155 . . . . 0.0 110.243 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 190' ' ' TYR . 7.6 tptt -107.82 145.91 32.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.229 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 191' ' ' GLY . 0.9 OUTLIER -76.26 -57.14 4.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.098 . . . . 0.0 111.064 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.569 ' N ' ' CD1' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.531 1.057 0 O-C-N 124.48 1.112 . . . . 0.0 110.953 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -105.24 -159.79 0.72 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.439 1.087 . . . . 0.0 110.316 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 62.5 m-85 -138.5 134.68 34.27 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.491 1.119 . . . . 0.0 111.028 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -130.19 160.87 40.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.588 1.18 . . . . 0.0 109.231 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.744 ' NE ' HD13 ' A' ' 158' ' ' ILE . 8.5 tpp85 -126.64 128.27 46.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 0.0 110.316 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.947 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -102.3 119.64 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.428 1.08 . . . . 0.0 109.363 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.913 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -125.3 26.87 6.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.31 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' ' CZ ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -134.15 -21.16 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.419 1.074 . . . . 0.0 111.049 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.432 ' HB2' ' N ' ' A' ' 155' ' ' LYS . 1.6 t70 58.79 155.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 109.34 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.706 ' O ' ' C ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER -159.96 -46.69 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 0.0 110.968 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.706 ' C ' ' O ' ' A' ' 143' ' ' PHE . 1.6 t30 -7.79 87.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.567 1.167 . . . . 0.0 109.305 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . -108.27 -38.82 1.9 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.547 1.155 . . . . 0.0 110.972 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.476 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 1.5 t-20 -163.34 -25.23 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.505 0.768 . . . . 0.0 109.276 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 3.3 p-10 47.47 46.32 17.38 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.517 1.136 . . . . 0.0 109.297 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.21 -7.68 55.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.44 1.087 . . . . 0.0 110.29 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -175.86 34.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.504 1.127 . . . . 0.0 110.285 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.447 ' OD2' ' CE2' ' A' ' 143' ' ' PHE . 0.0 OUTLIER -158.03 170.96 21.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.604 1.19 . . . . 0.0 109.269 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.746 HD21 HD22 ' A' ' 159' ' ' LEU . 1.7 tp -93.88 118.91 67.36 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.471 1.107 . . . . 0.0 109.279 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.05 126.15 9.75 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.478 1.778 . . . . 0.0 110.946 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.653 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 38.8 p90 -127.55 169.96 13.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.451 1.094 . . . . 0.0 111.06 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -121.95 178.19 4.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 0.0 109.287 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.587 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -80.62 51.75 1.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.947 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 149.82 35.23 0.04 OUTLIER Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.547 1.154 . . . . 0.0 110.965 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -94.89 162.07 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.5 0.765 . . . . 0.0 109.36 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.744 HD13 ' NE ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -118.47 122.24 69.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 0.0 109.285 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.746 HD22 HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -131.13 -179.63 5.45 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.519 1.137 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.655 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.5 ptp85 -133.02 155.22 49.58 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -93.84 116.72 35.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.139 . . . . 0.0 109.296 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -100.64 -49.08 4.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.452 1.095 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.75 174.32 12.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.18 118.53 8.47 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.465 1.103 . . . . 0.0 109.269 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -52.37 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.469 1.773 . . . . 0.0 110.984 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -127.76 -98.8 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.597 1.186 . . . . 0.0 110.291 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -157.83 -44.52 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.31 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -57.43 -43.58 83.96 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.418 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 35.5 m95 -118.89 144.22 46.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 0.0 108.052 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.46 ' CD2' HG22 ' A' ' 184' ' ' VAL . 46.5 m0 -118.14 145.26 45.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 107.976 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -87.19 86.18 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.528 1.143 . . . . 0.0 109.357 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.739 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -98.83 168.02 10.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 0.0 109.264 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.7 mt-10 -115.35 140.34 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 0.0 110.319 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.659 ' HB2' HD13 ' A' ' 151' ' ' LEU . 2.1 t0 -78.08 159.96 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.265 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -21.29 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.503 1.127 . . . . 0.0 110.0 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.8 -28.51 33.14 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.387 1.054 . . . . 0.0 110.254 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.04 30.62 3.6 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 124.452 1.095 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 mmmt -95.01 117.31 29.94 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.406 0.71 . . . . 0.0 109.238 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.475 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -85.17 111.85 20.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 0.0 110.296 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.61 167.58 30.37 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.47 1.106 . . . . 0.0 110.977 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 ptp -88.52 138.62 31.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 0.778 . . . . 0.0 110.978 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 6.8 pt -134.86 164.18 45.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.524 1.14 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.833 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.9 143.64 29.66 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.443 1.76 . . . . 0.0 111.044 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.765 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 55.1 t -79.54 -35.86 1.02 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.765 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -67.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.586 1.835 . . . . 0.0 111.021 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.75 ' CZ ' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -38.82 -26.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.451 1.094 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.9 m -117.33 169.65 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.541 1.151 . . . . 0.0 109.268 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.913 ' CD ' HD21 ' A' ' 140' ' ' LEU . 2.6 mt-10 -125.07 -161.25 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.448 1.092 . . . . 0.0 110.365 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.09 130.26 51.9 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.467 1.105 . . . . 0.0 109.282 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.457 ' HB3' ' CB ' ' A' ' 136' ' ' TYR . 52.2 t80 -96.99 -44.0 7.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.464 1.102 . . . . 0.0 111.008 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 O-C-N 124.477 1.111 . . . . 0.0 111.063 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.653 ' CB ' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.5 OUTLIER -179.8 -50.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.541 1.151 . . . . 0.0 110.286 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -143.58 122.38 12.66 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.462 1.101 . . . . 0.0 110.978 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 188' ' ' GLU . 2.0 m -128.91 169.62 19.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.778 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.8 ptp180 -132.07 174.63 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -134.13 92.04 2.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 0.0 109.338 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.855 HD21 ' OE1' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -92.41 16.82 10.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 1.105 . . . . 0.0 109.292 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.657 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -126.79 -13.98 5.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.448 1.093 . . . . 0.0 111.038 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.7 158.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 0.0 109.327 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.65 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 28.7 t80 -159.35 -56.28 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.542 1.151 . . . . 0.0 110.984 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.0 t30 70.92 53.15 0.27 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.547 1.155 . . . . 0.0 109.353 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.583 ' HA2' ' CE2' ' A' ' 143' ' ' PHE . . . -38.74 -75.54 0.09 OUTLIER Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.495 1.122 . . . . 0.0 111.011 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 0.8 OUTLIER 156.05 -18.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.488 0.758 . . . . 0.0 109.238 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 83.87 172.1 0.08 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.519 1.137 . . . . 0.0 109.333 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.486 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 1.2 tm-20 61.84 10.22 3.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 0.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 2.0 pt-20 179.64 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.427 1.08 . . . . 0.0 110.36 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.413 ' N ' ' HG2' ' A' ' 149' ' ' GLU . 79.9 m-20 -143.63 109.88 5.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.53 1.144 . . . . 0.0 109.336 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.96 HD21 ' CD2' ' A' ' 159' ' ' LEU . 1.2 tp -63.69 116.8 29.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 0.0 109.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.551 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 132.39 15.27 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.5 1.789 . . . . 0.0 110.974 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.65 ' CE1' ' CB ' ' A' ' 143' ' ' PHE . 13.4 p90 -142.36 155.53 45.16 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -165.58 146.57 7.07 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.608 1.193 . . . . 0.0 109.3 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.474 ' HA ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 61.29 78.24 0.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 0.0 109.336 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 33.4 47.1 0.39 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.508 1.13 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.778 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 42.4 t0 -39.91 161.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.313 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.774 HD11 ' NH2' ' A' ' 138' ' ' ARG . 2.1 mm -126.56 116.52 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.96 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -138.03 -176.04 4.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 109.294 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.653 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.8 ptp180 -131.76 147.69 52.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.809 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -87.18 117.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.507 1.129 . . . . 0.0 109.306 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.511 ' NE ' ' CZ ' ' A' ' 179' ' ' ARG . 3.2 ttt180 -103.33 -48.13 4.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 0.0 110.354 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.78 165.27 30.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 109.34 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 103.28 3.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.482 1.114 . . . . 0.0 109.255 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.435 ' CD ' ' HE1' ' A' ' 181' ' ' MET . 18.2 Cg_endo -75.05 -57.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -107.39 -173.27 2.25 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.468 1.105 . . . . 0.0 110.307 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.39 18.16 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.441 1.088 . . . . 0.0 110.303 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -114.22 -48.8 2.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.532 1.145 . . . . 0.0 110.278 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.423 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 52.7 m95 -119.29 137.95 53.35 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 108.03 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.618 ' CE2' HG21 ' A' ' 184' ' ' VAL . 43.7 m0 -114.81 144.95 42.68 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.521 1.138 . . . . 0.0 108.005 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 28.6 t-20 -94.29 95.14 8.72 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 0.0 109.297 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.809 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -107.36 163.51 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 179' ' ' ARG . 2.2 mt-10 -108.44 141.07 40.84 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.539 1.149 . . . . 0.0 110.269 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.557 ' HA ' HD23 ' A' ' 159' ' ' LEU . 3.9 t70 -83.89 164.62 19.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 94.6 p -51.79 -21.04 2.5 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.153 . . . . 0.0 109.972 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.04 -28.12 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.485 1.115 . . . . 0.0 110.292 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 104.59 32.14 4.3 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.479 1.112 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -103.1 118.97 37.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 0.745 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.511 ' CZ ' ' NE ' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -86.71 115.38 24.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.49 1.119 . . . . 0.0 110.32 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -143.52 164.74 27.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.513 1.133 . . . . 0.0 111.022 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.435 ' HE1' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -87.14 137.63 32.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.454 0.738 . . . . 0.0 110.998 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.547 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 28.1 pt -139.18 158.71 68.77 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 0.0 109.352 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.715 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.3 Cg_endo -75.0 139.56 24.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.527 1.803 . . . . 0.0 111.068 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.5 t -78.5 -32.05 0.81 Allowed Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.241 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -33.3 4.76 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.541 1.811 . . . . 0.0 110.975 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.657 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -91.52 26.13 2.4 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.16 . . . . 0.0 111.01 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 183' ' ' PRO . 22.9 m -151.69 168.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.157 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.855 ' OE1' HD21 ' A' ' 140' ' ' LEU . 3.2 mt-10 -139.91 -162.23 1.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.321 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.574 ' HD2' HG12 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -119.32 141.92 48.58 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.507 1.13 . . . . 0.0 109.3 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 138' ' ' ARG . 1.6 t80 -67.01 -51.42 55.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 0.0 110.972 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.056 0 O-C-N 124.535 1.147 . . . . 0.0 110.988 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 1.0 OUTLIER 172.6 -58.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 0.0 110.28 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.485 ' HB3' ' CB ' ' A' ' 190' ' ' TYR . 1.9 m-85 -133.04 133.42 43.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 0.0 111.039 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.523 ' CG1' HD13 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -127.43 157.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.154 . . . . 0.0 109.273 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.9 OUTLIER -116.56 147.28 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.309 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.9 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.88 93.74 4.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 0.0 109.268 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.043 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -107.61 37.65 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.565 1.165 . . . . 0.0 109.368 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.77 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 1.5 m-85 -142.53 -17.73 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.44 1.088 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER 55.13 160.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.555 1.159 . . . . 0.0 109.364 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.646 ' HB3' ' CE2' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -160.5 -43.75 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.511 1.132 . . . . 0.0 111.006 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.64 ' C ' ' O ' ' A' ' 143' ' ' PHE . 7.9 t30 18.07 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.577 1.173 . . . . 0.0 109.314 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . 67.31 -66.95 0.24 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.436 1.085 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 147' ' ' ASP . 18.7 p30 -168.02 -18.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.439 0.729 . . . . 0.0 109.262 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.527 ' CG ' ' O ' ' A' ' 146' ' ' ASN . 5.1 p-10 50.63 59.73 4.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 0.0 109.225 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.9 OUTLIER -73.6 -12.19 60.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.139 . . . . 0.0 110.261 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 16.5 tt0 -179.64 36.1 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.511 1.132 . . . . 0.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 73.9 m-20 -153.61 156.53 38.13 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 0.0 109.321 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.862 HD12 ' HD2' ' A' ' 152' ' ' PRO . 5.9 tp -73.52 114.08 28.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 0.0 109.307 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.862 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.08 120.87 6.22 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.477 1.777 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.695 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 48.4 p90 -130.32 167.89 17.78 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.516 1.135 . . . . 0.0 110.997 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -114.83 172.8 6.82 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 109.293 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.451 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -78.5 83.26 4.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 0.0 109.337 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.9 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 127.33 20.73 1.74 Allowed Glycine 0 CA--C 1.529 0.916 0 O-C-N 124.488 1.117 . . . . 0.0 110.961 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.568 ' C ' HD12 ' A' ' 158' ' ' ILE . 19.5 t0 -85.31 155.42 21.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.415 0.715 . . . . 0.0 109.353 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.649 HD11 ' CZ ' ' A' ' 138' ' ' ARG . 1.8 mp -117.12 130.81 71.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 109.275 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.574 HD22 HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -137.7 -178.87 5.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 0.0 109.263 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.668 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.7 mtm105 -131.24 145.86 52.08 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.508 1.13 . . . . 0.0 110.246 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -88.01 117.76 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.13 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.7 tpp85 -108.48 -48.04 3.4 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 0.0 110.317 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -145.94 -176.4 5.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 109.295 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -176.54 109.16 0.24 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -53.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.526 1.803 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -100.78 -169.85 1.77 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.489 1.118 . . . . 0.0 110.286 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -102.56 -34.0 9.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -73.07 -46.24 52.7 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.11 . . . . 0.0 110.263 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -108.19 137.95 45.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.729 ' O ' ' HA ' ' A' ' 181' ' ' MET . 22.7 m0 -116.92 176.44 5.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 107.983 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -124.53 98.62 5.81 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.846 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -115.49 164.66 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 0.0 109.275 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -106.31 138.45 42.47 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.539 1.15 . . . . 0.0 110.263 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.496 ' O ' ' NH2' ' A' ' 160' ' ' ARG . 9.9 t0 -80.69 161.72 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 0.0 109.279 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.7 t -51.09 -21.36 1.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.559 1.162 . . . . 0.0 110.022 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -78.44 -23.63 46.49 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.574 1.171 . . . . 0.0 110.384 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 97.59 31.93 6.52 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.513 1.133 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -103.24 126.63 50.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 0.746 . . . . 0.0 109.317 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.441 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.8 mtp-105 -86.15 111.54 20.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 0.0 110.299 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -144.53 169.78 26.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.501 1.125 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.729 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.6 mtm -87.82 132.85 34.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.783 . . . . 0.0 111.015 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.738 HD12 ' HG ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -128.22 151.09 75.7 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.46 1.1 . . . . 0.0 109.311 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.693 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.04 141.21 26.24 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.473 1.775 . . . . 0.0 110.964 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 65.0 t -80.78 -32.57 0.67 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.474 1.109 . . . . 0.0 109.303 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -37.68 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.542 1.812 . . . . 0.0 111.051 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.77 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.2 m-85 -87.12 22.48 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.462 1.101 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.1 m -152.75 164.31 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 1.043 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.4 OUTLIER -125.51 -161.82 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.459 1.099 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.0 137.02 53.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.451 1.095 . . . . 0.0 109.305 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.485 ' CB ' ' HB3' ' A' ' 136' ' ' TYR . 4.5 t80 -69.0 -52.04 32.96 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 0.0 111.023 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.021 0 O-C-N 124.467 1.104 . . . . 0.0 110.971 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.581 ' HB1' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 1.6 tt0 171.61 -36.61 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.54 1.15 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.486 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 1.4 m-85 -141.82 126.66 18.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.424 1.078 . . . . 0.0 111.013 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 17.2 m -145.33 147.17 18.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 0.0 109.289 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.802 ' HB3' HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -127.17 136.44 52.07 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 0.0 110.285 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.001 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -91.17 138.17 31.8 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.481 1.113 . . . . 0.0 109.226 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.976 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.98 19.6 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.539 1.149 . . . . 0.0 109.336 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.581 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -135.07 -4.7 2.41 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.4 OUTLIER 54.45 163.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.701 ' O ' ' N ' ' A' ' 145' ' ' GLY . 1.7 t80 -161.37 -36.94 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.498 1.124 . . . . 0.0 111.043 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 143' ' ' PHE . 21.7 t30 -35.67 85.84 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 0.0 109.236 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . -122.49 -29.63 1.28 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.485 1.116 . . . . 0.0 110.997 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 0.2 OUTLIER -151.27 -33.66 0.15 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.533 0.784 . . . . 0.0 109.287 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.493 ' CB ' ' HG3' ' A' ' 152' ' ' PRO . 4.5 p-10 45.66 53.17 8.86 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.454 1.096 . . . . 0.0 109.345 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.65 9.13 8.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 1.163 . . . . 0.0 110.28 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 170.7 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.54 1.15 . . . . 0.0 110.363 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 143' ' ' PHE . 59.1 m-20 -92.22 157.36 16.73 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.473 1.108 . . . . 0.0 109.294 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.672 HD12 ' N ' ' A' ' 152' ' ' PRO . 0.8 OUTLIER -77.35 119.6 78.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 0.0 109.319 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.672 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.5 Cg_endo -74.92 121.58 6.7 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.463 1.77 . . . . 0.0 111.005 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.629 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 29.3 p90 -134.7 169.52 17.2 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.424 1.077 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.26 175.77 5.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.564 1.165 . . . . 0.0 109.263 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.593 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -78.48 83.4 4.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.573 1.171 . . . . 0.0 109.281 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 1.001 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.81 23.84 2.43 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.52 1.138 . . . . 0.0 111.013 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 27.8 t0 -84.82 158.15 20.75 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.508 0.769 . . . . 0.0 109.37 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 138' ' ' ARG . 10.1 mm -111.12 140.54 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.453 1.095 . . . . 0.0 109.293 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -149.89 -172.8 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.2 mpp_? -137.53 156.88 47.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.255 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -98.93 115.14 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.12 . . . . 0.0 109.293 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.535 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 6.2 ptt85 -104.13 -43.85 5.14 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.555 1.16 . . . . 0.0 110.309 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.535 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 0.7 OUTLIER -136.86 166.06 24.51 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.539 1.149 . . . . 0.0 109.267 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.27 88.13 2.61 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.371 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -43.86 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.481 1.78 . . . . 0.0 111.029 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.34 -170.59 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 0.0 110.358 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.81 -32.2 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.541 1.15 . . . . 0.0 110.28 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.98 -35.99 64.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.513 1.133 . . . . 0.0 110.277 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.495 ' CZ3' ' CG ' ' A' ' 150' ' ' ASP . 47.6 m95 -122.05 138.77 54.32 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.533 1.146 . . . . 0.0 107.962 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.653 ' CE3' ' CG2' ' A' ' 184' ' ' VAL . 29.5 m0 -120.35 143.8 48.2 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.515 1.134 . . . . 0.0 107.953 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 3.1 t-20 -88.63 92.99 9.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 109.26 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -106.0 166.19 10.67 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.535 1.147 . . . . 0.0 109.3 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.0 mt-10 -115.0 138.58 50.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 0.0 110.346 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 177' ' ' GLY . 3.1 t0 -77.18 160.63 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.519 1.137 . . . . 0.0 109.33 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.4 m -51.16 -21.25 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 0.0 110.038 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.85 -27.99 28.33 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.463 1.102 . . . . 0.0 110.298 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.68 29.64 3.8 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.443 1.089 . . . . 0.0 111.032 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -89.57 114.98 26.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.542 0.789 . . . . 0.0 109.334 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.523 ' CZ ' ' NH1' ' A' ' 162' ' ' ARG . 4.2 mtp180 -86.36 108.58 18.52 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 0.0 110.26 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.84 162.5 29.72 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.393 1.058 . . . . 0.0 110.986 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 5.9 mtm -88.67 147.28 24.6 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 0.75 . . . . 0.0 110.99 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.507 ' CD1' ' CD1' ' A' ' 159' ' ' LEU . 23.0 pt -148.8 163.36 26.14 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.0 138.42 23.01 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.439 1.757 . . . . 0.0 110.999 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.828 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 1.0 OUTLIER -79.81 -31.85 0.69 Allowed Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 0.0 109.365 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.828 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -10.79 21.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.518 1.799 . . . . 0.0 111.027 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.692 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -99.64 -4.52 30.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.485 ' HB ' ' C ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -142.79 170.47 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 109.286 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.976 ' CD ' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -119.52 -171.6 2.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.59 ' NZ ' ' CZ3' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -123.01 116.32 23.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 0.0 109.3 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -101.15 97.62 8.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 0.0 110.954 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 O-C-N 124.587 1.179 . . . . 0.0 111.022 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.894 ' HB2' ' HE3' ' A' ' 189' ' ' LYS . . . . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 1.7 tt0 156.35 -36.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 0.0 110.288 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 0.6 OUTLIER -137.27 134.93 36.69 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.533 1.146 . . . . 0.0 110.989 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -127.73 159.43 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.416 1.073 . . . . 0.0 109.281 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.2 tpp85 -124.95 116.41 22.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.303 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.92 114.88 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 0.0 109.284 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.055 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.38 28.95 5.88 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.508 1.13 . . . . 0.0 109.296 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -139.72 -6.87 1.29 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 1.1 . . . . 0.0 111.023 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.578 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 50.42 165.35 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 0.0 109.309 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.659 ' CD2' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -159.03 -44.33 0.06 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.632 ' C ' ' O ' ' A' ' 143' ' ' PHE . 17.9 t30 19.16 92.69 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.47 1.106 . . . . 0.0 109.302 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.586 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -108.85 -44.82 1.08 Allowed Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.534 1.146 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 145' ' ' GLY . 7.0 p30 149.62 6.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.496 0.762 . . . . 0.0 109.258 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.507 ' OD2' ' O ' ' A' ' 147' ' ' ASP . 0.8 OUTLIER 49.35 37.76 12.38 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.127 . . . . 0.0 109.326 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 0.9 OUTLIER -83.74 10.33 9.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.438 1.086 . . . . 0.0 110.304 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 3.2 tt0 169.54 -26.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.482 1.114 . . . . 0.0 110.333 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -114.33 -178.82 3.46 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.525 1.14 . . . . 0.0 109.387 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.72 HD21 ' CD2' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -106.83 116.26 59.01 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 0.0 109.31 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.659 ' HA ' ' CD2' ' A' ' 143' ' ' PHE . 18.3 Cg_endo -75.04 121.32 6.49 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.469 1.773 . . . . 0.0 110.971 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.618 ' CE1' ' HD2' ' A' ' 183' ' ' PRO . 18.1 p90 -119.42 -175.87 3.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.423 1.077 . . . . 0.0 111.027 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -140.52 164.04 31.23 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.115 . . . . 0.0 109.331 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -65.62 90.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.287 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 118.92 19.92 4.26 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.485 1.116 . . . . 0.0 110.956 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 24.9 t0 -84.32 145.98 27.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 0.754 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.746 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.7 mp -111.85 124.67 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.436 1.085 . . . . 0.0 109.29 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.72 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -131.49 -174.95 3.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 0.0 109.309 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.716 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.1 147.67 46.21 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.525 1.14 . . . . 0.0 110.299 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.775 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -86.35 118.76 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.237 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.6 ttt180 -103.52 -47.37 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 0.0 110.318 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 50.4 m-20 -148.75 158.46 44.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -127.69 85.4 60.87 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 0.0 109.33 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -44.57 0.33 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.517 1.799 . . . . 0.0 110.983 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -109.21 -164.78 0.96 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 0.0 110.316 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -105.71 -55.42 2.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 110.283 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.413 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 15.3 pt20 -77.95 -26.26 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.542 1.151 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 72.5 m95 -106.98 133.19 52.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.483 1.115 . . . . 0.0 108.004 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.648 ' O ' HD13 ' A' ' 182' ' ' ILE . 7.9 m0 -125.76 141.86 51.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 0.0 108.027 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.432 ' HB2' ' HE2' ' A' ' 181' ' ' MET . 9.6 t-20 -91.9 87.52 6.26 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.775 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -104.11 164.29 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.217 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.5 mt-10 -105.91 137.88 43.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.404 1.065 . . . . 0.0 110.323 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.37 167.93 20.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.584 1.178 . . . . 0.0 109.256 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.6 m -57.91 -15.93 10.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -84.67 -21.87 30.06 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 1.083 . . . . 0.0 110.316 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 99.23 28.41 7.67 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.495 1.122 . . . . 0.0 110.989 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -102.21 121.81 42.97 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.472 0.748 . . . . 0.0 109.283 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -85.21 114.42 22.31 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 110.259 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -145.64 174.52 25.59 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.533 1.146 . . . . 0.0 111.043 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.563 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -86.78 146.62 26.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 0.741 . . . . 0.0 110.972 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -148.79 145.43 19.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.423 1.077 . . . . 0.0 109.325 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.634 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.05 130.68 13.45 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.533 1.807 . . . . 0.0 111.015 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.835 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 16.9 m -74.47 -28.62 0.86 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.127 . . . . 0.0 109.255 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -13.93 21.35 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.434 1.755 . . . . 0.0 110.989 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.712 ' O ' HD12 ' A' ' 140' ' ' LEU . 3.3 m-85 -96.52 -36.4 10.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 0.0 111.005 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' A' ' 139' ' ' ALA . 2.6 m -108.81 173.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.532 1.145 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 1.055 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.7 mt-10 -124.88 -159.69 0.9 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.447 1.092 . . . . 0.0 110.331 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.894 ' HE3' ' HB2' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -122.28 125.39 45.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 0.0 109.295 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -114.47 155.75 25.82 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 0.0 110.993 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.026 0 O-C-N 124.474 1.109 . . . . 0.0 111.016 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.899 ' HB1' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.573 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 5.2 pt-20 173.23 -42.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.13 . . . . 0.0 110.281 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 135' ' ' GLU . 18.3 m-85 -145.39 137.52 25.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.48 1.113 . . . . 0.0 111.006 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 188' ' ' GLU . 10.6 m -147.99 154.94 10.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.488 1.117 . . . . 0.0 109.257 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -133.6 144.68 49.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.542 1.152 . . . . 0.0 110.265 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.929 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.73 128.71 45.07 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.549 1.156 . . . . 0.0 109.303 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.928 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -120.0 22.03 11.63 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.43 1.082 . . . . 0.0 109.285 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -138.26 -10.83 1.46 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 110.976 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 55.45 154.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.551 1.157 . . . . 0.0 109.34 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.644 ' CE1' ' OD1' ' A' ' 144' ' ' ASN . 1.5 t80 -144.18 -85.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.644 ' OD1' ' CE1' ' A' ' 143' ' ' PHE . 15.7 p30 149.33 -14.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.573 1.171 . . . . 0.0 109.308 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.43 -144.32 47.18 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.522 1.139 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.499 ' CB ' ' HB2' ' A' ' 150' ' ' ASP . 0.5 OUTLIER 171.17 -31.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.482 0.754 . . . . 0.0 109.343 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 81.22 161.65 0.15 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.509 1.131 . . . . 0.0 109.252 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 0.7 OUTLIER 70.43 -4.13 1.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.516 1.135 . . . . 0.0 110.275 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 3.4 mt-10 157.24 35.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 0.0 110.29 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.499 ' HB2' ' CB ' ' A' ' 146' ' ' ASN . 1.4 m-20 -161.46 117.11 2.1 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.507 1.13 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 HD22 ' A' ' 159' ' ' LEU . 1.4 tp -93.6 114.39 62.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.281 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.03 134.13 17.39 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.509 1.794 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.651 ' CD1' ' CB ' ' A' ' 139' ' ' ALA . 18.3 p90 -151.88 171.62 17.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 0.0 110.975 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -108.75 -171.03 1.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.339 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.557 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.79 34.25 0.6 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.459 1.099 . . . . 0.0 109.336 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.929 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.29 39.77 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.432 1.082 . . . . 0.0 111.091 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.677 ' O ' HD12 ' A' ' 158' ' ' ILE . 3.8 m-20 -91.84 166.64 12.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 0.779 . . . . 0.0 109.332 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.677 HD12 ' O ' ' A' ' 157' ' ' ASP . 1.5 mp -128.09 134.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.586 1.179 . . . . 0.0 109.339 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.885 HD22 HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -146.01 -178.16 5.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 0.0 109.291 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.729 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.47 146.5 52.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.102 . . . . 0.0 110.272 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.899 HG21 ' HB1' ' A' ' 134' ' ' ALA . 1.2 mp -83.94 124.32 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.526 1.141 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -100.22 -51.72 3.58 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 0.0 110.248 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.49 ' O ' ' NZ ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -150.33 163.59 37.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.298 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HE2' HG23 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -117.39 89.6 32.11 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.122 . . . . 0.0 109.294 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -35.6 3.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.469 1.773 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.15 -160.68 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.271 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.35 -49.46 2.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 0.0 110.297 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -82.39 -22.39 35.43 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 67.4 m95 -110.95 138.94 46.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 0.0 108.033 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.502 ' O ' HG22 ' A' ' 182' ' ' ILE . 24.8 m0 -119.91 134.3 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 0.0 107.946 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.521 ' ND2' ' CE ' ' A' ' 181' ' ' MET . 27.9 t-20 -86.88 101.64 13.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.265 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.834 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -118.6 166.61 12.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 109.287 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.459 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 3.3 mt-10 -111.33 133.94 53.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 0.0 110.318 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.466 ' HA ' HD23 ' A' ' 159' ' ' LEU . 4.5 t70 -77.34 164.49 25.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 0.0 109.296 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 92.2 p -53.55 -18.98 3.25 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 1.11 . . . . 0.0 109.992 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.03 -20.92 37.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.495 1.122 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.99 31.75 7.16 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.571 1.169 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -103.09 118.71 37.41 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 0.762 . . . . 0.0 109.305 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.5 mtt85 -87.59 115.24 24.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.62 178.42 26.2 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.454 1.096 . . . . 0.0 111.065 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.569 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -85.96 136.39 33.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.524 0.779 . . . . 0.0 110.981 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.723 HG12 HG11 ' A' ' 187' ' ' VAL . 11.6 tt -131.67 142.38 45.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.576 1.172 . . . . 0.0 109.282 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.966 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.97 138.12 22.67 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.435 1.755 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.766 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.5 t -70.81 -36.07 4.96 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.128 . . . . 0.0 109.32 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.766 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.475 1.776 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.623 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -38.43 -27.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 0.0 110.981 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.3 m -118.84 177.61 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.423 1.077 . . . . 0.0 109.33 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.928 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.8 OUTLIER -135.5 -163.14 1.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.415 1.072 . . . . 0.0 110.269 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.7 ' HZ1' ' N ' ' A' ' 134' ' ' ALA . 10.3 tptp -96.22 165.81 12.04 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.125 . . . . 0.0 109.24 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.556 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 0.8 OUTLIER 78.09 147.66 0.09 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.505 1.128 . . . . 0.0 111.0 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.502 ' C ' HG23 ' A' ' 158' ' ' ILE . . . . . . . . 0 CA--C 1.529 0.948 0 O-C-N 124.497 1.123 . . . . 0.0 111.063 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.631 ' HB1' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 2.3 tt0 -118.67 -172.1 2.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.139 . . . . 0.0 110.333 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.78 99.9 3.15 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.512 1.133 . . . . 0.0 110.981 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.516 HG22 HD13 ' A' ' 161' ' ' ILE . 31.6 m -124.39 141.06 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 0.0 109.308 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -97.53 -170.0 1.93 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -149.2 94.19 2.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 0.0 109.245 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.844 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.75 33.53 1.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 109.311 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.701 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -136.74 -10.63 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.523 1.139 . . . . 0.0 111.073 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.593 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 49.89 165.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.092 . . . . 0.0 109.365 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 1.9 t80 -153.32 -50.77 0.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 111.075 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.544 ' C ' ' O ' ' A' ' 143' ' ' PHE . 12.3 t-20 29.27 90.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 0.0 109.304 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -105.04 -42.14 1.84 Allowed Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.497 1.123 . . . . 0.0 110.992 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.588 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 5.8 p30 150.35 -8.85 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.467 0.745 . . . . 0.0 109.288 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.681 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 61.96 36.55 15.6 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 1.156 . . . . 0.0 109.313 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -78.1 3.93 13.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.475 1.109 . . . . 0.0 110.316 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' HG2' ' N ' ' A' ' 150' ' ' ASP . 2.3 pt-20 179.85 -29.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.52 1.137 . . . . 0.0 110.328 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 169' ' ' TRP . 10.5 m-20 -113.23 -175.01 2.57 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.467 1.104 . . . . 0.0 109.297 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.929 HD23 HD11 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -108.25 119.13 50.68 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.457 1.098 . . . . 0.0 109.309 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.646 ' N ' HD12 ' A' ' 151' ' ' LEU . 17.9 Cg_endo -75.07 121.32 6.48 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.527 1.804 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.765 ' CD2' ' HB1' ' A' ' 139' ' ' ALA . 38.0 p90 -117.44 170.47 8.7 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.524 1.14 . . . . 0.0 111.032 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 139' ' ' ALA . 3.0 mptt -108.36 -179.96 4.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.449 1.093 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.497 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.99 85.62 7.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 109.272 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 121.33 23.21 2.68 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.445 1.091 . . . . 0.0 111.017 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 11.6 t70 -83.91 157.28 22.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.551 0.795 . . . . 0.0 109.338 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.4 mp -114.08 131.77 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.58 1.175 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD2' HD21 ' A' ' 151' ' ' LEU . 3.1 mp -144.48 133.92 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 0.0 109.271 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.713 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -91.58 143.36 26.65 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.1 mp -87.06 116.76 30.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.56 1.162 . . . . 0.0 109.295 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -109.28 -34.79 6.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.435 ' HB2' ' CD ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -138.64 155.72 48.06 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.553 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 6.5 ttpt -143.59 88.74 7.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 109.296 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.04 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.502 1.791 . . . . 0.0 110.978 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -101.18 -168.21 1.53 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 168' ' ' GLN . 21.4 pt-20 -105.44 -43.0 5.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.473 1.108 . . . . 0.0 110.344 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.424 ' N ' ' HG3' ' A' ' 167' ' ' GLU . 17.9 pt20 -62.86 -39.15 93.54 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.588 1.18 . . . . 0.0 110.326 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.512 ' CZ3' ' HB3' ' A' ' 150' ' ' ASP . 31.5 m95 -124.94 145.61 49.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 181' ' ' MET . 25.0 m0 -123.07 -179.61 4.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.68 104.23 7.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -123.92 167.55 13.97 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.4 1.062 . . . . 0.0 109.244 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.2 mt-10 -108.93 134.01 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.58 160.53 32.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.1 m -53.06 -19.83 3.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.122 . . . . 0.0 110.06 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.2 -26.81 35.66 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.565 1.165 . . . . 0.0 110.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.9 31.04 4.31 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.543 1.152 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.2 mmtp -99.56 121.07 40.66 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.547 0.793 . . . . 0.0 109.343 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.45 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 3.0 mtt85 -85.8 111.09 19.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 0.0 110.282 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.14 -175.52 20.86 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.559 1.162 . . . . 0.0 111.056 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.761 ' C ' HD12 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -88.24 146.02 25.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.929 HD11 HD23 ' A' ' 151' ' ' LEU . 4.2 mp -139.62 145.14 42.14 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.826 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -75.05 152.49 40.59 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.477 1.777 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.4 t -87.05 -39.21 0.52 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.504 1.792 . . . . 0.0 110.963 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.701 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 2.4 m-85 -80.65 40.33 0.51 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.474 1.109 . . . . 0.0 111.019 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 184' ' ' VAL . 18.2 m -155.63 164.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.579 1.174 . . . . 0.0 109.297 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.844 ' CG ' HD11 ' A' ' 140' ' ' LEU . 7.3 mm-40 -138.2 -168.45 2.37 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.55 1.156 . . . . 0.0 110.353 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -102.98 138.43 39.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.567 1.167 . . . . 0.0 109.273 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 138' ' ' ARG . 0.8 OUTLIER -75.13 132.0 40.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 0.0 110.934 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.969 0 O-C-N 124.572 1.17 . . . . 0.0 110.942 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.725 ' HB1' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.514 ' N ' ' HB ' ' A' ' 161' ' ' ILE . 15.7 tt0 171.89 -39.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.48 1.113 . . . . 0.0 110.283 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.591 ' CD1' ' HG3' ' A' ' 160' ' ' ARG . 5.7 m-85 -142.25 133.06 25.63 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.449 1.093 . . . . 0.0 111.016 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.447 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 3.9 m -137.27 166.79 24.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 1.3 ptp180 -127.9 164.32 22.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 110.229 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.685 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.14 93.74 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.115 . . . . 0.0 109.344 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.891 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -96.53 25.23 5.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.442 1.089 . . . . 0.0 109.312 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.73 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -137.79 -11.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.412 1.07 . . . . 0.0 110.987 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.522 ' OD1' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 55.79 159.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 0.0 109.287 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.66 ' CB ' ' CE1' ' A' ' 153' ' ' PHE . 44.1 t80 -164.05 -55.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.157 . . . . 0.0 110.989 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.517 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 20.7 t30 58.91 93.02 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.146 . . . . 0.0 109.315 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -86.75 -67.53 1.35 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.508 1.13 . . . . 0.0 111.003 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 2.5 t30 152.29 -17.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 0.745 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 87.27 171.99 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.095 . . . . 0.0 109.256 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.556 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 3.5 mt-10 68.08 10.76 8.02 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 0.0 110.287 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -178.05 -32.84 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.514 1.134 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -148.8 117.87 6.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.414 1.071 . . . . 0.0 109.298 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.849 ' CD2' HD23 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -70.43 117.63 56.77 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.436 1.085 . . . . 0.0 109.355 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.67 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -74.99 128.14 11.25 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.487 1.783 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.677 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 10.2 p90 -137.22 152.98 50.47 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.478 1.111 . . . . 0.0 110.961 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.522 ' CG ' ' OD1' ' A' ' 142' ' ' ASP . 7.9 mtpt -155.82 149.47 25.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.521 ' O ' ' C ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER 46.75 91.01 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 0.0 109.301 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 27.85 45.2 0.04 OUTLIER Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.508 1.13 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -43.78 168.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.536 0.786 . . . . 0.0 109.269 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 158' ' ' ILE . 21.0 mm -118.08 127.63 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.512 1.132 . . . . 0.0 109.261 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.849 HD23 ' CD2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -143.23 177.75 8.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.494 1.121 . . . . 0.0 109.326 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.723 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.1 mpp_? -135.9 153.66 51.38 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.131 . . . . 0.0 110.255 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.725 HG21 ' HB1' ' A' ' 134' ' ' ALA . 1.2 mp -86.09 118.93 33.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.543 1.152 . . . . 0.0 109.308 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.83 -54.06 2.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.566 1.166 . . . . 0.0 110.301 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 171' ' ' ASN . 5.1 m-20 -149.75 123.9 9.48 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.583 ' CD ' ' CG ' ' A' ' 170' ' ' TRP . 8.5 mmtt -114.0 94.31 33.64 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 0.0 109.311 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.473 1.775 . . . . 0.0 111.008 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -115.54 -173.03 2.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.256 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.18 -29.91 10.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.426 1.079 . . . . 0.0 110.311 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -62.85 -50.48 70.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.582 1.176 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.471 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 17.3 m95 -122.08 151.15 41.19 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.583 1.177 . . . . 0.0 108.008 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.583 ' CG ' ' CD ' ' A' ' 164' ' ' LYS . 8.7 m0 -127.3 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 163' ' ' ASP . 6.1 t-20 -94.15 91.37 6.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.723 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -104.85 165.74 10.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 0.0 109.323 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.7 mt-10 -108.51 143.72 37.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 0.0 110.273 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.444 ' HB2' HD13 ' A' ' 151' ' ' LEU . 29.8 t0 -78.3 165.75 23.5 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 109.345 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.1 t -56.88 -17.65 10.23 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 0.0 110.049 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.21 -27.22 26.25 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.468 1.105 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 107.78 29.92 4.2 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.433 1.083 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -97.79 122.8 41.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 0.797 . . . . 0.0 109.295 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.443 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 14.8 mtp180 -85.42 114.71 22.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.564 1.165 . . . . 0.0 110.261 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.32 167.75 29.04 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.455 1.097 . . . . 0.0 111.028 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 1.5 mtt -87.91 147.78 24.91 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 0.777 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.637 ' C ' HD12 ' A' ' 182' ' ' ILE . 2.3 pp -148.72 160.71 35.17 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.451 1.094 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.99 147.61 34.21 Favored 'Trans proline' 0 C--N 1.359 1.095 0 O-C-N 124.528 1.804 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 2.0 t -80.9 -37.17 0.94 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.04 -66.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.73 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.0 OUTLIER -42.53 -22.05 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.454 1.096 . . . . 0.0 110.994 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.5 m -113.17 172.01 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.31 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.891 ' CG ' HD11 ' A' ' 140' ' ' LEU . 6.0 mm-40 -142.77 -166.91 2.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 110.247 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -104.43 149.28 25.56 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.475 1.11 . . . . 0.0 109.352 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.525 ' CB ' ' HB3' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -90.71 85.85 6.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.53 1.144 . . . . 0.0 111.051 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 O-C-N 124.504 1.128 . . . . 0.0 110.964 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.556 ' CA ' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.5 tt0 172.39 -40.01 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 0.0 110.273 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.78 112.71 6.04 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 0.0 110.982 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.799 HG12 ' HG2' ' A' ' 189' ' ' LYS . 18.2 m -133.06 142.54 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 0.0 109.292 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.713 ' O ' ' HB ' ' A' ' 187' ' ' VAL . 2.6 ptp180 -115.84 170.62 8.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.833 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.78 137.5 54.67 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.477 1.111 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.014 HD21 ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.55 22.57 4.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 0.0 109.296 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.665 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.6 OUTLIER -139.87 -3.26 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 0.0 110.963 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 51.35 166.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 0.0 109.343 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -162.03 -53.64 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.142 . . . . 0.0 111.05 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 48.48 -84.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.5 1.125 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . 72.13 -56.6 1.48 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.462 1.101 . . . . 0.0 111.031 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.508 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 3.1 m-20 156.08 -16.92 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.549 0.794 . . . . 0.0 109.299 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.755 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 70.24 37.11 1.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.507 1.13 . . . . 0.0 109.316 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 5.6 mt-10 -66.45 -13.75 61.23 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.487 1.117 . . . . 0.0 110.283 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.502 ' O ' ' CG ' ' A' ' 149' ' ' GLU . 7.5 tt0 176.44 32.31 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.555 1.159 . . . . 0.0 110.293 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.464 ' OD1' ' C ' ' A' ' 149' ' ' GLU . 0.8 OUTLIER -154.54 173.92 15.64 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.578 1.174 . . . . 0.0 109.3 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.88 HD12 ' HD2' ' A' ' 152' ' ' PRO . 9.9 tp -95.73 115.92 65.87 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.111 . . . . 0.0 109.241 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.88 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 125.34 9.25 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.682 ' HB3' HD11 ' A' ' 182' ' ' ILE . 31.5 p90 -131.94 178.13 7.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.501 1.126 . . . . 0.0 111.012 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -124.81 -176.43 3.54 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.152 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.527 ' HB3' ' CG ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -83.08 42.82 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 0.0 109.238 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 161.69 39.26 0.02 OUTLIER Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.549 1.156 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.721 ' OD2' HD11 ' A' ' 159' ' ' LEU . 37.4 t70 -100.42 156.07 17.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.408 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 1.3 mp -118.24 129.31 74.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.149 . . . . 0.0 109.299 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.721 HD11 ' OD2' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -145.41 136.71 24.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.57 1.168 . . . . 0.0 109.28 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.677 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 12.2 ptm180 -90.12 147.76 23.41 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.484 1.115 . . . . 0.0 110.301 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -91.35 118.48 36.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 109.326 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.525 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 9.2 ptt85 -101.22 -44.22 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 1.092 . . . . 0.0 110.264 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 35.7 t0 -150.91 171.73 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 0.0 109.274 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.579 ' HG2' ' CD1' ' A' ' 170' ' ' TRP . 1.1 mptt -135.87 122.48 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.546 1.154 . . . . 0.0 109.275 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 181' ' ' MET . 18.3 Cg_endo -75.02 -47.63 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 O-C-N 124.434 1.755 . . . . 0.0 111.037 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -123.47 -100.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 110.391 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.74 -67.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 110.334 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.604 ' HG3' ' CD1' ' A' ' 169' ' ' TRP . 7.6 pt20 -53.87 -38.14 64.43 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.528 1.142 . . . . 0.0 110.283 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CD1' ' HG3' ' A' ' 168' ' ' GLN . 80.7 m95 -102.47 128.44 49.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 108.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.579 ' CD1' ' HG2' ' A' ' 164' ' ' LYS . 37.5 m0 -115.44 140.35 49.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.595 1.184 . . . . 0.0 108.006 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.85 98.4 11.46 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.596 1.185 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.9 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.62 165.62 12.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 4.0 mt-10 -108.23 133.41 52.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 110.269 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.526 ' HA ' HD23 ' A' ' 159' ' ' LEU . 1.2 t0 -73.47 160.7 31.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 0.0 109.252 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 9.9 p -50.84 -21.24 1.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 109.977 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -83.24 -29.62 28.32 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 0.0 110.285 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 109.87 31.66 3.08 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.504 1.127 . . . . 0.0 111.036 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.0 OUTLIER -94.77 117.97 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.428 0.723 . . . . 0.0 109.236 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 7.4 mtp180 -86.09 108.43 18.28 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.396 1.06 . . . . 0.0 110.321 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.26 174.04 30.55 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.529 1.143 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.437 ' CG ' ' HG3' ' A' ' 165' ' ' PRO . 24.2 mtp -87.84 146.27 25.68 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.589 0.817 . . . . 0.0 110.995 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.705 HD12 ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -139.06 150.63 65.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.4 1.062 . . . . 0.0 109.285 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.829 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -74.96 136.32 20.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.49 1.784 . . . . 0.0 110.967 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.752 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.8 t -69.35 -36.87 7.71 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.141 . . . . 0.0 109.31 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -69.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.474 1.776 . . . . 0.0 110.961 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.665 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.9 OUTLIER -44.14 -18.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.561 1.163 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.1 m -117.71 162.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 0.0 109.314 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 1.014 ' HG3' HD21 ' A' ' 140' ' ' LEU . 5.5 mm-40 -115.41 -170.89 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.558 1.162 . . . . 0.0 110.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.799 ' HG2' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -138.65 154.64 48.65 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 0.0 109.316 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.518 ' HB2' ' NH2' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -120.28 112.05 18.56 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.502 1.126 . . . . 0.0 110.916 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 O-C-N 124.457 1.098 . . . . 0.0 111.024 179.927 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.473 ' HB1' ' CZ ' ' A' ' 160' ' ' ARG . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -116.61 -155.48 0.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 0.0 110.319 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 11.6 m-85 -144.86 136.34 25.34 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.502 1.127 . . . . 0.0 111.024 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.523 ' O ' HD12 ' A' ' 158' ' ' ILE . 4.6 m -133.95 140.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.432 1.082 . . . . 0.0 109.318 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 15.0 tpp85 -113.9 115.11 27.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.484 1.115 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.024 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.32 124.75 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.511 1.132 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.954 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -139.42 34.0 2.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 0.0 109.303 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.719 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.2 t80 -129.77 -15.97 3.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 111.037 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 53.59 159.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 0.0 109.295 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.65 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -165.52 -50.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.998 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 143' ' ' PHE . 3.4 p30 30.42 93.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 0.0 109.303 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -107.79 -40.92 1.65 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.533 1.146 . . . . 0.0 111.037 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.547 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 6.4 p30 154.79 -20.5 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.6 0.823 . . . . 0.0 109.338 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.783 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 77.88 43.02 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.331 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 3.8 mt-10 -77.87 8.25 4.86 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.579 1.174 . . . . 0.0 110.279 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 2.0 tt0 166.38 -23.91 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 0.0 110.315 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 181' ' ' MET . 0.3 OUTLIER -113.13 174.77 5.74 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.553 1.158 . . . . 0.0 109.33 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.797 HD21 ' CD2' ' A' ' 159' ' ' LEU . 0.6 OUTLIER -98.2 117.03 65.43 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.255 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.676 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.04 120.66 6.15 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.454 1.765 . . . . 0.0 110.953 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.65 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.5 p90 -117.31 168.66 10.14 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -126.9 8.0 6.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 0.0 109.251 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 88.28 137.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.559 1.162 . . . . 0.0 109.28 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 1.024 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 81.19 20.11 65.48 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 124.504 1.127 . . . . 0.0 111.029 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.792 ' CG ' ' HB3' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -99.88 113.79 26.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.443 0.731 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.63 HD13 ' O ' ' A' ' 190' ' ' TYR . 5.3 tp -88.57 126.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.432 1.083 . . . . 0.0 109.299 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -130.99 -174.44 3.38 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.482 1.114 . . . . 0.0 109.266 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.597 ' HG3' ' N ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -127.23 144.7 50.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.531 1.144 . . . . 0.0 110.329 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -84.5 116.1 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.52 1.137 . . . . 0.0 109.284 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 -49.05 2.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.4 161.96 28.24 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 109.328 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.554 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -154.66 85.71 3.65 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -38.81 1.42 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.468 1.772 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -118.34 -175.98 2.98 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.5 -30.84 9.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 0.0 110.316 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -76.87 -38.57 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.119 . . . . 0.0 110.316 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.475 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 60.9 m95 -117.24 139.09 51.23 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 108.015 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.554 ' CD1' ' HG3' ' A' ' 164' ' ' LYS . 34.1 m0 -120.86 144.33 48.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 0.0 108.016 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -91.36 95.76 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.57 1.169 . . . . 0.0 109.316 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.602 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -107.46 156.98 18.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.454 1.096 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.2 mt-10 -106.38 132.77 52.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.114 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.747 ' OD1' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -75.57 162.69 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.58 1.175 . . . . 0.0 109.281 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.2 t -50.96 -20.95 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.52 1.137 . . . . 0.0 110.059 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.38 -27.91 41.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.463 1.102 . . . . 0.0 110.251 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 103.42 30.94 5.13 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.512 1.133 . . . . 0.0 111.032 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 11.1 ptmt -101.9 122.12 43.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 0.763 . . . . 0.0 109.254 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.457 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.73 116.08 24.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 0.0 110.29 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -146.34 152.55 24.66 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.485 1.115 . . . . 0.0 111.023 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 10.4 mtp -87.19 131.21 34.26 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 0.802 . . . . 0.0 111.019 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.632 ' CD1' HD13 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -132.26 165.26 37.43 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 0.0 109.271 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.758 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.98 133.05 16.15 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 111.015 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.833 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.8 t -78.04 -31.5 0.8 Allowed Pre-proline 0 C--N 1.324 -0.539 0 O-C-N 124.523 1.139 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.833 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.99 -19.91 17.39 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.518 1.799 . . . . 0.0 110.97 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.758 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.54 -0.34 52.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.963 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 139' ' ' ALA . 7.1 m -135.04 169.77 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.433 1.083 . . . . 0.0 109.322 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.954 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.2 mt-10 -125.26 -158.36 0.83 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.534 1.146 . . . . 0.0 110.223 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 22.9 mmmt -107.02 108.1 19.43 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.63 ' O ' HD13 ' A' ' 158' ' ' ILE . 0.3 OUTLIER 69.06 -57.74 0.51 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 0.0 111.012 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.961 0 O-C-N 124.45 1.094 . . . . 0.0 111.031 -179.95 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -148.64 -159.04 0.98 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.571 1.169 . . . . 0.0 110.309 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 22.2 m-85 -141.34 162.25 35.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 0.0 111.02 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.908 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.6 m -146.35 148.03 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.487 1.117 . . . . 0.0 109.325 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.768 HH21 ' N ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -113.75 112.86 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.367 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.95 121.41 30.32 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.531 1.144 . . . . 0.0 109.254 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.923 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -124.03 27.24 7.24 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.719 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -133.83 -17.16 2.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER 54.19 156.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.564 1.165 . . . . 0.0 109.239 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.62 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 0.8 OUTLIER -163.83 -94.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 111.017 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.62 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 3.8 m-20 145.29 2.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 0.0 109.317 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 143' ' ' PHE . . . 44.55 -101.87 0.03 OUTLIER Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.494 1.121 . . . . 0.0 110.984 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 147' ' ' ASP . 20.8 t-20 170.42 -25.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.453 0.737 . . . . 0.0 109.288 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 146' ' ' ASN . 0.0 OUTLIER 82.23 167.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.105 . . . . 0.0 109.252 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER 61.06 13.36 4.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.557 1.161 . . . . 0.0 110.34 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 0.9 OUTLIER 164.31 -25.24 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.542 1.151 . . . . 0.0 110.296 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.511 ' HB3' ' CA ' ' A' ' 145' ' ' GLY . 1.1 m-20 -116.29 142.35 46.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.603 1.19 . . . . 0.0 109.315 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.074 HD21 HD22 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -105.53 118.57 55.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 0.0 109.323 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 144' ' ' ASN . 18.4 Cg_endo -75.04 130.1 12.92 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.538 1.809 . . . . 0.0 110.984 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 143' ' ' PHE . 42.2 p90 -134.35 175.9 9.1 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.518 1.136 . . . . 0.0 110.983 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -129.33 -176.83 4.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.294 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.503 ' HG2' ' HA ' ' A' ' 140' ' ' LEU . 1.4 tmpt? -82.32 82.9 7.63 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.413 1.07 . . . . 0.0 109.285 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 123.69 29.39 1.17 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.468 1.105 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.57 ' OD2' HD21 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -100.16 129.8 46.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.456 0.739 . . . . 0.0 109.294 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.908 HD13 ' O ' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -99.26 120.8 49.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.487 1.117 . . . . 0.0 109.343 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 1.074 HD22 HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -118.14 -173.32 2.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.445 1.091 . . . . 0.0 109.314 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 2.9 mpt_? -129.3 141.87 50.98 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.548 1.155 . . . . 0.0 110.288 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.429 ' HB ' ' CG ' ' A' ' 135' ' ' GLU . 1.2 mp -87.88 116.03 29.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.451 1.094 . . . . 0.0 109.262 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.06 -48.91 4.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -148.96 165.37 31.81 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.464 1.103 . . . . 0.0 109.273 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.546 ' HE2' ' CD2' ' A' ' 170' ' ' TRP . 25.7 mttt -138.35 95.34 10.38 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.112 . . . . 0.0 109.256 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -29.13 8.48 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.497 1.788 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -128.27 -171.14 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.115 . . . . 0.0 110.376 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.77 -27.59 9.24 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 110.256 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -80.96 -36.22 31.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.451 1.094 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.506 ' CE3' ' C ' ' A' ' 182' ' ' ILE . 35.3 m95 -124.22 143.92 50.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 107.991 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.645 ' CD2' HG22 ' A' ' 184' ' ' VAL . 54.5 m0 -119.88 146.53 45.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 0.0 108.064 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -87.55 92.83 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.583 1.177 . . . . 0.0 109.339 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -103.48 164.63 11.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.565 1.166 . . . . 0.0 109.304 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 1.9 mt-10 -112.5 135.01 53.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 0.0 110.277 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.853 ' OD1' HD11 ' A' ' 151' ' ' LEU . 1.1 t0 -73.15 158.17 35.8 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.518 1.136 . . . . 0.0 109.347 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.3 p -49.49 -22.06 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.529 1.143 . . . . 0.0 109.926 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -82.84 -29.79 29.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.348 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 112.06 30.99 2.78 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.496 1.123 . . . . 0.0 111.022 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -92.33 116.79 29.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.532 0.783 . . . . 0.0 109.278 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.484 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.4 mtp-105 -86.32 108.94 18.65 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.292 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.2 162.25 29.41 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.492 1.12 . . . . 0.0 111.002 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.7 mtp -87.62 137.36 32.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.504 0.767 . . . . 0.0 110.999 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.762 HD13 HD13 ' A' ' 159' ' ' LEU . 9.2 pt -133.33 168.98 15.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.421 1.075 . . . . 0.0 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.643 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 141.57 26.75 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.515 1.797 . . . . 0.0 110.973 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.793 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 79.9 t -78.94 -34.16 0.94 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.521 1.138 . . . . 0.0 109.214 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.793 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.54 1.811 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.719 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 1.4 m-85 -31.55 -35.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.571 1.17 . . . . 0.0 110.979 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -115.88 172.35 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.475 1.11 . . . . 0.0 109.273 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.923 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -123.62 -173.24 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 110.317 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -107.23 135.24 49.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 0.0 109.312 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -122.45 -36.54 2.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 0.0 110.956 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.441 ' N ' ' HB2' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.984 0 O-C-N 124.438 1.087 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.561 ' CA ' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 3.6 tt0 177.12 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.441 1.088 . . . . 0.0 110.309 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.609 ' CD2' ' C ' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -149.23 131.24 15.29 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.503 1.127 . . . . 0.0 110.949 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.02 ' O ' HD12 ' A' ' 158' ' ' ILE . 1.6 m -128.77 158.39 41.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 109.277 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.703 HH21 HD13 ' A' ' 158' ' ' ILE . 2.9 tpp85 -129.36 121.46 27.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 110.324 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.846 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.24 126.48 34.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.452 1.095 . . . . 0.0 109.328 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.043 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -132.99 25.06 4.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.557 1.161 . . . . 0.0 109.308 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -143.03 0.13 1.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 111.026 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 141' ' ' PHE . 1.3 m-20 51.6 166.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.327 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.709 ' O ' ' C ' ' A' ' 144' ' ' ASN . 8.2 t80 -167.93 -38.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.495 1.122 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.745 HD22 ' N ' ' A' ' 145' ' ' GLY . 1.2 t30 2.73 -80.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.54 1.15 . . . . 0.0 109.331 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.745 ' N ' HD22 ' A' ' 144' ' ' ASN . . . 60.74 -74.48 0.01 OUTLIER Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.578 1.174 . . . . 0.0 110.998 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 144' ' ' ASN . 29.9 p-10 -149.95 -24.47 0.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.541 0.789 . . . . 0.0 109.275 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 146' ' ' ASN . 5.1 p-10 49.17 59.26 4.59 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.489 1.118 . . . . 0.0 109.314 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.67 5.11 9.9 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.473 1.108 . . . . 0.0 110.332 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 179.79 -31.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.536 1.147 . . . . 0.0 110.351 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.604 ' OD2' ' CH2' ' A' ' 169' ' ' TRP . 89.1 m-20 -87.26 160.12 18.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 0.0 109.256 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.75 HD23 HD13 ' A' ' 159' ' ' LEU . 1.2 tp -79.31 121.56 83.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.561 1.163 . . . . 0.0 109.314 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.646 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.95 130.91 13.77 Favored 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.517 1.799 . . . . 0.0 110.981 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.656 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 23.6 p90 -147.97 167.54 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.456 1.098 . . . . 0.0 111.025 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -125.66 173.34 9.07 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.479 1.112 . . . . 0.0 109.234 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.86 ' HG2' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -64.44 94.55 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.846 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.63 11.0 4.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.56 1.163 . . . . 0.0 110.994 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.698 ' HB2' ' HB3' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -75.51 153.44 37.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.591 0.818 . . . . 0.0 109.333 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.02 HD12 ' O ' ' A' ' 137' ' ' VAL . 8.5 tp -134.68 129.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.75 HD13 HD23 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -138.08 177.75 7.64 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 109.269 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.703 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -123.68 140.19 53.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.402 1.064 . . . . 0.0 110.31 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 1.029 HD12 ' HB2' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -84.12 118.65 31.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.52 1.138 . . . . 0.0 109.288 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.553 ' CZ ' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -103.18 -46.39 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 0.0 110.343 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -146.98 163.24 36.84 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 0.0 109.261 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.43 118.28 6.25 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.483 1.114 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.522 ' CD ' ' HE1' ' A' ' 181' ' ' MET . 18.2 Cg_endo -74.99 -65.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.451 1.764 . . . . 0.0 111.02 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -102.86 -105.76 0.27 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.551 1.157 . . . . 0.0 110.321 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.37 -46.55 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.519 1.137 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -54.99 -39.82 69.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 0.0 110.321 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.604 ' CH2' ' OD2' ' A' ' 150' ' ' ASP . 24.1 m95 -118.66 144.77 45.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.615 ' CD2' HG22 ' A' ' 184' ' ' VAL . 41.3 m0 -124.78 148.5 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.424 ' CA ' ' HE3' ' A' ' 181' ' ' MET . 61.1 t-20 -99.5 101.76 13.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.475 1.109 . . . . 0.0 109.308 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 1.029 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -119.12 164.5 15.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 3.3 mt-10 -104.46 133.73 48.85 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 1.156 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.441 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 21.2 t0 -74.6 164.65 26.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.5 t -53.98 -18.86 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.028 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -81.97 -24.85 35.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 110.253 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.96 27.39 7.03 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.51 1.131 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.48 ' HD2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -99.43 121.15 40.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.474 0.749 . . . . 0.0 109.307 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.553 ' NH1' ' CZ ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -85.82 112.18 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 0.0 110.327 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.8 170.88 28.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.522 ' HE1' ' CD ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER -88.87 143.15 27.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 0.773 . . . . 0.0 110.971 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -139.64 160.28 61.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.467 1.105 . . . . 0.0 109.313 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.94 145.74 32.05 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.464 1.771 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.741 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.6 t -79.45 -37.74 1.21 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.498 1.124 . . . . 0.0 109.308 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.741 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.0 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.454 1.765 . . . . 0.0 110.999 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.637 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.9 OUTLIER -32.3 -35.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.529 1.143 . . . . 0.0 110.971 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 185' ' ' PRO . 0.9 OUTLIER -112.09 169.18 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 0.0 109.316 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 1.043 ' CG ' HD11 ' A' ' 140' ' ' LEU . 1.5 mt-10 -126.61 -157.78 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.528 1.143 . . . . 0.0 110.307 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.33 130.96 54.67 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.582 1.176 . . . . 0.0 109.327 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.53 ' CG ' ' N ' ' A' ' 191' ' ' GLY . 17.8 t80 -107.89 -99.39 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.478 1.111 . . . . 0.0 110.977 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.609 ' C ' ' CD2' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.993 0 O-C-N 124.489 1.118 . . . . 0.0 110.986 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.519 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -178.8 -137.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.12 . . . . 0.0 110.264 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 18.2 m-85 -145.64 164.74 30.8 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.484 1.115 . . . . 0.0 111.012 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 13.4 m -146.92 147.97 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 109.366 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 3.6 ptp180 -117.56 119.57 35.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.537 1.148 . . . . 0.0 110.308 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.043 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.24 100.04 12.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 0.0 109.251 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.904 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -98.38 36.27 1.64 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.414 1.071 . . . . 0.0 109.318 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.645 ' HB3' ' CD2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -140.2 -11.61 1.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.597 1.186 . . . . 0.0 111.036 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.588 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER 52.38 158.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.188 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.599 ' O ' ' C ' ' A' ' 144' ' ' ASN . 2.0 t80 -157.88 -49.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 0.0 110.975 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 143' ' ' PHE . 37.7 m-80 23.83 90.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.438 1.086 . . . . 0.0 109.366 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -103.48 -46.0 1.48 Allowed Glycine 0 CA--C 1.529 0.94 0 O-C-N 124.483 1.114 . . . . 0.0 111.05 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.548 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 0.9 OUTLIER 160.2 -24.11 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.446 0.733 . . . . 0.0 109.277 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.717 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 79.7 34.28 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.538 1.149 . . . . 0.0 109.283 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 0.6 OUTLIER -80.82 14.09 2.33 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.504 1.128 . . . . 0.0 110.314 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 8.8 tt0 168.05 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.466 1.104 . . . . 0.0 110.273 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 0.5 OUTLIER -114.77 -176.99 3.02 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.519 1.137 . . . . 0.0 109.351 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 152' ' ' PRO . 0.9 OUTLIER -108.22 118.29 52.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.664 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.06 123.29 7.74 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.503 1.791 . . . . 0.0 110.984 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.688 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 21.8 p90 -125.02 -179.26 4.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.13 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -114.46 -176.53 2.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.498 ' N ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -81.44 66.07 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.336 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 1.043 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 125.04 35.56 0.62 Allowed Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.498 1.124 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.628 ' OD2' HD21 ' A' ' 159' ' ' LEU . 4.3 t70 -85.2 139.85 31.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 0.764 . . . . 0.0 109.274 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.903 HG23 ' C ' ' A' ' 191' ' ' GLY . 8.9 mm -93.92 134.58 31.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.485 1.116 . . . . 0.0 109.315 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.628 HD21 ' OD2' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -143.77 172.37 12.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 0.0 109.312 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 9.6 ttt180 -113.34 139.65 48.69 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 0.0 110.334 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.935 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -90.55 111.36 23.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.525 1.14 . . . . 0.0 109.23 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -53.66 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.337 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -150.31 -179.84 7.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.563 1.164 . . . . 0.0 109.303 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.597 ' CB ' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -162.62 111.97 1.09 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 0.0 109.252 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -57.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.484 1.781 . . . . 0.0 110.996 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.0 -121.85 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 0.0 110.342 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 -46.46 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.549 1.155 . . . . 0.0 110.3 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -66.19 -17.18 64.57 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.537 1.148 . . . . 0.0 110.284 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.507 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 79.1 m95 -133.17 132.77 41.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.494 1.122 . . . . 0.0 108.028 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 184' ' ' VAL . 20.8 m0 -124.75 139.72 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.49 ' CB ' ' HE3' ' A' ' 181' ' ' MET . 36.9 t-20 -87.24 100.46 12.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.57 1.169 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.935 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.41 167.46 10.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.479 1.112 . . . . 0.0 109.359 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.7 mt-10 -112.46 124.82 53.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.438 1.086 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 159' ' ' LEU . 2.3 t70 -66.64 161.53 23.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 0.0 109.326 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.0 p -52.48 -20.57 2.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.118 . . . . 0.0 109.962 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -78.5 -25.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.125 . . . . 0.0 110.291 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.28 31.25 5.95 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.535 1.147 . . . . 0.0 110.991 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.647 ' HE2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -104.2 124.74 49.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 0.773 . . . . 0.0 109.274 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.44 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 2.5 mtm180 -85.4 113.46 21.71 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.482 1.114 . . . . 0.0 110.319 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -145.22 176.7 24.1 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.544 1.153 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.494 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -88.39 144.61 26.28 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 0.746 . . . . 0.0 111.05 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.489 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 12.8 tt -144.53 140.74 16.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.265 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.595 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.89 139.3 24.43 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.421 1.748 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.809 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 3.0 t -81.9 -31.82 0.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.496 1.123 . . . . 0.0 109.305 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.809 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -74.96 -26.76 10.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.415 1.745 . . . . 0.0 111.02 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CD2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.95 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.691 HG12 ' CB ' ' A' ' 139' ' ' ALA . 1.5 m -146.86 -174.53 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 109.35 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.904 ' CD ' HD21 ' A' ' 140' ' ' LEU . 3.2 mt-10 -134.13 -171.05 2.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 110.366 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.9 OUTLIER -101.08 168.05 9.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.422 1.076 . . . . 0.0 109.317 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.618 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 1.6 t80 81.43 -37.77 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 0.0 111.009 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.903 ' C ' HG23 ' A' ' 158' ' ' ILE . . . . . . . . 0 CA--C 1.531 1.064 0 O-C-N 124.492 1.12 . . . . 0.0 111.001 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.636 ' OE2' ' CE1' ' A' ' 136' ' ' TYR . 4.7 mm-40 -115.7 -163.23 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 1.116 . . . . 0.0 110.242 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.636 ' CE1' ' OE2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -137.9 144.72 41.45 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.443 1.09 . . . . 0.0 111.005 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 158' ' ' ILE . 6.1 m -148.13 142.9 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.386 1.054 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.73 HH21 HD13 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -106.49 146.33 30.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.46 1.1 . . . . 0.0 110.362 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.958 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -115.41 97.94 6.45 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.573 1.171 . . . . 0.0 109.269 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.864 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -108.89 30.62 6.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 0.0 109.348 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.753 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -133.77 -17.71 2.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 0.0 110.981 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER 54.31 159.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.457 1.098 . . . . 0.0 109.269 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' A' ' 145' ' ' GLY . 2.4 t80 -164.82 -38.46 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 0.0 110.969 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.534 ' C ' ' O ' ' A' ' 143' ' ' PHE . 15.8 t30 -29.9 89.15 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.529 1.143 . . . . 0.0 109.256 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 143' ' ' PHE . . . -126.14 -30.34 0.87 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.477 1.111 . . . . 0.0 111.044 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 5.6 m-20 -153.73 -35.67 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.48 0.753 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 4.4 p-10 47.92 47.85 18.29 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.547 1.154 . . . . 0.0 109.329 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.11 -8.08 54.89 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.12 . . . . 0.0 110.304 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -178.96 34.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.47 1.106 . . . . 0.0 110.28 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.586 ' OD1' ' CE1' ' A' ' 143' ' ' PHE . 2.8 p30 -158.43 154.69 27.3 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.45 1.094 . . . . 0.0 109.29 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.9 HD12 ' HD2' ' A' ' 152' ' ' PRO . 14.2 tp -74.01 117.28 60.06 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.9 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.03 117.5 4.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.541 1.811 . . . . 0.0 110.959 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.67 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 49.6 p90 -125.72 178.51 5.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 0.0 111.034 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 139' ' ' ALA . 12.5 mttm -125.77 179.69 5.06 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.53 1.144 . . . . 0.0 109.287 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.708 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -83.73 79.83 9.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 0.0 109.283 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.958 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 134.11 21.33 0.78 Allowed Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.509 1.131 . . . . 0.0 111.027 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 17.6 t70 -90.67 147.04 23.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.42 0.717 . . . . 0.0 109.313 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.73 HD13 HH21 ' A' ' 138' ' ' ARG . 7.6 tp -111.19 136.71 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.531 1.145 . . . . 0.0 109.294 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.623 HD22 HD13 ' A' ' 182' ' ' ILE . 0.4 OUTLIER -142.35 166.8 23.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.114 . . . . 0.0 109.299 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.653 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -115.61 146.82 41.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.483 1.114 . . . . 0.0 110.308 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.851 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -88.04 121.74 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.472 1.108 . . . . 0.0 109.304 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.439 ' CD ' ' HD3' ' A' ' 179' ' ' ARG . 11.6 ttm-85 -106.15 -45.76 4.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.45 1.094 . . . . 0.0 110.296 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -148.96 152.2 35.92 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.461 1.1 . . . . 0.0 109.334 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -141.1 90.09 9.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 0.0 109.341 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 -55.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.486 1.782 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.02 -177.08 5.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 110.353 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.84 5.91 20.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 0.0 110.331 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.36 -48.13 2.81 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.457 1.098 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.593 ' CE3' ' HB3' ' A' ' 181' ' ' MET . 48.2 m95 -105.07 143.11 33.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.544 1.153 . . . . 0.0 108.038 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.565 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 15.5 m0 -127.11 136.15 51.72 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.5 1.125 . . . . 0.0 108.027 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.3 m-80 -88.5 96.33 10.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.547 1.154 . . . . 0.0 109.29 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.851 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -109.99 160.79 16.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 0.0 109.255 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -103.03 129.36 49.78 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.47 1.106 . . . . 0.0 110.282 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.95 162.03 30.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 109.249 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.5 t -52.18 -20.3 2.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 0.0 109.951 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.97 -24.09 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.524 1.14 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.94 30.18 6.87 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.509 1.131 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.5 pttt -105.17 124.8 50.16 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.537 0.786 . . . . 0.0 109.256 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HD3' ' CD ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -85.38 114.07 22.15 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.56 1.163 . . . . 0.0 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -146.22 176.9 24.91 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.39 1.056 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.593 ' HB3' ' CE3' ' A' ' 169' ' ' TRP . 0.7 OUTLIER -86.29 143.58 27.83 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.466 0.745 . . . . 0.0 111.031 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.623 HD13 HD22 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -142.81 144.83 31.21 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 0.0 109.279 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.785 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.05 139.31 24.0 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.459 1.768 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 78.3 t -80.91 -32.3 0.65 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.343 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -35.65 3.02 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.52 1.8 . . . . 0.0 111.04 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.753 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 1.6 m-85 -88.13 15.05 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 183' ' ' PRO . 2.4 m -152.86 164.06 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.122 . . . . 0.0 109.302 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.864 ' CG ' HD11 ' A' ' 140' ' ' LEU . 0.5 OUTLIER -119.56 -162.83 0.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.239 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.6 OUTLIER -116.85 150.41 38.45 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.507 1.129 . . . . 0.0 109.346 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.55 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 1.9 t80 77.67 -67.61 0.19 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.49 1.119 . . . . 0.0 111.023 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.65 ' HA3' HD13 ' A' ' 158' ' ' ILE . . . . . . . . 0 CA--C 1.53 1.025 0 O-C-N 124.536 1.147 . . . . 0.0 111.015 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.562 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -136.69 -156.1 0.67 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.536 1.147 . . . . 0.0 110.408 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 159' ' ' LEU . 63.3 m-85 -145.54 142.98 29.66 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.47 1.106 . . . . 0.0 110.994 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.552 HG13 HD13 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -135.53 164.22 33.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.555 1.159 . . . . 0.0 109.33 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 18.2 tpp85 -119.94 156.18 31.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.432 1.082 . . . . 0.0 110.314 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -130.02 83.26 2.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.278 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.916 HD21 ' OE1' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -101.13 22.75 11.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 0.0 109.351 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.783 ' CE1' ' CZ ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -123.56 -18.93 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 0.0 111.016 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 57.88 152.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.52 1.138 . . . . 0.0 109.249 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.599 ' O ' ' C ' ' A' ' 144' ' ' ASN . 2.6 t80 -153.0 -53.05 0.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.534 1.146 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 143' ' ' PHE . 6.3 t30 22.05 90.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 0.0 109.279 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -107.43 -45.6 1.13 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.477 1.11 . . . . 0.0 110.962 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.623 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 0.6 OUTLIER 169.25 -31.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.571 0.806 . . . . 0.0 109.282 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.679 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 87.48 38.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 0.0 109.335 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 6.3 tp10 -78.77 11.71 2.47 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.572 1.17 . . . . 0.0 110.302 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 7.3 tt0 166.3 -26.47 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.462 1.101 . . . . 0.0 110.286 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 0.2 OUTLIER -109.68 172.51 6.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.548 1.155 . . . . 0.0 109.255 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.895 HD21 HD22 ' A' ' 159' ' ' LEU . 3.0 tp -99.9 120.73 56.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.696 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.06 138.88 23.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.501 1.79 . . . . 0.0 111.04 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.867 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 8.3 p90 -160.78 -178.26 6.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER 170.73 146.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.305 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.23 68.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 37.97 50.15 2.07 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.485 1.115 . . . . 0.0 110.941 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.875 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -58.54 135.63 57.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 0.0 109.366 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.447 HD11 ' NH2' ' A' ' 138' ' ' ARG . 2.1 mm -99.35 122.65 51.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.503 1.127 . . . . 0.0 109.312 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.895 HD22 HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -128.46 -177.61 4.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 0.0 109.328 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.611 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -128.31 144.86 51.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 110.256 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.552 HD13 HG13 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -86.45 116.03 28.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 0.0 109.299 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -105.56 -52.0 2.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.55 1.156 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.35 168.13 25.02 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.502 1.126 . . . . 0.0 109.199 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -140.48 114.39 7.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.443 1.089 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -73.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.52 1.8 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -98.76 -99.74 0.22 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.13 -50.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 0.0 110.339 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -52.81 -43.61 66.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.522 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 69.7 m95 -115.21 142.42 46.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 108.015 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.486 ' CD2' HG22 ' A' ' 184' ' ' VAL . 33.8 m0 -121.16 145.43 47.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.04 94.46 9.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 109.354 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -110.08 164.37 12.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.139 . . . . 0.0 109.273 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.6 mt-10 -110.37 134.19 52.54 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.33 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.451 ' CB ' ' HG3' ' A' ' 178' ' ' LYS . 6.2 t70 -74.56 165.4 25.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.3 t -56.04 -17.49 7.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.138 . . . . 0.0 109.953 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.53 -22.52 32.39 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.461 1.1 . . . . 0.0 110.246 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.72 32.11 6.08 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.546 1.154 . . . . 0.0 110.991 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.637 ' HD2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -102.79 123.06 45.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 0.771 . . . . 0.0 109.356 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.449 ' NE ' ' OE2' ' A' ' 173' ' ' GLU . 5.3 mtt85 -86.28 115.22 23.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -148.11 167.37 28.94 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.541 1.151 . . . . 0.0 111.015 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 41.2 mmm -88.93 138.82 31.06 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.548 0.793 . . . . 0.0 111.005 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.705 HD12 ' O ' ' A' ' 182' ' ' ILE . 2.3 pp -135.24 155.75 78.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.556 1.16 . . . . 0.0 109.294 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.711 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.3 Cg_endo -74.95 138.52 23.27 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.462 1.769 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 51.3 t -78.67 -32.76 0.84 Allowed Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 109.305 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.01 2.81 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.405 1.739 . . . . 0.0 110.986 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.783 ' CZ ' ' CE1' ' A' ' 141' ' ' PHE . 2.4 m-85 -90.01 23.43 2.8 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.775 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 4.3 m -152.55 157.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.456 1.098 . . . . 0.0 109.317 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.916 ' OE1' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -113.77 -164.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 110.334 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 141.24 49.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 0.0 109.245 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -119.52 123.37 43.83 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.411 1.069 . . . . 0.0 111.013 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 O-C-N 124.495 1.122 . . . . 0.0 110.983 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 161' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 6.6 pt-20 169.62 -45.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.451 1.095 . . . . 0.0 110.305 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 32.3 m-85 -136.26 140.47 43.48 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 0.0 111.0 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -131.02 162.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.512 1.133 . . . . 0.0 109.232 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 10.4 tpp85 -129.98 112.64 13.7 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.48 1.112 . . . . 0.0 110.348 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.083 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -84.13 117.1 23.25 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.967 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -127.32 25.44 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 0.0 109.263 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.23 -15.77 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 0.0 110.983 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.556 ' O ' ' CE2' ' A' ' 186' ' ' TYR . 0.8 OUTLIER 53.91 161.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 0.0 109.324 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.627 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 9.7 t80 -136.12 -79.84 0.41 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.5 1.125 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.627 ' CB ' ' O ' ' A' ' 143' ' ' PHE . 9.4 m-20 145.87 138.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 0.0 109.26 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 152' ' ' PRO . . . -58.02 128.85 48.55 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.449 1.093 . . . . 0.0 110.978 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 147' ' ' ASP . 7.8 p-10 -161.57 -44.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 0.765 . . . . 0.0 109.275 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 146' ' ' ASN . 3.5 p30 44.46 -173.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 0.0 109.293 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 72.33 3.19 4.6 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.479 1.112 . . . . 0.0 110.266 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -160.99 -46.96 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.591 ' CG ' ' CH2' ' A' ' 169' ' ' TRP . 7.5 m-20 -144.06 153.66 42.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 109.252 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.985 HD23 HD11 ' A' ' 182' ' ' ILE . 5.4 tp -83.28 123.42 77.11 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 0.0 109.287 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.894 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.98 164.68 32.9 Favored 'Trans proline' 0 C--N 1.362 1.24 0 O-C-N 124.519 1.8 . . . . 0.0 111.043 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.522 ' CE2' HG23 ' A' ' 182' ' ' ILE . 28.5 p90 179.11 179.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 1.146 . . . . 0.0 110.943 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 9.7 mttt -113.16 -177.51 3.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.257 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -94.07 77.91 4.07 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.531 1.145 . . . . 0.0 109.256 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 1.083 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 146.07 19.72 0.13 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.482 1.114 . . . . 0.0 110.994 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.82 163.77 13.93 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 0.0 109.344 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.506 HG23 HH21 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -118.42 128.22 75.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.244 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.603 HD13 HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -132.89 -174.17 3.4 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.502 1.127 . . . . 0.0 109.281 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.663 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.3 ptp180 -133.34 150.1 51.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 110.265 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -94.09 115.9 34.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.529 1.143 . . . . 0.0 109.29 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HD2' ' NH1' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -96.29 -54.64 3.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 0.0 110.318 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.448 ' C ' ' HG2' ' A' ' 164' ' ' LYS . 0.4 OUTLIER -151.31 174.21 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.522 1.139 . . . . 0.0 109.322 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HZ1' HG13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -127.86 100.46 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 109.337 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 170' ' ' TRP . 18.2 Cg_endo -74.98 -38.21 1.7 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.499 1.789 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -134.55 -165.77 1.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.522 1.139 . . . . 0.0 110.328 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -93.07 -71.48 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.511 1.132 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 169' ' ' TRP . 1.6 pt20 -61.74 -27.67 68.89 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.484 1.115 . . . . 0.0 110.265 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.591 ' CH2' ' CG ' ' A' ' 150' ' ' ASP . 37.3 m95 -108.55 137.82 45.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.491 1.119 . . . . 0.0 108.043 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.658 ' O ' ' HA ' ' A' ' 181' ' ' MET . 9.1 m0 -123.72 175.06 7.08 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.458 1.099 . . . . 0.0 108.059 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -124.91 96.07 4.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 0.0 109.248 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.918 ' HB3' HD12 ' A' ' 182' ' ' ILE . . . -109.74 168.21 9.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 0.0 109.326 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.494 ' CD ' ' NH1' ' A' ' 179' ' ' ARG . 2.0 mt-10 -113.38 139.44 48.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 151' ' ' LEU . 4.9 t70 -78.0 161.73 27.28 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.529 1.143 . . . . 0.0 109.267 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.57 -20.26 1.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.141 . . . . 0.0 110.027 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -79.46 -26.51 41.71 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 0.0 110.274 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 102.4 26.04 7.49 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.523 1.14 . . . . 0.0 110.991 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.783 ' HD3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.36 128.57 40.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 0.754 . . . . 0.0 109.318 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.494 ' NH1' ' CD ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -86.03 116.71 24.42 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 0.0 110.336 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.5 170.89 30.39 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.456 1.097 . . . . 0.0 111.005 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.658 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.7 mtt -86.35 144.65 27.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 0.0 110.951 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.985 HD11 HD23 ' A' ' 151' ' ' LEU . 97.1 mt -143.29 140.54 17.82 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.325 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.666 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.33 15.35 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.506 1.793 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.822 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.4 t -72.25 -31.2 1.6 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 0.0 109.269 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.822 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.04 -7.67 19.34 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.478 1.778 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.666 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.6 m-85 -100.82 -30.25 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 0.0 111.029 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -123.13 172.36 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 0.0 109.298 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.967 ' CG ' HD11 ' A' ' 140' ' ' LEU . 2.1 mt-10 -124.27 -158.6 0.82 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.425 ' HE3' ' N ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -118.36 129.55 55.49 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.487 1.117 . . . . 0.0 109.283 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -113.47 118.84 35.61 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.452 1.095 . . . . 0.0 110.972 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 O-C-N 124.457 1.098 . . . . 0.0 111.075 179.933 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.9 OUTLIER 171.86 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.457 1.098 . . . . 0.0 110.295 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CD1' ' HA3' ' A' ' 191' ' ' GLY . 14.8 m-85 -141.25 119.95 12.54 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 0.0 111.038 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 188' ' ' GLU . 3.3 m -136.4 151.27 28.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.309 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -116.76 165.05 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 0.0 110.372 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.95 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -118.15 115.51 24.94 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.489 1.118 . . . . 0.0 109.299 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.95 HD11 ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -112.6 28.73 8.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.422 1.076 . . . . 0.0 109.371 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -133.48 -13.18 2.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.963 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER 53.83 155.98 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 0.0 109.33 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.64 ' O ' ' C ' ' A' ' 144' ' ' ASN . 1.7 t80 -162.92 -47.57 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 0.0 111.093 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.64 ' C ' ' O ' ' A' ' 143' ' ' PHE . 12.7 t-20 19.08 90.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -107.36 -38.35 2.12 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 124.472 1.107 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' GLY . 1.8 m-20 153.03 -18.32 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 0.752 . . . . 0.0 109.237 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.772 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 76.59 38.49 0.28 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.082 . . . . 0.0 109.292 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 39.7 tt0 -74.2 -0.71 17.66 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.56 1.162 . . . . 0.0 110.338 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 2.8 pt-20 174.92 -23.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.464 1.103 . . . . 0.0 110.41 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 4.4 m-20 -111.73 171.21 7.63 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.528 1.143 . . . . 0.0 109.329 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.716 ' C ' HD12 ' A' ' 151' ' ' LEU . 0.4 OUTLIER -94.57 112.67 58.7 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.698 ' N ' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -74.96 124.79 8.91 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.534 1.807 . . . . 0.0 110.997 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.685 ' HE2' HG21 ' A' ' 182' ' ' ILE . 1.2 p90 -141.83 176.26 9.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.469 1.106 . . . . 0.0 110.978 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.429 ' C ' ' HA ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -100.49 -172.12 2.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.533 1.146 . . . . 0.0 109.285 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.558 ' CE ' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -85.12 34.39 0.56 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 0.0 109.235 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.95 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 168.01 39.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.498 1.123 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.689 ' O ' HD12 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -87.26 171.54 10.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.505 0.767 . . . . 0.0 109.317 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 157' ' ' ASP . 1.3 mp -125.86 136.77 59.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 0.0 109.285 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.627 HD22 HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -147.66 -172.05 3.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.516 1.135 . . . . 0.0 109.259 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.65 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 13.8 mtm180 -136.42 152.51 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.092 . . . . 0.0 110.251 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -89.61 119.69 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.246 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HD2' ' NE ' ' A' ' 179' ' ' ARG . 0.0 OUTLIER -107.82 -48.72 3.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.548 1.155 . . . . 0.0 110.284 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.42 ' OD1' ' NE ' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -138.13 162.62 33.74 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.499 1.124 . . . . 0.0 109.328 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 98.84 3.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.536 1.148 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -44.15 0.36 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.517 1.798 . . . . 0.0 110.979 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -174.96 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.08 -16.97 18.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.424 1.077 . . . . 0.0 110.318 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -89.79 -32.91 16.73 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.072 . . . . 0.0 110.3 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.581 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 44.3 m95 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.674 ' CE3' HG22 ' A' ' 184' ' ' VAL . 28.1 m0 -125.55 144.54 50.52 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 0.0 108.03 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -101.98 99.83 10.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 0.0 109.301 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.786 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -111.28 163.16 14.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.124 . . . . 0.0 109.309 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 2.6 mt-10 -106.28 134.56 49.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.325 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 177' ' ' GLY . 8.4 t0 -79.3 164.02 24.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.316 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.4 t -51.85 -20.0 2.02 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 110.002 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.91 -23.97 48.51 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.538 1.149 . . . . 0.0 110.263 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 174' ' ' ASP . . . 95.93 30.42 7.95 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.403 1.065 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -107.3 132.55 52.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.477 0.751 . . . . 0.0 109.311 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.425 ' NE ' ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -87.01 122.39 30.8 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.24 150.98 22.86 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.486 1.116 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 150' ' ' ASP . 2.3 ptm -103.66 138.19 40.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.57 0.806 . . . . 0.0 111.014 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.685 HG21 ' HE2' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -149.55 172.2 5.49 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 0.0 109.323 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.821 ' HB2' ' HD2' ' A' ' 185' ' ' PRO . 18.3 Cg_endo -74.96 145.7 31.94 Favored 'Trans proline' 0 C--N 1.359 1.083 0 O-C-N 124.501 1.79 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 13.5 t -71.85 -30.28 1.48 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.448 1.093 . . . . 0.0 109.237 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -3.73 14.35 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.456 1.766 . . . . 0.0 111.0 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.679 ' CG ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -102.56 -14.42 16.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.508 1.13 . . . . 0.0 111.011 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 32.4 m -132.19 169.34 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 0.0 109.349 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.95 ' CG ' HD11 ' A' ' 140' ' ' LEU . 4.1 mm-40 -130.11 -168.75 2.01 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.486 1.117 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.631 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.3 OUTLIER -95.36 172.45 8.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.631 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 1.6 t80 82.08 155.96 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.507 1.13 . . . . 0.0 110.986 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.5 ' HA3' ' CD1' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.936 0 O-C-N 124.551 1.157 . . . . 0.0 111.054 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.511 ' CB ' ' HD3' ' A' ' 160' ' ' ARG . . . . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -128.49 -164.38 1.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.454 1.096 . . . . 0.0 110.234 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.509 ' CG ' ' C ' ' A' ' 191' ' ' GLY . 57.6 m-85 -140.17 120.16 13.63 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.464 1.103 . . . . 0.0 111.026 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 182' ' ' ILE . 27.3 m -133.78 145.84 32.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 109.287 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.845 ' HA ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -123.44 152.72 41.35 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.453 1.096 . . . . 0.0 110.239 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.774 ' HB1' ' CD1' ' A' ' 153' ' ' PHE . . . -110.62 107.9 17.64 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.269 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.993 HD21 ' CD ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -105.06 22.72 14.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 0.0 109.325 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.809 ' CD1' ' CE2' ' A' ' 186' ' ' TYR . 1.3 t80 -122.44 -14.37 7.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.604 1.19 . . . . 0.0 111.047 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 3.2 m-20 57.97 145.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.553 1.158 . . . . 0.0 109.294 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.617 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -156.87 -61.44 0.09 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 0.0 110.93 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 146' ' ' ASN . 45.5 m-20 69.04 -68.14 0.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.556 ' HA3' ' CE1' ' A' ' 143' ' ' PHE . . . 65.03 -64.17 0.08 OUTLIER Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.497 1.123 . . . . 0.0 110.961 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.616 ' O ' ' OD1' ' A' ' 147' ' ' ASP . 5.1 p30 152.67 -6.32 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.474 0.75 . . . . 0.0 109.284 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.641 ' CG ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 64.18 32.4 12.56 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 0.0 109.323 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 1.2 tt0 -75.87 3.45 10.03 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.472 1.108 . . . . 0.0 110.355 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 3.3 pt-20 177.69 -28.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.531 1.144 . . . . 0.0 110.284 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 147' ' ' ASP . 16.6 m-20 -109.05 179.86 4.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.304 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.02 HD21 HD22 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -102.02 126.57 33.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -74.99 140.49 25.53 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.56 1.821 . . . . 0.0 111.034 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.774 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 2.5 p90 -158.92 165.58 33.8 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.442 1.089 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 174.31 158.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 109.332 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.43 40.28 14.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 109.328 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 59.42 40.51 96.2 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.47 1.106 . . . . 0.0 111.049 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.845 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 5.5 t0 -46.87 141.23 4.13 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.774 . . . . 0.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.809 HD11 ' HA3' ' A' ' 191' ' ' GLY . 0.4 OUTLIER -95.19 125.64 47.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.448 1.092 . . . . 0.0 109.362 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 1.02 HD22 HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -139.27 -178.57 5.42 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.502 1.126 . . . . 0.0 109.315 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.713 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -133.0 146.82 52.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.468 1.105 . . . . 0.0 110.261 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.989 HD12 ' HB2' ' A' ' 172' ' ' ALA . 0.9 OUTLIER -87.52 120.35 36.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.482 1.114 . . . . 0.0 109.249 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 0.6 OUTLIER -103.12 -48.02 4.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.561 1.163 . . . . 0.0 110.251 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -148.78 166.87 27.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.477 1.11 . . . . 0.0 109.284 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.92 100.6 5.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.566 1.166 . . . . 0.0 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -52.03 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.469 1.773 . . . . 0.0 111.028 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -104.15 -173.1 2.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.459 1.099 . . . . 0.0 110.287 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -109.7 13.5 23.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.561 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 10.4 tt0 -123.43 -42.13 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.561 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 58.0 m95 -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.565 1.166 . . . . 0.0 108.018 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -114.46 142.57 46.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 14.1 t30 -91.49 94.24 9.36 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.343 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.989 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -111.46 162.22 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.568 1.167 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.482 ' HB2' ' NE ' ' A' ' 160' ' ' ARG . 2.3 mt-10 -104.05 134.09 47.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 0.0 110.363 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.736 ' HA ' HD23 ' A' ' 159' ' ' LEU . 7.4 t0 -75.98 166.77 23.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 0.0 109.359 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.441 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 33.2 m -55.31 -18.51 6.56 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.482 1.114 . . . . 0.0 110.003 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.28 -20.2 34.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 0.0 110.276 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.81 26.18 10.82 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.538 1.149 . . . . 0.0 111.02 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.458 ' HG3' ' CB ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.3 119.95 35.7 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 0.774 . . . . 0.0 109.289 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -86.15 113.4 22.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 0.0 110.341 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -148.8 173.53 28.7 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.462 1.101 . . . . 0.0 110.966 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.413 ' O ' ' HB3' ' A' ' 150' ' ' ASP . 37.6 mmm -87.47 144.76 26.57 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.458 0.74 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 137' ' ' VAL . 7.9 pt -140.76 155.25 69.35 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.439 1.087 . . . . 0.0 109.367 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.903 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.08 143.98 29.44 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.547 1.814 . . . . 0.0 110.974 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.714 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 48.8 t -73.89 -39.45 4.4 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 0.0 109.331 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.0 Cg_endo -75.04 -75.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.415 1.745 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.809 ' CE2' ' CD1' ' A' ' 141' ' ' PHE . 1.5 m-85 -32.57 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.525 1.141 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 183' ' ' PRO . 1.0 OUTLIER -112.68 171.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.137 . . . . 0.0 109.247 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.993 ' CD ' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -137.4 -167.44 2.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 0.0 110.304 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.635 ' O ' ' CB ' ' A' ' 190' ' ' TYR . 0.3 OUTLIER -102.0 -174.46 2.59 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 0.0 109.282 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.635 ' CB ' ' O ' ' A' ' 189' ' ' LYS . 1.9 t80 82.6 136.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.508 1.13 . . . . 0.0 111.013 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.809 ' HA3' HD11 ' A' ' 158' ' ' ILE . . . . . . . . 0 CA--C 1.53 0.988 0 O-C-N 124.464 1.102 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 stop_ save_